{
  "AAC": {
    "p_e_ratio": 36.93,
    "peg_ratio": 1.39,
    "earnings_per_share": 0.65,
    "ebitda": 30850000.0,
    "eps_estimate_current_year": 0.83,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 22.32,
    "fifty_two_week_high": 46.6,
    "fifty_two_week_low": 15.09,
    "percent_change_from_200_day_moving_average": -0.2615,
    "percent_change_from_50_day_moving_average": 0.08380000000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.46,
    "two_hundred_day_moving_average": 32.76,
    "volume": 401503.0,
    "market_cap": 542080000.0,
    "price_to_sales_ttm": 3.29,
    "price_to_book_mrq": 4.6,
    "roa_ttm": 0.10439999999999999,
    "roe_ttm": 0.17809999999999998,
    "shares_outstanding": 22410000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.636,
    "operating_cash_flow_ttm": 14660000.0,
    "levered_cash_flow_ttm": -26750000.0,
    "book_value_per_share_mrq": 5.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AAC Holdings, Inc."
  },
  "AAVL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.69,
    "ebitda": -37390000.0,
    "eps_estimate_current_year": -1.68,
    "eps_estimate_next_quarter": -0.47,
    "fifty_day_moving_average": 11.47,
    "fifty_two_week_high": 62.48,
    "fifty_two_week_low": 9.36,
    "percent_change_from_200_day_moving_average": -0.6217,
    "percent_change_from_50_day_moving_average": -0.1426,
    "shares_owned": "N/A",
    "short_ratio": 2.46,
    "two_hundred_day_moving_average": 25.98,
    "volume": 580182.0,
    "market_cap": 252390000.0,
    "price_to_sales_ttm": 267.2,
    "price_to_book_mrq": 0.96,
    "roa_ttm": -0.13949999999999999,
    "roe_ttm": -0.2414,
    "shares_outstanding": 25680000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1038,
    "operating_cash_flow_ttm": -27020000.0,
    "levered_cash_flow_ttm": -13310000.0,
    "book_value_per_share_mrq": 10.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Avalanche Biotechnologies, Inc."
  },
  "ABAX": {
    "p_e_ratio": 36.54,
    "peg_ratio": 1.95,
    "earnings_per_share": 1.29,
    "ebitda": 43830000.0,
    "eps_estimate_current_year": 1.25,
    "eps_estimate_next_quarter": 0.33,
    "fifty_day_moving_average": 47.95,
    "fifty_two_week_high": 66.89,
    "fifty_two_week_low": 44.07,
    "percent_change_from_200_day_moving_average": -0.1318,
    "percent_change_from_50_day_moving_average": -0.0154,
    "shares_owned": "N/A",
    "short_ratio": 19.12,
    "two_hundred_day_moving_average": 54.38,
    "volume": 178795.0,
    "market_cap": 1070000000.0000001,
    "price_to_sales_ttm": 5.04,
    "price_to_book_mrq": 4.74,
    "roa_ttm": 0.0947,
    "roe_ttm": 0.10769999999999999,
    "shares_outstanding": 22720000.0,
    "pcnt_held_by_insiders": 0.0582,
    "pcnt_held_by_institutions": 1.04,
    "pcnt_short_of_float": 0.2141,
    "operating_cash_flow_ttm": 27810000.0,
    "levered_cash_flow_ttm": 35690000.0,
    "book_value_per_share_mrq": 9.91,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Abaxis, Inc."
  },
  "ABEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.6,
    "ebitda": -6970000.0,
    "eps_estimate_current_year": -0.39,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.19,
    "fifty_two_week_high": 16.5,
    "fifty_two_week_low": 2.75,
    "percent_change_from_200_day_moving_average": -0.0983,
    "percent_change_from_50_day_moving_average": -0.059699999999999996,
    "shares_owned": "N/A",
    "short_ratio": 7.14,
    "two_hundred_day_moving_average": 5.41,
    "volume": 128494.0,
    "market_cap": 159530000.0,
    "price_to_sales_ttm": 156.65,
    "price_to_book_mrq": 2.41,
    "roa_ttm": -0.11710000000000001,
    "roe_ttm": -0.8906000000000001,
    "shares_outstanding": 32689999.999999996,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.4072,
    "operating_cash_flow_ttm": -6280000.0,
    "levered_cash_flow_ttm": -11320000.0,
    "book_value_per_share_mrq": 2.01,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Abeona Therapeutics Inc."
  },
  "ABIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.18,
    "ebitda": -10340000.0,
    "eps_estimate_current_year": -1.75,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.5,
    "fifty_two_week_high": 10.85,
    "fifty_two_week_low": 4.55,
    "percent_change_from_200_day_moving_average": -0.0593,
    "percent_change_from_50_day_moving_average": -0.0574,
    "shares_owned": "N/A",
    "short_ratio": 4.68,
    "two_hundred_day_moving_average": 6.52,
    "volume": 52533.0,
    "market_cap": 55360000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.31,
    "roa_ttm": -0.1972,
    "roe_ttm": -0.3284,
    "shares_outstanding": 9030000.0,
    "pcnt_held_by_insiders": 0.2536,
    "pcnt_held_by_institutions": 0.04,
    "pcnt_short_of_float": 0.0447,
    "operating_cash_flow_ttm": -9470000.0,
    "levered_cash_flow_ttm": -5510000.0,
    "book_value_per_share_mrq": 4.85,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ARCA biopharma, Inc."
  },
  "ABMD": {
    "p_e_ratio": 36.27,
    "peg_ratio": 8.08,
    "earnings_per_share": 2.82,
    "ebitda": 49810000.0,
    "eps_estimate_current_year": 0.75,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 98.25,
    "fifty_two_week_high": 110.68,
    "fifty_two_week_low": 21.84,
    "percent_change_from_200_day_moving_average": 0.36579999999999996,
    "percent_change_from_50_day_moving_average": 0.042199999999999994,
    "shares_owned": "N/A",
    "short_ratio": 1.69,
    "two_hundred_day_moving_average": 74.97,
    "volume": 580811.0,
    "market_cap": 4310000000.0,
    "price_to_sales_ttm": 16.8,
    "price_to_book_mrq": 13.9,
    "roa_ttm": 0.1052,
    "roe_ttm": 0.5195000000000001,
    "shares_outstanding": 42050000.0,
    "pcnt_held_by_insiders": 0.096,
    "pcnt_held_by_institutions": 1.067,
    "pcnt_short_of_float": 0.056100000000000004,
    "operating_cash_flow_ttm": 51010000.0,
    "levered_cash_flow_ttm": 676500.0,
    "book_value_per_share_mrq": 7.39,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ABIOMED, Inc."
  },
  "ABUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.29,
    "ebitda": -34550000.0,
    "eps_estimate_current_year": -1.11,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 6.91,
    "fifty_two_week_low": 6.5,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 7.13,
    "two_hundred_day_moving_average": 0.0,
    "volume": 414219.0,
    "market_cap": 356940000.0,
    "price_to_sales_ttm": 21.98,
    "price_to_book_mrq": 0.63,
    "roa_ttm": -0.0484,
    "roe_ttm": -0.1201,
    "shares_outstanding": 54330000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1032,
    "operating_cash_flow_ttm": -49210000.0,
    "levered_cash_flow_ttm": -22000000.0,
    "book_value_per_share_mrq": 10.84,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arbutus Biopharma Corporation"
  },
  "ACAD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.38,
    "earnings_per_share": -1.34,
    "ebitda": -124070000.0,
    "eps_estimate_current_year": -1.56,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 39.58,
    "fifty_two_week_high": 51.99,
    "fifty_two_week_low": 22.04,
    "percent_change_from_200_day_moving_average": -0.0496,
    "percent_change_from_50_day_moving_average": -0.0438,
    "shares_owned": "N/A",
    "short_ratio": 10.61,
    "two_hundred_day_moving_average": 39.83,
    "volume": 1068674.0,
    "market_cap": 3810000000.0,
    "price_to_sales_ttm": 57301.75,
    "price_to_book_mrq": 14.98,
    "roa_ttm": -0.24530000000000002,
    "roe_ttm": -0.4387,
    "shares_outstanding": 100720000.0,
    "pcnt_held_by_insiders": 0.2584,
    "pcnt_held_by_institutions": 0.669,
    "pcnt_short_of_float": 0.2183,
    "operating_cash_flow_ttm": -90500000.0,
    "levered_cash_flow_ttm": -36790000.0,
    "book_value_per_share_mrq": 2.55,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ACADIA Pharmaceuticals Inc."
  },
  "ACHC": {
    "p_e_ratio": 49.04,
    "peg_ratio": 1.29,
    "earnings_per_share": 1.53,
    "ebitda": 300870000.0,
    "eps_estimate_current_year": 2.18,
    "eps_estimate_next_quarter": 0.59,
    "fifty_day_moving_average": 76.38,
    "fifty_two_week_high": 85.62,
    "fifty_two_week_low": 46.87,
    "percent_change_from_200_day_moving_average": 0.0139,
    "percent_change_from_50_day_moving_average": -0.0144,
    "shares_owned": "N/A",
    "short_ratio": 2.93,
    "two_hundred_day_moving_average": 74.25,
    "volume": 468596.0,
    "market_cap": 5390000000.0,
    "price_to_sales_ttm": 3.77,
    "price_to_book_mrq": 3.14,
    "roa_ttm": 0.057,
    "roe_ttm": 0.0751,
    "shares_outstanding": 71640000.0,
    "pcnt_held_by_insiders": 0.2447,
    "pcnt_held_by_institutions": 0.7090000000000001,
    "pcnt_short_of_float": 0.056100000000000004,
    "operating_cash_flow_ttm": 177190000.0,
    "levered_cash_flow_ttm": -20800000.0,
    "book_value_per_share_mrq": 23.6,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Acadia Healthcare Company, Inc."
  },
  "ACHN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.74,
    "earnings_per_share": -0.8,
    "ebitda": -85430000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": 0.02,
    "fifty_day_moving_average": 7.83,
    "fifty_two_week_high": 16.87,
    "fifty_two_week_low": 6.71,
    "percent_change_from_200_day_moving_average": -0.0601,
    "percent_change_from_50_day_moving_average": 0.09359999999999999,
    "shares_owned": "N/A",
    "short_ratio": 9.22,
    "two_hundred_day_moving_average": 9.11,
    "volume": 2774549.0,
    "market_cap": 1170000000.0,
    "price_to_sales_ttm": 1630.53,
    "price_to_book_mrq": 4.15,
    "roa_ttm": -0.26789999999999997,
    "roe_ttm": -0.4648,
    "shares_outstanding": 136390000.0,
    "pcnt_held_by_insiders": 0.4411,
    "pcnt_held_by_institutions": 0.586,
    "pcnt_short_of_float": 0.2147,
    "operating_cash_flow_ttm": -62590000.0,
    "levered_cash_flow_ttm": -31940000.0,
    "book_value_per_share_mrq": 2.05,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Achillion Pharmaceuticals, Inc."
  },
  "ACOR": {
    "p_e_ratio": 123.14,
    "peg_ratio": 1.58,
    "earnings_per_share": 0.24,
    "ebitda": 59660000.0,
    "eps_estimate_current_year": 0.71,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 31.94,
    "fifty_two_week_high": 45.45,
    "fifty_two_week_low": 27.92,
    "percent_change_from_200_day_moving_average": -0.0889,
    "percent_change_from_50_day_moving_average": -0.0669,
    "shares_owned": "N/A",
    "short_ratio": 9.07,
    "two_hundred_day_moving_average": 32.71,
    "volume": 408527.0,
    "market_cap": 1280000000.0,
    "price_to_sales_ttm": 2.94,
    "price_to_book_mrq": 2.29,
    "roa_ttm": 0.028900000000000002,
    "roe_ttm": 0.0192,
    "shares_outstanding": 42850000.0,
    "pcnt_held_by_insiders": 0.02,
    "pcnt_held_by_institutions": 1.026,
    "pcnt_short_of_float": 0.2305,
    "operating_cash_flow_ttm": 46010000.0,
    "levered_cash_flow_ttm": 40320000.0,
    "book_value_per_share_mrq": 13.09,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acorda Therapeutics, Inc."
  },
  "ACRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.9,
    "ebitda": -34070000.0,
    "eps_estimate_current_year": -0.54,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 4.2,
    "fifty_two_week_high": 9.32,
    "fifty_two_week_low": 2.96,
    "percent_change_from_200_day_moving_average": -0.0332,
    "percent_change_from_50_day_moving_average": -0.0665,
    "shares_owned": "N/A",
    "short_ratio": 13.26,
    "two_hundred_day_moving_average": 4.05,
    "volume": 404361.0,
    "market_cap": 173950000.0,
    "price_to_sales_ttm": 24.18,
    "price_to_book_mrq": 5.19,
    "roa_ttm": -0.2716,
    "roe_ttm": -0.7211,
    "shares_outstanding": 44370000.0,
    "pcnt_held_by_insiders": 0.3567,
    "pcnt_held_by_institutions": 0.5710000000000001,
    "pcnt_short_of_float": 0.20420000000000002,
    "operating_cash_flow_ttm": -35950000.0,
    "levered_cash_flow_ttm": -25640000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "AcelRx Pharmaceuticals, Inc."
  },
  "ACST": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.028,
    "ebitda": -7330000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.3543,
    "fifty_two_week_high": 1.05,
    "fifty_two_week_low": 0.28,
    "percent_change_from_200_day_moving_average": -0.090613,
    "percent_change_from_50_day_moving_average": -0.008428,
    "shares_owned": "N/A",
    "short_ratio": 0.62,
    "two_hundred_day_moving_average": 0.3863,
    "volume": 78092.0,
    "market_cap": 37450000.0,
    "price_to_sales_ttm": 230.97,
    "price_to_book_mrq": 1.57,
    "roa_ttm": -0.19039999999999999,
    "roe_ttm": -0.1175,
    "shares_outstanding": 106610000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": -5790000.0,
    "levered_cash_flow_ttm": -2500000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acasti Pharma Inc."
  },
  "ACUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.72,
    "ebitda": -5610000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 3.0,
    "fifty_two_week_high": 6.75,
    "fifty_two_week_low": 2.05,
    "percent_change_from_200_day_moving_average": -0.2883,
    "percent_change_from_50_day_moving_average": -0.0953,
    "shares_owned": "N/A",
    "short_ratio": 1.11,
    "two_hundred_day_moving_average": 3.81,
    "volume": 15219.0,
    "market_cap": 31980000.0,
    "price_to_sales_ttm": 4.85,
    "price_to_book_mrq": 6.15,
    "roa_ttm": -0.2032,
    "roe_ttm": -0.9695999999999999,
    "shares_outstanding": 11800000.0,
    "pcnt_held_by_insiders": 0.3452,
    "pcnt_held_by_institutions": 0.249,
    "pcnt_short_of_float": 0.0042,
    "operating_cash_flow_ttm": -5490000.0,
    "levered_cash_flow_ttm": -3610000.0,
    "book_value_per_share_mrq": 0.43,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Acura Pharmaceuticals, Inc."
  },
  "ADAP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.86,
    "earnings_per_share": -1.67,
    "ebitda": -15270000.0,
    "eps_estimate_current_year": -0.4,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 12.71,
    "fifty_two_week_high": 21.57,
    "fifty_two_week_low": 10.01,
    "percent_change_from_200_day_moving_average": -0.2382,
    "percent_change_from_50_day_moving_average": -0.0719,
    "shares_owned": "N/A",
    "short_ratio": 6.29,
    "two_hundred_day_moving_average": 15.49,
    "volume": 61236.0,
    "market_cap": 835260000.0,
    "price_to_sales_ttm": 190.71,
    "price_to_book_mrq": 0.04,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 70780000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 24320000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 303.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Adaptimmune Therapeutics plc"
  },
  "ADHD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.61,
    "ebitda": -27780000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 8.0,
    "fifty_two_week_high": 20.87,
    "fifty_two_week_low": 3.12,
    "percent_change_from_200_day_moving_average": 0.0966,
    "percent_change_from_50_day_moving_average": -0.049699999999999994,
    "shares_owned": "N/A",
    "short_ratio": 9.23,
    "two_hundred_day_moving_average": 6.93,
    "volume": 141805.0,
    "market_cap": 153540000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.22,
    "roa_ttm": -0.425,
    "roe_ttm": -0.7437999999999999,
    "shares_outstanding": 20200000.0,
    "pcnt_held_by_insiders": 0.4631,
    "pcnt_held_by_institutions": 0.302,
    "pcnt_short_of_float": 0.0613,
    "operating_cash_flow_ttm": -25720000.0,
    "levered_cash_flow_ttm": -15580000.0,
    "book_value_per_share_mrq": 1.83,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-28"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alcobra Ltd."
  },
  "ADK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.16,
    "ebitda": 14910000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.64,
    "fifty_two_week_high": 4.9,
    "fifty_two_week_low": 3.32,
    "percent_change_from_200_day_moving_average": -0.0681,
    "percent_change_from_50_day_moving_average": -0.0124,
    "shares_owned": "N/A",
    "short_ratio": 5.52,
    "two_hundred_day_moving_average": 3.85,
    "volume": 27020.0,
    "market_cap": 71370000.0,
    "price_to_sales_ttm": 0.35,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0202,
    "roe_ttm": -0.23170000000000002,
    "shares_outstanding": 19880000.0,
    "pcnt_held_by_insiders": 0.2481,
    "pcnt_held_by_institutions": 0.20199999999999999,
    "pcnt_short_of_float": 0.009399999999999999,
    "operating_cash_flow_ttm": -5430000.0,
    "levered_cash_flow_ttm": -138750.0,
    "book_value_per_share_mrq": -0.33,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "AdCare Health Systems, Inc."
  },
  "ADMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.56,
    "ebitda": -13080000.0,
    "eps_estimate_current_year": -1.6,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 9.21,
    "fifty_two_week_high": 14.0,
    "fifty_two_week_low": 7.51,
    "percent_change_from_200_day_moving_average": 0.0263,
    "percent_change_from_50_day_moving_average": -0.0031,
    "shares_owned": "N/A",
    "short_ratio": 7.12,
    "two_hundred_day_moving_average": 8.95,
    "volume": 19731.0,
    "market_cap": 98280000.0,
    "price_to_sales_ttm": 16.89,
    "price_to_book_mrq": 10.06,
    "roa_ttm": -0.2918,
    "roe_ttm": -1.3961000000000001,
    "shares_outstanding": 10710000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0197,
    "operating_cash_flow_ttm": -14040000.0,
    "levered_cash_flow_ttm": -11000000.0,
    "book_value_per_share_mrq": 0.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ADMA Biologics, Inc."
  },
  "ADMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.31,
    "ebitda": -12930000.0,
    "eps_estimate_current_year": -0.87,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.87,
    "fifty_two_week_high": 7.26,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": 0.025699999999999997,
    "percent_change_from_50_day_moving_average": 0.1497,
    "shares_owned": "N/A",
    "short_ratio": 3.85,
    "two_hundred_day_moving_average": 4.34,
    "volume": 11467.0,
    "market_cap": 59770000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.09,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13430000.0,
    "pcnt_held_by_insiders": 0.3071,
    "pcnt_held_by_institutions": 0.11,
    "pcnt_short_of_float": 0.0196,
    "operating_cash_flow_ttm": -9510000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Adamis Pharmaceuticals Corporation"
  },
  "ADMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -1.45,
    "ebitda": -18640000.0,
    "eps_estimate_current_year": -3.19,
    "eps_estimate_next_quarter": -0.84,
    "fifty_day_moving_average": 20.83,
    "fifty_two_week_high": 30.86,
    "fifty_two_week_low": 13.6,
    "percent_change_from_200_day_moving_average": -0.073,
    "percent_change_from_50_day_moving_average": -0.07429999999999999,
    "shares_owned": "N/A",
    "short_ratio": 4.68,
    "two_hundred_day_moving_average": 20.8,
    "volume": 152188.0,
    "market_cap": 354830000.0,
    "price_to_sales_ttm": 11.35,
    "price_to_book_mrq": 2.61,
    "roa_ttm": -0.0805,
    "roe_ttm": -0.1895,
    "shares_outstanding": 18400000.0,
    "pcnt_held_by_insiders": 0.4058,
    "pcnt_held_by_institutions": 0.115,
    "pcnt_short_of_float": 0.0622,
    "operating_cash_flow_ttm": -12020000.0,
    "levered_cash_flow_ttm": -942050.0,
    "book_value_per_share_mrq": 7.36,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Adamas Pharmaceuticals, Inc."
  },
  "ADPT": {
    "p_e_ratio": 117.63,
    "peg_ratio": 1.12,
    "earnings_per_share": 0.97,
    "ebitda": 33980000.0,
    "eps_estimate_current_year": 1.22,
    "eps_estimate_next_quarter": 0.35,
    "fifty_day_moving_average": 106.94,
    "fifty_two_week_high": 123.97,
    "fifty_two_week_low": 24.22,
    "percent_change_from_200_day_moving_average": 0.4164,
    "percent_change_from_50_day_moving_average": 0.07139999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.07,
    "two_hundred_day_moving_average": 80.89,
    "volume": 145306.0,
    "market_cap": 1630000000.0,
    "price_to_sales_ttm": 4.28,
    "price_to_book_mrq": 22.53,
    "roa_ttm": 0.029900000000000003,
    "roe_ttm": 0.20629999999999998,
    "shares_outstanding": 14210000.0,
    "pcnt_held_by_insiders": 0.1648,
    "pcnt_held_by_institutions": 0.14400000000000002,
    "pcnt_short_of_float": 0.3258,
    "operating_cash_flow_ttm": -16910000.0,
    "levered_cash_flow_ttm": -48820000.0,
    "book_value_per_share_mrq": 4.91,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Adeptus Health Inc."
  },
  "ADRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.86,
    "earnings_per_share": -1.24,
    "ebitda": -22930000.0,
    "eps_estimate_current_year": -1.18,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 21.12,
    "fifty_two_week_high": 49.25,
    "fifty_two_week_low": 16.28,
    "percent_change_from_200_day_moving_average": -0.2457,
    "percent_change_from_50_day_moving_average": 0.016200000000000003,
    "shares_owned": "N/A",
    "short_ratio": 7.23,
    "two_hundred_day_moving_average": 28.45,
    "volume": 98198.0,
    "market_cap": 1340000000.0,
    "price_to_sales_ttm": 41.92,
    "price_to_book_mrq": 5.54,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 62280000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0767,
    "operating_cash_flow_ttm": 189130000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aduro BioTech, Inc."
  },
  "ADUS": {
    "p_e_ratio": 31.16,
    "peg_ratio": 1.82,
    "earnings_per_share": 1.12,
    "ebitda": 24520000.0,
    "eps_estimate_current_year": 1.24,
    "eps_estimate_next_quarter": 0.36,
    "fifty_day_moving_average": 30.04,
    "fifty_two_week_high": 35.83,
    "fifty_two_week_low": 17.02,
    "percent_change_from_200_day_moving_average": 0.2775,
    "percent_change_from_50_day_moving_average": 0.16690000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.42,
    "two_hundred_day_moving_average": 27.45,
    "volume": 80844.0,
    "market_cap": 386690000.0,
    "price_to_sales_ttm": 1.13,
    "price_to_book_mrq": 2.79,
    "roa_ttm": 0.0707,
    "roe_ttm": 0.0968,
    "shares_outstanding": 11030000.0,
    "pcnt_held_by_insiders": 0.4543,
    "pcnt_held_by_institutions": 0.518,
    "pcnt_short_of_float": 0.0248,
    "operating_cash_flow_ttm": 27070000.0,
    "levered_cash_flow_ttm": 18150000.0,
    "book_value_per_share_mrq": 12.23,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Addus HomeCare Corporation"
  },
  "ADXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.53,
    "ebitda": -39000000.0,
    "eps_estimate_current_year": -1.57,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 15.5,
    "fifty_two_week_high": 30.13,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.17629999999999998,
    "percent_change_from_50_day_moving_average": -0.0374,
    "shares_owned": "N/A",
    "short_ratio": 7.64,
    "two_hundred_day_moving_average": 18.11,
    "volume": 1192273.0,
    "market_cap": 497820000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.21,
    "roa_ttm": -0.38189999999999996,
    "roe_ttm": -0.6241,
    "shares_outstanding": 33369999.999999996,
    "pcnt_held_by_insiders": 0.0911,
    "pcnt_held_by_institutions": 0.096,
    "pcnt_short_of_float": 0.36450000000000005,
    "operating_cash_flow_ttm": -20030000.0,
    "levered_cash_flow_ttm": -8270000.0,
    "book_value_per_share_mrq": 3.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Advaxis, Inc."
  },
  "AEGR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.65,
    "earnings_per_share": -1.43,
    "ebitda": -639999.0,
    "eps_estimate_current_year": -1.99,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 17.79,
    "fifty_two_week_high": 36.19,
    "fifty_two_week_low": 15.99,
    "percent_change_from_200_day_moving_average": -0.2162,
    "percent_change_from_50_day_moving_average": -0.0827,
    "shares_owned": "N/A",
    "short_ratio": 14.89,
    "two_hundred_day_moving_average": 20.82,
    "volume": 255193.0,
    "market_cap": 467090000.0,
    "price_to_sales_ttm": 2.15,
    "price_to_book_mrq": 3.14,
    "roa_ttm": -0.0262,
    "roe_ttm": -0.3196,
    "shares_outstanding": 28620000.0,
    "pcnt_held_by_insiders": 0.2502,
    "pcnt_held_by_institutions": 0.937,
    "pcnt_short_of_float": 0.5257999999999999,
    "operating_cash_flow_ttm": 27720000.0,
    "levered_cash_flow_ttm": -25120000.0,
    "book_value_per_share_mrq": 5.24,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aegerion Pharmaceuticals, Inc."
  },
  "AEMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.7,
    "ebitda": -3870000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.93,
    "fifty_two_week_high": 36.0,
    "fifty_two_week_low": 5.5,
    "percent_change_from_200_day_moving_average": -0.07629999999999999,
    "percent_change_from_50_day_moving_average": 0.0447,
    "shares_owned": "N/A",
    "short_ratio": 1.96,
    "two_hundred_day_moving_average": 8.96,
    "volume": 146823.0,
    "market_cap": 63010000.0,
    "price_to_sales_ttm": 71.75,
    "price_to_book_mrq": 12.77,
    "roa_ttm": -0.6867,
    "roe_ttm": -5.7715,
    "shares_outstanding": 7610000.0,
    "pcnt_held_by_insiders": 0.12029999999999999,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0276,
    "operating_cash_flow_ttm": -5080000.0,
    "levered_cash_flow_ttm": -4030000.0000000005,
    "book_value_per_share_mrq": 0.67,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Aethlon Medical, Inc."
  },
  "AERI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.65,
    "ebitda": -66819999.99999999,
    "eps_estimate_current_year": -2.58,
    "eps_estimate_next_quarter": -0.71,
    "fifty_day_moving_average": 17.59,
    "fifty_two_week_high": 35.89,
    "fifty_two_week_low": 8.84,
    "percent_change_from_200_day_moving_average": 0.1821,
    "percent_change_from_50_day_moving_average": 0.317,
    "shares_owned": "N/A",
    "short_ratio": 9.21,
    "two_hundred_day_moving_average": 19.6,
    "volume": 639363.0,
    "market_cap": 595290000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 18.06,
    "roa_ttm": -0.3574,
    "roe_ttm": -1.5146000000000002,
    "shares_outstanding": 25690000.0,
    "pcnt_held_by_insiders": 0.4757,
    "pcnt_held_by_institutions": 0.336,
    "pcnt_short_of_float": 0.2827,
    "operating_cash_flow_ttm": -50390000.0,
    "levered_cash_flow_ttm": -19520000.0,
    "book_value_per_share_mrq": 1.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Aerie Pharmaceuticals, Inc."
  },
  "AEZS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.417,
    "ebitda": -34080000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.1063,
    "fifty_two_week_high": 1.4,
    "fifty_two_week_low": 0.05,
    "percent_change_from_200_day_moving_average": -0.713865,
    "percent_change_from_50_day_moving_average": -0.128766,
    "shares_owned": "N/A",
    "short_ratio": 0.38,
    "two_hundred_day_moving_average": 0.3236,
    "volume": 67635065.0,
    "market_cap": 16880000.0,
    "price_to_sales_ttm": 49.95,
    "price_to_book_mrq": 1.15,
    "roa_ttm": -0.3837,
    "roe_ttm": -3.2985,
    "shares_outstanding": 182290000.0,
    "pcnt_held_by_insiders": 0.0886,
    "pcnt_held_by_institutions": 0.092,
    "pcnt_short_of_float": 0.0664,
    "operating_cash_flow_ttm": -33430000.0,
    "levered_cash_flow_ttm": -16379999.999999998,
    "book_value_per_share_mrq": 0.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aeterna Zentaris Inc."
  },
  "AFAM": {
    "p_e_ratio": 24.24,
    "peg_ratio": 1.88,
    "earnings_per_share": 1.88,
    "ebitda": 36570000.0,
    "eps_estimate_current_year": 2.14,
    "eps_estimate_next_quarter": 0.55,
    "fifty_day_moving_average": 46.57,
    "fifty_two_week_high": 50.48,
    "fifty_two_week_low": 25.01,
    "percent_change_from_200_day_moving_average": 0.0745,
    "percent_change_from_50_day_moving_average": -0.0195,
    "shares_owned": "N/A",
    "short_ratio": 4.28,
    "two_hundred_day_moving_average": 42.49,
    "volume": 83201.0,
    "market_cap": 448390000.0,
    "price_to_sales_ttm": 0.83,
    "price_to_book_mrq": 1.76,
    "roa_ttm": 0.0572,
    "roe_ttm": 0.0742,
    "shares_outstanding": 9820000.0,
    "pcnt_held_by_insiders": 0.2706,
    "pcnt_held_by_institutions": 0.5379999999999999,
    "pcnt_short_of_float": 0.0779,
    "operating_cash_flow_ttm": 13780000.0,
    "levered_cash_flow_ttm": 8800000.0,
    "book_value_per_share_mrq": 25.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Almost Family Inc."
  },
  "AFMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -17210000.0,
    "eps_estimate_current_year": -0.8,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 10.45,
    "fifty_two_week_high": 24.2,
    "fifty_two_week_low": 3.55,
    "percent_change_from_200_day_moving_average": -0.26289999999999997,
    "percent_change_from_50_day_moving_average": -0.247,
    "shares_owned": "N/A",
    "short_ratio": 3.84,
    "two_hundred_day_moving_average": 10.68,
    "volume": 118823.0,
    "market_cap": 234010000.0,
    "price_to_sales_ttm": 25.22,
    "price_to_book_mrq": 3.06,
    "roa_ttm": -0.26289999999999997,
    "roe_ttm": "N/A",
    "shares_outstanding": 29730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0959,
    "operating_cash_flow_ttm": -16820000.0,
    "levered_cash_flow_ttm": -20940000.0,
    "book_value_per_share_mrq": 2.5,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Affimed N.V."
  },
  "AGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.39,
    "ebitda": -54720000.0,
    "eps_estimate_current_year": -1.05,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 7.08,
    "fifty_two_week_high": 10.16,
    "fifty_two_week_low": 2.56,
    "percent_change_from_200_day_moving_average": -0.17059999999999997,
    "percent_change_from_50_day_moving_average": -0.1543,
    "shares_owned": "N/A",
    "short_ratio": 9.23,
    "two_hundred_day_moving_average": 7.22,
    "volume": 1026041.0,
    "market_cap": 506800000.0,
    "price_to_sales_ttm": 37.44,
    "price_to_book_mrq": 5.8,
    "roa_ttm": -0.25239999999999996,
    "roe_ttm": -1.2875999999999999,
    "shares_outstanding": 84610000.0,
    "pcnt_held_by_insiders": 0.0667,
    "pcnt_held_by_institutions": 0.511,
    "pcnt_short_of_float": 0.16390000000000002,
    "operating_cash_flow_ttm": -28190000.0,
    "levered_cash_flow_ttm": -19740000.0,
    "book_value_per_share_mrq": 1.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Agenus Inc."
  },
  "AGIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.66,
    "ebitda": -58990000.0,
    "eps_estimate_current_year": -2.34,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 91.83,
    "fifty_two_week_high": 138.85,
    "fifty_two_week_low": 47.5,
    "percent_change_from_200_day_moving_average": -0.1434,
    "percent_change_from_50_day_moving_average": -0.032,
    "shares_owned": "N/A",
    "short_ratio": 7.34,
    "two_hundred_day_moving_average": 103.78,
    "volume": 270361.0,
    "market_cap": 3330000000.0,
    "price_to_sales_ttm": 34.27,
    "price_to_book_mrq": 8.13,
    "roa_ttm": -0.10189999999999999,
    "roe_ttm": -0.1978,
    "shares_outstanding": 37440000.0,
    "pcnt_held_by_insiders": 0.2956,
    "pcnt_held_by_institutions": 0.613,
    "pcnt_short_of_float": 0.2006,
    "operating_cash_flow_ttm": -52850000.0,
    "levered_cash_flow_ttm": -45230000.0,
    "book_value_per_share_mrq": 10.81,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Agios Pharmaceuticals, Inc."
  },
  "AGRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.49,
    "ebitda": -27510000.0,
    "eps_estimate_current_year": -1.6,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 8.4,
    "fifty_two_week_high": 13.19,
    "fifty_two_week_low": 5.77,
    "percent_change_from_200_day_moving_average": -0.1832,
    "percent_change_from_50_day_moving_average": -0.0421,
    "shares_owned": "N/A",
    "short_ratio": 10.11,
    "two_hundred_day_moving_average": 9.86,
    "volume": 100698.0,
    "market_cap": 179290000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.41,
    "roa_ttm": -0.26899999999999996,
    "roe_ttm": -0.6751,
    "shares_outstanding": 22270000.0,
    "pcnt_held_by_insiders": 0.7406999999999999,
    "pcnt_held_by_institutions": 0.016,
    "pcnt_short_of_float": 0.0581,
    "operating_cash_flow_ttm": -26480000.0,
    "levered_cash_flow_ttm": -14490000.0,
    "book_value_per_share_mrq": 1.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Agile Therapeutics, Inc."
  },
  "AGTC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.5,
    "ebitda": -24160000.0,
    "eps_estimate_current_year": -0.69,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 15.98,
    "fifty_two_week_high": 28.24,
    "fifty_two_week_low": 13.32,
    "percent_change_from_200_day_moving_average": -0.27190000000000003,
    "percent_change_from_50_day_moving_average": -0.15560000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.05,
    "two_hundred_day_moving_average": 18.53,
    "volume": 94410.0,
    "market_cap": 242190000.0,
    "price_to_sales_ttm": 106.39,
    "price_to_book_mrq": 2.69,
    "roa_ttm": -0.183,
    "roe_ttm": -0.3032,
    "shares_outstanding": 17950000.0,
    "pcnt_held_by_insiders": 0.4521,
    "pcnt_held_by_institutions": 0.10800000000000001,
    "pcnt_short_of_float": 0.0687,
    "operating_cash_flow_ttm": -19490000.0,
    "levered_cash_flow_ttm": -10480000.0,
    "book_value_per_share_mrq": 5.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Applied Genetic Technologies Corporation"
  },
  "AHPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.2,
    "ebitda": -294564.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.46,
    "fifty_two_week_high": 3.7,
    "fifty_two_week_low": 1.29,
    "percent_change_from_200_day_moving_average": -0.1465,
    "percent_change_from_50_day_moving_average": -0.10980000000000001,
    "shares_owned": "N/A",
    "short_ratio": 13.4,
    "two_hundred_day_moving_average": 1.52,
    "volume": 29.0,
    "market_cap": 10440000.0,
    "price_to_sales_ttm": 0.29,
    "price_to_book_mrq": 0.49,
    "roa_ttm": -0.038,
    "roe_ttm": -0.0728,
    "shares_outstanding": 8029999.999999999,
    "pcnt_held_by_insiders": 0.4454,
    "pcnt_held_by_institutions": 0.385,
    "pcnt_short_of_float": 0.0089,
    "operating_cash_flow_ttm": 498880.0,
    "levered_cash_flow_ttm": 955180.0,
    "book_value_per_share_mrq": 2.64,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Allied Healthcare Products Inc."
  },
  "AHS": {
    "p_e_ratio": 38.76,
    "peg_ratio": 2.43,
    "earnings_per_share": 0.96,
    "ebitda": 111190000.0,
    "eps_estimate_current_year": 1.23,
    "eps_estimate_next_quarter": 0.3,
    "fifty_day_moving_average": 34.63,
    "fifty_two_week_high": 37.47,
    "fifty_two_week_low": 14.96,
    "percent_change_from_200_day_moving_average": 0.3055,
    "percent_change_from_50_day_moving_average": 0.0746,
    "shares_owned": "N/A",
    "short_ratio": 1.77,
    "two_hundred_day_moving_average": 28.5,
    "volume": 895670.0,
    "market_cap": 1770000000.0,
    "price_to_sales_ttm": 1.4,
    "price_to_book_mrq": 5.95,
    "roa_ttm": 0.0806,
    "roe_ttm": 0.1782,
    "shares_outstanding": 47650000.0,
    "pcnt_held_by_insiders": 0.0154,
    "pcnt_held_by_institutions": 0.943,
    "pcnt_short_of_float": 0.0392,
    "operating_cash_flow_ttm": 54320000.0,
    "levered_cash_flow_ttm": 24420000.0,
    "book_value_per_share_mrq": 6.05,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AMN Healthcare Services Inc."
  },
  "AIMT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.78,
    "ebitda": -17530000.0,
    "eps_estimate_current_year": -1.2,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 25.23,
    "fifty_two_week_low": 23.74,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.17,
    "two_hundred_day_moving_average": 0.0,
    "volume": 262241.0,
    "market_cap": 1040000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 42250000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.003,
    "operating_cash_flow_ttm": -14290000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -4.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aimmune Therapeutics, Inc."
  },
  "AIQ": {
    "p_e_ratio": 17.88,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.53,
    "ebitda": 114600000.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 14.43,
    "fifty_two_week_high": 25.83,
    "fifty_two_week_low": 9.11,
    "percent_change_from_200_day_moving_average": -0.4963,
    "percent_change_from_50_day_moving_average": -0.3446,
    "shares_owned": "N/A",
    "short_ratio": 7.47,
    "two_hundred_day_moving_average": 18.78,
    "volume": 134376.0,
    "market_cap": 100210000.0,
    "price_to_sales_ttm": 0.25,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0695,
    "roe_ttm": "N/A",
    "shares_outstanding": 10590000.0,
    "pcnt_held_by_insiders": 0.5356000000000001,
    "pcnt_held_by_institutions": 0.42200000000000004,
    "pcnt_short_of_float": 0.0288,
    "operating_cash_flow_ttm": 105440000.0,
    "levered_cash_flow_ttm": 33920000.0,
    "book_value_per_share_mrq": -16.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Alliance Healthcare Services, Inc."
  },
  "AKAO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.13,
    "ebitda": -19990000.0,
    "eps_estimate_current_year": -1.43,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 6.92,
    "fifty_two_week_high": 14.19,
    "fifty_two_week_low": 5.3,
    "percent_change_from_200_day_moving_average": 0.0054,
    "percent_change_from_50_day_moving_average": 0.010700000000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.88,
    "two_hundred_day_moving_average": 6.95,
    "volume": 46809.0,
    "market_cap": 126630000.0,
    "price_to_sales_ttm": 4.89,
    "price_to_book_mrq": 2.09,
    "roa_ttm": -0.1711,
    "roe_ttm": -0.2973,
    "shares_outstanding": 18120000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0554,
    "operating_cash_flow_ttm": -13760000.0,
    "levered_cash_flow_ttm": -7650000.0,
    "book_value_per_share_mrq": 3.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Achaogen, Inc."
  },
  "AKBA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.9,
    "ebitda": -41750000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 8.56,
    "fifty_two_week_high": 23.41,
    "fifty_two_week_low": 5.91,
    "percent_change_from_200_day_moving_average": 0.2225,
    "percent_change_from_50_day_moving_average": 0.3059,
    "shares_owned": "N/A",
    "short_ratio": 5.88,
    "two_hundred_day_moving_average": 9.15,
    "volume": 466494.0,
    "market_cap": 322910000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.98,
    "roa_ttm": -0.18539999999999998,
    "roe_ttm": -0.303,
    "shares_outstanding": 28880000.0,
    "pcnt_held_by_insiders": 0.33,
    "pcnt_held_by_institutions": 0.122,
    "pcnt_short_of_float": 0.12380000000000001,
    "operating_cash_flow_ttm": -35270000.0,
    "levered_cash_flow_ttm": -21240000.0,
    "book_value_per_share_mrq": 5.63,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Akebia Therapeutics, Inc."
  },
  "AKER": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.08,
    "ebitda": -5220000.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.15,
    "fifty_two_week_high": 5.28,
    "fifty_two_week_low": 2.27,
    "percent_change_from_200_day_moving_average": -0.1396,
    "percent_change_from_50_day_moving_average": 0.1057,
    "shares_owned": "N/A",
    "short_ratio": 0.92,
    "two_hundred_day_moving_average": 4.04,
    "volume": 14713.0,
    "market_cap": 17900000.0,
    "price_to_sales_ttm": 5.21,
    "price_to_book_mrq": 1.45,
    "roa_ttm": -0.2235,
    "roe_ttm": -0.37829999999999997,
    "shares_outstanding": 5140000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0095,
    "operating_cash_flow_ttm": -5050000.0,
    "levered_cash_flow_ttm": -2120000.0,
    "book_value_per_share_mrq": 2.36,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Akers Biosciences Inc."
  },
  "AKRX": {
    "p_e_ratio": 110.03,
    "peg_ratio": 0.78,
    "earnings_per_share": 0.33,
    "ebitda": 208270000.0,
    "eps_estimate_current_year": 1.95,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 40.83,
    "fifty_two_week_high": 57.1,
    "fifty_two_week_low": 33.0,
    "percent_change_from_200_day_moving_average": -0.17739999999999997,
    "percent_change_from_50_day_moving_average": -0.0999,
    "shares_owned": "N/A",
    "short_ratio": 6.5,
    "two_hundred_day_moving_average": 44.68,
    "volume": 455559.0,
    "market_cap": 4210000000.0,
    "price_to_sales_ttm": 7.17,
    "price_to_book_mrq": 10.79,
    "roa_ttm": 0.08,
    "roe_ttm": 0.1108,
    "shares_outstanding": 114430000.0,
    "pcnt_held_by_insiders": 0.23879999999999998,
    "pcnt_held_by_institutions": 0.78,
    "pcnt_short_of_float": 0.0802,
    "operating_cash_flow_ttm": 30920000.0,
    "levered_cash_flow_ttm": -201080000.0,
    "book_value_per_share_mrq": 3.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Akorn, Inc."
  },
  "ALDR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.96,
    "earnings_per_share": -0.31,
    "ebitda": -10390000.0,
    "eps_estimate_current_year": -1.9,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 40.09,
    "fifty_two_week_high": 54.9,
    "fifty_two_week_low": 10.52,
    "percent_change_from_200_day_moving_average": -0.015700000000000002,
    "percent_change_from_50_day_moving_average": -0.0605,
    "shares_owned": "N/A",
    "short_ratio": 5.84,
    "two_hundred_day_moving_average": 38.27,
    "volume": 669720.0,
    "market_cap": 1640000000.0,
    "price_to_sales_ttm": 36.89,
    "price_to_book_mrq": 3.82,
    "roa_ttm": -0.0263,
    "roe_ttm": -0.0449,
    "shares_outstanding": 43510000.0,
    "pcnt_held_by_insiders": 0.2712,
    "pcnt_held_by_institutions": 0.078,
    "pcnt_short_of_float": 0.1868,
    "operating_cash_flow_ttm": -58970000.0,
    "levered_cash_flow_ttm": -29940000.0,
    "book_value_per_share_mrq": 10.04,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alder Biopharmaceuticals Inc."
  },
  "ALDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.34,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 7.35,
    "fifty_two_week_high": 13.5,
    "fifty_two_week_low": 5.39,
    "percent_change_from_200_day_moving_average": -0.2025,
    "percent_change_from_50_day_moving_average": -0.0679,
    "shares_owned": "N/A",
    "short_ratio": 1.45,
    "two_hundred_day_moving_average": 8.59,
    "volume": 5800.0,
    "market_cap": 66530000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.11,
    "roa_ttm": -0.2378,
    "roe_ttm": -0.4268,
    "shares_outstanding": 9710000.0,
    "pcnt_held_by_insiders": 0.1465,
    "pcnt_held_by_institutions": 0.003,
    "pcnt_short_of_float": 0.015700000000000002,
    "operating_cash_flow_ttm": -6260000.0,
    "levered_cash_flow_ttm": -3160000.0,
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aldeyra Therapeutics, Inc."
  },
  "ALGN": {
    "p_e_ratio": 32.12,
    "peg_ratio": 2.09,
    "earnings_per_share": 1.78,
    "ebitda": 211650000.0,
    "eps_estimate_current_year": 1.59,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 57.68,
    "fifty_two_week_high": 66.53,
    "fifty_two_week_low": 43.27,
    "percent_change_from_200_day_moving_average": -0.031200000000000002,
    "percent_change_from_50_day_moving_average": -0.008100000000000001,
    "shares_owned": "N/A",
    "short_ratio": 12.53,
    "two_hundred_day_moving_average": 59.05,
    "volume": 323800.0,
    "market_cap": 4580000000.0,
    "price_to_sales_ttm": 5.72,
    "price_to_book_mrq": 5.92,
    "roa_ttm": 0.12689999999999999,
    "roe_ttm": 0.201,
    "shares_outstanding": 80080000.0,
    "pcnt_held_by_insiders": 0.1518,
    "pcnt_held_by_institutions": 0.802,
    "pcnt_short_of_float": 0.10099999999999999,
    "operating_cash_flow_ttm": 237760000.0,
    "levered_cash_flow_ttm": 147980000.0,
    "book_value_per_share_mrq": 9.61,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Align Technology Inc."
  },
  "ALIM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.81,
    "ebitda": -38540000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 3.39,
    "fifty_two_week_high": 6.48,
    "fifty_two_week_low": 2.53,
    "percent_change_from_200_day_moving_average": -0.4157,
    "percent_change_from_50_day_moving_average": -0.25079999999999997,
    "shares_owned": "N/A",
    "short_ratio": 18.82,
    "two_hundred_day_moving_average": 4.35,
    "volume": 92718.0,
    "market_cap": 112800000.0,
    "price_to_sales_ttm": 8.3,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.37079999999999996,
    "roe_ttm": -1.475,
    "shares_outstanding": 44410000.0,
    "pcnt_held_by_insiders": 0.5171,
    "pcnt_held_by_institutions": 0.425,
    "pcnt_short_of_float": 0.0892,
    "operating_cash_flow_ttm": -41760000.0,
    "levered_cash_flow_ttm": -51360000.0,
    "book_value_per_share_mrq": -0.8,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Alimera Sciences, Inc."
  },
  "ALNY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.72,
    "earnings_per_share": -2.35,
    "ebitda": -200910000.0,
    "eps_estimate_current_year": -3.27,
    "eps_estimate_next_quarter": -0.91,
    "fifty_day_moving_average": 105.68,
    "fifty_two_week_high": 140.0,
    "fifty_two_week_low": 72.8,
    "percent_change_from_200_day_moving_average": -0.196,
    "percent_change_from_50_day_moving_average": -0.11710000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.29,
    "two_hundred_day_moving_average": 116.04,
    "volume": 934854.0,
    "market_cap": 7890000000.0,
    "price_to_sales_ttm": 132.35,
    "price_to_book_mrq": 5.84,
    "roa_ttm": -0.1054,
    "roe_ttm": -0.15990000000000001,
    "shares_outstanding": 84620000.0,
    "pcnt_held_by_insiders": 0.21850000000000003,
    "pcnt_held_by_institutions": 0.732,
    "pcnt_short_of_float": 0.0848,
    "operating_cash_flow_ttm": -159050000.0,
    "levered_cash_flow_ttm": -92200000.0,
    "book_value_per_share_mrq": 16.66,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alnylam Pharmaceuticals, Inc."
  },
  "ALOG": {
    "p_e_ratio": 31.95,
    "peg_ratio": 1.35,
    "earnings_per_share": 2.66,
    "ebitda": 63450000.0,
    "eps_estimate_current_year": 4.3,
    "eps_estimate_next_quarter": 1.04,
    "fifty_day_moving_average": 81.48,
    "fifty_two_week_high": 92.31,
    "fifty_two_week_low": 63.28,
    "percent_change_from_200_day_moving_average": 0.0194,
    "percent_change_from_50_day_moving_average": 0.0432,
    "shares_owned": "N/A",
    "short_ratio": 10.16,
    "two_hundred_day_moving_average": 83.38,
    "volume": 99497.0,
    "market_cap": 1060000000.0,
    "price_to_sales_ttm": 1.93,
    "price_to_book_mrq": 1.96,
    "roa_ttm": 0.0406,
    "roe_ttm": 0.0641,
    "shares_outstanding": 12440000.0,
    "pcnt_held_by_insiders": 0.0083,
    "pcnt_held_by_institutions": 0.976,
    "pcnt_short_of_float": 0.0922,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 42.77,
    "next_earnings_announcement_date": [
      "2015-12-07",
      "2015-12-11"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Analogic Corporation"
  },
  "ALQA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.22,
    "earnings_per_share": -1.34,
    "ebitda": -21310000.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 4.53,
    "fifty_two_week_high": 6.55,
    "fifty_two_week_low": 3.7,
    "percent_change_from_200_day_moving_average": -0.19469999999999998,
    "percent_change_from_50_day_moving_average": -0.1285,
    "shares_owned": "N/A",
    "short_ratio": 5.94,
    "two_hundred_day_moving_average": 4.91,
    "volume": 22023.0,
    "market_cap": 109290000.0,
    "price_to_sales_ttm": 12.9,
    "price_to_book_mrq": 1.82,
    "roa_ttm": -0.2089,
    "roe_ttm": -0.5646,
    "shares_outstanding": 27670000.0,
    "pcnt_held_by_insiders": 0.4465,
    "pcnt_held_by_institutions": 0.07200000000000001,
    "pcnt_short_of_float": 0.0204,
    "operating_cash_flow_ttm": -19280000.0,
    "levered_cash_flow_ttm": 777130.0,
    "book_value_per_share_mrq": 2.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Alliqua BioMedical, Inc."
  },
  "ALR": {
    "p_e_ratio": 19.71,
    "peg_ratio": 2.15,
    "earnings_per_share": 2.62,
    "ebitda": 538360000.0,
    "eps_estimate_current_year": 2.42,
    "eps_estimate_next_quarter": 0.75,
    "fifty_day_moving_average": 52.57,
    "fifty_two_week_high": 55.99,
    "fifty_two_week_low": 35.62,
    "percent_change_from_200_day_moving_average": 0.018500000000000003,
    "percent_change_from_50_day_moving_average": -0.0158,
    "shares_owned": "N/A",
    "short_ratio": 4.45,
    "two_hundred_day_moving_average": 50.8,
    "volume": 256627.0,
    "market_cap": 4440000000.0,
    "price_to_sales_ttm": 1.75,
    "price_to_book_mrq": 2.87,
    "roa_ttm": 0.020499999999999997,
    "roe_ttm": -0.048499999999999995,
    "shares_outstanding": 85730000.0,
    "pcnt_held_by_insiders": 0.0816,
    "pcnt_held_by_institutions": 0.897,
    "pcnt_short_of_float": 0.0379,
    "operating_cash_flow_ttm": 138950000.0,
    "levered_cash_flow_ttm": -204760000.0,
    "book_value_per_share_mrq": 18.14,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Alere Inc."
  },
  "ALXA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.73,
    "ebitda": -33810000.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 1.21,
    "fifty_two_week_high": 2.96,
    "fifty_two_week_low": 0.8,
    "percent_change_from_200_day_moving_average": -0.016200000000000003,
    "percent_change_from_50_day_moving_average": 0.1565,
    "shares_owned": "N/A",
    "short_ratio": 20.6,
    "two_hundred_day_moving_average": 1.42,
    "volume": 50913.0,
    "market_cap": 27220000.0,
    "price_to_sales_ttm": 5.93,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.426,
    "roe_ttm": "N/A",
    "shares_outstanding": 19440000.0,
    "pcnt_held_by_insiders": 0.0417,
    "pcnt_held_by_institutions": 0.47200000000000003,
    "pcnt_short_of_float": 0.0412,
    "operating_cash_flow_ttm": -37770000.0,
    "levered_cash_flow_ttm": -18030000.0,
    "book_value_per_share_mrq": -3.29,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Alexza Pharmaceuticals Inc."
  },
  "AMAG": {
    "p_e_ratio": 8.05,
    "peg_ratio": 0.03,
    "earnings_per_share": 5.66,
    "ebitda": 153980000.0,
    "eps_estimate_current_year": 5.24,
    "eps_estimate_next_quarter": 1.67,
    "fifty_day_moving_average": 59.99,
    "fifty_two_week_high": 77.73,
    "fifty_two_week_low": 22.47,
    "percent_change_from_200_day_moving_average": -0.2701,
    "percent_change_from_50_day_moving_average": -0.2395,
    "shares_owned": "N/A",
    "short_ratio": 7.03,
    "two_hundred_day_moving_average": 62.5,
    "volume": 1140113.0,
    "market_cap": 1550000000.0,
    "price_to_sales_ttm": 4.71,
    "price_to_book_mrq": 1.93,
    "roa_ttm": 0.0676,
    "roe_ttm": 0.4208,
    "shares_outstanding": 34020000.0,
    "pcnt_held_by_insiders": 0.0704,
    "pcnt_held_by_institutions": 1.092,
    "pcnt_short_of_float": 0.2086,
    "operating_cash_flow_ttm": 93340000.0,
    "levered_cash_flow_ttm": 147150000.0,
    "book_value_per_share_mrq": 23.1,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "AMAG Pharmaceuticals, Inc."
  },
  "AMDA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.926,
    "ebitda": -13800000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.461,
    "fifty_two_week_high": 3.43,
    "fifty_two_week_low": 0.204,
    "percent_change_from_200_day_moving_average": -0.099156,
    "percent_change_from_50_day_moving_average": -0.159436,
    "shares_owned": "N/A",
    "short_ratio": 2.12,
    "two_hundred_day_moving_average": 0.4302,
    "volume": 567663.0,
    "market_cap": 25480000.0,
    "price_to_sales_ttm": 1.27,
    "price_to_book_mrq": 3.23,
    "roa_ttm": -0.2414,
    "roe_ttm": -2.2538,
    "shares_outstanding": 65760000.00000001,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1419,
    "operating_cash_flow_ttm": -11440000.0,
    "levered_cash_flow_ttm": -5010000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Amedica Corporation"
  },
  "AMED": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.39,
    "earnings_per_share": -0.21,
    "ebitda": 89340000.0,
    "eps_estimate_current_year": 1.42,
    "eps_estimate_next_quarter": 0.35,
    "fifty_day_moving_average": 42.16,
    "fifty_two_week_high": 48.34,
    "fifty_two_week_low": 19.03,
    "percent_change_from_200_day_moving_average": 0.2007,
    "percent_change_from_50_day_moving_average": 0.008,
    "shares_owned": "N/A",
    "short_ratio": 3.41,
    "two_hundred_day_moving_average": 35.4,
    "volume": 299678.0,
    "market_cap": 1430000000.0,
    "price_to_sales_ttm": 1.16,
    "price_to_book_mrq": 3.68,
    "roa_ttm": 0.0604,
    "roe_ttm": -0.0161,
    "shares_outstanding": 33670000.0,
    "pcnt_held_by_insiders": 0.1308,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.06480000000000001,
    "operating_cash_flow_ttm": 86970000.0,
    "levered_cash_flow_ttm": 43590000.0,
    "book_value_per_share_mrq": 11.27,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Amedisys Inc."
  },
  "AMEH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -536161.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.64,
    "fifty_two_week_high": 10.0,
    "fifty_two_week_low": 0.45,
    "percent_change_from_200_day_moving_average": -0.08460000000000001,
    "percent_change_from_50_day_moving_average": -0.2078,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 6.61,
    "volume": 300.0,
    "market_cap": 29420000.0,
    "price_to_sales_ttm": 0.75,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.052300000000000006,
    "roe_ttm": "N/A",
    "shares_outstanding": 4860000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": 298190.0,
    "levered_cash_flow_ttm": 2880000.0,
    "book_value_per_share_mrq": -1.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Apollo Medical Holdings, Inc."
  },
  "AMPE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.65,
    "ebitda": -34160000.0,
    "eps_estimate_current_year": -0.61,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.86,
    "fifty_two_week_high": 9.01,
    "fifty_two_week_low": 1.94,
    "percent_change_from_200_day_moving_average": -0.1568,
    "percent_change_from_50_day_moving_average": 0.0943,
    "shares_owned": "N/A",
    "short_ratio": 24.05,
    "two_hundred_day_moving_average": 3.71,
    "volume": 839909.0,
    "market_cap": 162750000.0,
    "price_to_sales_ttm": 704.53,
    "price_to_book_mrq": 3.41,
    "roa_ttm": -0.306,
    "roe_ttm": -0.5246999999999999,
    "shares_outstanding": 52000000.0,
    "pcnt_held_by_insiders": 0.10949999999999999,
    "pcnt_held_by_institutions": 0.309,
    "pcnt_short_of_float": 0.1394,
    "operating_cash_flow_ttm": -24950000.0,
    "levered_cash_flow_ttm": -16170000.000000002,
    "book_value_per_share_mrq": 0.99,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ampio Pharmaceuticals, Inc."
  },
  "AMPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.34,
    "ebitda": -14930000.0,
    "eps_estimate_current_year": 2.91,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 14.22,
    "fifty_two_week_high": 18.3,
    "fifty_two_week_low": 9.76,
    "percent_change_from_200_day_moving_average": -0.1664,
    "percent_change_from_50_day_moving_average": -0.0965,
    "shares_owned": "N/A",
    "short_ratio": 5.97,
    "two_hundred_day_moving_average": 15.42,
    "volume": 199870.0,
    "market_cap": 582590000.0,
    "price_to_sales_ttm": 2.65,
    "price_to_book_mrq": 2.1,
    "roa_ttm": -0.0455,
    "roe_ttm": -0.053099999999999994,
    "shares_outstanding": 45340000.0,
    "pcnt_held_by_insiders": 0.0898,
    "pcnt_held_by_institutions": 0.4,
    "pcnt_short_of_float": 0.0377,
    "operating_cash_flow_ttm": 29790000.0,
    "levered_cash_flow_ttm": 16629999.999999998,
    "book_value_per_share_mrq": 6.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Amphastar Pharmaceuticals, Inc."
  },
  "AMRI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.24,
    "earnings_per_share": -0.33,
    "ebitda": 34830000.0,
    "eps_estimate_current_year": 0.9,
    "eps_estimate_next_quarter": 0.32,
    "fifty_day_moving_average": 20.59,
    "fifty_two_week_high": 23.95,
    "fifty_two_week_low": 13.73,
    "percent_change_from_200_day_moving_average": -0.0034000000000000002,
    "percent_change_from_50_day_moving_average": -0.045700000000000005,
    "shares_owned": "N/A",
    "short_ratio": 21.49,
    "two_hundred_day_moving_average": 19.72,
    "volume": 364570.0,
    "market_cap": 696650000.0,
    "price_to_sales_ttm": 1.98,
    "price_to_book_mrq": 2.55,
    "roa_ttm": 0.014199999999999999,
    "roe_ttm": -0.0415,
    "shares_outstanding": 35450000.0,
    "pcnt_held_by_insiders": 0.14300000000000002,
    "pcnt_held_by_institutions": 0.88,
    "pcnt_short_of_float": 0.3039,
    "operating_cash_flow_ttm": 17550000.0,
    "levered_cash_flow_ttm": -6790000.0,
    "book_value_per_share_mrq": 7.73,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Albany Molecular Research Inc."
  },
  "AMRN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -0.82,
    "ebitda": -98110000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 2.25,
    "fifty_two_week_high": 3.33,
    "fifty_two_week_low": 0.78,
    "percent_change_from_200_day_moving_average": 0.003,
    "percent_change_from_50_day_moving_average": 0.0171,
    "shares_owned": "N/A",
    "short_ratio": 10.3,
    "two_hundred_day_moving_average": 2.28,
    "volume": 540810.0,
    "market_cap": 419670000.0,
    "price_to_sales_ttm": 6.62,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3084,
    "roe_ttm": "N/A",
    "shares_outstanding": 183260000.0,
    "pcnt_held_by_insiders": 0.0393,
    "pcnt_held_by_institutions": 0.33299999999999996,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -71120000.0,
    "levered_cash_flow_ttm": -63760000.0,
    "book_value_per_share_mrq": -0.62,
    "next_earnings_announcement_date": "2015-11-02",
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Amarin Corporation plc"
  },
  "AMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.33,
    "ebitda": 9190000.0,
    "eps_estimate_current_year": 0.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.26,
    "fifty_two_week_high": 3.05,
    "fifty_two_week_low": 1.81,
    "percent_change_from_200_day_moving_average": -0.2489,
    "percent_change_from_50_day_moving_average": -0.17190000000000003,
    "shares_owned": "N/A",
    "short_ratio": 0.38,
    "two_hundred_day_moving_average": 2.49,
    "volume": 5637.0,
    "market_cap": 10030000.0,
    "price_to_sales_ttm": 0.61,
    "price_to_book_mrq": 0.51,
    "roa_ttm": 0.0304,
    "roe_ttm": -0.0347,
    "shares_outstanding": 5360000.0,
    "pcnt_held_by_insiders": 0.3713,
    "pcnt_held_by_institutions": 0.07400000000000001,
    "pcnt_short_of_float": 0.0011,
    "operating_cash_flow_ttm": 8250000.0,
    "levered_cash_flow_ttm": 760120.0,
    "book_value_per_share_mrq": 3.67,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "American Shared Hospital Services"
  },
  "AMSG": {
    "p_e_ratio": 63.65,
    "peg_ratio": 1.2,
    "earnings_per_share": 1.34,
    "ebitda": 607510000.0,
    "eps_estimate_current_year": 3.55,
    "eps_estimate_next_quarter": 1.04,
    "fifty_day_moving_average": 81.22,
    "fifty_two_week_high": 87.33,
    "fifty_two_week_low": 47.68,
    "percent_change_from_200_day_moving_average": 0.207,
    "percent_change_from_50_day_moving_average": 0.047,
    "shares_owned": "N/A",
    "short_ratio": 4.4,
    "two_hundred_day_moving_average": 70.46,
    "volume": 490809.0,
    "market_cap": 4120000000.0,
    "price_to_sales_ttm": 1.75,
    "price_to_book_mrq": 2.56,
    "roa_ttm": 0.08199999999999999,
    "roe_ttm": 0.1476,
    "shares_outstanding": 48440000.0,
    "pcnt_held_by_insiders": 0.11460000000000001,
    "pcnt_held_by_institutions": 0.7170000000000001,
    "pcnt_short_of_float": 0.0581,
    "operating_cash_flow_ttm": 510180000.0,
    "levered_cash_flow_ttm": 331410000.0,
    "book_value_per_share_mrq": 32.93,
    "next_earnings_announcement_date": "2015-11-03",
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AmSurg Corp."
  },
  "ANAC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 8.79,
    "earnings_per_share": -1.57,
    "ebitda": -71190000.0,
    "eps_estimate_current_year": -1.06,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 136.18,
    "fifty_two_week_high": 156.93,
    "fifty_two_week_low": 22.29,
    "percent_change_from_200_day_moving_average": 0.35840000000000005,
    "percent_change_from_50_day_moving_average": -0.0832,
    "shares_owned": "N/A",
    "short_ratio": 4.46,
    "two_hundred_day_moving_average": 91.91,
    "volume": 802611.0,
    "market_cap": 5500000000.0,
    "price_to_sales_ttm": 113.22,
    "price_to_book_mrq": 87.05,
    "roa_ttm": -0.26899999999999996,
    "roe_ttm": -0.9020999999999999,
    "shares_outstanding": 44020000.0,
    "pcnt_held_by_insiders": 0.2071,
    "pcnt_held_by_institutions": 0.812,
    "pcnt_short_of_float": 0.0924,
    "operating_cash_flow_ttm": -21060000.0,
    "levered_cash_flow_ttm": -28870000.0,
    "book_value_per_share_mrq": 1.48,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anacor Pharmaceuticals, Inc."
  },
  "ANCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.74,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.45,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.49,
    "fifty_two_week_high": 3.88,
    "fifty_two_week_low": 1.02,
    "percent_change_from_200_day_moving_average": -0.38299999999999995,
    "percent_change_from_50_day_moving_average": -0.1957,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 1.95,
    "volume": 0.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": null,
    "sector": null,
    "industry": null
  },
  "ANGO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.52,
    "earnings_per_share": -0.09,
    "ebitda": 51200000.0,
    "eps_estimate_current_year": 0.64,
    "eps_estimate_next_quarter": 0.15,
    "fifty_day_moving_average": 14.78,
    "fifty_two_week_high": 19.8,
    "fifty_two_week_low": 13.34,
    "percent_change_from_200_day_moving_average": -0.10869999999999999,
    "percent_change_from_50_day_moving_average": -0.023799999999999998,
    "shares_owned": "N/A",
    "short_ratio": 9.38,
    "two_hundred_day_moving_average": 16.19,
    "volume": 60714.0,
    "market_cap": 522520000.0,
    "price_to_sales_ttm": 1.49,
    "price_to_book_mrq": 0.96,
    "roa_ttm": 0.0177,
    "roe_ttm": -0.006,
    "shares_outstanding": 36210000.0,
    "pcnt_held_by_insiders": 0.2797,
    "pcnt_held_by_institutions": 0.639,
    "pcnt_short_of_float": 0.0492,
    "operating_cash_flow_ttm": 26240000.0,
    "levered_cash_flow_ttm": 22610000.0,
    "book_value_per_share_mrq": 15.18,
    "next_earnings_announcement_date": [
      "2015-10-07",
      "2015-10-12"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "AngioDynamics Inc."
  },
  "ANIK": {
    "p_e_ratio": 20.04,
    "peg_ratio": 0.8,
    "earnings_per_share": 1.67,
    "ebitda": 44470000.0,
    "eps_estimate_current_year": 1.48,
    "eps_estimate_next_quarter": 0.4,
    "fifty_day_moving_average": 35.51,
    "fifty_two_week_high": 45.35,
    "fifty_two_week_low": 31.36,
    "percent_change_from_200_day_moving_average": -0.0713,
    "percent_change_from_50_day_moving_average": -0.0583,
    "shares_owned": "N/A",
    "short_ratio": 17.45,
    "two_hundred_day_moving_average": 36.01,
    "volume": 122415.0,
    "market_cap": 489300000.0,
    "price_to_sales_ttm": 5.91,
    "price_to_book_mrq": 2.66,
    "roa_ttm": 0.13019999999999998,
    "roe_ttm": 0.1435,
    "shares_outstanding": 14630000.0,
    "pcnt_held_by_insiders": 0.033,
    "pcnt_held_by_institutions": 0.687,
    "pcnt_short_of_float": 0.19079999999999997,
    "operating_cash_flow_ttm": 37030000.0,
    "levered_cash_flow_ttm": 31190000.0,
    "book_value_per_share_mrq": 12.7,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anika Therapeutics Inc."
  },
  "ANIP": {
    "p_e_ratio": 14.53,
    "peg_ratio": 0.83,
    "earnings_per_share": 3.09,
    "ebitda": 40860000.0,
    "eps_estimate_current_year": 2.46,
    "eps_estimate_next_quarter": 0.72,
    "fifty_day_moving_average": 53.02,
    "fifty_two_week_high": 73.54,
    "fifty_two_week_low": 24.24,
    "percent_change_from_200_day_moving_average": -0.2462,
    "percent_change_from_50_day_moving_average": -0.1533,
    "shares_owned": "N/A",
    "short_ratio": 4.19,
    "two_hundred_day_moving_average": 59.55,
    "volume": 596237.0,
    "market_cap": 514049999.99999994,
    "price_to_sales_ttm": 6.96,
    "price_to_book_mrq": 3.57,
    "roa_ttm": 0.1219,
    "roe_ttm": 0.2961,
    "shares_outstanding": 11450000.0,
    "pcnt_held_by_insiders": 0.4501,
    "pcnt_held_by_institutions": 0.317,
    "pcnt_short_of_float": 0.17190000000000003,
    "operating_cash_flow_ttm": 17230000.0,
    "levered_cash_flow_ttm": -26040000.0,
    "book_value_per_share_mrq": 13.07,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ANI Pharmaceuticals, Inc."
  },
  "ANTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.14,
    "ebitda": -28780000.0,
    "eps_estimate_current_year": -1.09,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 8.46,
    "fifty_two_week_high": 11.65,
    "fifty_two_week_low": 1.46,
    "percent_change_from_200_day_moving_average": 0.2494,
    "percent_change_from_50_day_moving_average": 0.0285,
    "shares_owned": "N/A",
    "short_ratio": 2.15,
    "two_hundred_day_moving_average": 6.96,
    "volume": 472047.0,
    "market_cap": 346740000.0,
    "price_to_sales_ttm": 660.23,
    "price_to_book_mrq": 11.84,
    "roa_ttm": -0.595,
    "roe_ttm": -1.6581000000000001,
    "shares_outstanding": 39850000.0,
    "pcnt_held_by_insiders": 0.1463,
    "pcnt_held_by_institutions": 0.419,
    "pcnt_short_of_float": 0.0633,
    "operating_cash_flow_ttm": -25170000.0,
    "levered_cash_flow_ttm": -12850000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anthera Pharmaceuticals, Inc."
  },
  "APHB": {
    "p_e_ratio": 2.25,
    "peg_ratio": 0.0,
    "earnings_per_share": 2.6,
    "ebitda": -10630000.0,
    "eps_estimate_current_year": -6.5,
    "eps_estimate_next_quarter": -1.78,
    "fifty_day_moving_average": 0.18,
    "fifty_two_week_high": 6.15,
    "fifty_two_week_low": 0.07,
    "percent_change_from_200_day_moving_average": 27.662300000000002,
    "percent_change_from_50_day_moving_average": 30.695100000000004,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 0.2,
    "volume": 13134.0,
    "market_cap": 33830000.0,
    "price_to_sales_ttm": 85.05,
    "price_to_book_mrq": 2.62,
    "roa_ttm": -0.2,
    "roe_ttm": 0.7606,
    "shares_outstanding": 5780000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": -10790000.0,
    "levered_cash_flow_ttm": -4470000.0,
    "book_value_per_share_mrq": 2.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "AmpliPhi Biosciences Corporation"
  },
  "APPY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.06,
    "earnings_per_share": -0.29,
    "ebitda": -8830000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 0.41,
    "fifty_two_week_high": 2.09,
    "fifty_two_week_low": 0.35,
    "percent_change_from_200_day_moving_average": -0.2523,
    "percent_change_from_50_day_moving_average": -0.1164,
    "shares_owned": "N/A",
    "short_ratio": 8.62,
    "two_hundred_day_moving_average": 0.48,
    "volume": 201635.0,
    "market_cap": 11160000.0,
    "price_to_sales_ttm": 77.93,
    "price_to_book_mrq": 0.58,
    "roa_ttm": -0.1975,
    "roe_ttm": -0.3762,
    "shares_outstanding": 30990000.0,
    "pcnt_held_by_insiders": 0.0069,
    "pcnt_held_by_institutions": 0.217,
    "pcnt_short_of_float": 0.0393,
    "operating_cash_flow_ttm": -8070000.0,
    "levered_cash_flow_ttm": -5050000.0,
    "book_value_per_share_mrq": 0.65,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Venaxis, Inc."
  },
  "APRI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.71,
    "ebitda": -31930000.0,
    "eps_estimate_current_year": -0.48,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 1.44,
    "fifty_two_week_high": 2.75,
    "fifty_two_week_low": 0.92,
    "percent_change_from_200_day_moving_average": -0.0584,
    "percent_change_from_50_day_moving_average": 0.08,
    "shares_owned": "N/A",
    "short_ratio": 10.1,
    "two_hundred_day_moving_average": 1.65,
    "volume": 107988.0,
    "market_cap": 78140000.0,
    "price_to_sales_ttm": 16.58,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.271,
    "roe_ttm": -7.4624,
    "shares_outstanding": 50410000.0,
    "pcnt_held_by_insiders": 0.0084,
    "pcnt_held_by_institutions": 0.087,
    "pcnt_short_of_float": 0.0663,
    "operating_cash_flow_ttm": -27930000.0,
    "levered_cash_flow_ttm": -21870000.0,
    "book_value_per_share_mrq": -0.06,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Apricus Biosciences, Inc."
  },
  "AQXP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.38,
    "ebitda": -24850000.0,
    "eps_estimate_current_year": -1.82,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 16.36,
    "fifty_two_week_high": 55.75,
    "fifty_two_week_low": 1.38,
    "percent_change_from_200_day_moving_average": 0.9662000000000001,
    "percent_change_from_50_day_moving_average": 0.1263,
    "shares_owned": "N/A",
    "short_ratio": 0.2,
    "two_hundred_day_moving_average": 9.37,
    "volume": 208946.0,
    "market_cap": 299070000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.48,
    "roa_ttm": -0.37670000000000003,
    "roe_ttm": -0.6735,
    "shares_outstanding": 16230000.0,
    "pcnt_held_by_insiders": 0.41590000000000005,
    "pcnt_held_by_institutions": 0.462,
    "pcnt_short_of_float": 0.1955,
    "operating_cash_flow_ttm": -23290000.0,
    "levered_cash_flow_ttm": -13430000.0,
    "book_value_per_share_mrq": 2.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Aquinox Pharmaceuticals Inc."
  },
  "ARAY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.09,
    "earnings_per_share": -0.51,
    "ebitda": -7180000.0,
    "eps_estimate_current_year": -0.26,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 6.39,
    "fifty_two_week_high": 10.01,
    "fifty_two_week_low": 5.65,
    "percent_change_from_200_day_moving_average": -0.1576,
    "percent_change_from_50_day_moving_average": -0.0447,
    "shares_owned": "N/A",
    "short_ratio": 10.09,
    "two_hundred_day_moving_average": 7.24,
    "volume": 462604.0,
    "market_cap": 486450000.0,
    "price_to_sales_ttm": 1.3,
    "price_to_book_mrq": 6.51,
    "roa_ttm": -0.024300000000000002,
    "roe_ttm": -0.46130000000000004,
    "shares_outstanding": 79750000.0,
    "pcnt_held_by_insiders": 0.022099999999999998,
    "pcnt_held_by_institutions": 1.079,
    "pcnt_short_of_float": 0.2296,
    "operating_cash_flow_ttm": -16730000.0,
    "levered_cash_flow_ttm": -22890000.0,
    "book_value_per_share_mrq": 0.95,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Accuray Incorporated"
  },
  "ARDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.28,
    "ebitda": -3640000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 7.25,
    "fifty_two_week_high": 10.54,
    "fifty_two_week_low": 6.17,
    "percent_change_from_200_day_moving_average": 0.0669,
    "percent_change_from_50_day_moving_average": 0.040999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 0.3,
    "two_hundred_day_moving_average": 7.08,
    "volume": 4522.0,
    "market_cap": 111190000.0,
    "price_to_sales_ttm": 3.31,
    "price_to_book_mrq": 2.96,
    "roa_ttm": -0.0449,
    "roe_ttm": -0.1041,
    "shares_outstanding": 14730000.0,
    "pcnt_held_by_insiders": 0.8362,
    "pcnt_held_by_institutions": 0.002,
    "pcnt_short_of_float": 0.0001,
    "operating_cash_flow_ttm": -1390000.0,
    "levered_cash_flow_ttm": 110120.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Aradigm Corporation"
  },
  "ARDX": {
    "p_e_ratio": 178.91,
    "peg_ratio": -0.65,
    "earnings_per_share": 0.12,
    "ebitda": 2170000.0,
    "eps_estimate_current_year": -1.08,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 19.22,
    "fifty_two_week_high": 35.48,
    "fifty_two_week_low": 7.95,
    "percent_change_from_200_day_moving_average": 0.38060000000000005,
    "percent_change_from_50_day_moving_average": 0.1075,
    "shares_owned": "N/A",
    "short_ratio": 8.16,
    "two_hundred_day_moving_average": 15.42,
    "volume": 108226.0,
    "market_cap": 551930000.0,
    "price_to_sales_ttm": 14.61,
    "price_to_book_mrq": 3.9,
    "roa_ttm": 0.0079,
    "roe_ttm": 0.015700000000000002,
    "shares_outstanding": 25920000.0,
    "pcnt_held_by_insiders": 0.44689999999999996,
    "pcnt_held_by_institutions": 0.08900000000000001,
    "pcnt_short_of_float": 0.1349,
    "operating_cash_flow_ttm": -47910000.0,
    "levered_cash_flow_ttm": -19070000.0,
    "book_value_per_share_mrq": 5.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ardelyx, Inc."
  },
  "ARGS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.44,
    "ebitda": -65750000.0,
    "eps_estimate_current_year": -3.52,
    "eps_estimate_next_quarter": -0.88,
    "fifty_day_moving_average": 5.8,
    "fifty_two_week_high": 10.56,
    "fifty_two_week_low": 4.11,
    "percent_change_from_200_day_moving_average": -0.2351,
    "percent_change_from_50_day_moving_average": -0.0392,
    "shares_owned": "N/A",
    "short_ratio": 8.42,
    "two_hundred_day_moving_average": 7.28,
    "volume": 10935.0,
    "market_cap": 115240000.0,
    "price_to_sales_ttm": 117.97,
    "price_to_book_mrq": 24.61,
    "roa_ttm": -0.6711,
    "roe_ttm": -2.0976,
    "shares_outstanding": 20690000.0,
    "pcnt_held_by_insiders": 0.6225,
    "pcnt_held_by_institutions": 0.22399999999999998,
    "pcnt_short_of_float": 0.0659,
    "operating_cash_flow_ttm": -54960000.0,
    "levered_cash_flow_ttm": -41450000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Argos Therapeutics, Inc."
  },
  "ARIA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.16,
    "earnings_per_share": -0.92,
    "ebitda": -157150000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 7.68,
    "fifty_two_week_high": 10.07,
    "fifty_two_week_low": 4.9,
    "percent_change_from_200_day_moving_average": -0.1417,
    "percent_change_from_50_day_moving_average": -0.0647,
    "shares_owned": "N/A",
    "short_ratio": 7.91,
    "two_hundred_day_moving_average": 8.37,
    "volume": 2008737.0,
    "market_cap": 1360000000.0,
    "price_to_sales_ttm": 10.26,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1989,
    "roe_ttm": -3.1504000000000003,
    "shares_outstanding": 188900000.0,
    "pcnt_held_by_insiders": 0.0803,
    "pcnt_held_by_institutions": 0.583,
    "pcnt_short_of_float": 0.2664,
    "operating_cash_flow_ttm": -40320000.0,
    "levered_cash_flow_ttm": -55100000.0,
    "book_value_per_share_mrq": -0.07,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ariad Pharmaceuticals Inc."
  },
  "ARNA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.29,
    "earnings_per_share": -0.41,
    "ebitda": -95380000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 3.01,
    "fifty_two_week_high": 6.28,
    "fifty_two_week_low": 2.52,
    "percent_change_from_200_day_moving_average": -0.3641,
    "percent_change_from_50_day_moving_average": -0.1487,
    "shares_owned": "N/A",
    "short_ratio": 8.38,
    "two_hundred_day_moving_average": 4.03,
    "volume": 1159337.0,
    "market_cap": 620140000.0,
    "price_to_sales_ttm": 16.3,
    "price_to_book_mrq": 5.89,
    "roa_ttm": -0.1979,
    "roe_ttm": -0.8928,
    "shares_outstanding": 242240000.0,
    "pcnt_held_by_insiders": 0.0046,
    "pcnt_held_by_institutions": 0.466,
    "pcnt_short_of_float": 0.11939999999999999,
    "operating_cash_flow_ttm": -95340000.0,
    "levered_cash_flow_ttm": -37110000.0,
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arena Pharmaceuticals, Inc."
  },
  "ARQL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.12,
    "earnings_per_share": -0.29,
    "ebitda": -19190000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 1.73,
    "fifty_two_week_high": 2.5,
    "fifty_two_week_low": 1.04,
    "percent_change_from_200_day_moving_average": 0.08900000000000001,
    "percent_change_from_50_day_moving_average": 0.1825,
    "shares_owned": "N/A",
    "short_ratio": 6.94,
    "two_hundred_day_moving_average": 1.87,
    "volume": 190506.0,
    "market_cap": 128280000.0,
    "price_to_sales_ttm": 11.24,
    "price_to_book_mrq": 3.88,
    "roa_ttm": -0.1881,
    "roe_ttm": -0.44880000000000003,
    "shares_outstanding": 62880000.0,
    "pcnt_held_by_insiders": 0.1257,
    "pcnt_held_by_institutions": 0.506,
    "pcnt_short_of_float": 0.0158,
    "operating_cash_flow_ttm": -27740000.0,
    "levered_cash_flow_ttm": -12360000.0,
    "book_value_per_share_mrq": 0.53,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ArQule Inc."
  },
  "ARRY": {
    "p_e_ratio": 73.77,
    "peg_ratio": -1.04,
    "earnings_per_share": 0.07,
    "ebitda": -101260000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 5.72,
    "fifty_two_week_high": 8.59,
    "fifty_two_week_low": 2.98,
    "percent_change_from_200_day_moving_average": -0.25989999999999996,
    "percent_change_from_50_day_moving_average": -0.1097,
    "shares_owned": "N/A",
    "short_ratio": 14.95,
    "two_hundred_day_moving_average": 6.88,
    "volume": 1081258.0,
    "market_cap": 724420000.0,
    "price_to_sales_ttm": 14.19,
    "price_to_book_mrq": 17.27,
    "roa_ttm": -0.3918,
    "roe_ttm": 1.1067,
    "shares_outstanding": 142320000.0,
    "pcnt_held_by_insiders": 0.16469999999999999,
    "pcnt_held_by_institutions": 0.861,
    "pcnt_short_of_float": 0.21420000000000003,
    "operating_cash_flow_ttm": -5790000.0,
    "levered_cash_flow_ttm": -69300000.0,
    "book_value_per_share_mrq": 0.3,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Array BioPharma Inc."
  },
  "ARWR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.65,
    "earnings_per_share": -1.61,
    "ebitda": -76660000.0,
    "eps_estimate_current_year": -1.58,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 6.05,
    "fifty_two_week_high": 15.88,
    "fifty_two_week_low": 4.35,
    "percent_change_from_200_day_moving_average": 0.011000000000000001,
    "percent_change_from_50_day_moving_average": 0.1143,
    "shares_owned": "N/A",
    "short_ratio": 11.52,
    "two_hundred_day_moving_average": 6.67,
    "volume": 2050524.0,
    "market_cap": 401040000.0,
    "price_to_sales_ttm": 1098.1,
    "price_to_book_mrq": 3.19,
    "roa_ttm": -0.2867,
    "roe_ttm": -0.5663,
    "shares_outstanding": 59500000.0,
    "pcnt_held_by_insiders": 0.060599999999999994,
    "pcnt_held_by_institutions": 0.764,
    "pcnt_short_of_float": 0.2639,
    "operating_cash_flow_ttm": -64610000.0,
    "levered_cash_flow_ttm": -41000000.0,
    "book_value_per_share_mrq": 2.21,
    "next_earnings_announcement_date": [
      "2015-11-23",
      "2015-11-27"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arrowhead Research Corp."
  },
  "ASMB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.66,
    "ebitda": -31190000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 13.65,
    "fifty_two_week_high": 20.5,
    "fifty_two_week_low": 6.51,
    "percent_change_from_200_day_moving_average": -0.17550000000000002,
    "percent_change_from_50_day_moving_average": -0.07150000000000001,
    "shares_owned": "N/A",
    "short_ratio": 7.01,
    "two_hundred_day_moving_average": 15.37,
    "volume": 89346.0,
    "market_cap": 217800000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.66,
    "roa_ttm": -0.2345,
    "roe_ttm": -0.4146,
    "shares_outstanding": 17190000.0,
    "pcnt_held_by_insiders": 0.0097,
    "pcnt_held_by_institutions": 0.204,
    "pcnt_short_of_float": 0.0834,
    "operating_cash_flow_ttm": -15520000.0,
    "levered_cash_flow_ttm": -3120000.0,
    "book_value_per_share_mrq": 7.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Assembly Biosciences, Inc."
  },
  "ASND": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.39,
    "earnings_per_share": -0.97,
    "ebitda": -33060000.000000004,
    "eps_estimate_current_year": -2.14,
    "eps_estimate_next_quarter": -0.67,
    "fifty_day_moving_average": 19.31,
    "fifty_two_week_high": 23.81,
    "fifty_two_week_low": 14.75,
    "percent_change_from_200_day_moving_average": 0.0429,
    "percent_change_from_50_day_moving_average": -0.0043,
    "shares_owned": "N/A",
    "short_ratio": 3.53,
    "two_hundred_day_moving_average": 18.44,
    "volume": 23385.0,
    "market_cap": 465290000.0,
    "price_to_sales_ttm": 41.67,
    "price_to_book_mrq": 3.1,
    "roa_ttm": -0.2214,
    "roe_ttm": -0.29510000000000003,
    "shares_outstanding": 24200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -36230000.0,
    "levered_cash_flow_ttm": -27010000.0,
    "book_value_per_share_mrq": 6.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ascendis Pharma A/S"
  },
  "AST": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.36,
    "ebitda": -13620000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 4.5,
    "fifty_two_week_high": 15.1,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": -0.2579,
    "percent_change_from_50_day_moving_average": 0.1907,
    "shares_owned": "N/A",
    "short_ratio": 12.54,
    "two_hundred_day_moving_average": 7.22,
    "volume": 118594.0,
    "market_cap": 201550000.0,
    "price_to_sales_ttm": 78.9,
    "price_to_book_mrq": 4.55,
    "roa_ttm": -0.193,
    "roe_ttm": -0.28859999999999997,
    "shares_outstanding": 37600000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1769,
    "operating_cash_flow_ttm": -14390000.0,
    "levered_cash_flow_ttm": -15460000.0,
    "book_value_per_share_mrq": 1.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Asterias Biotherapeutics, Inc."
  },
  "ATEC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.22,
    "earnings_per_share": -0.149,
    "ebitda": 23010000.0,
    "eps_estimate_current_year": -0.16,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 0.587,
    "fifty_two_week_high": 1.8,
    "fifty_two_week_low": 0.365,
    "percent_change_from_200_day_moving_average": -0.6926399999999999,
    "percent_change_from_50_day_moving_average": -0.37835,
    "shares_owned": "N/A",
    "short_ratio": 7.93,
    "two_hundred_day_moving_average": 1.188,
    "volume": 164013.0,
    "market_cap": 36440000.0,
    "price_to_sales_ttm": 0.2,
    "price_to_book_mrq": 0.3,
    "roa_ttm": 0.0085,
    "roe_ttm": -0.06860000000000001,
    "shares_outstanding": 99850000.0,
    "pcnt_held_by_insiders": 0.35,
    "pcnt_held_by_institutions": 0.28,
    "pcnt_short_of_float": 0.0426,
    "operating_cash_flow_ttm": 8180000.0,
    "levered_cash_flow_ttm": 142880.0,
    "book_value_per_share_mrq": 1.35,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Alphatec Holdings, Inc."
  },
  "ATHX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.16,
    "earnings_per_share": -0.33,
    "ebitda": -27950000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.18,
    "fifty_two_week_high": 3.43,
    "fifty_two_week_low": 0.9,
    "percent_change_from_200_day_moving_average": -0.1648,
    "percent_change_from_50_day_moving_average": 0.1099,
    "shares_owned": "N/A",
    "short_ratio": 8.22,
    "two_hundred_day_moving_average": 1.57,
    "volume": 209403.0,
    "market_cap": 108880000.0,
    "price_to_sales_ttm": 76.07,
    "price_to_book_mrq": 5.25,
    "roa_ttm": -0.45530000000000004,
    "roe_ttm": -0.9488,
    "shares_outstanding": 83120000.0,
    "pcnt_held_by_insiders": 0.19469999999999998,
    "pcnt_held_by_institutions": 0.174,
    "pcnt_short_of_float": 0.0388,
    "operating_cash_flow_ttm": -17110000.0,
    "levered_cash_flow_ttm": -6820000.0,
    "book_value_per_share_mrq": 0.26,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Athersys, Inc."
  },
  "ATNM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.687,
    "ebitda": -29130000.0,
    "eps_estimate_current_year": -0.69,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 2.174,
    "fifty_two_week_high": 8.12,
    "fifty_two_week_low": 1.52,
    "percent_change_from_200_day_moving_average": -0.12304999999999999,
    "percent_change_from_50_day_moving_average": 0.04186,
    "shares_owned": "N/A",
    "short_ratio": 2.74,
    "two_hundred_day_moving_average": 2.583,
    "volume": 254696.0,
    "market_cap": 92040000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.05,
    "roa_ttm": -0.8733,
    "roe_ttm": -1.5966999999999998,
    "shares_outstanding": 40640000.0,
    "pcnt_held_by_insiders": 0.22510000000000002,
    "pcnt_held_by_institutions": 0.051,
    "pcnt_short_of_float": 0.1002,
    "operating_cash_flow_ttm": -20370000.0,
    "levered_cash_flow_ttm": -17660000.0,
    "book_value_per_share_mrq": 0.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Actinium Pharmaceuticals, Inc."
  },
  "ATOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.62,
    "ebitda": -12720000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.89,
    "fifty_two_week_high": 2.65,
    "fifty_two_week_low": 0.7,
    "percent_change_from_200_day_moving_average": -0.3983,
    "percent_change_from_50_day_moving_average": -0.1166,
    "shares_owned": "N/A",
    "short_ratio": 4.18,
    "two_hundred_day_moving_average": 1.31,
    "volume": 121965.0,
    "market_cap": 22950000.0,
    "price_to_sales_ttm": 4.65,
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.4525,
    "roe_ttm": -0.9904000000000001,
    "shares_outstanding": 29050000.0,
    "pcnt_held_by_insiders": 0.1956,
    "pcnt_held_by_institutions": 0.024,
    "pcnt_short_of_float": 0.0268,
    "operating_cash_flow_ttm": -12220000.0,
    "levered_cash_flow_ttm": -7510000.0,
    "book_value_per_share_mrq": 0.45,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Atossa Genetics, Inc."
  },
  "ATRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.55,
    "ebitda": -36450000.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.59,
    "fifty_day_moving_average": 46.0,
    "fifty_two_week_high": 65.56,
    "fifty_two_week_low": 9.66,
    "percent_change_from_200_day_moving_average": -0.0697,
    "percent_change_from_50_day_moving_average": -0.0642,
    "shares_owned": "N/A",
    "short_ratio": 6.89,
    "two_hundred_day_moving_average": 46.27,
    "volume": 173427.0,
    "market_cap": 1230000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.99,
    "roa_ttm": -0.2076,
    "roe_ttm": -0.3947,
    "shares_outstanding": 28510000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1186,
    "operating_cash_flow_ttm": -21910000.0,
    "levered_cash_flow_ttm": -6980000.0,
    "book_value_per_share_mrq": 6.18,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Atara Biotherapeutics, Inc."
  },
  "ATRC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.43,
    "earnings_per_share": -0.59,
    "ebitda": -18120000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 25.79,
    "fifty_two_week_high": 28.15,
    "fifty_two_week_low": 13.19,
    "percent_change_from_200_day_moving_average": 0.0025,
    "percent_change_from_50_day_moving_average": -0.09300000000000001,
    "shares_owned": "N/A",
    "short_ratio": 16.67,
    "two_hundred_day_moving_average": 23.33,
    "volume": 231728.0,
    "market_cap": 667490000.0,
    "price_to_sales_ttm": 5.66,
    "price_to_book_mrq": 5.18,
    "roa_ttm": -0.09269999999999999,
    "roe_ttm": -0.1215,
    "shares_outstanding": 28540000.0,
    "pcnt_held_by_insiders": 0.087,
    "pcnt_held_by_institutions": 0.826,
    "pcnt_short_of_float": 0.1176,
    "operating_cash_flow_ttm": -9620000.0,
    "levered_cash_flow_ttm": -10700000.0,
    "book_value_per_share_mrq": 4.51,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "AtriCure, Inc."
  },
  "ATRI": {
    "p_e_ratio": 25.61,
    "peg_ratio": 0.0,
    "earnings_per_share": 14.97,
    "ebitda": 51230000.0,
    "eps_estimate_current_year": 9.9,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 388.27,
    "fifty_two_week_high": 428.85,
    "fifty_two_week_low": 288.5,
    "percent_change_from_200_day_moving_average": 0.042199999999999994,
    "percent_change_from_50_day_moving_average": -0.0125,
    "shares_owned": "N/A",
    "short_ratio": 7.9,
    "two_hundred_day_moving_average": 367.88,
    "volume": 7438.0,
    "market_cap": 704850000.0,
    "price_to_sales_ttm": 4.88,
    "price_to_book_mrq": 5.13,
    "roa_ttm": 0.15990000000000001,
    "roe_ttm": 0.2,
    "shares_outstanding": 1840000.0,
    "pcnt_held_by_insiders": 0.2073,
    "pcnt_held_by_institutions": 0.514,
    "pcnt_short_of_float": 0.0537,
    "operating_cash_flow_ttm": 33910000.0,
    "levered_cash_flow_ttm": 20040000.0,
    "book_value_per_share_mrq": 75.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ATRION Corp."
  },
  "ATRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.19,
    "earnings_per_share": -0.19,
    "ebitda": -23930000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 1.88,
    "fifty_two_week_high": 3.04,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.183,
    "percent_change_from_50_day_moving_average": -0.014199999999999999,
    "shares_owned": "N/A",
    "short_ratio": 14.37,
    "two_hundred_day_moving_average": 2.26,
    "volume": 656791.0,
    "market_cap": 286390000.0,
    "price_to_sales_ttm": 7.51,
    "price_to_book_mrq": 3.66,
    "roa_ttm": -0.18230000000000002,
    "roe_ttm": -0.3849,
    "shares_outstanding": 154810000.0,
    "pcnt_held_by_insiders": 0.109,
    "pcnt_held_by_institutions": 0.389,
    "pcnt_short_of_float": 0.0784,
    "operating_cash_flow_ttm": -33060000.000000004,
    "levered_cash_flow_ttm": -31740000.0,
    "book_value_per_share_mrq": 0.5,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Antares Pharma Inc."
  },
  "AUPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.41,
    "ebitda": -19080000.0,
    "eps_estimate_current_year": -0.7,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 3.41,
    "fifty_two_week_high": 5.65,
    "fifty_two_week_low": 1.41,
    "percent_change_from_200_day_moving_average": -0.1116,
    "percent_change_from_50_day_moving_average": -0.030699999999999998,
    "shares_owned": "N/A",
    "short_ratio": 2.28,
    "two_hundred_day_moving_average": 3.73,
    "volume": 10062.0,
    "market_cap": 106800000.0,
    "price_to_sales_ttm": 410.43,
    "price_to_book_mrq": 3.82,
    "roa_ttm": -0.24600000000000002,
    "roe_ttm": -0.3274,
    "shares_outstanding": 32270000.000000004,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -15090000.0,
    "levered_cash_flow_ttm": -8320000.0,
    "book_value_per_share_mrq": 0.87,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Aurinia Pharmaceuticals Inc."
  },
  "AVEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.84,
    "ebitda": -24610000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.39,
    "fifty_two_week_high": 3.5,
    "fifty_two_week_low": 0.61,
    "percent_change_from_200_day_moving_average": -0.1617,
    "percent_change_from_50_day_moving_average": -0.0294,
    "shares_owned": "N/A",
    "short_ratio": 0.76,
    "two_hundred_day_moving_average": 1.61,
    "volume": 345519.0,
    "market_cap": 75220000.0,
    "price_to_sales_ttm": 58.95,
    "price_to_book_mrq": 6.58,
    "roa_ttm": -0.3154,
    "roe_ttm": -1.5349000000000002,
    "shares_outstanding": 55720000.0,
    "pcnt_held_by_insiders": 0.0438,
    "pcnt_held_by_institutions": 0.489,
    "pcnt_short_of_float": 0.04,
    "operating_cash_flow_ttm": -46280000.0,
    "levered_cash_flow_ttm": -13370000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "AVEO Pharmaceuticals, Inc."
  },
  "AVGR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.57,
    "ebitda": -30330000.0,
    "eps_estimate_current_year": -3.79,
    "eps_estimate_next_quarter": -0.89,
    "fifty_day_moving_average": 14.92,
    "fifty_two_week_high": 17.47,
    "fifty_two_week_low": 9.35,
    "percent_change_from_200_day_moving_average": 0.1401,
    "percent_change_from_50_day_moving_average": -0.0276,
    "shares_owned": "N/A",
    "short_ratio": 12.47,
    "two_hundred_day_moving_average": 12.73,
    "volume": 57296.0,
    "market_cap": 177610000.0,
    "price_to_sales_ttm": 15.77,
    "price_to_book_mrq": 5.08,
    "roa_ttm": -0.45549999999999996,
    "roe_ttm": "-1,298.70%",
    "shares_outstanding": 12240000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.091,
    "operating_cash_flow_ttm": -28140000.0,
    "levered_cash_flow_ttm": -16620000.000000002,
    "book_value_per_share_mrq": 2.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Avinger, Inc."
  },
  "AXDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.87,
    "ebitda": -38130000.0,
    "eps_estimate_current_year": -1.12,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 19.32,
    "fifty_two_week_high": 31.29,
    "fifty_two_week_low": 16.5,
    "percent_change_from_200_day_moving_average": -0.2182,
    "percent_change_from_50_day_moving_average": -0.0784,
    "shares_owned": "N/A",
    "short_ratio": 19.22,
    "two_hundred_day_moving_average": 22.77,
    "volume": 110931.0,
    "market_cap": 796060000.0,
    "price_to_sales_ttm": 6282.04,
    "price_to_book_mrq": 16.29,
    "roa_ttm": -0.36469999999999997,
    "roe_ttm": -0.6049,
    "shares_outstanding": 44720000.0,
    "pcnt_held_by_insiders": 0.4576,
    "pcnt_held_by_institutions": 0.21100000000000002,
    "pcnt_short_of_float": 0.3239,
    "operating_cash_flow_ttm": -27340000.0,
    "levered_cash_flow_ttm": -17540000.0,
    "book_value_per_share_mrq": 1.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Accelerate Diagnostics, Inc."
  },
  "AXGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.79,
    "ebitda": -8990000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 4.38,
    "fifty_two_week_high": 5.74,
    "fifty_two_week_low": 2.22,
    "percent_change_from_200_day_moving_average": 0.39990000000000003,
    "percent_change_from_50_day_moving_average": 0.1367,
    "shares_owned": "N/A",
    "short_ratio": 0.82,
    "two_hundred_day_moving_average": 3.56,
    "volume": 126535.0,
    "market_cap": 148370000.0,
    "price_to_sales_ttm": 6.15,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2407,
    "roe_ttm": "N/A",
    "shares_outstanding": 29790000.0,
    "pcnt_held_by_insiders": 0.4265,
    "pcnt_held_by_institutions": 0.19699999999999998,
    "pcnt_short_of_float": 0.0027,
    "operating_cash_flow_ttm": -10740000.0,
    "levered_cash_flow_ttm": -8700000.0,
    "book_value_per_share_mrq": -0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "AxoGen, Inc."
  },
  "AXN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.02,
    "ebitda": 5630000.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.57,
    "fifty_two_week_high": 3.48,
    "fifty_two_week_low": 0.18,
    "percent_change_from_200_day_moving_average": 0.015600000000000001,
    "percent_change_from_50_day_moving_average": 0.086,
    "shares_owned": "N/A",
    "short_ratio": 7.36,
    "two_hundred_day_moving_average": 1.68,
    "volume": 182962.0,
    "market_cap": 119390000.0,
    "price_to_sales_ttm": 5.6,
    "price_to_book_mrq": 20.87,
    "roa_ttm": 0.0669,
    "roe_ttm": -0.8066,
    "shares_outstanding": 69820000.0,
    "pcnt_held_by_insiders": 0.4359,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0252,
    "operating_cash_flow_ttm": 4590000.0,
    "levered_cash_flow_ttm": -3580000.0,
    "book_value_per_share_mrq": 0.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Aoxing Pharmaceutical Company, Inc."
  },
  "AXON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.16,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.18,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 13.0,
    "fifty_two_week_high": 31.17,
    "fifty_two_week_low": 9.99,
    "percent_change_from_200_day_moving_average": -0.0048,
    "percent_change_from_50_day_moving_average": 0.2242,
    "shares_owned": "N/A",
    "short_ratio": 6.53,
    "two_hundred_day_moving_average": 16.0,
    "volume": 270199.0,
    "market_cap": 1580000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.81,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 99150000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1935,
    "operating_cash_flow_ttm": -1640000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Axovant Sciences Ltd."
  },
  "BABY": {
    "p_e_ratio": 37.95,
    "peg_ratio": 1.29,
    "earnings_per_share": 1.12,
    "ebitda": 71970000.0,
    "eps_estimate_current_year": 1.51,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 42.26,
    "fifty_two_week_high": 46.98,
    "fifty_two_week_low": 27.8,
    "percent_change_from_200_day_moving_average": 0.04190000000000001,
    "percent_change_from_50_day_moving_average": 0.0049,
    "shares_owned": "N/A",
    "short_ratio": 10.69,
    "two_hundred_day_moving_average": 40.76,
    "volume": 179176.0,
    "market_cap": 1380000000.0,
    "price_to_sales_ttm": 3.73,
    "price_to_book_mrq": 3.65,
    "roa_ttm": 0.086,
    "roe_ttm": 0.1043,
    "shares_outstanding": 32500000.0,
    "pcnt_held_by_insiders": 0.043,
    "pcnt_held_by_institutions": 0.84,
    "pcnt_short_of_float": 0.0718,
    "operating_cash_flow_ttm": 42520000.0,
    "levered_cash_flow_ttm": 36310000.0,
    "book_value_per_share_mrq": 11.58,
    "next_earnings_announcement_date": [
      "2015-10-20",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Natus Medical Inc."
  },
  "BCLI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.58,
    "ebitda": -9560000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 3.06,
    "fifty_two_week_high": 8.47,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.2189,
    "percent_change_from_50_day_moving_average": -0.0575,
    "shares_owned": "N/A",
    "short_ratio": 4.71,
    "two_hundred_day_moving_average": 3.69,
    "volume": 265356.0,
    "market_cap": 53230000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.24,
    "roa_ttm": -0.36729999999999996,
    "roe_ttm": -0.6788,
    "shares_outstanding": 18480000.0,
    "pcnt_held_by_insiders": 0.0062,
    "pcnt_held_by_institutions": 0.002,
    "pcnt_short_of_float": 0.0431,
    "operating_cash_flow_ttm": -6710000.0,
    "levered_cash_flow_ttm": -3170000.0,
    "book_value_per_share_mrq": 0.97,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Brainstorm Cell Therapeutics Inc."
  },
  "BCRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.91,
    "earnings_per_share": -0.43,
    "ebitda": -35680000.0,
    "eps_estimate_current_year": -0.62,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 12.2,
    "fifty_two_week_high": 16.83,
    "fifty_two_week_low": 7.85,
    "percent_change_from_200_day_moving_average": 0.054299999999999994,
    "percent_change_from_50_day_moving_average": 0.038599999999999995,
    "shares_owned": "N/A",
    "short_ratio": 8.01,
    "two_hundred_day_moving_average": 12.02,
    "volume": 826924.0,
    "market_cap": 927940000.0,
    "price_to_sales_ttm": 22.1,
    "price_to_book_mrq": 12.0,
    "roa_ttm": -0.1534,
    "roe_ttm": -0.3691,
    "shares_outstanding": 73240000.0,
    "pcnt_held_by_insiders": 0.2481,
    "pcnt_held_by_institutions": 0.583,
    "pcnt_short_of_float": 0.20370000000000002,
    "operating_cash_flow_ttm": -8119999.999999999,
    "levered_cash_flow_ttm": -2810000.0,
    "book_value_per_share_mrq": 1.04,
    "next_earnings_announcement_date": "2015-11-05",
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioCryst Pharmaceuticals, Inc."
  },
  "BDSI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.36,
    "earnings_per_share": -1.37,
    "ebitda": -62660000.0,
    "eps_estimate_current_year": -0.22,
    "eps_estimate_next_quarter": 0.62,
    "fifty_day_moving_average": 6.84,
    "fifty_two_week_high": 18.33,
    "fifty_two_week_low": 5.89,
    "percent_change_from_200_day_moving_average": -0.25170000000000003,
    "percent_change_from_50_day_moving_average": -0.034300000000000004,
    "shares_owned": "N/A",
    "short_ratio": 8.41,
    "two_hundred_day_moving_average": 8.83,
    "volume": 1881269.0,
    "market_cap": 346770000.0,
    "price_to_sales_ttm": 19.06,
    "price_to_book_mrq": 10.45,
    "roa_ttm": -0.42310000000000003,
    "roe_ttm": -1.4539,
    "shares_outstanding": 52460000.0,
    "pcnt_held_by_insiders": 0.0909,
    "pcnt_held_by_institutions": 0.7390000000000001,
    "pcnt_short_of_float": 0.2477,
    "operating_cash_flow_ttm": -39440000.0,
    "levered_cash_flow_ttm": -22200000.0,
    "book_value_per_share_mrq": 0.67,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioDelivery Sciences International, Inc."
  },
  "BEAT": {
    "p_e_ratio": 1096.92,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.01,
    "ebitda": 21540000.0,
    "eps_estimate_current_year": 0.41,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 13.98,
    "fifty_two_week_high": 16.96,
    "fifty_two_week_low": 6.46,
    "percent_change_from_200_day_moving_average": 0.3209,
    "percent_change_from_50_day_moving_average": 0.019799999999999998,
    "shares_owned": "N/A",
    "short_ratio": 3.33,
    "two_hundred_day_moving_average": 10.8,
    "volume": 244861.0,
    "market_cap": 386710000.0,
    "price_to_sales_ttm": 2.35,
    "price_to_book_mrq": 5.79,
    "roa_ttm": 0.0473,
    "roe_ttm": 0.006500000000000001,
    "shares_outstanding": 27120000.0,
    "pcnt_held_by_insiders": 0.1559,
    "pcnt_held_by_institutions": 0.648,
    "pcnt_short_of_float": 0.0537,
    "operating_cash_flow_ttm": 7930000.0,
    "levered_cash_flow_ttm": 1470000.0,
    "book_value_per_share_mrq": 2.48,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "BioTelemetry, Inc."
  },
  "BGMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.822,
    "ebitda": -5530000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.8411,
    "fifty_two_week_high": 4.88,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.806431,
    "percent_change_from_50_day_moving_average": -0.47749699999999995,
    "shares_owned": "N/A",
    "short_ratio": 2.66,
    "two_hundred_day_moving_average": 2.2705,
    "volume": 103634.0,
    "market_cap": 3810000.0,
    "price_to_sales_ttm": 1.71,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5596,
    "roe_ttm": -8.828899999999999,
    "shares_outstanding": 8660000.0,
    "pcnt_held_by_insiders": 0.3711,
    "pcnt_held_by_institutions": 0.127,
    "pcnt_short_of_float": 0.1014,
    "operating_cash_flow_ttm": -5390000.0,
    "levered_cash_flow_ttm": -2710000.0,
    "book_value_per_share_mrq": -0.27,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "BG Medicine, Inc."
  },
  "BIND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.91,
    "ebitda": -32880000.000000004,
    "eps_estimate_current_year": -1.91,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 4.65,
    "fifty_two_week_high": 10.75,
    "fifty_two_week_low": 4.09,
    "percent_change_from_200_day_moving_average": -0.2021,
    "percent_change_from_50_day_moving_average": -0.0388,
    "shares_owned": "N/A",
    "short_ratio": 6.86,
    "two_hundred_day_moving_average": 5.6,
    "volume": 61336.0,
    "market_cap": 92740000.0,
    "price_to_sales_ttm": 7.14,
    "price_to_book_mrq": 2.81,
    "roa_ttm": -0.315,
    "roe_ttm": -0.7876000000000001,
    "shares_outstanding": 20750000.0,
    "pcnt_held_by_insiders": 0.4163,
    "pcnt_held_by_institutions": 0.281,
    "pcnt_short_of_float": 0.044800000000000006,
    "operating_cash_flow_ttm": -32159999.999999996,
    "levered_cash_flow_ttm": -21160000.0,
    "book_value_per_share_mrq": 1.63,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BIND Therapeutics, Inc."
  },
  "BIO": {
    "p_e_ratio": 41.72,
    "peg_ratio": 3.95,
    "earnings_per_share": 3.31,
    "ebitda": 312020000.0,
    "eps_estimate_current_year": 3.54,
    "eps_estimate_next_quarter": 1.34,
    "fifty_day_moving_average": 141.72,
    "fifty_two_week_high": 152.38,
    "fifty_two_week_low": 102.71,
    "percent_change_from_200_day_moving_average": -0.0334,
    "percent_change_from_50_day_moving_average": -0.0258,
    "shares_owned": "N/A",
    "short_ratio": 7.4,
    "two_hundred_day_moving_average": 142.84,
    "volume": 97335.0,
    "market_cap": 4030000000.0000005,
    "price_to_sales_ttm": 1.91,
    "price_to_book_mrq": 1.7,
    "roa_ttm": 0.0305,
    "roe_ttm": 0.042,
    "shares_outstanding": 24050000.0,
    "pcnt_held_by_insiders": 0.9390999999999999,
    "pcnt_held_by_institutions": 0.006,
    "pcnt_short_of_float": 0.051,
    "operating_cash_flow_ttm": 198850000.0,
    "levered_cash_flow_ttm": 152290000.0,
    "book_value_per_share_mrq": 80.89,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Bio-Rad Laboratories, Inc."
  },
  "BIOC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.06,
    "earnings_per_share": -1.67,
    "ebitda": -14730000.0,
    "eps_estimate_current_year": 0.4,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 2.11,
    "fifty_two_week_high": 4.91,
    "fifty_two_week_low": 1.09,
    "percent_change_from_200_day_moving_average": -0.0124,
    "percent_change_from_50_day_moving_average": 0.2097,
    "shares_owned": "N/A",
    "short_ratio": 3.34,
    "two_hundred_day_moving_average": 2.58,
    "volume": 150730.0,
    "market_cap": 47690000.0,
    "price_to_sales_ttm": 151.34,
    "price_to_book_mrq": 4.27,
    "roa_ttm": -0.5913,
    "roe_ttm": -1.7372,
    "shares_outstanding": 18700000.0,
    "pcnt_held_by_insiders": 0.4715,
    "pcnt_held_by_institutions": 0.091,
    "pcnt_short_of_float": 0.1378,
    "operating_cash_flow_ttm": -13860000.0,
    "levered_cash_flow_ttm": -7420000.0,
    "book_value_per_share_mrq": 0.59,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Biocept, Inc."
  },
  "BIOD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.57,
    "ebitda": -19690000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 0.76,
    "fifty_two_week_high": 2.0,
    "fifty_two_week_low": 0.55,
    "percent_change_from_200_day_moving_average": -0.353,
    "percent_change_from_50_day_moving_average": -0.1188,
    "shares_owned": "N/A",
    "short_ratio": 5.37,
    "two_hundred_day_moving_average": 1.04,
    "volume": 165609.0,
    "market_cap": 41640000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.97,
    "roa_ttm": -0.35350000000000004,
    "roe_ttm": -0.5579999999999999,
    "shares_outstanding": 62150000.0,
    "pcnt_held_by_insiders": 0.10210000000000001,
    "pcnt_held_by_institutions": 0.23800000000000002,
    "pcnt_short_of_float": 0.0425,
    "operating_cash_flow_ttm": -18080000.0,
    "levered_cash_flow_ttm": -10630000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": [
      "2015-12-15",
      "2015-12-21"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Biodel Inc."
  },
  "BIOL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.2,
    "earnings_per_share": -0.38,
    "ebitda": -15160000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.51,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 1.29,
    "percent_change_from_200_day_moving_average": -0.2586,
    "percent_change_from_50_day_moving_average": -0.1242,
    "shares_owned": "N/A",
    "short_ratio": 53.96,
    "two_hundred_day_moving_average": 1.78,
    "volume": 36426.0,
    "market_cap": 76810000.0,
    "price_to_sales_ttm": 1.6,
    "price_to_book_mrq": 2.49,
    "roa_ttm": -0.2546,
    "roe_ttm": -1.1825,
    "shares_outstanding": 58190000.0,
    "pcnt_held_by_insiders": 0.3111,
    "pcnt_held_by_institutions": 0.253,
    "pcnt_short_of_float": 0.0848,
    "operating_cash_flow_ttm": -24340000.0,
    "levered_cash_flow_ttm": -14960000.0,
    "book_value_per_share_mrq": 0.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "BIOLASE, Inc."
  },
  "BIOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.55,
    "earnings_per_share": -5.43,
    "ebitda": -52130000.0,
    "eps_estimate_current_year": -0.39,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 2.31,
    "fifty_two_week_high": 7.22,
    "fifty_two_week_low": 1.3,
    "percent_change_from_200_day_moving_average": -0.24420000000000003,
    "percent_change_from_50_day_moving_average": 0.1547,
    "shares_owned": "N/A",
    "short_ratio": 11.6,
    "two_hundred_day_moving_average": 3.53,
    "volume": 958803.0,
    "market_cap": 183510000.0,
    "price_to_sales_ttm": 0.19,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0623,
    "roe_ttm": -2.1751,
    "shares_outstanding": 68730000.0,
    "pcnt_held_by_insiders": 0.0816,
    "pcnt_held_by_institutions": 0.94,
    "pcnt_short_of_float": 0.3257,
    "operating_cash_flow_ttm": -46600000.0,
    "levered_cash_flow_ttm": 13200000.0,
    "book_value_per_share_mrq": -0.63,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "BioScrip, Inc."
  },
  "BITI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.11,
    "ebitda": -19430000.0,
    "eps_estimate_current_year": -2.88,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 17.273,
    "fifty_two_week_high": 25.39,
    "fifty_two_week_low": 15.56,
    "percent_change_from_200_day_moving_average": -0.15569,
    "percent_change_from_50_day_moving_average": -0.09597,
    "shares_owned": "N/A",
    "short_ratio": 2.13,
    "two_hundred_day_moving_average": 18.494,
    "volume": 21204.0,
    "market_cap": 191450000.0,
    "price_to_sales_ttm": 15.47,
    "price_to_book_mrq": 116.33,
    "roa_ttm": -0.0794,
    "roe_ttm": -0.4535,
    "shares_outstanding": 12260000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -19510000.0,
    "levered_cash_flow_ttm": -8279999.999999999,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Biotie Therapies Corp."
  },
  "BKD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.75,
    "earnings_per_share": -2.02,
    "ebitda": 791890000.0,
    "eps_estimate_current_year": 2.41,
    "eps_estimate_next_quarter": 0.6,
    "fifty_day_moving_average": 28.02,
    "fifty_two_week_high": 39.89,
    "fifty_two_week_low": 25.79,
    "percent_change_from_200_day_moving_average": -0.2416,
    "percent_change_from_50_day_moving_average": -0.0757,
    "shares_owned": "N/A",
    "short_ratio": 2.86,
    "two_hundred_day_moving_average": 34.15,
    "volume": 2338842.0,
    "market_cap": 4780000000.0,
    "price_to_sales_ttm": 1.17,
    "price_to_book_mrq": 1.81,
    "roa_ttm": -0.0034999999999999996,
    "roe_ttm": -0.1934,
    "shares_outstanding": 184520000.0,
    "pcnt_held_by_insiders": 0.0579,
    "pcnt_held_by_institutions": 0.635,
    "pcnt_short_of_float": 0.0617,
    "operating_cash_flow_ttm": 209260000.0,
    "levered_cash_flow_ttm": -228560000.0,
    "book_value_per_share_mrq": 14.55,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Brookdale Senior Living Inc."
  },
  "BLCM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.62,
    "ebitda": -26870000.0,
    "eps_estimate_current_year": -1.42,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 17.91,
    "fifty_two_week_high": 33.63,
    "fifty_two_week_low": 15.05,
    "percent_change_from_200_day_moving_average": -0.2164,
    "percent_change_from_50_day_moving_average": -0.039900000000000005,
    "shares_owned": "N/A",
    "short_ratio": 7.76,
    "two_hundred_day_moving_average": 21.95,
    "volume": 198459.0,
    "market_cap": 455690000.0,
    "price_to_sales_ttm": 531.38,
    "price_to_book_mrq": 2.59,
    "roa_ttm": -0.1753,
    "roe_ttm": -1.013,
    "shares_outstanding": 26490000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1425,
    "operating_cash_flow_ttm": -67250000.0,
    "levered_cash_flow_ttm": -15590000.0,
    "book_value_per_share_mrq": 6.7,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bellicum Pharmaceuticals, Inc."
  },
  "BLFS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.31,
    "ebitda": -3890000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 2.19,
    "fifty_two_week_high": 4.44,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": 0.053,
    "percent_change_from_50_day_moving_average": -0.019,
    "shares_owned": "N/A",
    "short_ratio": 0.21,
    "two_hundred_day_moving_average": 2.04,
    "volume": 48019.0,
    "market_cap": 26130000.0,
    "price_to_sales_ttm": 4.46,
    "price_to_book_mrq": 2.63,
    "roa_ttm": -0.18289999999999998,
    "roe_ttm": -0.3292,
    "shares_outstanding": 12150000.0,
    "pcnt_held_by_insiders": 0.4826,
    "pcnt_held_by_institutions": 0.009000000000000001,
    "pcnt_short_of_float": 0.0401,
    "operating_cash_flow_ttm": -3930000.0,
    "levered_cash_flow_ttm": -3380000.0,
    "book_value_per_share_mrq": 0.82,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "BioLife Solutions, Inc."
  },
  "BLPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.42,
    "ebitda": -52440000.0,
    "eps_estimate_current_year": -3.93,
    "eps_estimate_next_quarter": -0.92,
    "fifty_day_moving_average": 4.18,
    "fifty_two_week_high": 12.92,
    "fifty_two_week_low": 2.75,
    "percent_change_from_200_day_moving_average": -0.4861,
    "percent_change_from_50_day_moving_average": -0.0667,
    "shares_owned": "N/A",
    "short_ratio": 1.64,
    "two_hundred_day_moving_average": 7.59,
    "volume": 2862.0,
    "market_cap": 50360000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.98,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 12910000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.016,
    "operating_cash_flow_ttm": -45190000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bellerophon Therapeutics LLC"
  },
  "BLRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.33,
    "ebitda": -16469999.999999998,
    "eps_estimate_current_year": -0.36,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.57,
    "fifty_two_week_high": 3.28,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.11449999999999999,
    "percent_change_from_50_day_moving_average": 0.1003,
    "shares_owned": "N/A",
    "short_ratio": 2.07,
    "two_hundred_day_moving_average": 1.95,
    "volume": 70876.0,
    "market_cap": 94380000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.2243,
    "roe_ttm": -0.33130000000000004,
    "shares_outstanding": 54560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -14350000.0,
    "levered_cash_flow_ttm": -9670000.0,
    "book_value_per_share_mrq": 0.95,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "BioLineRx, Ltd."
  },
  "BLUE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -3.68,
    "ebitda": -93620000.0,
    "eps_estimate_current_year": -4.16,
    "eps_estimate_next_quarter": -0.98,
    "fifty_day_moving_average": 134.18,
    "fifty_two_week_high": 197.35,
    "fifty_two_week_low": 29.73,
    "percent_change_from_200_day_moving_average": -0.2316,
    "percent_change_from_50_day_moving_average": -0.1551,
    "shares_owned": "N/A",
    "short_ratio": 3.06,
    "two_hundred_day_moving_average": 147.55,
    "volume": 1169958.0,
    "market_cap": 4110000000.0000005,
    "price_to_sales_ttm": 180.81,
    "price_to_book_mrq": 4.69,
    "roa_ttm": -0.1012,
    "roe_ttm": -0.2086,
    "shares_outstanding": 36260000.0,
    "pcnt_held_by_insiders": 0.19699999999999998,
    "pcnt_held_by_institutions": 0.664,
    "pcnt_short_of_float": 0.1288,
    "operating_cash_flow_ttm": -72710000.0,
    "levered_cash_flow_ttm": -44630000.0,
    "book_value_per_share_mrq": 25.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "bluebird bio, Inc."
  },
  "BONE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -1.73,
    "ebitda": -4890000.0,
    "eps_estimate_current_year": -1.38,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 3.69,
    "fifty_two_week_high": 4.98,
    "fifty_two_week_low": 2.19,
    "percent_change_from_200_day_moving_average": -0.0053,
    "percent_change_from_50_day_moving_average": 0.0095,
    "shares_owned": "N/A",
    "short_ratio": 0.71,
    "two_hundred_day_moving_average": 3.75,
    "volume": 1234.0,
    "market_cap": 43810000.0,
    "price_to_sales_ttm": 1.19,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.13570000000000002,
    "roe_ttm": "N/A",
    "shares_outstanding": 11750000.0,
    "pcnt_held_by_insiders": 0.2391,
    "pcnt_held_by_institutions": 0.23199999999999998,
    "pcnt_short_of_float": 0.0113,
    "operating_cash_flow_ttm": -7540000.0,
    "levered_cash_flow_ttm": -3020000.0,
    "book_value_per_share_mrq": -1.59,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Xtant Medical Holdings, Inc."
  },
  "BOTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.54,
    "ebitda": -7100000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.2,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 1.92,
    "percent_change_from_200_day_moving_average": -0.0977,
    "percent_change_from_50_day_moving_average": -0.0767,
    "shares_owned": "N/A",
    "short_ratio": 0.56,
    "two_hundred_day_moving_average": 2.25,
    "volume": 49057.0,
    "market_cap": 78380000.0,
    "price_to_sales_ttm": 3.15,
    "price_to_book_mrq": 1.12,
    "roa_ttm": -0.053,
    "roe_ttm": -0.24420000000000003,
    "shares_outstanding": 38610000.0,
    "pcnt_held_by_insiders": 0.1324,
    "pcnt_held_by_institutions": 0.43,
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": -9600000.0,
    "levered_cash_flow_ttm": -13930000.0,
    "book_value_per_share_mrq": 1.8,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Biota Pharmaceuticals, Inc."
  },
  "BPMC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.92,
    "ebitda": -47570000.0,
    "eps_estimate_current_year": -2.65,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 28.03,
    "fifty_two_week_high": 37.17,
    "fifty_two_week_low": 19.96,
    "percent_change_from_200_day_moving_average": -0.1549,
    "percent_change_from_50_day_moving_average": -0.1277,
    "shares_owned": "N/A",
    "short_ratio": 12.37,
    "two_hundred_day_moving_average": 28.93,
    "volume": 346515.0,
    "market_cap": 662890000.0,
    "price_to_sales_ttm": 204.05,
    "price_to_book_mrq": 3.95,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 27110000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.08310000000000001,
    "operating_cash_flow_ttm": -26310000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.35,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Blueprint Medicines Corporation"
  },
  "BPMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.47,
    "ebitda": -17350000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 1.68,
    "fifty_two_week_high": 4.5,
    "fifty_two_week_low": 1.2,
    "percent_change_from_200_day_moving_average": -0.33130000000000004,
    "percent_change_from_50_day_moving_average": -0.1052,
    "shares_owned": "N/A",
    "short_ratio": 1.01,
    "two_hundred_day_moving_average": 2.24,
    "volume": 22991.0,
    "market_cap": 31520000.0,
    "price_to_sales_ttm": 1500.71,
    "price_to_book_mrq": 7.25,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 21010000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.006999999999999999,
    "operating_cash_flow_ttm": -11410000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.21,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioPharmX Corporation"
  },
  "BPTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.06,
    "ebitda": -5080000.0,
    "eps_estimate_current_year": -0.04,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.15,
    "fifty_two_week_high": 3.02,
    "fifty_two_week_low": 0.99,
    "percent_change_from_200_day_moving_average": -0.2305,
    "percent_change_from_50_day_moving_average": -0.1066,
    "shares_owned": "N/A",
    "short_ratio": 6.18,
    "two_hundred_day_moving_average": 1.34,
    "volume": 138297.0,
    "market_cap": 92460000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.86,
    "roa_ttm": -0.2148,
    "roe_ttm": -0.35409999999999997,
    "shares_outstanding": 89760000.0,
    "pcnt_held_by_insiders": 0.2323,
    "pcnt_held_by_institutions": 0.23199999999999998,
    "pcnt_short_of_float": 0.0078000000000000005,
    "operating_cash_flow_ttm": -4950000.0,
    "levered_cash_flow_ttm": -3120000.0,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Bio-Path Holdings, Inc."
  },
  "BRKR": {
    "p_e_ratio": 50.49,
    "peg_ratio": 1.78,
    "earnings_per_share": 0.35,
    "ebitda": 207500000.0,
    "eps_estimate_current_year": 0.76,
    "eps_estimate_next_quarter": 0.3,
    "fifty_day_moving_average": 18.94,
    "fifty_two_week_high": 22.32,
    "fifty_two_week_low": 17.26,
    "percent_change_from_200_day_moving_average": -0.10880000000000001,
    "percent_change_from_50_day_moving_average": -0.0672,
    "shares_owned": "N/A",
    "short_ratio": 6.72,
    "two_hundred_day_moving_average": 19.83,
    "volume": 454514.0,
    "market_cap": 2970000000.0,
    "price_to_sales_ttm": 1.78,
    "price_to_book_mrq": 3.92,
    "roa_ttm": 0.049400000000000006,
    "roe_ttm": 0.076,
    "shares_outstanding": 168150000.0,
    "pcnt_held_by_insiders": 0.3439,
    "pcnt_held_by_institutions": 0.6779999999999999,
    "pcnt_short_of_float": 0.057300000000000004,
    "operating_cash_flow_ttm": 108300000.0,
    "levered_cash_flow_ttm": 168060000.0,
    "book_value_per_share_mrq": 4.53,
    "next_earnings_announcement_date": "2015-11-03",
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Bruker Corporation"
  },
  "BSPM": {
    "p_e_ratio": 4.7356,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.146,
    "ebitda": 2120000.0,
    "eps_estimate_current_year": 0.6,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.6843,
    "fifty_two_week_high": 1.9,
    "fifty_two_week_low": 0.61,
    "percent_change_from_200_day_moving_average": -0.352385,
    "percent_change_from_50_day_moving_average": 0.010396,
    "shares_owned": "N/A",
    "short_ratio": 4.35,
    "two_hundred_day_moving_average": 1.0676,
    "volume": 85377.0,
    "market_cap": 10700000.0,
    "price_to_sales_ttm": 0.22,
    "price_to_book_mrq": 0.15,
    "roa_ttm": -0.0028000000000000004,
    "roe_ttm": 0.0321,
    "shares_outstanding": 15480000.0,
    "pcnt_held_by_insiders": 0.21530000000000002,
    "pcnt_held_by_institutions": 0.05,
    "pcnt_short_of_float": 0.0125,
    "operating_cash_flow_ttm": 2710000.0,
    "levered_cash_flow_ttm": -4380000.0,
    "book_value_per_share_mrq": 4.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Biostar Pharmaceuticals, Inc."
  },
  "BSTC": {
    "p_e_ratio": 53.33,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.04,
    "ebitda": 11420000.0,
    "eps_estimate_current_year": 1.89,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 52.75,
    "fifty_two_week_high": 72.07,
    "fifty_two_week_low": 32.88,
    "percent_change_from_200_day_moving_average": 0.1744,
    "percent_change_from_50_day_moving_average": 0.0495,
    "shares_owned": "N/A",
    "short_ratio": 2.33,
    "two_hundred_day_moving_average": 47.14,
    "volume": 78607.0,
    "market_cap": 379040000.0,
    "price_to_sales_ttm": 19.34,
    "price_to_book_mrq": 9.86,
    "roa_ttm": 0.2207,
    "roe_ttm": 0.2402,
    "shares_outstanding": 6850000.0,
    "pcnt_held_by_insiders": 0.4757,
    "pcnt_held_by_institutions": 0.309,
    "pcnt_short_of_float": 0.0698,
    "operating_cash_flow_ttm": 7250000.0,
    "levered_cash_flow_ttm": 6370000.0,
    "book_value_per_share_mrq": 5.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioSpecifics Technologies Corp."
  },
  "BTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -45210000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.09,
    "fifty_two_week_high": 5.95,
    "fifty_two_week_low": 2.2,
    "percent_change_from_200_day_moving_average": -0.1208,
    "percent_change_from_50_day_moving_average": 0.1728,
    "shares_owned": "N/A",
    "short_ratio": 26.03,
    "two_hundred_day_moving_average": 4.12,
    "volume": 195092.0,
    "market_cap": 286930000.0,
    "price_to_sales_ttm": 42.67,
    "price_to_book_mrq": 20.06,
    "roa_ttm": -0.4594,
    "roe_ttm": -0.8477,
    "shares_outstanding": 79260000.0,
    "pcnt_held_by_insiders": 0.5173,
    "pcnt_held_by_institutions": 0.11699999999999999,
    "pcnt_short_of_float": 0.1149,
    "operating_cash_flow_ttm": -36760000.0,
    "levered_cash_flow_ttm": -20760000.0,
    "book_value_per_share_mrq": 0.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioTime, Inc."
  },
  "BUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.16,
    "ebitda": -5370000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.91,
    "fifty_two_week_high": 3.31,
    "fifty_two_week_low": 1.66,
    "percent_change_from_200_day_moving_average": -0.15710000000000002,
    "percent_change_from_50_day_moving_average": -0.0326,
    "shares_owned": "N/A",
    "short_ratio": 1.64,
    "two_hundred_day_moving_average": 2.19,
    "volume": 2.0,
    "market_cap": 66040000.00000001,
    "price_to_sales_ttm": 825.36,
    "price_to_book_mrq": 11.56,
    "roa_ttm": -0.531,
    "roe_ttm": -0.8893000000000001,
    "shares_outstanding": 35700000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -3880000.0,
    "levered_cash_flow_ttm": -2220000.0,
    "book_value_per_share_mrq": 0.16,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Burcon Nutrascience Corporation"
  },
  "BVX": {
    "p_e_ratio": 32.0,
    "peg_ratio": -0.53,
    "earnings_per_share": 0.07,
    "ebitda": -7140000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 2.31,
    "fifty_two_week_high": 4.3,
    "fifty_two_week_low": 2.06,
    "percent_change_from_200_day_moving_average": -0.12050000000000001,
    "percent_change_from_50_day_moving_average": -0.0317,
    "shares_owned": "N/A",
    "short_ratio": 2.2,
    "two_hundred_day_moving_average": 2.55,
    "volume": 14854.0,
    "market_cap": 60920000.0,
    "price_to_sales_ttm": 2.16,
    "price_to_book_mrq": 2.29,
    "roa_ttm": -0.1518,
    "roe_ttm": -0.5365,
    "shares_outstanding": 27190000.0,
    "pcnt_held_by_insiders": 0.2205,
    "pcnt_held_by_institutions": 0.055,
    "pcnt_short_of_float": 0.0039000000000000003,
    "operating_cash_flow_ttm": -3220000.0,
    "levered_cash_flow_ttm": -2290000.0,
    "book_value_per_share_mrq": 0.97,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Bovie Medical Corporation"
  },
  "CALA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.05,
    "ebitda": -27390000.0,
    "eps_estimate_current_year": -1.94,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 5.92,
    "fifty_two_week_high": 33.48,
    "fifty_two_week_low": 4.31,
    "percent_change_from_200_day_moving_average": -0.3886,
    "percent_change_from_50_day_moving_average": 0.0255,
    "shares_owned": "N/A",
    "short_ratio": 6.21,
    "two_hundred_day_moving_average": 9.93,
    "volume": 116853.0,
    "market_cap": 109950000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.28,
    "roa_ttm": -0.2864,
    "roe_ttm": -0.502,
    "shares_outstanding": 18110000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.5676,
    "operating_cash_flow_ttm": -23750000.0,
    "levered_cash_flow_ttm": -17850000.0,
    "book_value_per_share_mrq": 4.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Calithera Biosciences, Inc."
  },
  "CANF": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -6100000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 2.01,
    "fifty_two_week_high": 7.85,
    "fifty_two_week_low": 1.46,
    "percent_change_from_200_day_moving_average": 1.1293,
    "percent_change_from_50_day_moving_average": 1.6129,
    "shares_owned": "N/A",
    "short_ratio": 2.2,
    "two_hundred_day_moving_average": 2.46,
    "volume": 16489202.0,
    "market_cap": 55850000.0,
    "price_to_sales_ttm": 620.32,
    "price_to_book_mrq": 9.48,
    "roa_ttm": -0.5482,
    "roe_ttm": -1.1715,
    "shares_outstanding": 10660000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -4750000.0,
    "levered_cash_flow_ttm": -3730000.0,
    "book_value_per_share_mrq": 0.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Can-Fite BioPharma Ltd."
  },
  "CAPN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.19,
    "ebitda": -8590000.0,
    "eps_estimate_current_year": -0.76,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 2.25,
    "fifty_two_week_high": 9.9,
    "fifty_two_week_low": 1.02,
    "percent_change_from_200_day_moving_average": -0.4153,
    "percent_change_from_50_day_moving_average": 0.0659,
    "shares_owned": "N/A",
    "short_ratio": 0.29,
    "two_hundred_day_moving_average": 4.1,
    "volume": 107391.0,
    "market_cap": 19150000.0,
    "price_to_sales_ttm": 168.32,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.9884999999999999,
    "roe_ttm": "N/A",
    "shares_outstanding": 7980000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1655,
    "operating_cash_flow_ttm": -6880000.0,
    "levered_cash_flow_ttm": 8260000.0,
    "book_value_per_share_mrq": -1.0,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Capnia, Inc."
  },
  "CAPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.74,
    "ebitda": -9750000.0,
    "eps_estimate_current_year": -1.01,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 4.28,
    "fifty_two_week_high": 10.68,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": -0.19649999999999998,
    "percent_change_from_50_day_moving_average": 0.0907,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 5.81,
    "volume": 8987.0,
    "market_cap": 75910000.0,
    "price_to_sales_ttm": 13.1,
    "price_to_book_mrq": 16.58,
    "roa_ttm": -0.2916,
    "roe_ttm": "-1,369.74%",
    "shares_outstanding": 16260000.000000002,
    "pcnt_held_by_insiders": 0.2815,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0052,
    "operating_cash_flow_ttm": -8300000.000000001,
    "levered_cash_flow_ttm": -1320000.0,
    "book_value_per_share_mrq": 0.28,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Capricor Therapeutics, Inc."
  },
  "CARA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.93,
    "ebitda": -20610000.0,
    "eps_estimate_current_year": -1.03,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 20.66,
    "fifty_two_week_high": 23.61,
    "fifty_two_week_low": 7.53,
    "percent_change_from_200_day_moving_average": 0.43729999999999997,
    "percent_change_from_50_day_moving_average": -0.022099999999999998,
    "shares_owned": "N/A",
    "short_ratio": 1.95,
    "two_hundred_day_moving_average": 14.05,
    "volume": 161848.0,
    "market_cap": 548730000.0,
    "price_to_sales_ttm": 159.69,
    "price_to_book_mrq": 10.75,
    "roa_ttm": -0.2332,
    "roe_ttm": -0.4054,
    "shares_outstanding": 27160000.0,
    "pcnt_held_by_insiders": 0.4578,
    "pcnt_held_by_institutions": 0.423,
    "pcnt_short_of_float": 0.053200000000000004,
    "operating_cash_flow_ttm": -19810000.0,
    "levered_cash_flow_ttm": -11910000.0,
    "book_value_per_share_mrq": 1.86,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cara Therapeutics Inc."
  },
  "CASI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.86,
    "ebitda": -7210000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.35,
    "fifty_two_week_high": 2.13,
    "fifty_two_week_low": 0.83,
    "percent_change_from_200_day_moving_average": -0.28059999999999996,
    "percent_change_from_50_day_moving_average": -0.20559999999999998,
    "shares_owned": "N/A",
    "short_ratio": 7.91,
    "two_hundred_day_moving_average": 1.49,
    "volume": 11052.0,
    "market_cap": 34720000.0,
    "price_to_sales_ttm": 504.13,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.4119,
    "roe_ttm": -5.8197,
    "shares_outstanding": 32450000.000000004,
    "pcnt_held_by_insiders": 0.37450000000000006,
    "pcnt_held_by_institutions": 0.14,
    "pcnt_short_of_float": 0.0040999999999999995,
    "operating_cash_flow_ttm": -4820000.0,
    "levered_cash_flow_ttm": -2350000.0,
    "book_value_per_share_mrq": -0.11,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CASI Pharmaceuticals, Inc."
  },
  "CASM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.24,
    "earnings_per_share": -0.38,
    "ebitda": -4520000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 1.14,
    "fifty_two_week_high": 1.98,
    "fifty_two_week_low": 1.01,
    "percent_change_from_200_day_moving_average": 0.0011,
    "percent_change_from_50_day_moving_average": 0.09179999999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.39,
    "two_hundred_day_moving_average": 1.25,
    "volume": 25086.0,
    "market_cap": 33330000.0,
    "price_to_sales_ttm": 1.47,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.20129999999999998,
    "roe_ttm": -0.9394,
    "shares_outstanding": 26670000.0,
    "pcnt_held_by_insiders": 0.0946,
    "pcnt_held_by_institutions": 0.439,
    "pcnt_short_of_float": 0.002,
    "operating_cash_flow_ttm": -3750000.0,
    "levered_cash_flow_ttm": -2500000.0,
    "book_value_per_share_mrq": -0.2,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "CAS Medical Systems Inc."
  },
  "CATB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -44.38,
    "ebitda": -25760000.0,
    "eps_estimate_current_year": -4.04,
    "eps_estimate_next_quarter": -0.73,
    "fifty_day_moving_average": 11.51,
    "fifty_two_week_high": 16.96,
    "fifty_two_week_low": 9.13,
    "percent_change_from_200_day_moving_average": -0.2194,
    "percent_change_from_50_day_moving_average": -0.1668,
    "shares_owned": "N/A",
    "short_ratio": 0.18,
    "two_hundred_day_moving_average": 12.29,
    "volume": 30550.0,
    "market_cap": 146710000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.2,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0012,
    "operating_cash_flow_ttm": -23870000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Catabasis Pharmaceuticals, Inc."
  },
  "CBAY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.2,
    "ebitda": -26440000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 2.75,
    "fifty_two_week_high": 13.39,
    "fifty_two_week_low": 2.44,
    "percent_change_from_200_day_moving_average": -0.3262,
    "percent_change_from_50_day_moving_average": -0.013999999999999999,
    "shares_owned": "N/A",
    "short_ratio": 2.17,
    "two_hundred_day_moving_average": 4.02,
    "volume": 194126.0,
    "market_cap": 60620000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.32,
    "roa_ttm": -0.6047,
    "roe_ttm": -1.7103,
    "shares_outstanding": 22370000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0191,
    "operating_cash_flow_ttm": -22830000.0,
    "levered_cash_flow_ttm": -20300000.0,
    "book_value_per_share_mrq": 1.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cymabay Therapeutics, Inc."
  },
  "CBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.8,
    "ebitda": -8100000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 5.5,
    "fifty_two_week_low": 5.25,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.92,
    "two_hundred_day_moving_average": 0.0,
    "volume": 13723.0,
    "market_cap": 60620000.0,
    "price_to_sales_ttm": 24.8,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11420000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0038,
    "operating_cash_flow_ttm": -7670000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -11.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Catalyst Biosciences, Inc."
  },
  "CBLI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.285,
    "ebitda": -13410000.0,
    "eps_estimate_current_year": -0.16,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.17,
    "fifty_two_week_high": 10.2,
    "fifty_two_week_low": 1.84,
    "percent_change_from_200_day_moving_average": 0.413454,
    "percent_change_from_50_day_moving_average": 0.191583,
    "shares_owned": "N/A",
    "short_ratio": 7.55,
    "two_hundred_day_moving_average": 3.5154,
    "volume": 49889.0,
    "market_cap": 53310000.0,
    "price_to_sales_ttm": 19.56,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.7391,
    "roe_ttm": -7.965800000000001,
    "shares_outstanding": 10730000.0,
    "pcnt_held_by_insiders": 0.154,
    "pcnt_held_by_institutions": 0.094,
    "pcnt_short_of_float": 0.2954,
    "operating_cash_flow_ttm": -11700000.0,
    "levered_cash_flow_ttm": -3410000.0,
    "book_value_per_share_mrq": -2.49,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cleveland BioLabs, Inc."
  },
  "CBM": {
    "p_e_ratio": 22.09,
    "peg_ratio": 1.59,
    "earnings_per_share": 2.0,
    "ebitda": 105620000.0,
    "eps_estimate_current_year": 2.05,
    "eps_estimate_next_quarter": 0.76,
    "fifty_day_moving_average": 47.38,
    "fifty_two_week_high": 54.6,
    "fifty_two_week_low": 15.76,
    "percent_change_from_200_day_moving_average": 0.025699999999999997,
    "percent_change_from_50_day_moving_average": -0.06570000000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.23,
    "two_hundred_day_moving_average": 43.16,
    "volume": 244337.0,
    "market_cap": 1390000000.0,
    "price_to_sales_ttm": 3.5,
    "price_to_book_mrq": 5.07,
    "roa_ttm": 0.10490000000000001,
    "roe_ttm": 0.2557,
    "shares_outstanding": 31370000.0,
    "pcnt_held_by_insiders": 0.0255,
    "pcnt_held_by_institutions": 0.978,
    "pcnt_short_of_float": 0.0356,
    "operating_cash_flow_ttm": 92640000.0,
    "levered_cash_flow_ttm": 53070000.0,
    "book_value_per_share_mrq": 8.68,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cambrex Corporation."
  },
  "CBMG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.7,
    "ebitda": -13670000.0,
    "eps_estimate_current_year": -1.68,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 23.09,
    "fifty_two_week_high": 49.0,
    "fifty_two_week_low": 11.5,
    "percent_change_from_200_day_moving_average": -0.34,
    "percent_change_from_50_day_moving_average": -0.1252,
    "shares_owned": "N/A",
    "short_ratio": 6.14,
    "two_hundred_day_moving_average": 30.61,
    "volume": 48236.0,
    "market_cap": 234720000.0,
    "price_to_sales_ttm": 140.93,
    "price_to_book_mrq": 3.76,
    "roa_ttm": -0.2057,
    "roe_ttm": -0.4114,
    "shares_outstanding": 11620000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.044500000000000005,
    "operating_cash_flow_ttm": -11280000.0,
    "levered_cash_flow_ttm": -6310000.0,
    "book_value_per_share_mrq": 5.31,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cellular Biomedicine Group Inc."
  },
  "CBMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.72,
    "ebitda": -5970000.0,
    "eps_estimate_current_year": -0.6,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 1.21,
    "fifty_two_week_high": 2.16,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.1771,
    "percent_change_from_50_day_moving_average": 0.0849,
    "shares_owned": "N/A",
    "short_ratio": 0.93,
    "two_hundred_day_moving_average": 1.59,
    "volume": 2735.0,
    "market_cap": 16610000.0,
    "price_to_sales_ttm": 1.76,
    "price_to_book_mrq": 1.84,
    "roa_ttm": -0.32189999999999996,
    "roe_ttm": -0.7595000000000001,
    "shares_outstanding": 12680000.0,
    "pcnt_held_by_insiders": 0.0702,
    "pcnt_held_by_institutions": 0.031,
    "pcnt_short_of_float": 0.0037,
    "operating_cash_flow_ttm": -7240000.0,
    "levered_cash_flow_ttm": -3860000.0,
    "book_value_per_share_mrq": 0.69,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "CombiMatrix Corporation"
  },
  "CBPO": {
    "p_e_ratio": 28.35,
    "peg_ratio": 1.04,
    "earnings_per_share": 3.11,
    "ebitda": 137920000.0,
    "eps_estimate_current_year": 3.43,
    "eps_estimate_next_quarter": 0.54,
    "fifty_day_moving_average": 102.42,
    "fifty_two_week_high": 128.0,
    "fifty_two_week_low": 47.23,
    "percent_change_from_200_day_moving_average": -0.1515,
    "percent_change_from_50_day_moving_average": -0.1404,
    "shares_owned": "N/A",
    "short_ratio": 0.58,
    "two_hundred_day_moving_average": 103.76,
    "volume": 139947.0,
    "market_cap": 2260000000.0,
    "price_to_sales_ttm": 8.39,
    "price_to_book_mrq": 6.66,
    "roa_ttm": 0.1693,
    "roe_ttm": 0.307,
    "shares_outstanding": 25710000.0,
    "pcnt_held_by_insiders": 0.21710000000000002,
    "pcnt_held_by_institutions": 0.49700000000000005,
    "pcnt_short_of_float": 0.0137,
    "operating_cash_flow_ttm": 89050000.0,
    "levered_cash_flow_ttm": 49110000.0,
    "book_value_per_share_mrq": 13.53,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "China Biologic Products, Inc."
  },
  "CBYL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.5,
    "ebitda": -17850000.0,
    "eps_estimate_current_year": -1.26,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 5.71,
    "fifty_two_week_high": 9.22,
    "fifty_two_week_low": 4.1,
    "percent_change_from_200_day_moving_average": -0.2731,
    "percent_change_from_50_day_moving_average": -0.149,
    "shares_owned": "N/A",
    "short_ratio": 9.77,
    "two_hundred_day_moving_average": 6.69,
    "volume": 17524.0,
    "market_cap": 127930000.0,
    "price_to_sales_ttm": 4079.91,
    "price_to_book_mrq": 2.2,
    "roa_ttm": -0.2983,
    "roe_ttm": -0.7482,
    "shares_outstanding": 26320000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0253,
    "operating_cash_flow_ttm": -18050000.0,
    "levered_cash_flow_ttm": -10350000.0,
    "book_value_per_share_mrq": 2.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Carbylan Therapeutics, Inc."
  },
  "CCM": {
    "p_e_ratio": 9.2,
    "peg_ratio": 1.12,
    "earnings_per_share": 0.54,
    "ebitda": 53010000.0,
    "eps_estimate_current_year": 0.23,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.07,
    "fifty_two_week_high": 8.23,
    "fifty_two_week_low": 4.51,
    "percent_change_from_200_day_moving_average": -0.2187,
    "percent_change_from_50_day_moving_average": -0.0288,
    "shares_owned": "N/A",
    "short_ratio": 0.84,
    "two_hundred_day_moving_average": 6.3,
    "volume": 29802.0,
    "market_cap": 73710000.0,
    "price_to_sales_ttm": 0.95,
    "price_to_book_mrq": 0.26,
    "roa_ttm": 0.0231,
    "roe_ttm": 0.045599999999999995,
    "shares_outstanding": 14980000.0,
    "pcnt_held_by_insiders": 0.2904,
    "pcnt_held_by_institutions": 0.39299999999999996,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 19.55,
    "next_earnings_announcement_date": [
      "2015-11-17",
      "2015-11-18"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Concord Medical Services Holdings Limited"
  },
  "CCXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.09,
    "ebitda": -47110000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 6.6,
    "fifty_two_week_high": 9.46,
    "fifty_two_week_low": 4.06,
    "percent_change_from_200_day_moving_average": -0.174,
    "percent_change_from_50_day_moving_average": -0.0378,
    "shares_owned": "N/A",
    "short_ratio": 33.18,
    "two_hundred_day_moving_average": 7.69,
    "volume": 56168.0,
    "market_cap": 279870000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.02,
    "roa_ttm": -0.2568,
    "roe_ttm": -0.4325,
    "shares_outstanding": 44070000.0,
    "pcnt_held_by_insiders": 0.4244,
    "pcnt_held_by_institutions": 0.616,
    "pcnt_short_of_float": 0.18510000000000001,
    "operating_cash_flow_ttm": -39220000.0,
    "levered_cash_flow_ttm": -23520000.0,
    "book_value_per_share_mrq": 2.06,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ChemoCentryx, Inc."
  },
  "CDTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.61,
    "ebitda": -20800000.0,
    "eps_estimate_current_year": -3.94,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 14.35,
    "fifty_two_week_high": 19.13,
    "fifty_two_week_low": 13.0,
    "percent_change_from_200_day_moving_average": -0.0548,
    "percent_change_from_50_day_moving_average": -0.0202,
    "shares_owned": "N/A",
    "short_ratio": 11.25,
    "two_hundred_day_moving_average": 14.88,
    "volume": 100255.0,
    "market_cap": 192260000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.59,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13670000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0463,
    "operating_cash_flow_ttm": -18310000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 8.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cidara Therapeutics, Inc."
  },
  "CDXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.18,
    "earnings_per_share": -0.39,
    "ebitda": -8540000.0,
    "eps_estimate_current_year": -0.22,
    "eps_estimate_next_quarter": 0.18,
    "fifty_day_moving_average": 3.79,
    "fifty_two_week_high": 5.65,
    "fifty_two_week_low": 2.05,
    "percent_change_from_200_day_moving_average": -0.12029999999999999,
    "percent_change_from_50_day_moving_average": -0.0516,
    "shares_owned": "N/A",
    "short_ratio": 1.59,
    "two_hundred_day_moving_average": 4.08,
    "volume": 63174.0,
    "market_cap": 144510000.0,
    "price_to_sales_ttm": 4.19,
    "price_to_book_mrq": 8.45,
    "roa_ttm": -0.22089999999999999,
    "roe_ttm": -0.6520999999999999,
    "shares_outstanding": 40250000.0,
    "pcnt_held_by_insiders": 0.3468,
    "pcnt_held_by_institutions": 0.285,
    "pcnt_short_of_float": 0.009399999999999999,
    "operating_cash_flow_ttm": -1300000.0,
    "levered_cash_flow_ttm": 3530000.0,
    "book_value_per_share_mrq": 0.43,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Codexis, Inc."
  },
  "CEMI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.59,
    "earnings_per_share": -0.22,
    "ebitda": -1650000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 4.33,
    "fifty_two_week_high": 5.25,
    "fifty_two_week_low": 3.33,
    "percent_change_from_200_day_moving_average": -0.1208,
    "percent_change_from_50_day_moving_average": -0.0789,
    "shares_owned": "N/A",
    "short_ratio": 0.68,
    "two_hundred_day_moving_average": 4.54,
    "volume": 4625.0,
    "market_cap": 38420000.0,
    "price_to_sales_ttm": 1.39,
    "price_to_book_mrq": 2.05,
    "roa_ttm": -0.0712,
    "roe_ttm": -0.1069,
    "shares_outstanding": 9630000.0,
    "pcnt_held_by_insiders": 0.2673,
    "pcnt_held_by_institutions": 0.073,
    "pcnt_short_of_float": 0.0023,
    "operating_cash_flow_ttm": -3450000.0,
    "levered_cash_flow_ttm": -4430000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Chembio Diagnostics, Inc."
  },
  "CEMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.81,
    "ebitda": -68070000.0,
    "eps_estimate_current_year": -1.82,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 36.29,
    "fifty_two_week_high": 46.99,
    "fifty_two_week_low": 9.67,
    "percent_change_from_200_day_moving_average": -0.011899999999999999,
    "percent_change_from_50_day_moving_average": -0.006,
    "shares_owned": "N/A",
    "short_ratio": 3.7,
    "two_hundred_day_moving_average": 36.5,
    "volume": 629714.0,
    "market_cap": 1580000000.0,
    "price_to_sales_ttm": 52.84,
    "price_to_book_mrq": 9.5,
    "roa_ttm": -0.30260000000000004,
    "roe_ttm": -0.7006999999999999,
    "shares_outstanding": 43880000.0,
    "pcnt_held_by_insiders": 0.4675,
    "pcnt_held_by_institutions": 0.397,
    "pcnt_short_of_float": 0.0932,
    "operating_cash_flow_ttm": -55560000.0,
    "levered_cash_flow_ttm": -35150000.0,
    "book_value_per_share_mrq": 3.71,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cempra, Inc."
  },
  "CERS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.66,
    "ebitda": -52540000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 5.13,
    "fifty_two_week_high": 7.03,
    "fifty_two_week_low": 3.6,
    "percent_change_from_200_day_moving_average": 0.07780000000000001,
    "percent_change_from_50_day_moving_average": 0.0223,
    "shares_owned": "N/A",
    "short_ratio": 19.16,
    "two_hundred_day_moving_average": 4.86,
    "volume": 772169.0,
    "market_cap": 507110000.0,
    "price_to_sales_ttm": 14.25,
    "price_to_book_mrq": 4.7,
    "roa_ttm": -0.2967,
    "roe_ttm": -0.7286,
    "shares_outstanding": 96780000.0,
    "pcnt_held_by_insiders": 0.0154,
    "pcnt_held_by_institutions": 0.635,
    "pcnt_short_of_float": 0.2384,
    "operating_cash_flow_ttm": -50860000.0,
    "levered_cash_flow_ttm": -30760000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cerus Corporation"
  },
  "CERU": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.43,
    "ebitda": -29630000.0,
    "eps_estimate_current_year": -1.63,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 4.09,
    "fifty_two_week_high": 10.87,
    "fifty_two_week_low": 2.77,
    "percent_change_from_200_day_moving_average": -0.1251,
    "percent_change_from_50_day_moving_average": 0.1725,
    "shares_owned": "N/A",
    "short_ratio": 4.72,
    "two_hundred_day_moving_average": 5.49,
    "volume": 52543.0,
    "market_cap": 131070000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.93,
    "roa_ttm": -0.2419,
    "roe_ttm": -0.49770000000000003,
    "shares_outstanding": 27310000.0,
    "pcnt_held_by_insiders": 0.5550999999999999,
    "pcnt_held_by_institutions": 0.027999999999999997,
    "pcnt_short_of_float": 0.0139,
    "operating_cash_flow_ttm": -26900000.0,
    "levered_cash_flow_ttm": -16300000.0,
    "book_value_per_share_mrq": 2.5,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cerulean Pharma Inc."
  },
  "CFMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.12,
    "earnings_per_share": -11.09,
    "ebitda": -44970000.0,
    "eps_estimate_current_year": -2.52,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 19.05,
    "fifty_two_week_high": 26.93,
    "fifty_two_week_low": 13.33,
    "percent_change_from_200_day_moving_average": -0.092,
    "percent_change_from_50_day_moving_average": -0.0336,
    "shares_owned": "N/A",
    "short_ratio": 3.79,
    "two_hundred_day_moving_average": 20.27,
    "volume": 321112.0,
    "market_cap": 749090000.0,
    "price_to_sales_ttm": 11.44,
    "price_to_book_mrq": 2.67,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 40690000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0405,
    "operating_cash_flow_ttm": -42150000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ConforMIS, Inc."
  },
  "CFRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.76,
    "ebitda": -20190000.0,
    "eps_estimate_current_year": -0.98,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 4.91,
    "fifty_two_week_high": 6.24,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.0958,
    "percent_change_from_50_day_moving_average": -0.0705,
    "shares_owned": "N/A",
    "short_ratio": 3.24,
    "two_hundred_day_moving_average": 5.04,
    "volume": 20137.0,
    "market_cap": 114360000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.6,
    "roa_ttm": -0.5592,
    "roe_ttm": -8.819700000000001,
    "shares_outstanding": 25080000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0118,
    "operating_cash_flow_ttm": -20360000.0,
    "levered_cash_flow_ttm": -15300000.0,
    "book_value_per_share_mrq": 1.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ContraFect Corporation"
  },
  "CGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -18100000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 5.44,
    "fifty_two_week_high": 9.65,
    "fifty_two_week_low": 4.64,
    "percent_change_from_200_day_moving_average": -0.1686,
    "percent_change_from_50_day_moving_average": 0.011699999999999999,
    "shares_owned": "N/A",
    "short_ratio": 11.69,
    "two_hundred_day_moving_average": 6.62,
    "volume": 67932.0,
    "market_cap": 277530000.0,
    "price_to_sales_ttm": 31.77,
    "price_to_book_mrq": 3.0,
    "roa_ttm": -0.1056,
    "roe_ttm": -0.20489999999999997,
    "shares_outstanding": 50460000.0,
    "pcnt_held_by_insiders": 0.10039999999999999,
    "pcnt_held_by_institutions": 0.165,
    "pcnt_short_of_float": 0.0404,
    "operating_cash_flow_ttm": -17430000.0,
    "levered_cash_flow_ttm": -10430000.0,
    "book_value_per_share_mrq": 1.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Compugen Ltd."
  },
  "CGIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -2.01,
    "ebitda": -18280000.0,
    "eps_estimate_current_year": -1.76,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 9.78,
    "fifty_two_week_high": 12.75,
    "fifty_two_week_low": 4.83,
    "percent_change_from_200_day_moving_average": -0.0464,
    "percent_change_from_50_day_moving_average": -0.021,
    "shares_owned": "N/A",
    "short_ratio": 3.84,
    "two_hundred_day_moving_average": 10.04,
    "volume": 11972.0,
    "market_cap": 94270000.0,
    "price_to_sales_ttm": 5.95,
    "price_to_book_mrq": 3.51,
    "roa_ttm": -0.2738,
    "roe_ttm": -0.5711999999999999,
    "shares_outstanding": 9850000.0,
    "pcnt_held_by_insiders": 0.32409999999999994,
    "pcnt_held_by_institutions": 0.254,
    "pcnt_short_of_float": 0.025699999999999997,
    "operating_cash_flow_ttm": -13880000.0,
    "levered_cash_flow_ttm": -10410000.0,
    "book_value_per_share_mrq": 2.72,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Cancer Genetics, Inc."
  },
  "CGNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.26,
    "earnings_per_share": -0.5,
    "ebitda": -4980000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 1.52,
    "fifty_two_week_high": 6.1,
    "fifty_two_week_low": 1.27,
    "percent_change_from_200_day_moving_average": -0.2228,
    "percent_change_from_50_day_moving_average": -0.1524,
    "shares_owned": "N/A",
    "short_ratio": 2.51,
    "two_hundred_day_moving_average": 1.66,
    "volume": 60917.0,
    "market_cap": 33780000.0,
    "price_to_sales_ttm": 1.1,
    "price_to_book_mrq": 1.76,
    "roa_ttm": -0.107,
    "roe_ttm": -0.5898,
    "shares_outstanding": 26190000.0,
    "pcnt_held_by_insiders": 0.0789,
    "pcnt_held_by_institutions": 0.551,
    "pcnt_short_of_float": 0.0060999999999999995,
    "operating_cash_flow_ttm": -5750000.0,
    "levered_cash_flow_ttm": -4930000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cogentix Medical, Inc."
  },
  "CHE": {
    "p_e_ratio": 22.93,
    "peg_ratio": 2.05,
    "earnings_per_share": 6.06,
    "ebitda": 204870000.0,
    "eps_estimate_current_year": 6.75,
    "eps_estimate_next_quarter": 1.9,
    "fifty_day_moving_average": 142.45,
    "fifty_two_week_high": 153.98,
    "fifty_two_week_low": 97.85,
    "percent_change_from_200_day_moving_average": 0.0677,
    "percent_change_from_50_day_moving_average": -0.0245,
    "shares_owned": "N/A",
    "short_ratio": 13.64,
    "two_hundred_day_moving_average": 130.15,
    "volume": 187179.0,
    "market_cap": 2350000000.0,
    "price_to_sales_ttm": 1.56,
    "price_to_book_mrq": 4.89,
    "roa_ttm": 0.1285,
    "roe_ttm": 0.2296,
    "shares_outstanding": 16920000.0,
    "pcnt_held_by_insiders": 0.0379,
    "pcnt_held_by_institutions": 1.3530000000000002,
    "pcnt_short_of_float": 0.1673,
    "operating_cash_flow_ttm": 134800000.0,
    "levered_cash_flow_ttm": 94010000.0,
    "book_value_per_share_mrq": 28.24,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Chemed Corp."
  },
  "CHEK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.49,
    "ebitda": -8960000.0,
    "eps_estimate_current_year": -1.34,
    "eps_estimate_next_quarter": -0.33,
    "fifty_day_moving_average": 2.84,
    "fifty_two_week_high": 6.3,
    "fifty_two_week_low": 1.82,
    "percent_change_from_200_day_moving_average": -0.27440000000000003,
    "percent_change_from_50_day_moving_average": 0.0342,
    "shares_owned": "N/A",
    "short_ratio": 0.36,
    "two_hundred_day_moving_average": 4.05,
    "volume": 2397.0,
    "market_cap": 31750000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.09,
    "roa_ttm": -0.491,
    "roe_ttm": -1.3014,
    "shares_outstanding": 10800000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Check-Cap Ltd."
  },
  "CHMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -266.98,
    "ebitda": -20270000.0,
    "eps_estimate_current_year": -2.45,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 26.13,
    "fifty_two_week_high": 30.52,
    "fifty_two_week_low": 19.0,
    "percent_change_from_200_day_moving_average": 0.021,
    "percent_change_from_50_day_moving_average": -0.0151,
    "shares_owned": "N/A",
    "short_ratio": 2.48,
    "two_hundred_day_moving_average": 25.21,
    "volume": 87658.0,
    "market_cap": 615960000.0,
    "price_to_sales_ttm": 232.37,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23930000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0235,
    "operating_cash_flow_ttm": -17970000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -396.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Chiasma, Inc."
  },
  "CHRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.72,
    "ebitda": -127430000.0,
    "eps_estimate_current_year": -0.27,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 29.4,
    "fifty_two_week_high": 38.1,
    "fifty_two_week_low": 12.38,
    "percent_change_from_200_day_moving_average": -0.0723,
    "percent_change_from_50_day_moving_average": -0.11230000000000001,
    "shares_owned": "N/A",
    "short_ratio": 11.52,
    "two_hundred_day_moving_average": 28.13,
    "volume": 142611.0,
    "market_cap": 1000000000.0,
    "price_to_sales_ttm": 28.48,
    "price_to_book_mrq": 10.35,
    "roa_ttm": -0.43090000000000006,
    "roe_ttm": -2.4101,
    "shares_outstanding": 38410000.0,
    "pcnt_held_by_insiders": 0.01,
    "pcnt_held_by_institutions": 0.858,
    "pcnt_short_of_float": 0.1151,
    "operating_cash_flow_ttm": -92360000.0,
    "levered_cash_flow_ttm": -70160000.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": [
      "2015-12-14",
      "2015-12-18"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Coherus Biosciences, Inc."
  },
  "CIVI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.21,
    "ebitda": 142680000.0,
    "eps_estimate_current_year": 0.62,
    "eps_estimate_next_quarter": 0.2,
    "fifty_day_moving_average": 24.78,
    "fifty_two_week_high": 27.85,
    "fifty_two_week_low": 11.88,
    "percent_change_from_200_day_moving_average": 0.2425,
    "percent_change_from_50_day_moving_average": 0.0969,
    "shares_owned": "N/A",
    "short_ratio": 5.35,
    "two_hundred_day_moving_average": 21.88,
    "volume": 164152.0,
    "market_cap": 1000000000.0,
    "price_to_sales_ttm": 0.74,
    "price_to_book_mrq": 8.22,
    "roa_ttm": 0.0432,
    "roe_ttm": -0.16260000000000002,
    "shares_outstanding": 36970000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.08410000000000001,
    "operating_cash_flow_ttm": 67960000.0,
    "levered_cash_flow_ttm": 42570000.0,
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": [
      "2015-12-15",
      "2015-12-21"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Civitas Solutions, Inc."
  },
  "CLBS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -1.69,
    "ebitda": -63710000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 1.58,
    "fifty_two_week_high": 7.22,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": -0.2353,
    "percent_change_from_50_day_moving_average": 0.0906,
    "shares_owned": "N/A",
    "short_ratio": 6.81,
    "two_hundred_day_moving_average": 2.25,
    "volume": 146179.0,
    "market_cap": 95200000.0,
    "price_to_sales_ttm": 5.58,
    "price_to_book_mrq": 1.55,
    "roa_ttm": -0.3157,
    "roe_ttm": -0.9111,
    "shares_outstanding": 55350000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.047,
    "operating_cash_flow_ttm": -46220000.0,
    "levered_cash_flow_ttm": -27260000.0,
    "book_value_per_share_mrq": 1.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Caladrius Biosciences, Inc."
  },
  "CLCD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.63,
    "ebitda": -11830000.0,
    "eps_estimate_current_year": -3.38,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 6.95,
    "fifty_two_week_high": 9.46,
    "fifty_two_week_low": 5.61,
    "percent_change_from_200_day_moving_average": -0.1825,
    "percent_change_from_50_day_moving_average": -0.057,
    "shares_owned": "N/A",
    "short_ratio": 0.34,
    "two_hundred_day_moving_average": 8.01,
    "volume": 23879.0,
    "market_cap": 99250000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.28,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15150000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0037,
    "operating_cash_flow_ttm": -8160000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CoLucid Pharmaceuticals, Inc."
  },
  "CLDN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.31,
    "ebitda": -48130000.0,
    "eps_estimate_current_year": -1.54,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 1.14,
    "fifty_two_week_high": 28.25,
    "fifty_two_week_low": 1.0,
    "percent_change_from_200_day_moving_average": -0.8122,
    "percent_change_from_50_day_moving_average": 0.0366,
    "shares_owned": "N/A",
    "short_ratio": 4.75,
    "two_hundred_day_moving_average": 6.28,
    "volume": 102810.0,
    "market_cap": 28220000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.66,
    "roa_ttm": -0.5388000000000001,
    "roe_ttm": -1.1592,
    "shares_outstanding": 23910000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0661,
    "operating_cash_flow_ttm": -43570000.0,
    "levered_cash_flow_ttm": -23780000.0,
    "book_value_per_share_mrq": 1.79,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celladon Corporation"
  },
  "CLDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.32,
    "ebitda": -122500000.0,
    "eps_estimate_current_year": -1.37,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 16.04,
    "fifty_two_week_high": 32.82,
    "fifty_two_week_low": 11.93,
    "percent_change_from_200_day_moving_average": -0.4432,
    "percent_change_from_50_day_moving_average": -0.171,
    "shares_owned": "N/A",
    "short_ratio": 6.96,
    "two_hundred_day_moving_average": 23.89,
    "volume": 1539336.0,
    "market_cap": 1310000000.0,
    "price_to_sales_ttm": 260.12,
    "price_to_book_mrq": 3.94,
    "roa_ttm": -0.2316,
    "roe_ttm": -0.4006,
    "shares_outstanding": 98600000.0,
    "pcnt_held_by_insiders": 0.0028000000000000004,
    "pcnt_held_by_institutions": 0.887,
    "pcnt_short_of_float": 0.19140000000000001,
    "operating_cash_flow_ttm": -106160000.0,
    "levered_cash_flow_ttm": -67080000.0,
    "book_value_per_share_mrq": 3.51,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celldex Therapeutics, Inc."
  },
  "CLLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.31,
    "ebitda": -16100000.000000002,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 32.76,
    "fifty_two_week_high": 50.0,
    "fifty_two_week_low": 27.21,
    "percent_change_from_200_day_moving_average": -0.0851,
    "percent_change_from_50_day_moving_average": -0.032799999999999996,
    "shares_owned": "N/A",
    "short_ratio": 6.54,
    "two_hundred_day_moving_average": 34.63,
    "volume": 87901.0,
    "market_cap": 1110000000.0,
    "price_to_sales_ttm": 29.31,
    "price_to_book_mrq": 4.03,
    "roa_ttm": -0.0564,
    "roe_ttm": -0.0699,
    "shares_outstanding": 35060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 34520000.0,
    "levered_cash_flow_ttm": 39600000.0,
    "book_value_per_share_mrq": 7.83,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cellectis S.A."
  },
  "CLRB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.1,
    "ebitda": -8950000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.07,
    "fifty_two_week_high": 3.89,
    "fifty_two_week_low": 1.76,
    "percent_change_from_200_day_moving_average": -0.0852,
    "percent_change_from_50_day_moving_average": -0.11380000000000001,
    "shares_owned": "N/A",
    "short_ratio": 1.65,
    "two_hundred_day_moving_average": 2.97,
    "volume": 117.0,
    "market_cap": 20570000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 8.66,
    "roa_ttm": -0.8047,
    "roe_ttm": "N/A",
    "shares_outstanding": 7560000.0,
    "pcnt_held_by_insiders": 0.0338,
    "pcnt_held_by_institutions": 0.011000000000000001,
    "pcnt_short_of_float": 0.0024,
    "operating_cash_flow_ttm": -8790000.0,
    "levered_cash_flow_ttm": -2950000.0,
    "book_value_per_share_mrq": 0.31,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cellectar Biosciences, Inc."
  },
  "CLSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.29,
    "ebitda": -21720000.0,
    "eps_estimate_current_year": -1.13,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 2.09,
    "fifty_two_week_high": 3.57,
    "fifty_two_week_low": 1.8,
    "percent_change_from_200_day_moving_average": -0.18899999999999997,
    "percent_change_from_50_day_moving_average": -0.0541,
    "shares_owned": "N/A",
    "short_ratio": 3.66,
    "two_hundred_day_moving_average": 2.44,
    "volume": 63386.0,
    "market_cap": 45600000.0,
    "price_to_sales_ttm": 92.11,
    "price_to_book_mrq": 1.58,
    "roa_ttm": -0.1977,
    "roe_ttm": -0.7004,
    "shares_outstanding": 23030000.0,
    "pcnt_held_by_insiders": 0.2634,
    "pcnt_held_by_institutions": 0.16699999999999998,
    "pcnt_short_of_float": 0.0321,
    "operating_cash_flow_ttm": -23960000.0,
    "levered_cash_flow_ttm": -12260000.0,
    "book_value_per_share_mrq": 1.27,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celsion Corp."
  },
  "CLTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -17.59,
    "ebitda": -9750000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 17.59,
    "fifty_two_week_high": 62.5,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": 2.8133,
    "percent_change_from_50_day_moving_average": 1.0468000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.14,
    "two_hundred_day_moving_average": 9.44,
    "volume": 0.0,
    "market_cap": 20020000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 20.59,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 556000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -8580000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celsus Therapeutics Plc"
  },
  "CLVS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.74,
    "ebitda": -229220000.0,
    "eps_estimate_current_year": -8.27,
    "eps_estimate_next_quarter": -2.24,
    "fifty_day_moving_average": 86.47,
    "fifty_two_week_high": 116.75,
    "fifty_two_week_low": 39.45,
    "percent_change_from_200_day_moving_average": 0.1778,
    "percent_change_from_50_day_moving_average": 0.1533,
    "shares_owned": "N/A",
    "short_ratio": 7.88,
    "two_hundred_day_moving_average": 84.67,
    "volume": 1270992.0,
    "market_cap": 3810000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 17.14,
    "roa_ttm": -0.22829999999999998,
    "roe_ttm": -0.7149,
    "shares_outstanding": 38210000.0,
    "pcnt_held_by_insiders": 0.2615,
    "pcnt_held_by_institutions": 0.818,
    "pcnt_short_of_float": 0.2155,
    "operating_cash_flow_ttm": -173800000.0,
    "levered_cash_flow_ttm": -86080000.0,
    "book_value_per_share_mrq": 5.85,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Clovis Oncology, Inc."
  },
  "CMN": {
    "p_e_ratio": 48.94,
    "peg_ratio": 2.55,
    "earnings_per_share": 1.08,
    "ebitda": 104250000.0,
    "eps_estimate_current_year": 1.14,
    "eps_estimate_next_quarter": 0.33,
    "fifty_day_moving_average": 51.98,
    "fifty_two_week_high": 58.04,
    "fifty_two_week_low": 33.7,
    "percent_change_from_200_day_moving_average": 0.053,
    "percent_change_from_50_day_moving_average": 0.017,
    "shares_owned": "N/A",
    "short_ratio": 7.32,
    "two_hundred_day_moving_average": 50.2,
    "volume": 99659.0,
    "market_cap": 2200000000.0,
    "price_to_sales_ttm": 3.99,
    "price_to_book_mrq": 5.47,
    "roa_ttm": 0.09519999999999999,
    "roe_ttm": 0.12119999999999999,
    "shares_outstanding": 41550000.0,
    "pcnt_held_by_insiders": 0.1776,
    "pcnt_held_by_institutions": 0.7859999999999999,
    "pcnt_short_of_float": 0.031,
    "operating_cash_flow_ttm": 56920000.0,
    "levered_cash_flow_ttm": 51830000.0,
    "book_value_per_share_mrq": 9.57,
    "next_earnings_announcement_date": "2015-09-29",
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Cantel Medical Corp."
  },
  "CMRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.13,
    "ebitda": -84910000.0,
    "eps_estimate_current_year": -2.33,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 50.38,
    "fifty_two_week_high": 58.04,
    "fifty_two_week_low": 26.63,
    "percent_change_from_200_day_moving_average": 0.0023,
    "percent_change_from_50_day_moving_average": -0.1183,
    "shares_owned": "N/A",
    "short_ratio": 8.63,
    "two_hundred_day_moving_average": 44.32,
    "volume": 466180.0,
    "market_cap": 2049999999.9999998,
    "price_to_sales_ttm": 270.43,
    "price_to_book_mrq": 5.2,
    "roa_ttm": -0.1704,
    "roe_ttm": -0.2857,
    "shares_outstanding": 46070000.0,
    "pcnt_held_by_insiders": 0.2781,
    "pcnt_held_by_institutions": 0.445,
    "pcnt_short_of_float": 0.109,
    "operating_cash_flow_ttm": -70180000.0,
    "levered_cash_flow_ttm": -39840000.0,
    "book_value_per_share_mrq": 8.71,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Chimerix, Inc."
  },
  "CNAT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.86,
    "earnings_per_share": -1.44,
    "ebitda": -23700000.0,
    "eps_estimate_current_year": -1.61,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 4.16,
    "fifty_two_week_high": 11.74,
    "fifty_two_week_low": 3.44,
    "percent_change_from_200_day_moving_average": 0.0756,
    "percent_change_from_50_day_moving_average": 0.3814,
    "shares_owned": "N/A",
    "short_ratio": 9.59,
    "two_hundred_day_moving_average": 5.34,
    "volume": 6194001.0,
    "market_cap": 113190000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.2,
    "roa_ttm": -0.3065,
    "roe_ttm": -0.5418999999999999,
    "shares_outstanding": 19720000.0,
    "pcnt_held_by_insiders": 0.4947,
    "pcnt_held_by_institutions": 0.397,
    "pcnt_short_of_float": 0.0913,
    "operating_cash_flow_ttm": -19500000.0,
    "levered_cash_flow_ttm": -11340000.0,
    "book_value_per_share_mrq": 2.26,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Conatus Pharmaceuticals Inc."
  },
  "CNC": {
    "p_e_ratio": 22.52,
    "peg_ratio": 1.47,
    "earnings_per_share": 2.79,
    "ebitda": 732000000.0,
    "eps_estimate_current_year": 2.82,
    "eps_estimate_next_quarter": 0.79,
    "fifty_day_moving_average": 65.23,
    "fifty_two_week_high": 83.0,
    "fifty_two_week_low": 37.53,
    "percent_change_from_200_day_moving_average": -0.0993,
    "percent_change_from_50_day_moving_average": -0.0374,
    "shares_owned": "N/A",
    "short_ratio": 5.36,
    "two_hundred_day_moving_average": 69.71,
    "volume": 1591791.0,
    "market_cap": 7480000000.0,
    "price_to_sales_ttm": 0.4,
    "price_to_book_mrq": 3.8,
    "roa_ttm": 0.0675,
    "roe_ttm": 0.1805,
    "shares_outstanding": 119090000.0,
    "pcnt_held_by_insiders": 0.025099999999999997,
    "pcnt_held_by_institutions": 0.9420000000000001,
    "pcnt_short_of_float": 0.0726,
    "operating_cash_flow_ttm": 1210000000.0,
    "levered_cash_flow_ttm": 1000000000.0,
    "book_value_per_share_mrq": 16.29,
    "next_earnings_announcement_date": "2015-10-27",
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Centene Corp."
  },
  "CNCE": {
    "p_e_ratio": 29.09,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.77,
    "ebitda": -32920000.0,
    "eps_estimate_current_year": 0.98,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 16.98,
    "fifty_two_week_high": 22.8,
    "fifty_two_week_low": 10.31,
    "percent_change_from_200_day_moving_average": 0.4177,
    "percent_change_from_50_day_moving_average": 0.3226,
    "shares_owned": "N/A",
    "short_ratio": 4.68,
    "two_hundred_day_moving_average": 15.84,
    "volume": 2043968.0,
    "market_cap": 492340000.0,
    "price_to_sales_ttm": 38.86,
    "price_to_book_mrq": 2.94,
    "roa_ttm": -0.162,
    "roe_ttm": 0.14880000000000002,
    "shares_outstanding": 21920000.0,
    "pcnt_held_by_insiders": 0.2789,
    "pcnt_held_by_institutions": 0.325,
    "pcnt_short_of_float": 0.0731,
    "operating_cash_flow_ttm": 15390000.0,
    "levered_cash_flow_ttm": -21670000.0,
    "book_value_per_share_mrq": 6.21,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Concert Pharmaceuticals, Inc."
  },
  "CNMD": {
    "p_e_ratio": 52.87,
    "peg_ratio": 1.99,
    "earnings_per_share": 0.97,
    "ebitda": 122500000.0,
    "eps_estimate_current_year": 1.83,
    "eps_estimate_next_quarter": 0.61,
    "fifty_day_moving_average": 53.58,
    "fifty_two_week_high": 60.66,
    "fifty_two_week_low": 36.51,
    "percent_change_from_200_day_moving_average": -0.054400000000000004,
    "percent_change_from_50_day_moving_average": -0.042800000000000005,
    "shares_owned": "N/A",
    "short_ratio": 9.44,
    "two_hundred_day_moving_average": 54.23,
    "volume": 103360.0,
    "market_cap": 1420000000.0,
    "price_to_sales_ttm": 1.98,
    "price_to_book_mrq": 2.48,
    "roa_ttm": 0.0446,
    "roe_ttm": 0.045899999999999996,
    "shares_outstanding": 27700000.0,
    "pcnt_held_by_insiders": 0.0753,
    "pcnt_held_by_institutions": 0.902,
    "pcnt_short_of_float": 0.051699999999999996,
    "operating_cash_flow_ttm": 65319999.99999999,
    "levered_cash_flow_ttm": 103550000.0,
    "book_value_per_share_mrq": 20.87,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "CONMED Corporation"
  },
  "CNXR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.18,
    "earnings_per_share": -0.77,
    "ebitda": -805000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": 0.31,
    "fifty_day_moving_average": 6.67,
    "fifty_two_week_high": 14.39,
    "fifty_two_week_low": 5.26,
    "percent_change_from_200_day_moving_average": -0.4476,
    "percent_change_from_50_day_moving_average": -0.20079999999999998,
    "shares_owned": "N/A",
    "short_ratio": 9.03,
    "two_hundred_day_moving_average": 9.65,
    "volume": 19874.0,
    "market_cap": 116590000.0,
    "price_to_sales_ttm": 1.27,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0394,
    "roe_ttm": "N/A",
    "shares_outstanding": 21870000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.141,
    "operating_cash_flow_ttm": -17420000.0,
    "levered_cash_flow_ttm": -14660000.0,
    "book_value_per_share_mrq": -1.65,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Connecture, Inc."
  },
  "CO": {
    "p_e_ratio": 33.99,
    "peg_ratio": 1.26,
    "earnings_per_share": 0.18,
    "ebitda": 43510000.0,
    "eps_estimate_current_year": 0.17,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 6.62,
    "fifty_two_week_high": 7.69,
    "fifty_two_week_low": 4.1,
    "percent_change_from_200_day_moving_average": 0.0242,
    "percent_change_from_50_day_moving_average": -0.06,
    "shares_owned": "N/A",
    "short_ratio": 0.51,
    "two_hundred_day_moving_average": 6.07,
    "volume": 88531.0,
    "market_cap": 498120000.0,
    "price_to_sales_ttm": 4.49,
    "price_to_book_mrq": 1.84,
    "roa_ttm": 0.035,
    "roe_ttm": 0.06,
    "shares_outstanding": 80080000.0,
    "pcnt_held_by_insiders": 0.8759999999999999,
    "pcnt_held_by_institutions": 0.114,
    "pcnt_short_of_float": 0.0063,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.39,
    "next_earnings_announcement_date": [
      "2015-11-23",
      "2015-11-27"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "China Cord Blood Corporation"
  },
  "COLL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.25,
    "ebitda": -17850000.0,
    "eps_estimate_current_year": -1.65,
    "eps_estimate_next_quarter": -0.47,
    "fifty_day_moving_average": 17.02,
    "fifty_two_week_high": 24.88,
    "fifty_two_week_low": 11.92,
    "percent_change_from_200_day_moving_average": 0.2343,
    "percent_change_from_50_day_moving_average": 0.2711,
    "shares_owned": "N/A",
    "short_ratio": 4.69,
    "two_hundred_day_moving_average": 17.53,
    "volume": 123427.0,
    "market_cap": 447680000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.32,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 20690000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0174,
    "operating_cash_flow_ttm": -18070000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.95,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Collegium Pharmaceutical, Inc."
  },
  "COO": {
    "p_e_ratio": 38.62,
    "peg_ratio": 1.32,
    "earnings_per_share": 4.01,
    "ebitda": 546340000.0,
    "eps_estimate_current_year": 7.56,
    "eps_estimate_next_quarter": 1.98,
    "fifty_day_moving_average": 162.24,
    "fifty_two_week_high": 190.0,
    "fifty_two_week_low": 142.11,
    "percent_change_from_200_day_moving_average": -0.11720000000000001,
    "percent_change_from_50_day_moving_average": -0.044500000000000005,
    "shares_owned": "N/A",
    "short_ratio": 5.5,
    "two_hundred_day_moving_average": 175.6,
    "volume": 490341.0,
    "market_cap": 7540000000.0,
    "price_to_sales_ttm": 4.15,
    "price_to_book_mrq": 2.79,
    "roa_ttm": 0.0582,
    "roe_ttm": 0.07429999999999999,
    "shares_outstanding": 48610000.0,
    "pcnt_held_by_insiders": 0.0068000000000000005,
    "pcnt_held_by_institutions": 1.022,
    "pcnt_short_of_float": 0.04650000000000001,
    "operating_cash_flow_ttm": 438510000.0,
    "levered_cash_flow_ttm": 152200000.0,
    "book_value_per_share_mrq": 55.28,
    "next_earnings_announcement_date": [
      "2015-12-02",
      "2015-12-07"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "The Cooper Companies Inc."
  },
  "CORI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.45,
    "ebitda": -16430000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 11.17,
    "fifty_two_week_high": 16.29,
    "fifty_two_week_low": 4.3,
    "percent_change_from_200_day_moving_average": -0.0055000000000000005,
    "percent_change_from_50_day_moving_average": -0.0096,
    "shares_owned": "N/A",
    "short_ratio": 2.47,
    "two_hundred_day_moving_average": 11.12,
    "volume": 122190.0,
    "market_cap": 245070000.0,
    "price_to_sales_ttm": 4.73,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1783,
    "roe_ttm": -4.3358,
    "shares_outstanding": 22160000.0,
    "pcnt_held_by_insiders": 0.0766,
    "pcnt_held_by_institutions": 0.087,
    "pcnt_short_of_float": 0.0552,
    "operating_cash_flow_ttm": -20590000.0,
    "levered_cash_flow_ttm": -14080000.0,
    "book_value_per_share_mrq": -0.3,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corium International, Inc."
  },
  "CORT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.45,
    "earnings_per_share": -0.16,
    "ebitda": -13200000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 5.02,
    "fifty_two_week_high": 7.67,
    "fifty_two_week_low": 2.59,
    "percent_change_from_200_day_moving_average": -0.1593,
    "percent_change_from_50_day_moving_average": -0.0664,
    "shares_owned": "N/A",
    "short_ratio": 12.41,
    "two_hundred_day_moving_average": 5.58,
    "volume": 176210.0,
    "market_cap": 508250000.0,
    "price_to_sales_ttm": 13.03,
    "price_to_book_mrq": 43.49,
    "roa_ttm": -0.18030000000000002,
    "roe_ttm": -2.2257,
    "shares_outstanding": 108370000.0,
    "pcnt_held_by_insiders": 0.3521,
    "pcnt_held_by_institutions": 0.375,
    "pcnt_short_of_float": 0.0781,
    "operating_cash_flow_ttm": -9250000.0,
    "levered_cash_flow_ttm": -7380000.0,
    "book_value_per_share_mrq": 0.11,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corcept Therapeutics Incorporated"
  },
  "CPHI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": -20510000.0,
    "eps_estimate_current_year": 0.42,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.231,
    "fifty_two_week_high": 0.56,
    "fifty_two_week_low": 0.16,
    "percent_change_from_200_day_moving_average": -0.25485,
    "percent_change_from_50_day_moving_average": -0.00927,
    "shares_owned": "N/A",
    "short_ratio": 0.51,
    "two_hundred_day_moving_average": 0.307,
    "volume": 72002.0,
    "market_cap": 9980000.0,
    "price_to_sales_ttm": 0.45,
    "price_to_book_mrq": 0.11,
    "roa_ttm": -0.1103,
    "roe_ttm": -0.251,
    "shares_outstanding": 43580000.0,
    "pcnt_held_by_insiders": 0.5025999999999999,
    "pcnt_held_by_institutions": 0.095,
    "pcnt_short_of_float": 0.0006,
    "operating_cash_flow_ttm": 1640000.0,
    "levered_cash_flow_ttm": 11650000.0,
    "book_value_per_share_mrq": 2.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "China Pharma Holdings, Inc."
  },
  "CPHR": {
    "p_e_ratio": 10.9746,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.413,
    "ebitda": 13480000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.284,
    "fifty_two_week_high": 18.0,
    "fifty_two_week_low": 4.323,
    "percent_change_from_200_day_moving_average": -0.49001199999999995,
    "percent_change_from_50_day_moving_average": -0.27872399999999997,
    "shares_owned": "N/A",
    "short_ratio": 1.76,
    "two_hundred_day_moving_average": 8.8875,
    "volume": 10102.0,
    "market_cap": 117700000.0,
    "price_to_sales_ttm": 4.44,
    "price_to_book_mrq": 2.26,
    "roa_ttm": 0.091,
    "roe_ttm": 0.22030000000000002,
    "shares_outstanding": 25970000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 13670000.0,
    "levered_cash_flow_ttm": 3730000.0,
    "book_value_per_share_mrq": 2.04,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cipher Pharmaceuticals Inc."
  },
  "CPIX": {
    "p_e_ratio": 53.67,
    "peg_ratio": 2.23,
    "earnings_per_share": 0.11,
    "ebitda": 4650000.0,
    "eps_estimate_current_year": 0.09,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.0,
    "fifty_two_week_high": 7.78,
    "fifty_two_week_low": 4.5,
    "percent_change_from_200_day_moving_average": -0.1207,
    "percent_change_from_50_day_moving_average": -0.025,
    "shares_owned": "N/A",
    "short_ratio": 15.64,
    "two_hundred_day_moving_average": 6.65,
    "volume": 9936.0,
    "market_cap": 97270000.0,
    "price_to_sales_ttm": 2.73,
    "price_to_book_mrq": 1.27,
    "roa_ttm": 0.0155,
    "roe_ttm": 0.0226,
    "shares_outstanding": 16629999.999999998,
    "pcnt_held_by_insiders": 0.36939999999999995,
    "pcnt_held_by_institutions": 0.385,
    "pcnt_short_of_float": 0.030600000000000002,
    "operating_cash_flow_ttm": 8940000.0,
    "levered_cash_flow_ttm": 746380.0,
    "book_value_per_share_mrq": 4.71,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Cumberland Pharmaceuticals, Inc."
  },
  "CPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.25,
    "ebitda": -17250000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 3.99,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 2.26,
    "percent_change_from_200_day_moving_average": -0.0406,
    "percent_change_from_50_day_moving_average": 0.0098,
    "shares_owned": "N/A",
    "short_ratio": 9.02,
    "two_hundred_day_moving_average": 4.2,
    "volume": 258322.0,
    "market_cap": 332380000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.39,
    "roa_ttm": -0.1891,
    "roe_ttm": -0.3552,
    "shares_outstanding": 82480000.0,
    "pcnt_held_by_insiders": 0.1895,
    "pcnt_held_by_institutions": 0.20199999999999999,
    "pcnt_short_of_float": 0.08410000000000001,
    "operating_cash_flow_ttm": -15570000.0,
    "levered_cash_flow_ttm": -9220000.0,
    "book_value_per_share_mrq": 0.77,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Catalyst Pharmaceuticals, Inc."
  },
  "CPXX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -17660000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 2.26,
    "fifty_two_week_high": 3.53,
    "fifty_two_week_low": 1.58,
    "percent_change_from_200_day_moving_average": -0.0673,
    "percent_change_from_50_day_moving_average": -0.056600000000000004,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 2.28,
    "volume": 312929.0,
    "market_cap": 71990000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.38,
    "roa_ttm": -0.36840000000000006,
    "roe_ttm": -1.2154,
    "shares_outstanding": 33800000.0,
    "pcnt_held_by_insiders": 0.5244,
    "pcnt_held_by_institutions": 0.133,
    "pcnt_short_of_float": 0.0308,
    "operating_cash_flow_ttm": -15020000.0,
    "levered_cash_flow_ttm": -9590000.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Celator Pharmaceuticals, Inc."
  },
  "CRBP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -6150000.0,
    "eps_estimate_current_year": -0.36,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 1.98,
    "fifty_two_week_high": 4.95,
    "fifty_two_week_low": 1.77,
    "percent_change_from_200_day_moving_average": -0.2584,
    "percent_change_from_50_day_moving_average": 0.053099999999999994,
    "shares_owned": "N/A",
    "short_ratio": 0.23,
    "two_hundred_day_moving_average": 2.82,
    "volume": 94220.0,
    "market_cap": 78450000.0,
    "price_to_sales_ttm": 613.7,
    "price_to_book_mrq": 9.91,
    "roa_ttm": -0.4265,
    "roe_ttm": -0.8465,
    "shares_outstanding": 37540000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0322,
    "operating_cash_flow_ttm": -3160000.0,
    "levered_cash_flow_ttm": -1470000.0,
    "book_value_per_share_mrq": 0.22,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corbus Pharmaceuticals Holdings, Inc."
  },
  "CRDC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -0.22,
    "ebitda": -17400000.0,
    "eps_estimate_current_year": -0.19,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.37,
    "fifty_two_week_high": 1.21,
    "fifty_two_week_low": 0.28,
    "percent_change_from_200_day_moving_average": -0.2216,
    "percent_change_from_50_day_moving_average": -0.0467,
    "shares_owned": "N/A",
    "short_ratio": 3.39,
    "two_hundred_day_moving_average": 0.45,
    "volume": 18259.0,
    "market_cap": 31150000.0,
    "price_to_sales_ttm": 10.57,
    "price_to_book_mrq": 1.43,
    "roa_ttm": -0.3054,
    "roe_ttm": -0.6161,
    "shares_outstanding": 89000000.0,
    "pcnt_held_by_insiders": 0.2364,
    "pcnt_held_by_institutions": 0.256,
    "pcnt_short_of_float": 0.0058,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.25,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Cardica Inc."
  },
  "CRIS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.5,
    "ebitda": -23440000.0,
    "eps_estimate_current_year": -0.52,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 2.62,
    "fifty_two_week_high": 3.75,
    "fifty_two_week_low": 1.09,
    "percent_change_from_200_day_moving_average": -0.1445,
    "percent_change_from_50_day_moving_average": -0.0438,
    "shares_owned": "N/A",
    "short_ratio": 8.81,
    "two_hundred_day_moving_average": 2.93,
    "volume": 280967.0,
    "market_cap": 325330000.0,
    "price_to_sales_ttm": 42.98,
    "price_to_book_mrq": 4.0,
    "roa_ttm": -0.1591,
    "roe_ttm": -0.8542000000000001,
    "shares_outstanding": 129610000.00000001,
    "pcnt_held_by_insiders": 0.0227,
    "pcnt_held_by_institutions": 0.523,
    "pcnt_short_of_float": 0.0736,
    "operating_cash_flow_ttm": -21320000.0,
    "levered_cash_flow_ttm": -11060000.0,
    "book_value_per_share_mrq": 0.63,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Curis, Inc."
  },
  "CRL": {
    "p_e_ratio": 23.61,
    "peg_ratio": 2.01,
    "earnings_per_share": 2.93,
    "ebitda": 290540000.0,
    "eps_estimate_current_year": 3.64,
    "eps_estimate_next_quarter": 0.95,
    "fifty_day_moving_average": 71.51,
    "fifty_two_week_high": 84.69,
    "fifty_two_week_low": 55.47,
    "percent_change_from_200_day_moving_average": -0.0665,
    "percent_change_from_50_day_moving_average": -0.0313,
    "shares_owned": "N/A",
    "short_ratio": 4.42,
    "two_hundred_day_moving_average": 74.2,
    "volume": 306290.0,
    "market_cap": 3240000000.0,
    "price_to_sales_ttm": 2.46,
    "price_to_book_mrq": 4.63,
    "roa_ttm": 0.0658,
    "roe_ttm": 0.19760000000000003,
    "shares_outstanding": 46780000.0,
    "pcnt_held_by_insiders": 0.018500000000000003,
    "pcnt_held_by_institutions": 1.038,
    "pcnt_short_of_float": 0.0461,
    "operating_cash_flow_ttm": 262980000.00000003,
    "levered_cash_flow_ttm": 207710000.0,
    "book_value_per_share_mrq": 14.98,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Charles River Laboratories International, Inc."
  },
  "CRMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.68,
    "ebitda": -13550000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 2.88,
    "fifty_two_week_high": 10.4,
    "fifty_two_week_low": 1.25,
    "percent_change_from_200_day_moving_average": -0.5196999999999999,
    "percent_change_from_50_day_moving_average": -0.0882,
    "shares_owned": "N/A",
    "short_ratio": 15.32,
    "two_hundred_day_moving_average": 5.48,
    "volume": 192153.0,
    "market_cap": 90030000.0,
    "price_to_sales_ttm": 316.7,
    "price_to_book_mrq": 2.48,
    "roa_ttm": -0.3605,
    "roe_ttm": -0.8104,
    "shares_outstanding": 34230000.0,
    "pcnt_held_by_insiders": 0.1631,
    "pcnt_held_by_institutions": 0.092,
    "pcnt_short_of_float": 0.2341,
    "operating_cash_flow_ttm": -9330000.0,
    "levered_cash_flow_ttm": -6090000.0,
    "book_value_per_share_mrq": 1.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CorMedix, Inc."
  },
  "CRME": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.36,
    "earnings_per_share": -1.32,
    "ebitda": -17840000.0,
    "eps_estimate_current_year": -1.01,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 9.46,
    "fifty_two_week_high": 11.31,
    "fifty_two_week_low": 7.12,
    "percent_change_from_200_day_moving_average": 0.065,
    "percent_change_from_50_day_moving_average": 0.0369,
    "shares_owned": "N/A",
    "short_ratio": 6.1,
    "two_hundred_day_moving_average": 9.21,
    "volume": 41023.0,
    "market_cap": 169150000.0,
    "price_to_sales_ttm": 6.5,
    "price_to_book_mrq": 16.52,
    "roa_ttm": -0.2847,
    "roe_ttm": -1.1522,
    "shares_outstanding": 17240000.0,
    "pcnt_held_by_insiders": 0.10369999999999999,
    "pcnt_held_by_institutions": 0.76,
    "pcnt_short_of_float": 0.0167,
    "operating_cash_flow_ttm": -13660000.0,
    "levered_cash_flow_ttm": -7260000.0,
    "book_value_per_share_mrq": 0.59,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Cardiome Pharma Corp."
  },
  "CRY": {
    "p_e_ratio": 83.33,
    "peg_ratio": -15.85,
    "earnings_per_share": 0.11,
    "ebitda": 10510000.0,
    "eps_estimate_current_year": -0.02,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 10.02,
    "fifty_two_week_high": 12.29,
    "fifty_two_week_low": 9.16,
    "percent_change_from_200_day_moving_average": -0.0986,
    "percent_change_from_50_day_moving_average": -0.051500000000000004,
    "shares_owned": "N/A",
    "short_ratio": 15.28,
    "two_hundred_day_moving_average": 10.54,
    "volume": 52619.0,
    "market_cap": 281690000.0,
    "price_to_sales_ttm": 1.89,
    "price_to_book_mrq": 1.81,
    "roa_ttm": 0.0154,
    "roe_ttm": 0.0225,
    "shares_outstanding": 29650000.0,
    "pcnt_held_by_insiders": 0.0946,
    "pcnt_held_by_institutions": 0.595,
    "pcnt_short_of_float": 0.0395,
    "operating_cash_flow_ttm": 12480000.0,
    "levered_cash_flow_ttm": 10450000.0,
    "book_value_per_share_mrq": 5.28,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "CryoLife Inc."
  },
  "CSBR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.96,
    "ebitda": -12210000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.08,
    "fifty_two_week_high": 10.08,
    "fifty_two_week_low": 2.4,
    "percent_change_from_200_day_moving_average": -0.026600000000000002,
    "percent_change_from_50_day_moving_average": 0.06849999999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.86,
    "two_hundred_day_moving_average": 6.68,
    "volume": 1091.0,
    "market_cap": 56560000.0,
    "price_to_sales_ttm": 6.37,
    "price_to_book_mrq": 10.55,
    "roa_ttm": -0.9987999999999999,
    "roe_ttm": -3.9436,
    "shares_outstanding": 8700000.0,
    "pcnt_held_by_insiders": 0.5997,
    "pcnt_held_by_institutions": 0.026000000000000002,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": -9390000.0,
    "levered_cash_flow_ttm": -4610000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Champions Oncology, Inc."
  },
  "CSII": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.6,
    "earnings_per_share": -1.04,
    "ebitda": -30320000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 23.65,
    "fifty_two_week_high": 41.28,
    "fifty_two_week_low": 19.96,
    "percent_change_from_200_day_moving_average": -0.341,
    "percent_change_from_50_day_moving_average": -0.15560000000000002,
    "shares_owned": "N/A",
    "short_ratio": 5.57,
    "two_hundred_day_moving_average": 30.3,
    "volume": 375603.0,
    "market_cap": 648630000.0,
    "price_to_sales_ttm": 3.71,
    "price_to_book_mrq": 4.67,
    "roa_ttm": -0.1155,
    "roe_ttm": -0.22519999999999998,
    "shares_outstanding": 32479999.999999996,
    "pcnt_held_by_insiders": 0.0895,
    "pcnt_held_by_institutions": 0.6409999999999999,
    "pcnt_short_of_float": 0.0882,
    "operating_cash_flow_ttm": -22360000.0,
    "levered_cash_flow_ttm": -36030000.0,
    "book_value_per_share_mrq": 4.37,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cardiovascular Systems Inc."
  },
  "CSU": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.14,
    "earnings_per_share": -0.71,
    "ebitda": 69820000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 21.39,
    "fifty_two_week_high": 27.75,
    "fifty_two_week_low": 20.11,
    "percent_change_from_200_day_moving_average": -0.08539999999999999,
    "percent_change_from_50_day_moving_average": 0.0353,
    "shares_owned": "N/A",
    "short_ratio": 7.35,
    "two_hundred_day_moving_average": 24.21,
    "volume": 275507.0,
    "market_cap": 653140000.0,
    "price_to_sales_ttm": 1.59,
    "price_to_book_mrq": 4.72,
    "roa_ttm": 0.011200000000000002,
    "roe_ttm": -0.1479,
    "shares_outstanding": 29500000.0,
    "pcnt_held_by_insiders": 0.1164,
    "pcnt_held_by_institutions": 0.196,
    "pcnt_short_of_float": 0.061399999999999996,
    "operating_cash_flow_ttm": 49390000.0,
    "levered_cash_flow_ttm": 35190000.0,
    "book_value_per_share_mrq": 4.68,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Capital Senior Living Corp."
  },
  "CTIC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.61,
    "ebitda": -64840000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 1.64,
    "fifty_two_week_high": 2.94,
    "fifty_two_week_low": 1.42,
    "percent_change_from_200_day_moving_average": -0.1624,
    "percent_change_from_50_day_moving_average": -0.0452,
    "shares_owned": "N/A",
    "short_ratio": 10.88,
    "two_hundred_day_moving_average": 1.87,
    "volume": 2523516.0,
    "market_cap": 283630000.0,
    "price_to_sales_ttm": 4.13,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6393,
    "roe_ttm": "N/A",
    "shares_outstanding": 180660000.0,
    "pcnt_held_by_insiders": 0.1677,
    "pcnt_held_by_institutions": 0.289,
    "pcnt_short_of_float": 0.0858,
    "operating_cash_flow_ttm": -50070000.0,
    "levered_cash_flow_ttm": -16690000.000000002,
    "book_value_per_share_mrq": -0.07,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CTI BioPharma Corp."
  },
  "CTLT": {
    "p_e_ratio": 15.49,
    "peg_ratio": 1.99,
    "earnings_per_share": 1.75,
    "ebitda": 418800000.0,
    "eps_estimate_current_year": 1.71,
    "eps_estimate_next_quarter": 0.39,
    "fifty_day_moving_average": 31.06,
    "fifty_two_week_high": 34.42,
    "fifty_two_week_low": 22.85,
    "percent_change_from_200_day_moving_average": -0.1109,
    "percent_change_from_50_day_moving_average": -0.12689999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.84,
    "two_hundred_day_moving_average": 30.5,
    "volume": 387468.0,
    "market_cap": 3380000000.0,
    "price_to_sales_ttm": 1.86,
    "price_to_book_mrq": 5.37,
    "roa_ttm": 0.0557,
    "roe_ttm": 1.5428,
    "shares_outstanding": 124520000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1061,
    "operating_cash_flow_ttm": 171800000.0,
    "levered_cash_flow_ttm": 107220000.0,
    "book_value_per_share_mrq": 5.1,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Catalent, Inc."
  },
  "CTRV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.62,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 3.88,
    "fifty_two_week_high": 5.76,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": -0.239,
    "percent_change_from_50_day_moving_average": -0.22640000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.09,
    "two_hundred_day_moving_average": 3.94,
    "volume": 20883.0,
    "market_cap": 66819999.99999999,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 22270000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0060999999999999995,
    "operating_cash_flow_ttm": -6030000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -0.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ContraVir Pharmaceuticals, Inc."
  },
  "CTSO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.79,
    "ebitda": -9200000.0,
    "eps_estimate_current_year": -0.36,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 6.88,
    "fifty_two_week_high": 15.24,
    "fifty_two_week_low": 4.4,
    "percent_change_from_200_day_moving_average": -0.1356,
    "percent_change_from_50_day_moving_average": -0.0527,
    "shares_owned": "N/A",
    "short_ratio": 10.17,
    "two_hundred_day_moving_average": 7.54,
    "volume": 79493.0,
    "market_cap": 163310000.0,
    "price_to_sales_ttm": 45.48,
    "price_to_book_mrq": 14.54,
    "roa_ttm": -0.4567,
    "roe_ttm": -0.9747,
    "shares_outstanding": 25050000.0,
    "pcnt_held_by_insiders": 0.006,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.056900000000000006,
    "operating_cash_flow_ttm": -8960000.0,
    "levered_cash_flow_ttm": -5750000.0,
    "book_value_per_share_mrq": 0.47,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Cytosorbents Corporation"
  },
  "CUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -18020000.0,
    "eps_estimate_current_year": -0.26,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 1.45,
    "fifty_two_week_high": 3.92,
    "fifty_two_week_low": 1.25,
    "percent_change_from_200_day_moving_average": -0.1588,
    "percent_change_from_50_day_moving_average": 0.056600000000000004,
    "shares_owned": "N/A",
    "short_ratio": 28.23,
    "two_hundred_day_moving_average": 1.82,
    "volume": 204088.0,
    "market_cap": 140430000.0,
    "price_to_sales_ttm": 9493.21,
    "price_to_book_mrq": 9.69,
    "roa_ttm": -0.3889,
    "roe_ttm": -1.061,
    "shares_outstanding": 91790000.0,
    "pcnt_held_by_insiders": 0.042699999999999995,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.1412,
    "operating_cash_flow_ttm": -16110000.0,
    "levered_cash_flow_ttm": -8780000.0,
    "book_value_per_share_mrq": 0.16,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Neuralstem, Inc."
  },
  "CUTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -5.62,
    "earnings_per_share": -0.67,
    "ebitda": -7720000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 14.81,
    "fifty_two_week_high": 16.37,
    "fifty_two_week_low": 9.51,
    "percent_change_from_200_day_moving_average": 0.0184,
    "percent_change_from_50_day_moving_average": -0.0043,
    "shares_owned": "N/A",
    "short_ratio": 5.71,
    "two_hundred_day_moving_average": 14.48,
    "volume": 55770.0,
    "market_cap": 208520000.0,
    "price_to_sales_ttm": 2.43,
    "price_to_book_mrq": 3.1,
    "roa_ttm": -0.0564,
    "roe_ttm": -0.1311,
    "shares_outstanding": 14140000.0,
    "pcnt_held_by_insiders": 0.061200000000000004,
    "pcnt_held_by_institutions": 0.6729999999999999,
    "pcnt_short_of_float": 0.042800000000000005,
    "operating_cash_flow_ttm": -5430000.0,
    "levered_cash_flow_ttm": -1700000.0,
    "book_value_per_share_mrq": 4.76,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cutera, Inc."
  },
  "CVM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.432,
    "ebitda": -34250000.0,
    "eps_estimate_current_year": -0.42,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.587,
    "fifty_two_week_high": 1.23,
    "fifty_two_week_low": 0.48,
    "percent_change_from_200_day_moving_average": -0.0435,
    "percent_change_from_50_day_moving_average": 0.25986,
    "shares_owned": "N/A",
    "short_ratio": 5.76,
    "two_hundred_day_moving_average": 0.773,
    "volume": 395328.0,
    "market_cap": 82830000.0,
    "price_to_sales_ttm": 104.8,
    "price_to_book_mrq": 21.15,
    "roa_ttm": -0.9235,
    "roe_ttm": -3.3804000000000003,
    "shares_outstanding": 112080000.0,
    "pcnt_held_by_insiders": 0.055999999999999994,
    "pcnt_held_by_institutions": 0.062,
    "pcnt_short_of_float": 0.0263,
    "operating_cash_flow_ttm": -24220000.0,
    "levered_cash_flow_ttm": -12940000.0,
    "book_value_per_share_mrq": 0.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CEL-SCI Corporation"
  },
  "CVRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.29,
    "ebitda": -23680000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 3.57,
    "fifty_two_week_high": 4.58,
    "fifty_two_week_low": 2.6,
    "percent_change_from_200_day_moving_average": -0.0886,
    "percent_change_from_50_day_moving_average": 0.015700000000000002,
    "shares_owned": "N/A",
    "short_ratio": 18.55,
    "two_hundred_day_moving_average": 3.98,
    "volume": 231066.0,
    "market_cap": 430270000.0,
    "price_to_sales_ttm": 149.27,
    "price_to_book_mrq": 8.46,
    "roa_ttm": -0.4071,
    "roe_ttm": -1.1645999999999999,
    "shares_outstanding": 118530000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0344,
    "operating_cash_flow_ttm": -25070000.0,
    "levered_cash_flow_ttm": -14720000.0,
    "book_value_per_share_mrq": 0.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Corindus Vascular Robotics Inc."
  },
  "CYAN": {
    "p_e_ratio": 137.33,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.05,
    "ebitda": 3340000.0,
    "eps_estimate_current_year": -0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.0,
    "fifty_two_week_high": 10.85,
    "fifty_two_week_low": 4.27,
    "percent_change_from_200_day_moving_average": -0.2737,
    "percent_change_from_50_day_moving_average": -0.11720000000000001,
    "shares_owned": "N/A",
    "short_ratio": 1.3,
    "two_hundred_day_moving_average": 8.51,
    "volume": 1190.0,
    "market_cap": 34390000.0,
    "price_to_sales_ttm": 1.01,
    "price_to_book_mrq": 1.58,
    "roa_ttm": 0.0412,
    "roe_ttm": 0.012,
    "shares_outstanding": 5570000.0,
    "pcnt_held_by_insiders": 0.3583,
    "pcnt_held_by_institutions": 0.21899999999999997,
    "pcnt_short_of_float": 0.0023,
    "operating_cash_flow_ttm": 1220000.0,
    "levered_cash_flow_ttm": -2830000.0,
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cyanotech Corp."
  },
  "CYBX": {
    "p_e_ratio": 31.8,
    "peg_ratio": 1.41,
    "earnings_per_share": 2.14,
    "ebitda": 110340000.0,
    "eps_estimate_current_year": 2.81,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 64.19,
    "fifty_two_week_high": 76.48,
    "fifty_two_week_low": 48.19,
    "percent_change_from_200_day_moving_average": 0.0765,
    "percent_change_from_50_day_moving_average": 0.0608,
    "shares_owned": "N/A",
    "short_ratio": 5.6,
    "two_hundred_day_moving_average": 63.25,
    "volume": 420121.0,
    "market_cap": 1770000000.0,
    "price_to_sales_ttm": 6.0,
    "price_to_book_mrq": 6.16,
    "roa_ttm": 0.2077,
    "roe_ttm": 0.2036,
    "shares_outstanding": 26000000.0,
    "pcnt_held_by_insiders": 0.023,
    "pcnt_held_by_institutions": 1.0270000000000001,
    "pcnt_short_of_float": 0.0663,
    "operating_cash_flow_ttm": 80320000.0,
    "levered_cash_flow_ttm": 76440000.0,
    "book_value_per_share_mrq": 11.28,
    "next_earnings_announcement_date": [
      "2015-11-18",
      "2015-11-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cyberonics Inc."
  },
  "CYCC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.68,
    "ebitda": -20140000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.58,
    "fifty_two_week_high": 3.72,
    "fifty_two_week_low": 0.49,
    "percent_change_from_200_day_moving_average": -0.20620000000000002,
    "percent_change_from_50_day_moving_average": 0.051699999999999996,
    "shares_owned": "N/A",
    "short_ratio": 3.91,
    "two_hundred_day_moving_average": 0.77,
    "volume": 84453.0,
    "market_cap": 21170000.0,
    "price_to_sales_ttm": 12.22,
    "price_to_book_mrq": 0.9,
    "roa_ttm": -0.3722,
    "roe_ttm": -0.6694,
    "shares_outstanding": 34700000.0,
    "pcnt_held_by_insiders": 0.0747,
    "pcnt_held_by_institutions": 0.092,
    "pcnt_short_of_float": 0.014499999999999999,
    "operating_cash_flow_ttm": -17550000.0,
    "levered_cash_flow_ttm": -12630000.0,
    "book_value_per_share_mrq": 0.7,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cyclacel Pharmaceuticals, Inc."
  },
  "CYH": {
    "p_e_ratio": 15.94,
    "peg_ratio": 1.24,
    "earnings_per_share": 3.02,
    "ebitda": 2920000000.0,
    "eps_estimate_current_year": 4.08,
    "eps_estimate_next_quarter": 1.18,
    "fifty_day_moving_average": 54.1,
    "fifty_two_week_high": 65.0,
    "fifty_two_week_low": 44.74,
    "percent_change_from_200_day_moving_average": -0.1231,
    "percent_change_from_50_day_moving_average": -0.1093,
    "shares_owned": "N/A",
    "short_ratio": 2.61,
    "two_hundred_day_moving_average": 54.96,
    "volume": 1706134.0,
    "market_cap": 5690000000.0,
    "price_to_sales_ttm": 0.28,
    "price_to_book_mrq": 1.31,
    "roa_ttm": 0.040999999999999995,
    "roe_ttm": 0.1092,
    "shares_outstanding": 118160000.0,
    "pcnt_held_by_insiders": 0.030699999999999998,
    "pcnt_held_by_institutions": 0.966,
    "pcnt_short_of_float": 0.0424,
    "operating_cash_flow_ttm": 1600000000.0,
    "levered_cash_flow_ttm": 647750000.0,
    "book_value_per_share_mrq": 36.44,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Community Health Systems, Inc."
  },
  "CYNO": {
    "p_e_ratio": 22.97,
    "peg_ratio": 1.42,
    "earnings_per_share": 1.42,
    "ebitda": 43250000.0,
    "eps_estimate_current_year": 1.07,
    "eps_estimate_next_quarter": 0.44,
    "fifty_day_moving_average": 34.3,
    "fifty_two_week_high": 42.97,
    "fifty_two_week_low": 19.04,
    "percent_change_from_200_day_moving_average": -0.0678,
    "percent_change_from_50_day_moving_average": -0.047400000000000005,
    "shares_owned": "N/A",
    "short_ratio": 4.71,
    "two_hundred_day_moving_average": 35.05,
    "volume": 329103.0,
    "market_cap": 741680000.0,
    "price_to_sales_ttm": 2.37,
    "price_to_book_mrq": 1.94,
    "roa_ttm": 0.0337,
    "roe_ttm": 0.08710000000000001,
    "shares_outstanding": 22700000.0,
    "pcnt_held_by_insiders": 0.0472,
    "pcnt_held_by_institutions": 0.852,
    "pcnt_short_of_float": 0.0525,
    "operating_cash_flow_ttm": 37340000.0,
    "levered_cash_flow_ttm": 14280000.0,
    "book_value_per_share_mrq": 17.0,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cynosure, Inc."
  },
  "CYTK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.44,
    "earnings_per_share": -0.45,
    "ebitda": -16520000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 6.97,
    "fifty_two_week_high": 8.61,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": 0.0684,
    "percent_change_from_50_day_moving_average": 0.042199999999999994,
    "shares_owned": "N/A",
    "short_ratio": 6.1,
    "two_hundred_day_moving_average": 6.8,
    "volume": 251555.0,
    "market_cap": 281370000.0,
    "price_to_sales_ttm": 6.53,
    "price_to_book_mrq": 3.67,
    "roa_ttm": -0.10220000000000001,
    "roe_ttm": -0.2208,
    "shares_outstanding": 38760000.0,
    "pcnt_held_by_insiders": 0.3482,
    "pcnt_held_by_institutions": 0.499,
    "pcnt_short_of_float": 0.0487,
    "operating_cash_flow_ttm": 7530000.0,
    "levered_cash_flow_ttm": 4910000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cytokinetics, Incorporated"
  },
  "CYTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.87,
    "ebitda": -55760000.0,
    "eps_estimate_current_year": -0.99,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 2.5,
    "fifty_two_week_high": 5.42,
    "fifty_two_week_low": 1.98,
    "percent_change_from_200_day_moving_average": -0.23370000000000002,
    "percent_change_from_50_day_moving_average": 0.0759,
    "shares_owned": "N/A",
    "short_ratio": 12.63,
    "two_hundred_day_moving_average": 3.51,
    "volume": 362826.0,
    "market_cap": 178830000.0,
    "price_to_sales_ttm": 1821.55,
    "price_to_book_mrq": 3.61,
    "roa_ttm": -0.4165,
    "roe_ttm": -0.7696999999999999,
    "shares_outstanding": 66480000.00000001,
    "pcnt_held_by_insiders": 0.2192,
    "pcnt_held_by_institutions": 0.391,
    "pcnt_short_of_float": 0.1787,
    "operating_cash_flow_ttm": -47450000.0,
    "levered_cash_flow_ttm": -33940000.0,
    "book_value_per_share_mrq": 0.76,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CytRx Corporation"
  },
  "CYTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.336,
    "ebitda": -24510000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.3894,
    "fifty_two_week_high": 1.47,
    "fifty_two_week_low": 0.28,
    "percent_change_from_200_day_moving_average": -0.46885800000000005,
    "percent_change_from_50_day_moving_average": -0.043985,
    "shares_owned": "N/A",
    "short_ratio": 5.55,
    "two_hundred_day_moving_average": 0.7009,
    "volume": 1247169.0,
    "market_cap": 61790000.0,
    "price_to_sales_ttm": 5.23,
    "price_to_book_mrq": 24.67,
    "roa_ttm": -0.3754,
    "roe_ttm": "-1,891.05%",
    "shares_outstanding": 165960000.0,
    "pcnt_held_by_insiders": 0.1702,
    "pcnt_held_by_institutions": 0.184,
    "pcnt_short_of_float": 0.0536,
    "operating_cash_flow_ttm": -21980000.0,
    "levered_cash_flow_ttm": -12770000.0,
    "book_value_per_share_mrq": 0.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cytori Therapeutics, Inc."
  },
  "DARA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.487,
    "ebitda": -9020000.0,
    "eps_estimate_current_year": -0.55,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 0.8569,
    "fifty_two_week_high": 1.11,
    "fifty_two_week_low": 0.67,
    "percent_change_from_200_day_moving_average": 0.06032,
    "percent_change_from_50_day_moving_average": 0.038563,
    "shares_owned": "N/A",
    "short_ratio": 0.98,
    "two_hundred_day_moving_average": 0.8393,
    "volume": 20326.0,
    "market_cap": 17580000.0,
    "price_to_sales_ttm": 5.81,
    "price_to_book_mrq": 1.98,
    "roa_ttm": -0.37579999999999997,
    "roe_ttm": -0.7439,
    "shares_outstanding": 19760000.0,
    "pcnt_held_by_insiders": 0.1435,
    "pcnt_held_by_institutions": 0.111,
    "pcnt_short_of_float": 0.0063,
    "operating_cash_flow_ttm": -8700000.0,
    "levered_cash_flow_ttm": -4059999.9999999995,
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "DARA BioSciences, Inc"
  },
  "DBVT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.84,
    "ebitda": -29880000.0,
    "eps_estimate_current_year": -1.2,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 39.83,
    "fifty_two_week_high": 44.76,
    "fifty_two_week_low": 20.26,
    "percent_change_from_200_day_moving_average": 0.3251,
    "percent_change_from_50_day_moving_average": 0.0355,
    "shares_owned": "N/A",
    "short_ratio": 2.51,
    "two_hundred_day_moving_average": 31.13,
    "volume": 109310.0,
    "market_cap": 1900000000.0,
    "price_to_sales_ttm": 319.19,
    "price_to_book_mrq": 13.61,
    "roa_ttm": -0.21760000000000002,
    "roe_ttm": -0.3895,
    "shares_outstanding": 46000000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -25690000.0,
    "levered_cash_flow_ttm": -17170000.0,
    "book_value_per_share_mrq": 3.03,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "DBV Technologies S.A."
  },
  "DCTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.393,
    "ebitda": -14650000.0,
    "eps_estimate_current_year": -2.22,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.478,
    "fifty_two_week_high": 2.13,
    "fifty_two_week_low": 0.36,
    "percent_change_from_200_day_moving_average": -0.424,
    "percent_change_from_50_day_moving_average": 0.00688,
    "shares_owned": "N/A",
    "short_ratio": 2.67,
    "two_hundred_day_moving_average": 0.835,
    "volume": 52469.0,
    "market_cap": 10470000.0,
    "price_to_sales_ttm": 7.67,
    "price_to_book_mrq": 0.47,
    "roa_ttm": -0.397,
    "roe_ttm": -0.7674,
    "shares_outstanding": 21760000.0,
    "pcnt_held_by_insiders": 0.015,
    "pcnt_held_by_institutions": 0.165,
    "pcnt_short_of_float": 0.065,
    "operating_cash_flow_ttm": -16020000.0,
    "levered_cash_flow_ttm": -10870000.0,
    "book_value_per_share_mrq": 1.06,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Delcath Systems, Inc."
  },
  "DEPO": {
    "p_e_ratio": 22.16,
    "peg_ratio": 1.32,
    "earnings_per_share": 1.09,
    "ebitda": 201630000.0,
    "eps_estimate_current_year": 0.61,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 28.89,
    "fifty_two_week_high": 33.74,
    "fifty_two_week_low": 13.55,
    "percent_change_from_200_day_moving_average": -0.061900000000000004,
    "percent_change_from_50_day_moving_average": -0.1661,
    "shares_owned": "N/A",
    "short_ratio": 7.95,
    "two_hundred_day_moving_average": 25.68,
    "volume": 801426.0,
    "market_cap": 1450000000.0,
    "price_to_sales_ttm": 3.91,
    "price_to_book_mrq": 4.21,
    "roa_ttm": 0.1161,
    "roe_ttm": 0.2581,
    "shares_outstanding": 60370000.0,
    "pcnt_held_by_insiders": 0.0046,
    "pcnt_held_by_institutions": 0.773,
    "pcnt_short_of_float": 0.2054,
    "operating_cash_flow_ttm": 39550000.0,
    "levered_cash_flow_ttm": 134230000.0,
    "book_value_per_share_mrq": 5.74,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "DepoMed Inc."
  },
  "DERM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.5,
    "ebitda": -46020000.0,
    "eps_estimate_current_year": -2.99,
    "eps_estimate_next_quarter": -0.97,
    "fifty_day_moving_average": 26.1,
    "fifty_two_week_high": 32.13,
    "fifty_two_week_low": 12.68,
    "percent_change_from_200_day_moving_average": 0.5448,
    "percent_change_from_50_day_moving_average": 0.12990000000000002,
    "shares_owned": "N/A",
    "short_ratio": 1.3,
    "two_hundred_day_moving_average": 19.09,
    "volume": 87491.0,
    "market_cap": 860250000.0,
    "price_to_sales_ttm": 101.67,
    "price_to_book_mrq": 5.92,
    "roa_ttm": -0.2657,
    "roe_ttm": -0.5326,
    "shares_outstanding": 29170000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0368,
    "operating_cash_flow_ttm": -33290000.0,
    "levered_cash_flow_ttm": -19920000.0,
    "book_value_per_share_mrq": 5.07,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dermira, Inc."
  },
  "DGX": {
    "p_e_ratio": 19.35,
    "peg_ratio": 1.43,
    "earnings_per_share": 3.41,
    "ebitda": 1470000000.0,
    "eps_estimate_current_year": 4.76,
    "eps_estimate_next_quarter": 1.21,
    "fifty_day_moving_average": 69.23,
    "fifty_two_week_high": 89.0,
    "fifty_two_week_low": 56.27,
    "percent_change_from_200_day_moving_average": -0.0901,
    "percent_change_from_50_day_moving_average": -0.0458,
    "shares_owned": "N/A",
    "short_ratio": 10.12,
    "two_hundred_day_moving_average": 72.6,
    "volume": 493557.0,
    "market_cap": 9480000000.0,
    "price_to_sales_ttm": 1.26,
    "price_to_book_mrq": 2.21,
    "roa_ttm": 0.07429999999999999,
    "roe_ttm": 0.126,
    "shares_outstanding": 143550000.0,
    "pcnt_held_by_insiders": 0.0036,
    "pcnt_held_by_institutions": 1.03,
    "pcnt_short_of_float": 0.0788,
    "operating_cash_flow_ttm": 901000000.0,
    "levered_cash_flow_ttm": 691750000.0,
    "book_value_per_share_mrq": 29.96,
    "next_earnings_announcement_date": "2015-10-22",
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Quest Diagnostics Inc."
  },
  "DHRM": {
    "p_e_ratio": 8.72,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.18,
    "ebitda": -1080000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.68,
    "fifty_two_week_high": 5.83,
    "fifty_two_week_low": 1.39,
    "percent_change_from_200_day_moving_average": -0.35509999999999997,
    "percent_change_from_50_day_moving_average": -0.0642,
    "shares_owned": "N/A",
    "short_ratio": 1.09,
    "two_hundred_day_moving_average": 2.43,
    "volume": 7907.0,
    "market_cap": 9180000.0,
    "price_to_sales_ttm": 0.8,
    "price_to_book_mrq": 0.23,
    "roa_ttm": -0.0241,
    "roe_ttm": 0.016399999999999998,
    "shares_outstanding": 5850000.0,
    "pcnt_held_by_insiders": 0.24359999999999998,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.0029,
    "operating_cash_flow_ttm": 4139999.9999999995,
    "levered_cash_flow_ttm": -5960000.0,
    "book_value_per_share_mrq": 7.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Dehaier Medical Systems Limited"
  },
  "DNAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.32,
    "earnings_per_share": -141.05,
    "ebitda": -31050000.0,
    "eps_estimate_current_year": -4.04,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 28.75,
    "fifty_two_week_high": 33.75,
    "fifty_two_week_low": 22.67,
    "percent_change_from_200_day_moving_average": 0.0013,
    "percent_change_from_50_day_moving_average": -0.0012,
    "shares_owned": "N/A",
    "short_ratio": 3.66,
    "two_hundred_day_moving_average": 28.67,
    "volume": 36975.0,
    "market_cap": 862970000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 30060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0338,
    "operating_cash_flow_ttm": -19090000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -174.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ProNAi Therapeutics, Inc."
  },
  "DPLO": {
    "p_e_ratio": 197.83,
    "peg_ratio": 1.84,
    "earnings_per_share": 0.18,
    "ebitda": 43940000.0,
    "eps_estimate_current_year": 0.59,
    "eps_estimate_next_quarter": 0.18,
    "fifty_day_moving_average": 41.63,
    "fifty_two_week_high": 52.33,
    "fifty_two_week_low": 15.04,
    "percent_change_from_200_day_moving_average": -0.07429999999999999,
    "percent_change_from_50_day_moving_average": -0.1255,
    "shares_owned": "N/A",
    "short_ratio": 8.79,
    "two_hundred_day_moving_average": 39.32,
    "volume": 892277.0,
    "market_cap": 2320000000.0,
    "price_to_sales_ttm": 0.83,
    "price_to_book_mrq": 4.69,
    "roa_ttm": 0.0276,
    "roe_ttm": 0.030299999999999997,
    "shares_outstanding": 63640000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1598,
    "operating_cash_flow_ttm": -70950000.0,
    "levered_cash_flow_ttm": -73250000.0,
    "book_value_per_share_mrq": 7.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Diplomat Pharmacy, Inc."
  },
  "DPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.2,
    "earnings_per_share": -1.79,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.79,
    "eps_estimate_next_quarter": -0.43,
    "fifty_day_moving_average": 13.8,
    "fifty_two_week_high": 17.1,
    "fifty_two_week_low": 9.5,
    "percent_change_from_200_day_moving_average": 0.0849,
    "percent_change_from_50_day_moving_average": 0.0695,
    "shares_owned": "N/A",
    "short_ratio": 1.94,
    "two_hundred_day_moving_average": 13.6,
    "volume": 66340.0,
    "market_cap": 152040000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.63,
    "roa_ttm": -0.2597,
    "roe_ttm": -0.4261,
    "shares_outstanding": 10300000.0,
    "pcnt_held_by_insiders": 0.4629,
    "pcnt_held_by_institutions": 0.253,
    "pcnt_short_of_float": 0.015600000000000001,
    "operating_cash_flow_ttm": -11840000.0,
    "levered_cash_flow_ttm": -5930000.0,
    "book_value_per_share_mrq": 3.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dipexium Pharmaceuticals, Inc."
  },
  "DRAD": {
    "p_e_ratio": 21.5,
    "peg_ratio": 1.34,
    "earnings_per_share": 0.18,
    "ebitda": 5880000.0,
    "eps_estimate_current_year": 0.19,
    "eps_estimate_next_quarter": 0.06,
    "fifty_day_moving_average": 3.94,
    "fifty_two_week_high": 5.48,
    "fifty_two_week_low": 3.5,
    "percent_change_from_200_day_moving_average": -0.0716,
    "percent_change_from_50_day_moving_average": -0.0187,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 4.17,
    "volume": 9250.0,
    "market_cap": 74910000.0,
    "price_to_sales_ttm": 1.31,
    "price_to_book_mrq": 2.1,
    "roa_ttm": 0.0545,
    "roe_ttm": 0.10640000000000001,
    "shares_outstanding": 19360000.0,
    "pcnt_held_by_insiders": 0.2217,
    "pcnt_held_by_institutions": 0.431,
    "pcnt_short_of_float": 0.0016,
    "operating_cash_flow_ttm": 5300000.0,
    "levered_cash_flow_ttm": 3770000.0,
    "book_value_per_share_mrq": 1.86,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Digirad Corporation"
  },
  "DRNA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.1,
    "ebitda": -55380000.0,
    "eps_estimate_current_year": -3.35,
    "eps_estimate_next_quarter": -0.87,
    "fifty_day_moving_average": 10.76,
    "fifty_two_week_high": 27.33,
    "fifty_two_week_low": 8.0,
    "percent_change_from_200_day_moving_average": -0.3688,
    "percent_change_from_50_day_moving_average": -0.0387,
    "shares_owned": "N/A",
    "short_ratio": 7.59,
    "two_hundred_day_moving_average": 16.38,
    "volume": 131370.0,
    "market_cap": 212930000.0,
    "price_to_sales_ttm": 1172.91,
    "price_to_book_mrq": 1.82,
    "roa_ttm": -0.2789,
    "roe_ttm": -0.4692,
    "shares_outstanding": 20590000.0,
    "pcnt_held_by_insiders": 0.2125,
    "pcnt_held_by_institutions": 0.6940000000000001,
    "pcnt_short_of_float": 0.1096,
    "operating_cash_flow_ttm": -42710000.0,
    "levered_cash_flow_ttm": -23120000.0,
    "book_value_per_share_mrq": 5.77,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dicerna Pharmaceuticals, Inc."
  },
  "DRRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.65,
    "earnings_per_share": -0.21,
    "ebitda": -20760000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 2.18,
    "fifty_two_week_high": 3.42,
    "fifty_two_week_low": 0.68,
    "percent_change_from_200_day_moving_average": 0.1035,
    "percent_change_from_50_day_moving_average": 0.136,
    "shares_owned": "N/A",
    "short_ratio": 11.52,
    "two_hundred_day_moving_average": 2.25,
    "volume": 250446.0,
    "market_cap": 298800000.0,
    "price_to_sales_ttm": 16.37,
    "price_to_book_mrq": 12.68,
    "roa_ttm": -0.2501,
    "roe_ttm": -0.9749,
    "shares_outstanding": 120480000.0,
    "pcnt_held_by_insiders": 0.13390000000000002,
    "pcnt_held_by_institutions": 0.41200000000000003,
    "pcnt_short_of_float": 0.0527,
    "operating_cash_flow_ttm": -16719999.999999998,
    "levered_cash_flow_ttm": -11000000.0,
    "book_value_per_share_mrq": 0.19,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "DURECT Corporation"
  },
  "DSCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.6,
    "ebitda": -37760000.0,
    "eps_estimate_current_year": -1.64,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 6.31,
    "fifty_two_week_high": 9.89,
    "fifty_two_week_low": 5.61,
    "percent_change_from_200_day_moving_average": -0.1099,
    "percent_change_from_50_day_moving_average": 0.0174,
    "shares_owned": "N/A",
    "short_ratio": 8.67,
    "two_hundred_day_moving_average": 7.21,
    "volume": 40174.0,
    "market_cap": 165680000.0,
    "price_to_sales_ttm": 1.92,
    "price_to_book_mrq": 1.48,
    "roa_ttm": -0.1819,
    "roe_ttm": -0.3191,
    "shares_outstanding": 25810000.0,
    "pcnt_held_by_insiders": 0.0567,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.0339,
    "operating_cash_flow_ttm": -29460000.0,
    "levered_cash_flow_ttm": -16040000.0,
    "book_value_per_share_mrq": 4.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Derma Sciences Inc."
  },
  "DSCO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -41660000.0,
    "eps_estimate_current_year": -0.4,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 0.43,
    "fifty_two_week_high": 2.01,
    "fifty_two_week_low": 0.35,
    "percent_change_from_200_day_moving_average": -0.5456,
    "percent_change_from_50_day_moving_average": -0.10800000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.83,
    "two_hundred_day_moving_average": 0.84,
    "volume": 265012.0,
    "market_cap": 42180000.0,
    "price_to_sales_ttm": 21.39,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.546,
    "roe_ttm": -2.5168,
    "shares_outstanding": 111000000.0,
    "pcnt_held_by_insiders": 0.0027,
    "pcnt_held_by_institutions": 0.64,
    "pcnt_short_of_float": 0.023,
    "operating_cash_flow_ttm": -39250000.0,
    "levered_cash_flow_ttm": -24400000.0,
    "book_value_per_share_mrq": -0.04,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Discovery Laboratories Inc."
  },
  "DVAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.67,
    "ebitda": -100820000.0,
    "eps_estimate_current_year": -3.26,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 29.1,
    "fifty_two_week_high": 32.49,
    "fifty_two_week_low": 13.4,
    "percent_change_from_200_day_moving_average": 0.1578,
    "percent_change_from_50_day_moving_average": -0.0148,
    "shares_owned": "N/A",
    "short_ratio": 6.43,
    "two_hundred_day_moving_average": 24.76,
    "volume": 322047.0,
    "market_cap": 1100000000.0,
    "price_to_sales_ttm": 167.32,
    "price_to_book_mrq": 11.78,
    "roa_ttm": -0.4514,
    "roe_ttm": -0.9051,
    "shares_outstanding": 38400000.0,
    "pcnt_held_by_insiders": 0.0064,
    "pcnt_held_by_institutions": 0.736,
    "pcnt_short_of_float": 0.1494,
    "operating_cash_flow_ttm": -87670000.0,
    "levered_cash_flow_ttm": -55820000.0,
    "book_value_per_share_mrq": 2.47,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dynavax Technologies Corporation"
  },
  "DVCR": {
    "p_e_ratio": 13.7,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.76,
    "ebitda": 21410000.0,
    "eps_estimate_current_year": 0.19,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 11.14,
    "fifty_two_week_high": 17.15,
    "fifty_two_week_low": 8.14,
    "percent_change_from_200_day_moving_average": -0.2114,
    "percent_change_from_50_day_moving_average": -0.0663,
    "shares_owned": "N/A",
    "short_ratio": 0.29,
    "two_hundred_day_moving_average": 13.19,
    "volume": 3563.0,
    "market_cap": 65120000.00000001,
    "price_to_sales_ttm": 0.17,
    "price_to_book_mrq": 5.22,
    "roa_ttm": 0.061500000000000006,
    "roe_ttm": 0.14029999999999998,
    "shares_outstanding": 6260000.0,
    "pcnt_held_by_insiders": 0.4424,
    "pcnt_held_by_institutions": 0.20600000000000002,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": 2380000.0,
    "levered_cash_flow_ttm": -930880.0,
    "book_value_per_share_mrq": 1.92,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Diversicare Healthcare Services Inc."
  },
  "DXCM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -23.64,
    "earnings_per_share": -0.26,
    "ebitda": -10300000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": 0.09,
    "fifty_day_moving_average": 93.46,
    "fifty_two_week_high": 103.29,
    "fifty_two_week_low": 38.77,
    "percent_change_from_200_day_moving_average": 0.3053,
    "percent_change_from_50_day_moving_average": 0.0758,
    "shares_owned": "N/A",
    "short_ratio": 1.57,
    "two_hundred_day_moving_average": 77.03,
    "volume": 887759.0,
    "market_cap": 8050000000.000001,
    "price_to_sales_ttm": 24.44,
    "price_to_book_mrq": 45.67,
    "roa_ttm": -0.0695,
    "roe_ttm": -0.1517,
    "shares_outstanding": 80080000.0,
    "pcnt_held_by_insiders": 0.0226,
    "pcnt_held_by_institutions": 0.9470000000000001,
    "pcnt_short_of_float": 0.0239,
    "operating_cash_flow_ttm": 39600000.0,
    "levered_cash_flow_ttm": 18830000.0,
    "book_value_per_share_mrq": 2.13,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "DexCom, Inc."
  },
  "DXR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.28,
    "ebitda": 0.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.63,
    "fifty_two_week_high": 9.18,
    "fifty_two_week_low": 5.4,
    "percent_change_from_200_day_moving_average": 0.18719999999999998,
    "percent_change_from_50_day_moving_average": 0.21989999999999998,
    "shares_owned": "N/A",
    "short_ratio": 12.36,
    "two_hundred_day_moving_average": 6.81,
    "volume": 5542.0,
    "market_cap": 31600000.0,
    "price_to_sales_ttm": 20.79,
    "price_to_book_mrq": 1.59,
    "roa_ttm": 0.0176,
    "roe_ttm": -0.2214,
    "shares_outstanding": 3910000.0,
    "pcnt_held_by_insiders": 0.7757999999999999,
    "pcnt_held_by_institutions": 0.063,
    "pcnt_short_of_float": 0.053099999999999994,
    "operating_cash_flow_ttm": 10210000.0,
    "levered_cash_flow_ttm": -5180000.0,
    "book_value_per_share_mrq": 5.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Daxor Corp."
  },
  "DYAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.88,
    "earnings_per_share": -0.14,
    "ebitda": -7430000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 22.97,
    "fifty_two_week_high": 30.55,
    "fifty_two_week_low": 9.19,
    "percent_change_from_200_day_moving_average": -0.0739,
    "percent_change_from_50_day_moving_average": -0.0176,
    "shares_owned": "N/A",
    "short_ratio": 6.32,
    "two_hundred_day_moving_average": 24.37,
    "volume": 633700.0,
    "market_cap": 3300000000.0,
    "price_to_sales_ttm": 34.82,
    "price_to_book_mrq": 10.41,
    "roa_ttm": -0.016399999999999998,
    "roe_ttm": -0.0894,
    "shares_outstanding": 146360000.0,
    "pcnt_held_by_insiders": 0.08779999999999999,
    "pcnt_held_by_institutions": 0.883,
    "pcnt_short_of_float": 0.0449,
    "operating_cash_flow_ttm": -11340000.0,
    "levered_cash_flow_ttm": -2660000.0,
    "book_value_per_share_mrq": 2.17,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dyax Corp."
  },
  "DYNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.14,
    "ebitda": 598676.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.03,
    "fifty_two_week_high": 5.76,
    "fifty_two_week_low": 2.7,
    "percent_change_from_200_day_moving_average": 0.0085,
    "percent_change_from_50_day_moving_average": 0.005699999999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.03,
    "two_hundred_day_moving_average": 3.02,
    "volume": 3711.0,
    "market_cap": 7690000.0,
    "price_to_sales_ttm": 0.27,
    "price_to_book_mrq": 1.33,
    "roa_ttm": -0.002,
    "roe_ttm": -0.0587,
    "shares_outstanding": 2520000.0,
    "pcnt_held_by_insiders": 0.24239999999999998,
    "pcnt_held_by_institutions": 0.04,
    "pcnt_short_of_float": 0.0006,
    "operating_cash_flow_ttm": -740240.0,
    "levered_cash_flow_ttm": 1340000.0,
    "book_value_per_share_mrq": 2.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Dynatronics Corp."
  },
  "EARS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.81,
    "ebitda": -28980000.0,
    "eps_estimate_current_year": -1.21,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 4.72,
    "fifty_two_week_high": 7.15,
    "fifty_two_week_low": 3.3,
    "percent_change_from_200_day_moving_average": -0.1674,
    "percent_change_from_50_day_moving_average": -0.0969,
    "shares_owned": "N/A",
    "short_ratio": 0.87,
    "two_hundred_day_moving_average": 5.12,
    "volume": 2331.0,
    "market_cap": 146090000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.6,
    "roa_ttm": -0.4484,
    "roe_ttm": -0.7906,
    "shares_outstanding": 34290000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0032,
    "operating_cash_flow_ttm": -22980000.0,
    "levered_cash_flow_ttm": -16010000.000000002,
    "book_value_per_share_mrq": 1.66,
    "next_earnings_announcement_date": [
      "2015-12-01",
      "2015-12-07"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Auris Medical Holding AG"
  },
  "EBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.85,
    "ebitda": -33299999.999999996,
    "eps_estimate_current_year": -1.41,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 3.3,
    "fifty_two_week_high": 13.77,
    "fifty_two_week_low": 2.25,
    "percent_change_from_200_day_moving_average": -0.5021,
    "percent_change_from_50_day_moving_average": -0.1346,
    "shares_owned": "N/A",
    "short_ratio": 0.58,
    "two_hundred_day_moving_average": 5.74,
    "volume": 94690.0,
    "market_cap": 55420000.0,
    "price_to_sales_ttm": 35.34,
    "price_to_book_mrq": 1.51,
    "roa_ttm": -0.4132,
    "roe_ttm": -0.8503000000000001,
    "shares_outstanding": 19380000.0,
    "pcnt_held_by_insiders": 0.2693,
    "pcnt_held_by_institutions": 0.598,
    "pcnt_short_of_float": 0.128,
    "operating_cash_flow_ttm": -33330000.0,
    "levered_cash_flow_ttm": -20260000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Eleven Biotherapeutics, Inc."
  },
  "EBS": {
    "p_e_ratio": 32.3,
    "peg_ratio": 2.24,
    "earnings_per_share": 0.96,
    "ebitda": 110080000.0,
    "eps_estimate_current_year": 1.45,
    "eps_estimate_next_quarter": 0.88,
    "fifty_day_moving_average": 33.3,
    "fifty_two_week_high": 36.2,
    "fifty_two_week_low": 19.31,
    "percent_change_from_200_day_moving_average": -0.0176,
    "percent_change_from_50_day_moving_average": -0.064,
    "shares_owned": "N/A",
    "short_ratio": 11.47,
    "two_hundred_day_moving_average": 31.73,
    "volume": 213791.0,
    "market_cap": 1210000000.0,
    "price_to_sales_ttm": 2.48,
    "price_to_book_mrq": 2.1,
    "roa_ttm": 0.053099999999999994,
    "roe_ttm": 0.0848,
    "shares_outstanding": 38800000.0,
    "pcnt_held_by_insiders": 0.2702,
    "pcnt_held_by_institutions": 0.754,
    "pcnt_short_of_float": 0.11789999999999999,
    "operating_cash_flow_ttm": 67370000.0,
    "levered_cash_flow_ttm": 18660000.0,
    "book_value_per_share_mrq": 14.51,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Emergent BioSolutions, Inc."
  },
  "ECTE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.33,
    "ebitda": -10010000.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.53,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 0.39,
    "percent_change_from_200_day_moving_average": -0.10289999999999999,
    "percent_change_from_50_day_moving_average": 0.0286,
    "shares_owned": "N/A",
    "short_ratio": 5.51,
    "two_hundred_day_moving_average": 1.75,
    "volume": 9000.0,
    "market_cap": 17470000.0,
    "price_to_sales_ttm": 902.73,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6759999999999999,
    "roe_ttm": -3.8989999999999996,
    "shares_outstanding": 11130000.0,
    "pcnt_held_by_insiders": 0.2059,
    "pcnt_held_by_institutions": 0.071,
    "pcnt_short_of_float": 0.0435,
    "operating_cash_flow_ttm": -7360000.0,
    "levered_cash_flow_ttm": -2390000.0,
    "book_value_per_share_mrq": -0.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Echo Therapeutics, Inc."
  },
  "ECYT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.84,
    "ebitda": -34120000.0,
    "eps_estimate_current_year": -1.08,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 5.25,
    "fifty_two_week_high": 8.09,
    "fifty_two_week_low": 4.61,
    "percent_change_from_200_day_moving_average": -0.0771,
    "percent_change_from_50_day_moving_average": 0.005699999999999999,
    "shares_owned": "N/A",
    "short_ratio": 14.92,
    "two_hundred_day_moving_average": 5.72,
    "volume": 204890.0,
    "market_cap": 221620000.0,
    "price_to_sales_ttm": 56.76,
    "price_to_book_mrq": 1.19,
    "roa_ttm": -0.10300000000000001,
    "roe_ttm": -0.1751,
    "shares_outstanding": 41970000.0,
    "pcnt_held_by_insiders": 0.1884,
    "pcnt_held_by_institutions": 0.542,
    "pcnt_short_of_float": 0.15039999999999998,
    "operating_cash_flow_ttm": -29740000.0,
    "levered_cash_flow_ttm": -18740000.0,
    "book_value_per_share_mrq": 4.47,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Endocyte, Inc."
  },
  "EDAP": {
    "p_e_ratio": 54.94,
    "peg_ratio": -19.5,
    "earnings_per_share": 0.09,
    "ebitda": -1330000.0,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 3.83,
    "fifty_two_week_high": 5.0,
    "fifty_two_week_low": 1.15,
    "percent_change_from_200_day_moving_average": 0.39899999999999997,
    "percent_change_from_50_day_moving_average": 0.27699999999999997,
    "shares_owned": "N/A",
    "short_ratio": 15.05,
    "two_hundred_day_moving_average": 3.5,
    "volume": 276494.0,
    "market_cap": 122040000.0,
    "price_to_sales_ttm": 3.87,
    "price_to_book_mrq": 6.86,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 24960000.0,
    "pcnt_held_by_insiders": 0.11359999999999999,
    "pcnt_held_by_institutions": 0.109,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.69,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EDAP TMS SA"
  },
  "EGLT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.2,
    "ebitda": -49220000.0,
    "eps_estimate_current_year": -3.04,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 12.9,
    "fifty_two_week_high": 17.03,
    "fifty_two_week_low": 3.81,
    "percent_change_from_200_day_moving_average": 0.20550000000000002,
    "percent_change_from_50_day_moving_average": 0.1291,
    "shares_owned": "N/A",
    "short_ratio": 6.97,
    "two_hundred_day_moving_average": 12.08,
    "volume": 102465.0,
    "market_cap": 363860000.0,
    "price_to_sales_ttm": 87.08,
    "price_to_book_mrq": 7.94,
    "roa_ttm": -0.3097,
    "roe_ttm": -1.1255,
    "shares_outstanding": 24990000.0,
    "pcnt_held_by_insiders": 0.7775,
    "pcnt_held_by_institutions": 0.209,
    "pcnt_short_of_float": 0.1352,
    "operating_cash_flow_ttm": -16300000.0,
    "levered_cash_flow_ttm": -15820000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Egalet Corporation"
  },
  "EGRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.28,
    "ebitda": -7900000.0,
    "eps_estimate_current_year": 0.95,
    "eps_estimate_next_quarter": 0.71,
    "fifty_day_moving_average": 80.59,
    "fifty_two_week_high": 104.17,
    "fifty_two_week_low": 10.81,
    "percent_change_from_200_day_moving_average": 0.22719999999999999,
    "percent_change_from_50_day_moving_average": 0.06570000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.38,
    "two_hundred_day_moving_average": 69.98,
    "volume": 370324.0,
    "market_cap": 1340000000.0,
    "price_to_sales_ttm": 24.42,
    "price_to_book_mrq": 13.65,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15590000.0,
    "pcnt_held_by_insiders": 0.3503,
    "pcnt_held_by_institutions": 0.139,
    "pcnt_short_of_float": 0.1865,
    "operating_cash_flow_ttm": -11050000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Eagle Pharmaceuticals Inc."
  },
  "ELGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.62,
    "earnings_per_share": -0.78,
    "ebitda": -36870000.0,
    "eps_estimate_current_year": -0.61,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 13.08,
    "fifty_two_week_high": 18.07,
    "fifty_two_week_low": 10.29,
    "percent_change_from_200_day_moving_average": -0.1319,
    "percent_change_from_50_day_moving_average": 0.0154,
    "shares_owned": "N/A",
    "short_ratio": 7.02,
    "two_hundred_day_moving_average": 15.3,
    "volume": 775581.0,
    "market_cap": 900130000.0,
    "price_to_sales_ttm": 6.09,
    "price_to_book_mrq": 8.67,
    "roa_ttm": -0.1058,
    "roe_ttm": -0.4217,
    "shares_outstanding": 67780000.0,
    "pcnt_held_by_insiders": 0.018600000000000002,
    "pcnt_held_by_institutions": 0.917,
    "pcnt_short_of_float": 0.1386,
    "operating_cash_flow_ttm": -32560000.000000004,
    "levered_cash_flow_ttm": -29120000.0,
    "book_value_per_share_mrq": 1.58,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Endologix Inc."
  },
  "ELMD": {
    "p_e_ratio": 14.62,
    "peg_ratio": 1.57,
    "earnings_per_share": 0.13,
    "ebitda": 2160000.0,
    "eps_estimate_current_year": 0.12,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.79,
    "fifty_two_week_high": 2.84,
    "fifty_two_week_low": 1.23,
    "percent_change_from_200_day_moving_average": -0.0718,
    "percent_change_from_50_day_moving_average": 0.0643,
    "shares_owned": "N/A",
    "short_ratio": 1.9,
    "two_hundred_day_moving_average": 2.05,
    "volume": 15082.0,
    "market_cap": 15510000.0,
    "price_to_sales_ttm": 0.81,
    "price_to_book_mrq": 1.11,
    "roa_ttm": 0.0537,
    "roe_ttm": 0.08199999999999999,
    "shares_outstanding": 8160000.0,
    "pcnt_held_by_insiders": 0.3635,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.0031,
    "operating_cash_flow_ttm": 2780000.0,
    "levered_cash_flow_ttm": 1670000.0,
    "book_value_per_share_mrq": 1.71,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Electromed, Inc."
  },
  "ELOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.99,
    "earnings_per_share": -0.15,
    "ebitda": 10590000.0,
    "eps_estimate_current_year": 0.25,
    "eps_estimate_next_quarter": 0.14,
    "fifty_day_moving_average": 9.4,
    "fifty_two_week_high": 12.9,
    "fifty_two_week_low": 8.09,
    "percent_change_from_200_day_moving_average": -0.2493,
    "percent_change_from_50_day_moving_average": -0.1264,
    "shares_owned": "N/A",
    "short_ratio": 2.02,
    "two_hundred_day_moving_average": 10.94,
    "volume": 76308.0,
    "market_cap": 299890000.0,
    "price_to_sales_ttm": 1.13,
    "price_to_book_mrq": 1.37,
    "roa_ttm": 0.0037,
    "roe_ttm": -0.023799999999999998,
    "shares_outstanding": 36530000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.72,
    "pcnt_short_of_float": 0.008,
    "operating_cash_flow_ttm": 5850000.0,
    "levered_cash_flow_ttm": 5380000.0,
    "book_value_per_share_mrq": 6.15,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-18"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Syneron Medical Ltd."
  },
  "ENSG": {
    "p_e_ratio": 23.48,
    "peg_ratio": 1.24,
    "earnings_per_share": 2.0,
    "ebitda": 95880000.0,
    "eps_estimate_current_year": 2.52,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 48.01,
    "fifty_two_week_high": 54.08,
    "fifty_two_week_low": 33.17,
    "percent_change_from_200_day_moving_average": -0.0171,
    "percent_change_from_50_day_moving_average": -0.022099999999999998,
    "shares_owned": "N/A",
    "short_ratio": 7.63,
    "two_hundred_day_moving_average": 47.77,
    "volume": 112260.0,
    "market_cap": 1200000000.0,
    "price_to_sales_ttm": 1.03,
    "price_to_book_mrq": 3.0,
    "roa_ttm": 0.0906,
    "roe_ttm": 0.1502,
    "shares_outstanding": 25560000.0,
    "pcnt_held_by_insiders": 0.1039,
    "pcnt_held_by_institutions": 0.7390000000000001,
    "pcnt_short_of_float": 0.04650000000000001,
    "operating_cash_flow_ttm": 54610000.0,
    "levered_cash_flow_ttm": -1930000.0,
    "book_value_per_share_mrq": 15.59,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "The Ensign Group, Inc."
  },
  "ENTA": {
    "p_e_ratio": 10.8,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.55,
    "ebitda": 115690000.0,
    "eps_estimate_current_year": 3.98,
    "eps_estimate_next_quarter": 1.39,
    "fifty_day_moving_average": 41.21,
    "fifty_two_week_high": 52.58,
    "fifty_two_week_low": 30.13,
    "percent_change_from_200_day_moving_average": -0.048499999999999995,
    "percent_change_from_50_day_moving_average": -0.0713,
    "shares_owned": "N/A",
    "short_ratio": 12.97,
    "two_hundred_day_moving_average": 40.22,
    "volume": 160753.0,
    "market_cap": 716180000.0,
    "price_to_sales_ttm": 4.84,
    "price_to_book_mrq": 3.16,
    "roa_ttm": 0.36229999999999996,
    "roe_ttm": 0.3546,
    "shares_outstanding": 18710000.0,
    "pcnt_held_by_insiders": 0.4962,
    "pcnt_held_by_institutions": 0.506,
    "pcnt_short_of_float": 0.2483,
    "operating_cash_flow_ttm": 74120000.0,
    "levered_cash_flow_ttm": 76580000.0,
    "book_value_per_share_mrq": 12.2,
    "next_earnings_announcement_date": [
      "2015-11-23",
      "2015-11-27"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enanta Pharmaceuticals, Inc."
  },
  "ENTL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.67,
    "earnings_per_share": -1.21,
    "ebitda": -7400000.0,
    "eps_estimate_current_year": -0.92,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 22.3,
    "fifty_two_week_high": 28.81,
    "fifty_two_week_low": 18.03,
    "percent_change_from_200_day_moving_average": -0.1067,
    "percent_change_from_50_day_moving_average": -0.053399999999999996,
    "shares_owned": "N/A",
    "short_ratio": 6.93,
    "two_hundred_day_moving_average": 23.63,
    "volume": 48509.0,
    "market_cap": 395300000.0,
    "price_to_sales_ttm": 7.28,
    "price_to_book_mrq": 5.97,
    "roa_ttm": -0.0908,
    "roe_ttm": -0.34409999999999996,
    "shares_outstanding": 18730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0678,
    "operating_cash_flow_ttm": -8510000.0,
    "levered_cash_flow_ttm": -7700000.0,
    "book_value_per_share_mrq": 3.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Entellus Medical, Inc."
  },
  "ENZ": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.31,
    "ebitda": -8480000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.98,
    "fifty_two_week_high": 5.38,
    "fifty_two_week_low": 2.26,
    "percent_change_from_200_day_moving_average": 0.1558,
    "percent_change_from_50_day_moving_average": 0.1355,
    "shares_owned": "N/A",
    "short_ratio": 7.16,
    "two_hundred_day_moving_average": 2.92,
    "volume": 563824.0,
    "market_cap": 155680000.0,
    "price_to_sales_ttm": 1.55,
    "price_to_book_mrq": 4.39,
    "roa_ttm": -0.1264,
    "roe_ttm": -0.3861,
    "shares_outstanding": 46060000.0,
    "pcnt_held_by_insiders": 0.1752,
    "pcnt_held_by_institutions": 0.344,
    "pcnt_short_of_float": 0.0171,
    "operating_cash_flow_ttm": -7130000.0,
    "levered_cash_flow_ttm": -2380000.0,
    "book_value_per_share_mrq": 0.74,
    "next_earnings_announcement_date": [
      "2015-10-07",
      "2015-10-12"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Enzo Biochem Inc."
  },
  "ENZN": {
    "p_e_ratio": 1.8,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.55,
    "ebitda": 0.0,
    "eps_estimate_current_year": 0.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.11,
    "fifty_two_week_high": 1.88,
    "fifty_two_week_low": 0.86,
    "percent_change_from_200_day_moving_average": -0.2003,
    "percent_change_from_50_day_moving_average": -0.11019999999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.93,
    "two_hundred_day_moving_average": 1.24,
    "volume": 343722.0,
    "market_cap": 43740000.0,
    "price_to_sales_ttm": 1.81,
    "price_to_book_mrq": 2.42,
    "roa_ttm": 0.46090000000000003,
    "roe_ttm": 1.2454,
    "shares_outstanding": 44180000.0,
    "pcnt_held_by_insiders": 0.1013,
    "pcnt_held_by_institutions": 0.58,
    "pcnt_short_of_float": 0.047400000000000005,
    "operating_cash_flow_ttm": 26360000.0,
    "levered_cash_flow_ttm": 36090000.0,
    "book_value_per_share_mrq": 0.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enzon Pharmaceuticals Inc."
  },
  "ENZY": {
    "p_e_ratio": 37.63,
    "peg_ratio": 1.1,
    "earnings_per_share": 0.28,
    "ebitda": 7510000.0,
    "eps_estimate_current_year": 0.3,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 9.43,
    "fifty_two_week_high": 10.83,
    "fifty_two_week_low": 5.38,
    "percent_change_from_200_day_moving_average": 0.19440000000000002,
    "percent_change_from_50_day_moving_average": 0.1139,
    "shares_owned": "N/A",
    "short_ratio": 2.58,
    "two_hundred_day_moving_average": 8.79,
    "volume": 16733.0,
    "market_cap": 236070000.0,
    "price_to_sales_ttm": 5.21,
    "price_to_book_mrq": 1.76,
    "roa_ttm": 0.023799999999999998,
    "roe_ttm": 0.0492,
    "shares_outstanding": 22480000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0048,
    "operating_cash_flow_ttm": 4830000.0,
    "levered_cash_flow_ttm": -3580000.0,
    "book_value_per_share_mrq": 5.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enzymotec Ltd."
  },
  "EPRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -2.82,
    "ebitda": -34430000.0,
    "eps_estimate_current_year": -2.04,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 5.44,
    "fifty_two_week_high": 11.75,
    "fifty_two_week_low": 3.78,
    "percent_change_from_200_day_moving_average": -0.13720000000000002,
    "percent_change_from_50_day_moving_average": 0.0774,
    "shares_owned": "N/A",
    "short_ratio": 7.28,
    "two_hundred_day_moving_average": 6.79,
    "volume": 86591.0,
    "market_cap": 138130000.0,
    "price_to_sales_ttm": 1951.03,
    "price_to_book_mrq": 2.44,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23570000.0,
    "pcnt_held_by_insiders": 0.3461,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.0529,
    "operating_cash_flow_ttm": -42230000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "EPIRUS Biopharmaceuticals, Inc."
  },
  "EPZM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.39,
    "ebitda": -120960000.0,
    "eps_estimate_current_year": -3.75,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 19.14,
    "fifty_two_week_high": 30.26,
    "fifty_two_week_low": 13.67,
    "percent_change_from_200_day_moving_average": -0.0282,
    "percent_change_from_50_day_moving_average": 0.016399999999999998,
    "shares_owned": "N/A",
    "short_ratio": 17.29,
    "two_hundred_day_moving_average": 20.01,
    "volume": 271543.0,
    "market_cap": 803860000.0,
    "price_to_sales_ttm": 40.01,
    "price_to_book_mrq": 3.86,
    "roa_ttm": -0.3155,
    "roe_ttm": -0.6114,
    "shares_outstanding": 41330000.0,
    "pcnt_held_by_insiders": 0.3422,
    "pcnt_held_by_institutions": 0.6970000000000001,
    "pcnt_short_of_float": 0.7321,
    "operating_cash_flow_ttm": -83820000.0,
    "levered_cash_flow_ttm": -117150000.0,
    "book_value_per_share_mrq": 5.07,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Epizyme, Inc."
  },
  "ERB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.04,
    "ebitda": 58614.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.862,
    "fifty_two_week_high": 4.01,
    "fifty_two_week_low": 1.6,
    "percent_change_from_200_day_moving_average": -0.24507400000000001,
    "percent_change_from_50_day_moving_average": 0.057841,
    "shares_owned": "N/A",
    "short_ratio": 3.45,
    "two_hundred_day_moving_average": 2.6091,
    "volume": 4313.0,
    "market_cap": 86840000.0,
    "price_to_sales_ttm": 4.09,
    "price_to_book_mrq": 5.78,
    "roa_ttm": -0.024300000000000002,
    "roe_ttm": -0.09939999999999999,
    "shares_outstanding": 44090000.0,
    "pcnt_held_by_insiders": 0.8225,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.0137,
    "operating_cash_flow_ttm": -1730000.0,
    "levered_cash_flow_ttm": -1780000.0,
    "book_value_per_share_mrq": 0.37,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ERBA Diagnostics, Inc."
  },
  "ESMC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.12,
    "ebitda": -912172.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.3,
    "fifty_two_week_high": 1.8,
    "fifty_two_week_low": 1.07,
    "percent_change_from_200_day_moving_average": -0.1821,
    "percent_change_from_50_day_moving_average": -0.1298,
    "shares_owned": "N/A",
    "short_ratio": 0.62,
    "two_hundred_day_moving_average": 1.38,
    "volume": 745.0,
    "market_cap": 8500000.0,
    "price_to_sales_ttm": 0.66,
    "price_to_book_mrq": 2.77,
    "roa_ttm": -0.0803,
    "roe_ttm": -0.2702,
    "shares_outstanding": 7530000.0,
    "pcnt_held_by_insiders": 0.019299999999999998,
    "pcnt_held_by_institutions": 0.09300000000000001,
    "pcnt_short_of_float": 0.0001,
    "operating_cash_flow_ttm": -1160000.0,
    "levered_cash_flow_ttm": -869840.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Escalon Medical Corp."
  },
  "ESPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.45,
    "earnings_per_share": -2.22,
    "ebitda": -42750000.0,
    "eps_estimate_current_year": -2.4,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 53.67,
    "fifty_two_week_high": 120.96,
    "fifty_two_week_low": 16.0,
    "percent_change_from_200_day_moving_average": -0.455,
    "percent_change_from_50_day_moving_average": -0.1537,
    "shares_owned": "N/A",
    "short_ratio": 2.55,
    "two_hundred_day_moving_average": 83.33,
    "volume": 995797.0,
    "market_cap": 1020000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.23,
    "roa_ttm": -0.1394,
    "roe_ttm": -0.23670000000000002,
    "shares_outstanding": 22490000.0,
    "pcnt_held_by_insiders": 0.7001000000000001,
    "pcnt_held_by_institutions": 0.22899999999999998,
    "pcnt_short_of_float": 0.3578,
    "operating_cash_flow_ttm": -34720000.0,
    "levered_cash_flow_ttm": -19380000.0,
    "book_value_per_share_mrq": 13.59,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Esperion Therapeutics, Inc."
  },
  "ETRM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.17,
    "earnings_per_share": -0.37,
    "ebitda": -25790000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 0.27,
    "fifty_two_week_high": 2.05,
    "fifty_two_week_low": 0.2,
    "percent_change_from_200_day_moving_average": -0.6565000000000001,
    "percent_change_from_50_day_moving_average": -0.0236,
    "shares_owned": "N/A",
    "short_ratio": 3.38,
    "two_hundred_day_moving_average": 0.76,
    "volume": 414788.0,
    "market_cap": 27670000.0,
    "price_to_sales_ttm": 358.27,
    "price_to_book_mrq": 14.0,
    "roa_ttm": -1.0058,
    "roe_ttm": -3.2876999999999996,
    "shares_outstanding": 106400000.0,
    "pcnt_held_by_insiders": 0.1986,
    "pcnt_held_by_institutions": 0.315,
    "pcnt_short_of_float": 0.0709,
    "operating_cash_flow_ttm": -20020000.0,
    "levered_cash_flow_ttm": -10100000.0,
    "book_value_per_share_mrq": 0.02,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EnteroMedics Inc."
  },
  "EVAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.08,
    "ebitda": -34370000.0,
    "eps_estimate_current_year": -2.14,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 3.82,
    "fifty_two_week_high": 7.7,
    "fifty_two_week_low": 3.26,
    "percent_change_from_200_day_moving_average": -0.1015,
    "percent_change_from_50_day_moving_average": -0.0060999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 0.8,
    "two_hundred_day_moving_average": 4.23,
    "volume": 1300.0,
    "market_cap": 61510000.0,
    "price_to_sales_ttm": 3.59,
    "price_to_book_mrq": 1.26,
    "roa_ttm": -0.2766,
    "roe_ttm": -0.5219,
    "shares_outstanding": 16190000.000000002,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0015,
    "operating_cash_flow_ttm": -32570000.0,
    "levered_cash_flow_ttm": -21560000.0,
    "book_value_per_share_mrq": 2.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Lombard Medical, Inc."
  },
  "EVGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.69,
    "ebitda": -15440000.0,
    "eps_estimate_current_year": -0.89,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 8.72,
    "fifty_two_week_high": 13.31,
    "fifty_two_week_low": 7.46,
    "percent_change_from_200_day_moving_average": -0.0672,
    "percent_change_from_50_day_moving_average": -0.014199999999999999,
    "shares_owned": "N/A",
    "short_ratio": 8.64,
    "two_hundred_day_moving_average": 9.22,
    "volume": 0.0,
    "market_cap": 218340000.0,
    "price_to_sales_ttm": 18.3,
    "price_to_book_mrq": 1.98,
    "roa_ttm": -0.0889,
    "roe_ttm": -0.1496,
    "shares_outstanding": 25390000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": -8990000.0,
    "levered_cash_flow_ttm": -8700000.0,
    "book_value_per_share_mrq": 4.35,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Evogene Ltd."
  },
  "EVHC": {
    "p_e_ratio": 42.34,
    "peg_ratio": 1.77,
    "earnings_per_share": 0.99,
    "ebitda": 593270000.0,
    "eps_estimate_current_year": 1.46,
    "eps_estimate_next_quarter": 0.45,
    "fifty_day_moving_average": 42.53,
    "fifty_two_week_high": 45.95,
    "fifty_two_week_low": 30.48,
    "percent_change_from_200_day_moving_average": 0.060599999999999994,
    "percent_change_from_50_day_moving_average": -0.0155,
    "shares_owned": "N/A",
    "short_ratio": 2.84,
    "two_hundred_day_moving_average": 39.48,
    "volume": 1064789.0,
    "market_cap": 7780000000.0,
    "price_to_sales_ttm": 1.57,
    "price_to_book_mrq": 4.09,
    "roa_ttm": 0.055,
    "roe_ttm": 0.106,
    "shares_outstanding": 185740000.0,
    "pcnt_held_by_insiders": 0.0184,
    "pcnt_held_by_institutions": 0.445,
    "pcnt_short_of_float": 0.0273,
    "operating_cash_flow_ttm": 341030000.0,
    "levered_cash_flow_ttm": 246680000.0,
    "book_value_per_share_mrq": 10.15,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Envision Healthcare Holdings, Inc."
  },
  "EVOK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.21,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 3.93,
    "fifty_two_week_high": 8.32,
    "fifty_two_week_low": 2.8,
    "percent_change_from_200_day_moving_average": -0.35609999999999997,
    "percent_change_from_50_day_moving_average": -0.1093,
    "shares_owned": "N/A",
    "short_ratio": 0.3,
    "two_hundred_day_moving_average": 5.44,
    "volume": 513478.0,
    "market_cap": 22190000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.3,
    "roa_ttm": -0.6037,
    "roe_ttm": -1.3866999999999998,
    "shares_outstanding": 6340000.0,
    "pcnt_held_by_insiders": 0.7432,
    "pcnt_held_by_institutions": 0.08199999999999999,
    "pcnt_short_of_float": 0.02,
    "operating_cash_flow_ttm": -11970000.0,
    "levered_cash_flow_ttm": -6810000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Evoke Pharma, Inc."
  },
  "EXAC": {
    "p_e_ratio": 16.37,
    "peg_ratio": 1.84,
    "earnings_per_share": 1.13,
    "ebitda": 43810000.0,
    "eps_estimate_current_year": 1.18,
    "eps_estimate_next_quarter": 0.38,
    "fifty_day_moving_average": 18.69,
    "fifty_two_week_high": 26.2,
    "fifty_two_week_low": 16.12,
    "percent_change_from_200_day_moving_average": -0.135,
    "percent_change_from_50_day_moving_average": -0.0103,
    "shares_owned": "N/A",
    "short_ratio": 6.65,
    "two_hundred_day_moving_average": 21.39,
    "volume": 40612.0,
    "market_cap": 260019999.99999997,
    "price_to_sales_ttm": 1.1,
    "price_to_book_mrq": 1.22,
    "roa_ttm": 0.0583,
    "roe_ttm": 0.075,
    "shares_outstanding": 14060000.0,
    "pcnt_held_by_insiders": 0.2848,
    "pcnt_held_by_institutions": 0.617,
    "pcnt_short_of_float": 0.042199999999999994,
    "operating_cash_flow_ttm": 25590000.0,
    "levered_cash_flow_ttm": 10160000.0,
    "book_value_per_share_mrq": 15.64,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Exactech Inc."
  },
  "EXAS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.44,
    "earnings_per_share": -1.61,
    "ebitda": -134430000.0,
    "eps_estimate_current_year": -1.74,
    "eps_estimate_next_quarter": -0.45,
    "fifty_day_moving_average": 21.44,
    "fifty_two_week_high": 32.85,
    "fifty_two_week_low": 17.34,
    "percent_change_from_200_day_moving_average": -0.2073,
    "percent_change_from_50_day_moving_average": -0.1051,
    "shares_owned": "N/A",
    "short_ratio": 21.21,
    "two_hundred_day_moving_average": 24.21,
    "volume": 906128.0,
    "market_cap": 1840000000.0,
    "price_to_sales_ttm": 131.45,
    "price_to_book_mrq": 7.52,
    "roa_ttm": -0.3444,
    "roe_ttm": -0.596,
    "shares_outstanding": 96090000.0,
    "pcnt_held_by_insiders": 0.013000000000000001,
    "pcnt_held_by_institutions": 0.8390000000000001,
    "pcnt_short_of_float": 0.3173,
    "operating_cash_flow_ttm": -117710000.0,
    "levered_cash_flow_ttm": -82250000.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Exact Sciences Corporation"
  },
  "EXEL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.32,
    "earnings_per_share": -1.02,
    "ebitda": -141760000.0,
    "eps_estimate_current_year": -0.81,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 5.89,
    "fifty_two_week_high": 6.81,
    "fifty_two_week_low": 1.26,
    "percent_change_from_200_day_moving_average": 0.528,
    "percent_change_from_50_day_moving_average": 0.0616,
    "shares_owned": "N/A",
    "short_ratio": 7.77,
    "two_hundred_day_moving_average": 4.09,
    "volume": 4440094.0,
    "market_cap": 1410000000.0,
    "price_to_sales_ttm": 45.34,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2606,
    "roe_ttm": "N/A",
    "shares_outstanding": 225430000.0,
    "pcnt_held_by_insiders": 0.0169,
    "pcnt_held_by_institutions": 0.8170000000000001,
    "pcnt_short_of_float": 0.271,
    "operating_cash_flow_ttm": -179900000.0,
    "levered_cash_flow_ttm": -89410000.0,
    "book_value_per_share_mrq": -0.96,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Exelixis, Inc."
  },
  "EYEG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.97,
    "ebitda": -3440000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.3,
    "fifty_two_week_high": 27.0,
    "fifty_two_week_low": 2.74,
    "percent_change_from_200_day_moving_average": -0.3713,
    "percent_change_from_50_day_moving_average": -0.21539999999999998,
    "shares_owned": "N/A",
    "short_ratio": 0.04,
    "two_hundred_day_moving_average": 5.36,
    "volume": 36478.0,
    "market_cap": 25790000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 25.11,
    "roa_ttm": -1.6173,
    "roe_ttm": "N/A",
    "shares_outstanding": 7650000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0024,
    "operating_cash_flow_ttm": -3210000.0,
    "levered_cash_flow_ttm": -2740000.0,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Eyegate Pharmaceuticals, Inc."
  },
  "EYES": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.0,
    "ebitda": -20410000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 10.63,
    "fifty_two_week_high": 24.02,
    "fifty_two_week_low": 8.05,
    "percent_change_from_200_day_moving_average": -0.2917,
    "percent_change_from_50_day_moving_average": -0.1437,
    "shares_owned": "N/A",
    "short_ratio": 10.07,
    "two_hundred_day_moving_average": 12.85,
    "volume": 144535.0,
    "market_cap": 326020000.0,
    "price_to_sales_ttm": 51.88,
    "price_to_book_mrq": 11.97,
    "roa_ttm": -0.5275,
    "roe_ttm": -4.5617,
    "shares_outstanding": 35830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.2555,
    "operating_cash_flow_ttm": -16710000.0,
    "levered_cash_flow_ttm": -6780000.0,
    "book_value_per_share_mrq": 0.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Second Sight Medical Products, Inc."
  },
  "FATE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.33,
    "ebitda": -25940000.0,
    "eps_estimate_current_year": -1.27,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 6.69,
    "fifty_two_week_high": 8.78,
    "fifty_two_week_low": 3.5,
    "percent_change_from_200_day_moving_average": 0.12480000000000001,
    "percent_change_from_50_day_moving_average": 0.0506,
    "shares_owned": "N/A",
    "short_ratio": 2.53,
    "two_hundred_day_moving_average": 6.25,
    "volume": 28669.0,
    "market_cap": 201720000.0,
    "price_to_sales_ttm": 602.66,
    "price_to_book_mrq": 3.87,
    "roa_ttm": -0.2605,
    "roe_ttm": -0.6283,
    "shares_outstanding": 28690000.0,
    "pcnt_held_by_insiders": 0.3343,
    "pcnt_held_by_institutions": 0.46799999999999997,
    "pcnt_short_of_float": 0.0239,
    "operating_cash_flow_ttm": -15970000.0,
    "levered_cash_flow_ttm": -12650000.0,
    "book_value_per_share_mrq": 1.79,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Fate Therapeutics, Inc."
  },
  "FBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.17,
    "earnings_per_share": -0.7,
    "ebitda": -28930000.0,
    "eps_estimate_current_year": -0.72,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 2.89,
    "fifty_two_week_high": 5.35,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.1268,
    "percent_change_from_50_day_moving_average": 0.004699999999999999,
    "shares_owned": "N/A",
    "short_ratio": 19.75,
    "two_hundred_day_moving_average": 3.32,
    "volume": 81310.0,
    "market_cap": 135820000.0,
    "price_to_sales_ttm": 269.76,
    "price_to_book_mrq": 2.41,
    "roa_ttm": -0.2073,
    "roe_ttm": -0.42729999999999996,
    "shares_outstanding": 46830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1114,
    "operating_cash_flow_ttm": -22950000.0,
    "levered_cash_flow_ttm": -12900000.0,
    "book_value_per_share_mrq": 1.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Fortress Biotech, Inc."
  },
  "FCSC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.64,
    "ebitda": -26400000.0,
    "eps_estimate_current_year": -0.68,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 6.1,
    "fifty_two_week_high": 7.6,
    "fifty_two_week_low": 2.28,
    "percent_change_from_200_day_moving_average": 0.1547,
    "percent_change_from_50_day_moving_average": -0.0159,
    "shares_owned": "N/A",
    "short_ratio": 8.74,
    "two_hundred_day_moving_average": 5.2,
    "volume": 70335.0,
    "market_cap": 263320000.0,
    "price_to_sales_ttm": 654.53,
    "price_to_book_mrq": 15.1,
    "roa_ttm": -0.3629,
    "roe_ttm": -0.8853,
    "shares_outstanding": 43890000.0,
    "pcnt_held_by_insiders": 0.0067,
    "pcnt_held_by_institutions": 0.6559999999999999,
    "pcnt_short_of_float": 0.1195,
    "operating_cash_flow_ttm": -22800000.0,
    "levered_cash_flow_ttm": -12480000.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Fibrocell Science, Inc."
  },
  "FGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.41,
    "ebitda": -65050000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 24.81,
    "fifty_two_week_high": 40.59,
    "fifty_two_week_low": 16.95,
    "percent_change_from_200_day_moving_average": 0.1426,
    "percent_change_from_50_day_moving_average": 0.1268,
    "shares_owned": "N/A",
    "short_ratio": 7.28,
    "two_hundred_day_moving_average": 24.46,
    "volume": 349865.0,
    "market_cap": 1690000000.0,
    "price_to_sales_ttm": 10.07,
    "price_to_book_mrq": 6.59,
    "roa_ttm": -0.0964,
    "roe_ttm": -0.3848,
    "shares_outstanding": 60560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.061900000000000004,
    "operating_cash_flow_ttm": 4030000.0000000005,
    "levered_cash_flow_ttm": -1560000.0,
    "book_value_per_share_mrq": 4.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "FibroGen, Inc."
  },
  "FLDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.17,
    "earnings_per_share": -1.97,
    "ebitda": -46170000.0,
    "eps_estimate_current_year": -2.04,
    "eps_estimate_next_quarter": -0.45,
    "fifty_day_moving_average": 12.63,
    "fifty_two_week_high": 46.38,
    "fifty_two_week_low": 10.4,
    "percent_change_from_200_day_moving_average": -0.6089,
    "percent_change_from_50_day_moving_average": -0.1765,
    "shares_owned": "N/A",
    "short_ratio": 4.78,
    "two_hundred_day_moving_average": 26.59,
    "volume": 445887.0,
    "market_cap": 298620000.0,
    "price_to_sales_ttm": 2.62,
    "price_to_book_mrq": 2.34,
    "roa_ttm": -0.0793,
    "roe_ttm": -0.3789,
    "shares_outstanding": 28710000.0,
    "pcnt_held_by_insiders": 0.07,
    "pcnt_held_by_institutions": 0.973,
    "pcnt_short_of_float": 0.2418,
    "operating_cash_flow_ttm": -30020000.0,
    "levered_cash_flow_ttm": -13430000.0,
    "book_value_per_share_mrq": 4.61,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Fluidigm Corporation"
  },
  "FLKS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.79,
    "ebitda": -20430000.0,
    "eps_estimate_current_year": -1.92,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 13.64,
    "fifty_two_week_high": 24.82,
    "fifty_two_week_low": 10.93,
    "percent_change_from_200_day_moving_average": -0.22039999999999998,
    "percent_change_from_50_day_moving_average": -0.011899999999999999,
    "shares_owned": "N/A",
    "short_ratio": 17.02,
    "two_hundred_day_moving_average": 17.29,
    "volume": 25438.0,
    "market_cap": 241810000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.91,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 17940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.08529999999999999,
    "operating_cash_flow_ttm": -15120000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Flex Pharma, Inc."
  },
  "FLML": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.58,
    "earnings_per_share": -1.08,
    "ebitda": 27610000.0,
    "eps_estimate_current_year": 0.46,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 22.12,
    "fifty_two_week_high": 26.09,
    "fifty_two_week_low": 9.3,
    "percent_change_from_200_day_moving_average": 0.0334,
    "percent_change_from_50_day_moving_average": -0.0755,
    "shares_owned": "N/A",
    "short_ratio": 3.33,
    "two_hundred_day_moving_average": 19.79,
    "volume": 221201.0,
    "market_cap": 823170000.0,
    "price_to_sales_ttm": 9.23,
    "price_to_book_mrq": 36.67,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 40250000.0,
    "pcnt_held_by_insiders": 0.1173,
    "pcnt_held_by_institutions": 0.599,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.55,
    "next_earnings_announcement_date": [
      "2015-10-29",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Flamel Technologies SA"
  },
  "FLXN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.94,
    "ebitda": -36110000.0,
    "eps_estimate_current_year": -2.3,
    "eps_estimate_next_quarter": -0.65,
    "fifty_day_moving_average": 24.11,
    "fifty_two_week_high": 30.37,
    "fifty_two_week_low": 14.5,
    "percent_change_from_200_day_moving_average": 0.12050000000000001,
    "percent_change_from_50_day_moving_average": 0.0394,
    "shares_owned": "N/A",
    "short_ratio": 6.83,
    "two_hundred_day_moving_average": 22.36,
    "volume": 212328.0,
    "market_cap": 538810000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.29,
    "roa_ttm": -0.2211,
    "roe_ttm": -0.3801,
    "shares_outstanding": 21500000.0,
    "pcnt_held_by_insiders": 0.6836,
    "pcnt_held_by_institutions": 0.31,
    "pcnt_short_of_float": 0.064,
    "operating_cash_flow_ttm": -29920000.0,
    "levered_cash_flow_ttm": -18660000.0,
    "book_value_per_share_mrq": 5.84,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Flexion Therapeutics, Inc."
  },
  "FMI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.57,
    "ebitda": -69110000.0,
    "eps_estimate_current_year": -2.71,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 21.93,
    "fifty_two_week_high": 54.28,
    "fifty_two_week_low": 18.25,
    "percent_change_from_200_day_moving_average": -0.39759999999999995,
    "percent_change_from_50_day_moving_average": -0.0391,
    "shares_owned": "N/A",
    "short_ratio": 6.67,
    "two_hundred_day_moving_average": 34.98,
    "volume": 182131.0,
    "market_cap": 724440000.0,
    "price_to_sales_ttm": 9.46,
    "price_to_book_mrq": 2.5,
    "roa_ttm": -0.2134,
    "roe_ttm": -0.3839,
    "shares_outstanding": 34380000.0,
    "pcnt_held_by_insiders": 0.2659,
    "pcnt_held_by_institutions": 0.521,
    "pcnt_short_of_float": 0.2585,
    "operating_cash_flow_ttm": -67240000.0,
    "levered_cash_flow_ttm": -53880000.0,
    "book_value_per_share_mrq": 8.45,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Foundation Medicine, Inc."
  },
  "FOLD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.99,
    "ebitda": -86200000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 16.01,
    "fifty_two_week_high": 18.83,
    "fifty_two_week_low": 5.13,
    "percent_change_from_200_day_moving_average": 0.1371,
    "percent_change_from_50_day_moving_average": -0.047400000000000005,
    "shares_owned": "N/A",
    "short_ratio": 7.49,
    "two_hundred_day_moving_average": 13.41,
    "volume": 2295225.0,
    "market_cap": 1810000000.0,
    "price_to_sales_ttm": 6206.19,
    "price_to_book_mrq": 5.52,
    "roa_ttm": -0.21030000000000001,
    "roe_ttm": -0.4917,
    "shares_outstanding": 118620000.0,
    "pcnt_held_by_insiders": 0.41619999999999996,
    "pcnt_held_by_institutions": 0.512,
    "pcnt_short_of_float": 0.20550000000000002,
    "operating_cash_flow_ttm": -73240000.0,
    "levered_cash_flow_ttm": -43440000.0,
    "book_value_per_share_mrq": 2.78,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Amicus Therapeutics, Inc."
  },
  "FOMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.73,
    "ebitda": -9470000.0,
    "eps_estimate_current_year": -0.71,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 10.04,
    "fifty_two_week_high": 14.0,
    "fifty_two_week_low": 4.75,
    "percent_change_from_200_day_moving_average": -0.1501,
    "percent_change_from_50_day_moving_average": -0.09939999999999999,
    "shares_owned": "N/A",
    "short_ratio": 4.92,
    "two_hundred_day_moving_average": 10.64,
    "volume": 113778.0,
    "market_cap": 276110000.0,
    "price_to_sales_ttm": 70.79,
    "price_to_book_mrq": 2.58,
    "roa_ttm": -0.09699999999999999,
    "roe_ttm": -0.2666,
    "shares_outstanding": 30540000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.084,
    "operating_cash_flow_ttm": -7070000.0,
    "levered_cash_flow_ttm": -10200000.0,
    "book_value_per_share_mrq": 3.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Foamix Pharmaceuticals Ltd."
  },
  "FONR": {
    "p_e_ratio": 6.73,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.91,
    "ebitda": 16129999.999999998,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 10.18,
    "fifty_two_week_high": 14.25,
    "fifty_two_week_low": 9.1,
    "percent_change_from_200_day_moving_average": 0.16219999999999998,
    "percent_change_from_50_day_moving_average": 0.2631,
    "shares_owned": "N/A",
    "short_ratio": 2.58,
    "two_hundred_day_moving_average": 11.07,
    "volume": 40000.0,
    "market_cap": 79450000.0,
    "price_to_sales_ttm": 1.0,
    "price_to_book_mrq": 2.13,
    "roa_ttm": 0.1052,
    "roe_ttm": 0.31920000000000004,
    "shares_outstanding": 6050000.0,
    "pcnt_held_by_insiders": 0.0192,
    "pcnt_held_by_institutions": 0.20800000000000002,
    "pcnt_short_of_float": 0.0075,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.97,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Fonar Corp."
  },
  "FPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.76,
    "ebitda": -40130000.0,
    "eps_estimate_current_year": -2.54,
    "eps_estimate_next_quarter": -0.66,
    "fifty_day_moving_average": 20.04,
    "fifty_two_week_high": 28.47,
    "fifty_two_week_low": 11.41,
    "percent_change_from_200_day_moving_average": -0.1328,
    "percent_change_from_50_day_moving_average": -0.031400000000000004,
    "shares_owned": "N/A",
    "short_ratio": 6.24,
    "two_hundred_day_moving_average": 22.38,
    "volume": 172866.0,
    "market_cap": 500880000.0,
    "price_to_sales_ttm": 23.81,
    "price_to_book_mrq": 3.48,
    "roa_ttm": -0.1441,
    "roe_ttm": -0.3357,
    "shares_outstanding": 25810000.0,
    "pcnt_held_by_insiders": 0.331,
    "pcnt_held_by_institutions": 0.511,
    "pcnt_short_of_float": 0.1459,
    "operating_cash_flow_ttm": -11400000.0,
    "levered_cash_flow_ttm": -23230000.0,
    "book_value_per_share_mrq": 5.66,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Five Prime Therapeutics, Inc."
  },
  "FVE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -4.42,
    "earnings_per_share": -1.78,
    "ebitda": 17130000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": 0.02,
    "fifty_day_moving_average": 3.38,
    "fifty_two_week_high": 5.07,
    "fifty_two_week_low": 2.92,
    "percent_change_from_200_day_moving_average": -0.2634,
    "percent_change_from_50_day_moving_average": -0.0866,
    "shares_owned": "N/A",
    "short_ratio": 4.42,
    "two_hundred_day_moving_average": 4.2,
    "volume": 203983.0,
    "market_cap": 151550000.0,
    "price_to_sales_ttm": 0.14,
    "price_to_book_mrq": 0.7,
    "roa_ttm": -0.0187,
    "roe_ttm": -0.3098,
    "shares_outstanding": 49050000.0,
    "pcnt_held_by_insiders": 0.1716,
    "pcnt_held_by_institutions": 0.608,
    "pcnt_short_of_float": 0.030899999999999997,
    "operating_cash_flow_ttm": 8510000.0,
    "levered_cash_flow_ttm": -3790000.0,
    "book_value_per_share_mrq": 4.45,
    "next_earnings_announcement_date": [
      "2015-12-14",
      "2015-12-18"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Five Star Quality Care Inc."
  },
  "FWP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.56,
    "earnings_per_share": -1.54,
    "ebitda": -34190000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 26.81,
    "fifty_two_week_high": 43.34,
    "fifty_two_week_low": 15.75,
    "percent_change_from_200_day_moving_average": -0.2703,
    "percent_change_from_50_day_moving_average": -0.142,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 31.52,
    "volume": 40722.0,
    "market_cap": 1070000000.0000001,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.6,
    "roa_ttm": -0.2052,
    "roe_ttm": -0.22440000000000002,
    "shares_outstanding": 46730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -18030000.0,
    "levered_cash_flow_ttm": -9820000.0,
    "book_value_per_share_mrq": 4.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Forward Pharma A/S"
  },
  "GALE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.3,
    "ebitda": -40740000.0,
    "eps_estimate_current_year": -0.32,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.59,
    "fifty_two_week_high": 2.39,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": 0.1386,
    "percent_change_from_50_day_moving_average": 0.13470000000000001,
    "shares_owned": "N/A",
    "short_ratio": 15.25,
    "two_hundred_day_moving_average": 1.58,
    "volume": 1218577.0,
    "market_cap": 291090000.0,
    "price_to_sales_ttm": 27.03,
    "price_to_book_mrq": 6.0,
    "roa_ttm": -0.28800000000000003,
    "roe_ttm": -1.0383,
    "shares_outstanding": 161720000.0,
    "pcnt_held_by_insiders": 0.0058,
    "pcnt_held_by_institutions": 0.297,
    "pcnt_short_of_float": 0.1462,
    "operating_cash_flow_ttm": -45260000.0,
    "levered_cash_flow_ttm": -22430000.0,
    "book_value_per_share_mrq": 0.31,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Galena Biopharma, Inc."
  },
  "GALT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.78,
    "ebitda": -16550000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 2.18,
    "fifty_two_week_high": 5.88,
    "fifty_two_week_low": 1.68,
    "percent_change_from_200_day_moving_average": -0.1801,
    "percent_change_from_50_day_moving_average": 0.0576,
    "shares_owned": "N/A",
    "short_ratio": 8.71,
    "two_hundred_day_moving_average": 2.82,
    "volume": 68779.0,
    "market_cap": 52640000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.2,
    "roa_ttm": -0.3378,
    "roe_ttm": -0.5844,
    "shares_outstanding": 22790000.0,
    "pcnt_held_by_insiders": 0.10400000000000001,
    "pcnt_held_by_institutions": 0.19899999999999998,
    "pcnt_short_of_float": 0.077,
    "operating_cash_flow_ttm": -13690000.0,
    "levered_cash_flow_ttm": -7390000.0,
    "book_value_per_share_mrq": 0.73,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Galectin Therapeutics, Inc."
  },
  "GB": {
    "p_e_ratio": 33.78,
    "peg_ratio": 2.35,
    "earnings_per_share": 1.74,
    "ebitda": 121360000.0,
    "eps_estimate_current_year": 2.65,
    "eps_estimate_next_quarter": 0.81,
    "fifty_day_moving_average": 55.83,
    "fifty_two_week_high": 63.19,
    "fifty_two_week_low": 42.23,
    "percent_change_from_200_day_moving_average": 0.0836,
    "percent_change_from_50_day_moving_average": 0.052199999999999996,
    "shares_owned": "N/A",
    "short_ratio": 3.39,
    "two_hundred_day_moving_average": 54.21,
    "volume": 114479.0,
    "market_cap": 1500000000.0,
    "price_to_sales_ttm": 2.23,
    "price_to_book_mrq": 2.36,
    "roa_ttm": 0.056299999999999996,
    "roe_ttm": 0.07429999999999999,
    "shares_outstanding": 25560000.0,
    "pcnt_held_by_insiders": 0.021400000000000002,
    "pcnt_held_by_institutions": 0.938,
    "pcnt_short_of_float": 0.024700000000000003,
    "operating_cash_flow_ttm": 77250000.0,
    "levered_cash_flow_ttm": 48190000.0,
    "book_value_per_share_mrq": 25.12,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Greatbatch, Inc."
  },
  "GBIM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.96,
    "ebitda": -5840000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.55,
    "fifty_two_week_high": 10.95,
    "fifty_two_week_low": 1.43,
    "percent_change_from_200_day_moving_average": -0.44659999999999994,
    "percent_change_from_50_day_moving_average": 0.0377,
    "shares_owned": "N/A",
    "short_ratio": 0.35,
    "two_hundred_day_moving_average": 4.79,
    "volume": 13669.0,
    "market_cap": 15240000.0,
    "price_to_sales_ttm": 2.91,
    "price_to_book_mrq": 5.42,
    "roa_ttm": -0.3234,
    "roe_ttm": "N/A",
    "shares_outstanding": 5750000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0116,
    "operating_cash_flow_ttm": -8570000.0,
    "levered_cash_flow_ttm": -12130000.0,
    "book_value_per_share_mrq": 0.49,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GlobeImmune Inc."
  },
  "GBSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -25.194,
    "ebitda": -14160000.0,
    "eps_estimate_current_year": -15.69,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 1.095,
    "fifty_two_week_high": 9.08,
    "fifty_two_week_low": 0.045,
    "percent_change_from_200_day_moving_average": -0.9643999999999999,
    "percent_change_from_50_day_moving_average": -0.91328,
    "shares_owned": "N/A",
    "short_ratio": 0.37,
    "two_hundred_day_moving_average": 2.668,
    "volume": 44666273.0,
    "market_cap": 8390000.0,
    "price_to_sales_ttm": 0.36,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6697,
    "roe_ttm": "N/A",
    "shares_outstanding": 88330000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.3893,
    "operating_cash_flow_ttm": -15670000.0,
    "levered_cash_flow_ttm": -12990000.0,
    "book_value_per_share_mrq": -7.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Great Basin Scientific, Inc."
  },
  "GBT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -14.75,
    "ebitda": -22370000.0,
    "eps_estimate_current_year": -5.55,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 47.69,
    "fifty_two_week_low": 46.07,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.97,
    "two_hundred_day_moving_average": 0.0,
    "volume": 73909.0,
    "market_cap": 1290000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 27810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0974,
    "operating_cash_flow_ttm": -21900000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -27.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Global Blood Therapeutics, Inc."
  },
  "GEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.85,
    "earnings_per_share": -4.68,
    "ebitda": 438010000.0,
    "eps_estimate_current_year": 0.37,
    "eps_estimate_next_quarter": 0.09,
    "fifty_day_moving_average": 7.07,
    "fifty_two_week_high": 9.32,
    "fifty_two_week_low": 5.81,
    "percent_change_from_200_day_moving_average": -0.0401,
    "percent_change_from_50_day_moving_average": -0.0725,
    "shares_owned": "N/A",
    "short_ratio": 5.53,
    "two_hundred_day_moving_average": 6.83,
    "volume": 85600.0,
    "market_cap": 1010000000.0,
    "price_to_sales_ttm": 0.21,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 73590000.0,
    "pcnt_held_by_insiders": 0.1808,
    "pcnt_held_by_institutions": 0.184,
    "pcnt_short_of_float": 0.0421,
    "operating_cash_flow_ttm": 63560000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -0.9,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Genesis Healthcare, Inc."
  },
  "GENE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.9,
    "ebitda": -6930000.0,
    "eps_estimate_current_year": -1.72,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.49,
    "fifty_two_week_high": 11.0,
    "fifty_two_week_low": 1.04,
    "percent_change_from_200_day_moving_average": -0.37020000000000003,
    "percent_change_from_50_day_moving_average": -0.09119999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.54,
    "two_hundred_day_moving_average": 3.59,
    "volume": 65263.0,
    "market_cap": 25830000.0,
    "price_to_sales_ttm": 18.09,
    "price_to_book_mrq": 1.91,
    "roa_ttm": -0.4493,
    "roe_ttm": -0.8477,
    "shares_outstanding": 11430000.0,
    "pcnt_held_by_insiders": 0.015,
    "pcnt_held_by_institutions": 0.01,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -6970000.0,
    "levered_cash_flow_ttm": -4520000.0,
    "book_value_per_share_mrq": 1.2,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Genetic Technologies Limited"
  },
  "GERN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -6.22,
    "earnings_per_share": -0.24,
    "ebitda": -36470000.0,
    "eps_estimate_current_year": -0.12,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 3.36,
    "fifty_two_week_high": 4.67,
    "fifty_two_week_low": 1.76,
    "percent_change_from_200_day_moving_average": -0.1375,
    "percent_change_from_50_day_moving_average": -0.0106,
    "shares_owned": "N/A",
    "short_ratio": 13.53,
    "two_hundred_day_moving_average": 3.85,
    "volume": 1900265.0,
    "market_cap": 525030000.0,
    "price_to_sales_ttm": 455.04,
    "price_to_book_mrq": 4.33,
    "roa_ttm": -0.14800000000000002,
    "roe_ttm": -0.2827,
    "shares_outstanding": 158140000.0,
    "pcnt_held_by_insiders": 0.0087,
    "pcnt_held_by_institutions": 0.526,
    "pcnt_short_of_float": 0.2249,
    "operating_cash_flow_ttm": 9970000.0,
    "levered_cash_flow_ttm": 21980000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Geron Corporation"
  },
  "GHDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.15,
    "earnings_per_share": -0.98,
    "ebitda": -25040000.0,
    "eps_estimate_current_year": -0.76,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 25.53,
    "fifty_two_week_high": 37.74,
    "fifty_two_week_low": 23.0,
    "percent_change_from_200_day_moving_average": -0.128,
    "percent_change_from_50_day_moving_average": -0.051,
    "shares_owned": "N/A",
    "short_ratio": 11.47,
    "two_hundred_day_moving_average": 27.79,
    "volume": 93633.0,
    "market_cap": 787020000.0,
    "price_to_sales_ttm": 2.86,
    "price_to_book_mrq": 5.27,
    "roa_ttm": -0.1074,
    "roe_ttm": -0.21280000000000002,
    "shares_outstanding": 32479999.999999996,
    "pcnt_held_by_insiders": 0.0785,
    "pcnt_held_by_institutions": 0.912,
    "pcnt_short_of_float": 0.1552,
    "operating_cash_flow_ttm": -10490000.0,
    "levered_cash_flow_ttm": -8300000.000000001,
    "book_value_per_share_mrq": 4.63,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Genomic Health Inc."
  },
  "GI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.27,
    "earnings_per_share": -4.22,
    "ebitda": -42370000.0,
    "eps_estimate_current_year": -2.78,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 15.98,
    "fifty_two_week_high": 19.69,
    "fifty_two_week_low": 13.32,
    "percent_change_from_200_day_moving_average": -0.16329999999999997,
    "percent_change_from_50_day_moving_average": -0.15460000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.28,
    "two_hundred_day_moving_average": 16.15,
    "volume": 57866.0,
    "market_cap": 334080000.0,
    "price_to_sales_ttm": 5.06,
    "price_to_book_mrq": 2.8,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 24730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1386,
    "operating_cash_flow_ttm": -40080000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EndoChoice Holdings, Inc."
  },
  "GKOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.62,
    "ebitda": -9200000.0,
    "eps_estimate_current_year": -1.56,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 30.75,
    "fifty_two_week_high": 33.92,
    "fifty_two_week_low": 26.12,
    "percent_change_from_200_day_moving_average": -0.11939999999999999,
    "percent_change_from_50_day_moving_average": -0.1252,
    "shares_owned": "N/A",
    "short_ratio": 3.62,
    "two_hundred_day_moving_average": 30.55,
    "volume": 142453.0,
    "market_cap": 861250000.0,
    "price_to_sales_ttm": 15.01,
    "price_to_book_mrq": 9.27,
    "roa_ttm": -0.10869999999999999,
    "roe_ttm": -0.8384,
    "shares_outstanding": 32020000.000000004,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0394,
    "operating_cash_flow_ttm": -2350000.0,
    "levered_cash_flow_ttm": 3350000.0,
    "book_value_per_share_mrq": 2.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Glaukos Corporation"
  },
  "GLMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.9,
    "ebitda": -10260000.0,
    "eps_estimate_current_year": -1.01,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 8.66,
    "fifty_two_week_high": 13.5,
    "fifty_two_week_low": 4.58,
    "percent_change_from_200_day_moving_average": -0.0986,
    "percent_change_from_50_day_moving_average": -0.004699999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.98,
    "two_hundred_day_moving_average": 9.56,
    "volume": 5932.0,
    "market_cap": 95690000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.58,
    "roa_ttm": -0.1929,
    "roe_ttm": -0.31370000000000003,
    "shares_outstanding": 11100000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0063,
    "operating_cash_flow_ttm": -8650000.0,
    "levered_cash_flow_ttm": -5700000.0,
    "book_value_per_share_mrq": 2.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Galmed Pharmaceuticals Ltd."
  },
  "GLYC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.57,
    "ebitda": -10650000.0,
    "eps_estimate_current_year": -0.66,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 7.18,
    "fifty_two_week_high": 9.68,
    "fifty_two_week_low": 6.18,
    "percent_change_from_200_day_moving_average": -0.1451,
    "percent_change_from_50_day_moving_average": -0.0633,
    "shares_owned": "N/A",
    "short_ratio": 7.55,
    "two_hundred_day_moving_average": 7.87,
    "volume": 6393.0,
    "market_cap": 128000000.0,
    "price_to_sales_ttm": 6.5,
    "price_to_book_mrq": 2.36,
    "roa_ttm": -0.10439999999999999,
    "roe_ttm": -0.1802,
    "shares_outstanding": 19020000.0,
    "pcnt_held_by_insiders": 0.1186,
    "pcnt_held_by_institutions": 0.742,
    "pcnt_short_of_float": 0.0152,
    "operating_cash_flow_ttm": -25760000.0,
    "levered_cash_flow_ttm": -21380000.0,
    "book_value_per_share_mrq": 2.9,
    "next_earnings_announcement_date": [
      "2015-10-29",
      "2015-11-02"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "GlycoMimetics, Inc."
  },
  "GMED": {
    "p_e_ratio": 22.85,
    "peg_ratio": 1.87,
    "earnings_per_share": 1.04,
    "ebitda": 174990000.0,
    "eps_estimate_current_year": 1.05,
    "eps_estimate_next_quarter": 0.29,
    "fifty_day_moving_average": 25.1,
    "fifty_two_week_high": 28.99,
    "fifty_two_week_low": 19.0,
    "percent_change_from_200_day_moving_average": -0.0629,
    "percent_change_from_50_day_moving_average": -0.0535,
    "shares_owned": "N/A",
    "short_ratio": 15.53,
    "two_hundred_day_moving_average": 25.36,
    "volume": 753463.0,
    "market_cap": 2260000000.0,
    "price_to_sales_ttm": 4.53,
    "price_to_book_mrq": 3.56,
    "roa_ttm": 0.1377,
    "roe_ttm": 0.1697,
    "shares_outstanding": 71190000.0,
    "pcnt_held_by_insiders": 0.0207,
    "pcnt_held_by_institutions": 0.821,
    "pcnt_short_of_float": 0.11230000000000001,
    "operating_cash_flow_ttm": 85420000.0,
    "levered_cash_flow_ttm": 50090000.0,
    "book_value_per_share_mrq": 6.77,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Globus Medical, Inc."
  },
  "GNCA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.21,
    "ebitda": -40990000.0,
    "eps_estimate_current_year": -1.93,
    "eps_estimate_next_quarter": -0.46,
    "fifty_day_moving_average": 11.72,
    "fifty_two_week_high": 16.18,
    "fifty_two_week_low": 6.15,
    "percent_change_from_200_day_moving_average": -0.1635,
    "percent_change_from_50_day_moving_average": -0.1458,
    "shares_owned": "N/A",
    "short_ratio": 4.21,
    "two_hundred_day_moving_average": 11.97,
    "volume": 145685.0,
    "market_cap": 280880000.0,
    "price_to_sales_ttm": 451.8,
    "price_to_book_mrq": 4.05,
    "roa_ttm": -0.37070000000000003,
    "roe_ttm": -0.7879999999999999,
    "shares_outstanding": 28060000.0,
    "pcnt_held_by_insiders": 0.1244,
    "pcnt_held_by_institutions": 0.12300000000000001,
    "pcnt_short_of_float": 0.0642,
    "operating_cash_flow_ttm": -34710000.0,
    "levered_cash_flow_ttm": -21040000.0,
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Genocea Biosciences, Inc."
  },
  "GNMK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.31,
    "earnings_per_share": -0.97,
    "ebitda": -37770000.0,
    "eps_estimate_current_year": -1.11,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 9.45,
    "fifty_two_week_high": 14.4,
    "fifty_two_week_low": 7.57,
    "percent_change_from_200_day_moving_average": -0.056100000000000004,
    "percent_change_from_50_day_moving_average": 0.0108,
    "shares_owned": "N/A",
    "short_ratio": 25.86,
    "two_hundred_day_moving_average": 10.12,
    "volume": 109202.0,
    "market_cap": 404780000.0,
    "price_to_sales_ttm": 12.0,
    "price_to_book_mrq": 6.45,
    "roa_ttm": -0.2686,
    "roe_ttm": -0.5176,
    "shares_outstanding": 42380000.0,
    "pcnt_held_by_insiders": 0.1014,
    "pcnt_held_by_institutions": 1.07,
    "pcnt_short_of_float": 0.2157,
    "operating_cash_flow_ttm": -31910000.0,
    "levered_cash_flow_ttm": -25640000.0,
    "book_value_per_share_mrq": 1.49,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "GenMark Diagnostics, Inc."
  },
  "GNVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.18,
    "earnings_per_share": -0.2,
    "ebitda": -3850000.0,
    "eps_estimate_current_year": -0.4,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 2.43,
    "fifty_two_week_high": 4.67,
    "fifty_two_week_low": 1.61,
    "percent_change_from_200_day_moving_average": 0.0387,
    "percent_change_from_50_day_moving_average": 0.0675,
    "shares_owned": "N/A",
    "short_ratio": 2.68,
    "two_hundred_day_moving_average": 2.49,
    "volume": 50383.0,
    "market_cap": 44730000.0,
    "price_to_sales_ttm": 10.29,
    "price_to_book_mrq": 4.31,
    "roa_ttm": -0.1802,
    "roe_ttm": -0.2829,
    "shares_outstanding": 17270000.0,
    "pcnt_held_by_insiders": 0.1855,
    "pcnt_held_by_institutions": 0.23,
    "pcnt_short_of_float": 0.004,
    "operating_cash_flow_ttm": -3410000.0,
    "levered_cash_flow_ttm": -2740000.0,
    "book_value_per_share_mrq": 0.6,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GenVec, Inc."
  },
  "GTXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.599,
    "ebitda": -20370000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 0.9186,
    "fifty_two_week_high": 1.59,
    "fifty_two_week_low": 0.41,
    "percent_change_from_200_day_moving_average": -0.113305,
    "percent_change_from_50_day_moving_average": -0.030996000000000003,
    "shares_owned": "N/A",
    "short_ratio": 23.3,
    "two_hundred_day_moving_average": 1.0038,
    "volume": 53682.0,
    "market_cap": 124950000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.41869999999999996,
    "roe_ttm": "N/A",
    "shares_outstanding": 140370000.0,
    "pcnt_held_by_insiders": 0.698,
    "pcnt_held_by_institutions": 0.075,
    "pcnt_short_of_float": 0.050300000000000004,
    "operating_cash_flow_ttm": -20630000.0,
    "levered_cash_flow_ttm": 57830000.0,
    "book_value_per_share_mrq": -0.22,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GTX Inc."
  },
  "GWPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.49,
    "earnings_per_share": -2.5,
    "ebitda": -66690000.0,
    "eps_estimate_current_year": -3.7,
    "eps_estimate_next_quarter": -1.53,
    "fifty_day_moving_average": 107.49,
    "fifty_two_week_high": 133.98,
    "fifty_two_week_low": 58.16,
    "percent_change_from_200_day_moving_average": -0.075,
    "percent_change_from_50_day_moving_average": -0.0501,
    "shares_owned": "N/A",
    "short_ratio": 5.21,
    "two_hundred_day_moving_average": 110.37,
    "volume": 172586.0,
    "market_cap": 2130000000.0,
    "price_to_sales_ttm": 45.98,
    "price_to_book_mrq": 5.45,
    "roa_ttm": -0.11380000000000001,
    "roe_ttm": -0.1549,
    "shares_outstanding": 20890000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -53270000.0,
    "levered_cash_flow_ttm": -57000000.0,
    "book_value_per_share_mrq": 19.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "GW Pharmaceuticals plc"
  },
  "HAE": {
    "p_e_ratio": 92.0,
    "peg_ratio": 1.44,
    "earnings_per_share": 0.38,
    "ebitda": 133650000.0,
    "eps_estimate_current_year": 2.02,
    "eps_estimate_next_quarter": 0.62,
    "fifty_day_moving_average": 37.06,
    "fifty_two_week_high": 45.43,
    "fifty_two_week_low": 33.75,
    "percent_change_from_200_day_moving_average": -0.1406,
    "percent_change_from_50_day_moving_average": -0.0567,
    "shares_owned": "N/A",
    "short_ratio": 10.98,
    "two_hundred_day_moving_average": 40.68,
    "volume": 259538.0,
    "market_cap": 1780000000.0,
    "price_to_sales_ttm": 1.97,
    "price_to_book_mrq": 2.24,
    "roa_ttm": 0.022099999999999998,
    "roe_ttm": 0.0252,
    "shares_outstanding": 50890000.0,
    "pcnt_held_by_insiders": 0.0049,
    "pcnt_held_by_institutions": 1.084,
    "pcnt_short_of_float": 0.056799999999999996,
    "operating_cash_flow_ttm": 122690000.0,
    "levered_cash_flow_ttm": 23680000.0,
    "book_value_per_share_mrq": 15.56,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Haemonetics Corporation"
  },
  "HALO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.31,
    "ebitda": -29620000.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 18.76,
    "fifty_two_week_high": 25.25,
    "fifty_two_week_low": 7.51,
    "percent_change_from_200_day_moving_average": -0.026000000000000002,
    "percent_change_from_50_day_moving_average": -0.0393,
    "shares_owned": "N/A",
    "short_ratio": 7.86,
    "two_hundred_day_moving_average": 18.5,
    "volume": 1422641.0,
    "market_cap": 2280000000.0,
    "price_to_sales_ttm": 20.48,
    "price_to_book_mrq": 43.67,
    "roa_ttm": -0.1101,
    "roe_ttm": -0.7134,
    "shares_outstanding": 126610000.0,
    "pcnt_held_by_insiders": 0.042300000000000004,
    "pcnt_held_by_institutions": 0.7090000000000001,
    "pcnt_short_of_float": 0.1315,
    "operating_cash_flow_ttm": -19020000.0,
    "levered_cash_flow_ttm": -3670000.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Halozyme Therapeutics, Inc."
  },
  "HART": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.45,
    "ebitda": -10100000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.0279,
    "fifty_two_week_high": 8.399,
    "fifty_two_week_low": 0.56,
    "percent_change_from_200_day_moving_average": -0.540939,
    "percent_change_from_50_day_moving_average": -0.079279,
    "shares_owned": "N/A",
    "short_ratio": 0.77,
    "two_hundred_day_moving_average": 2.0616,
    "volume": 121763.0,
    "market_cap": 11380000.0,
    "price_to_sales_ttm": 100.19,
    "price_to_book_mrq": 1.48,
    "roa_ttm": -0.5611999999999999,
    "roe_ttm": -1.1467,
    "shares_outstanding": 12020000.0,
    "pcnt_held_by_insiders": 0.1948,
    "pcnt_held_by_institutions": 0.4,
    "pcnt_short_of_float": 0.019799999999999998,
    "operating_cash_flow_ttm": -7890000.0,
    "levered_cash_flow_ttm": -2670000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Harvard Apparatus Regenerative Technology, Inc."
  },
  "HBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.06,
    "earnings_per_share": -0.01,
    "ebitda": 6810000.0,
    "eps_estimate_current_year": 0.22,
    "eps_estimate_next_quarter": 0.11,
    "fifty_day_moving_average": 4.46,
    "fifty_two_week_high": 6.84,
    "fifty_two_week_low": 4.07,
    "percent_change_from_200_day_moving_average": -0.2022,
    "percent_change_from_50_day_moving_average": -0.0613,
    "shares_owned": "N/A",
    "short_ratio": 11.84,
    "two_hundred_day_moving_average": 5.25,
    "volume": 172172.0,
    "market_cap": 142150000.0,
    "price_to_sales_ttm": 1.31,
    "price_to_book_mrq": 1.52,
    "roa_ttm": 0.0116,
    "roe_ttm": -0.0045000000000000005,
    "shares_outstanding": 33930000.0,
    "pcnt_held_by_insiders": 0.1724,
    "pcnt_held_by_institutions": 0.532,
    "pcnt_short_of_float": 0.0471,
    "operating_cash_flow_ttm": 884000.0,
    "levered_cash_flow_ttm": -1340000.0,
    "book_value_per_share_mrq": 2.8,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Harvard Bioscience Inc."
  },
  "HEB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.081,
    "ebitda": -17660000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.1749,
    "fifty_two_week_high": 0.4,
    "fifty_two_week_low": 0.14,
    "percent_change_from_200_day_moving_average": -0.17359200000000002,
    "percent_change_from_50_day_moving_average": 0.008252,
    "shares_owned": "N/A",
    "short_ratio": 0.05,
    "two_hundred_day_moving_average": 0.2133,
    "volume": 173724.0,
    "market_cap": 43530000.0,
    "price_to_sales_ttm": 254.97,
    "price_to_book_mrq": 1.59,
    "roa_ttm": -0.3603,
    "roe_ttm": -0.6039,
    "shares_outstanding": 246890000.0,
    "pcnt_held_by_insiders": 0.0177,
    "pcnt_held_by_institutions": 0.062,
    "pcnt_short_of_float": 0.0001,
    "operating_cash_flow_ttm": -16950000.0,
    "levered_cash_flow_ttm": -13490000.0,
    "book_value_per_share_mrq": 0.11,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Hemispherx Biopharma, Inc."
  },
  "HGR": {
    "p_e_ratio": 8.99,
    "peg_ratio": 0.95,
    "earnings_per_share": 1.65,
    "ebitda": 156160000.0,
    "eps_estimate_current_year": 1.62,
    "eps_estimate_next_quarter": 0.58,
    "fifty_day_moving_average": 18.14,
    "fifty_two_week_high": 26.79,
    "fifty_two_week_low": 14.68,
    "percent_change_from_200_day_moving_average": -0.3264,
    "percent_change_from_50_day_moving_average": -0.1827,
    "shares_owned": "N/A",
    "short_ratio": 19.24,
    "two_hundred_day_moving_average": 22.02,
    "volume": 266588.0,
    "market_cap": 509250000.0,
    "price_to_sales_ttm": 0.49,
    "price_to_book_mrq": 0.86,
    "roa_ttm": 0.0559,
    "roe_ttm": 0.10289999999999999,
    "shares_outstanding": 34340000.0,
    "pcnt_held_by_insiders": 0.0716,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.0683,
    "operating_cash_flow_ttm": 51130000.0,
    "levered_cash_flow_ttm": -5880000.0,
    "book_value_per_share_mrq": 17.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Hanger, Inc."
  },
  "HH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.116,
    "ebitda": -6560000.0,
    "eps_estimate_current_year": 0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.1554,
    "fifty_two_week_high": 0.66,
    "fifty_two_week_low": 0.12,
    "percent_change_from_200_day_moving_average": -0.571286,
    "percent_change_from_50_day_moving_average": -0.13015000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.1,
    "two_hundred_day_moving_average": 0.3154,
    "volume": 142329.0,
    "market_cap": 10480000.0,
    "price_to_sales_ttm": 0.39,
    "price_to_book_mrq": 2.03,
    "roa_ttm": -0.2793,
    "roe_ttm": -0.9661,
    "shares_outstanding": 77500000.0,
    "pcnt_held_by_insiders": 0.071,
    "pcnt_held_by_institutions": 0.529,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": -7350000.0,
    "levered_cash_flow_ttm": 288630.0,
    "book_value_per_share_mrq": 0.07,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Hooper Holmes Inc."
  },
  "HIIQ": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.11,
    "earnings_per_share": -0.12,
    "ebitda": 4019999.9999999995,
    "eps_estimate_current_year": 0.15,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 4.67,
    "fifty_two_week_high": 11.99,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": -0.16519999999999999,
    "percent_change_from_50_day_moving_average": 0.0463,
    "shares_owned": "N/A",
    "short_ratio": 18.62,
    "two_hundred_day_moving_average": 5.86,
    "volume": 90011.0,
    "market_cap": 37840000.0,
    "price_to_sales_ttm": 0.4,
    "price_to_book_mrq": 0.98,
    "roa_ttm": 0.0072,
    "roe_ttm": -0.0095,
    "shares_outstanding": 7740000.0,
    "pcnt_held_by_insiders": 0.054299999999999994,
    "pcnt_held_by_institutions": 0.965,
    "pcnt_short_of_float": 0.21780000000000002,
    "operating_cash_flow_ttm": -969000.0,
    "levered_cash_flow_ttm": 2690000.0,
    "book_value_per_share_mrq": 4.99,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Health Insurance Innovations, Inc."
  },
  "HLS": {
    "p_e_ratio": 22.03,
    "peg_ratio": 1.63,
    "earnings_per_share": 1.85,
    "ebitda": 621600000.0,
    "eps_estimate_current_year": 2.26,
    "eps_estimate_next_quarter": 0.61,
    "fifty_day_moving_average": 43.04,
    "fifty_two_week_high": 48.37,
    "fifty_two_week_low": 35.84,
    "percent_change_from_200_day_moving_average": -0.08439999999999999,
    "percent_change_from_50_day_moving_average": -0.0537,
    "shares_owned": "N/A",
    "short_ratio": 8.52,
    "two_hundred_day_moving_average": 44.49,
    "volume": 520114.0,
    "market_cap": 3720000000.0,
    "price_to_sales_ttm": 1.39,
    "price_to_book_mrq": 6.14,
    "roa_ttm": 0.1038,
    "roe_ttm": 0.317,
    "shares_outstanding": 91450000.0,
    "pcnt_held_by_insiders": 0.0254,
    "pcnt_held_by_institutions": 0.9490000000000001,
    "pcnt_short_of_float": 0.0675,
    "operating_cash_flow_ttm": 414700000.0,
    "levered_cash_flow_ttm": 149190000.0,
    "book_value_per_share_mrq": 6.62,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "HEALTHSOUTH Corp."
  },
  "HLTH": {
    "p_e_ratio": 74.72,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.07,
    "ebitda": 24470000.0,
    "eps_estimate_current_year": 0.25,
    "eps_estimate_next_quarter": 0.2,
    "fifty_day_moving_average": 5.21,
    "fifty_two_week_high": 9.34,
    "fifty_two_week_low": 1.07,
    "percent_change_from_200_day_moving_average": -0.1268,
    "percent_change_from_50_day_moving_average": 0.0332,
    "shares_owned": "N/A",
    "short_ratio": 6.72,
    "two_hundred_day_moving_average": 6.16,
    "volume": 358046.0,
    "market_cap": 381400000.0,
    "price_to_sales_ttm": 2.53,
    "price_to_book_mrq": 4.49,
    "roa_ttm": 0.15130000000000002,
    "roe_ttm": 0.35969999999999996,
    "shares_outstanding": 70890000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 7070000.0,
    "levered_cash_flow_ttm": 3530000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Nobilis Health Corp."
  },
  "HNSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.01,
    "earnings_per_share": -0.53,
    "ebitda": -38580000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 5.52,
    "fifty_two_week_high": 12.3,
    "fifty_two_week_low": 3.79,
    "percent_change_from_200_day_moving_average": -0.45020000000000004,
    "percent_change_from_50_day_moving_average": -0.2047,
    "shares_owned": "N/A",
    "short_ratio": 41.12,
    "two_hundred_day_moving_average": 7.98,
    "volume": 300178.0,
    "market_cap": 828750000.0,
    "price_to_sales_ttm": 53.04,
    "price_to_book_mrq": 42.74,
    "roa_ttm": -0.42369999999999997,
    "roe_ttm": -3.4794,
    "shares_outstanding": 188780000.0,
    "pcnt_held_by_insiders": 0.2722,
    "pcnt_held_by_institutions": 0.336,
    "pcnt_short_of_float": 0.114,
    "operating_cash_flow_ttm": -42350000.0,
    "levered_cash_flow_ttm": -24620000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": "2015-11-05",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Hansen Medical, Inc."
  },
  "HNT": {
    "p_e_ratio": 62.18,
    "peg_ratio": 1.02,
    "earnings_per_share": 1.06,
    "ebitda": 380440000.0,
    "eps_estimate_current_year": 3.32,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 66.28,
    "fifty_two_week_high": 76.67,
    "fifty_two_week_low": 42.61,
    "percent_change_from_200_day_moving_average": 0.0487,
    "percent_change_from_50_day_moving_average": -0.009399999999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.95,
    "two_hundred_day_moving_average": 62.61,
    "volume": 1072555.0,
    "market_cap": 5070000000.0,
    "price_to_sales_ttm": 0.32,
    "price_to_book_mrq": 2.93,
    "roa_ttm": 0.0425,
    "roe_ttm": 0.04769999999999999,
    "shares_outstanding": 77290000.0,
    "pcnt_held_by_insiders": 0.0203,
    "pcnt_held_by_institutions": 0.239,
    "pcnt_short_of_float": 0.0116,
    "operating_cash_flow_ttm": 1080000000.0,
    "levered_cash_flow_ttm": 212660000.0,
    "book_value_per_share_mrq": 22.15,
    "next_earnings_announcement_date": "2015-11-12",
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Health Net, Inc."
  },
  "HRC": {
    "p_e_ratio": 40.27,
    "peg_ratio": 1.94,
    "earnings_per_share": 1.42,
    "ebitda": 274200000.0,
    "eps_estimate_current_year": 2.53,
    "eps_estimate_next_quarter": 0.58,
    "fifty_day_moving_average": 53.48,
    "fifty_two_week_high": 58.73,
    "fifty_two_week_low": 39.58,
    "percent_change_from_200_day_moving_average": 0.0929,
    "percent_change_from_50_day_moving_average": 0.0699,
    "shares_owned": "N/A",
    "short_ratio": 6.99,
    "two_hundred_day_moving_average": 52.36,
    "volume": 505836.0,
    "market_cap": 3250000000.0,
    "price_to_sales_ttm": 1.7,
    "price_to_book_mrq": 4.24,
    "roa_ttm": 0.0672,
    "roe_ttm": 0.10189999999999999,
    "shares_outstanding": 56720000.0,
    "pcnt_held_by_insiders": 0.0202,
    "pcnt_held_by_institutions": 0.8809999999999999,
    "pcnt_short_of_float": 0.0548,
    "operating_cash_flow_ttm": 200500000.0,
    "levered_cash_flow_ttm": 28450000.0,
    "book_value_per_share_mrq": 13.38,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Hill-Rom Holdings, Inc."
  },
  "HRT": {
    "p_e_ratio": 48.3612,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.129,
    "ebitda": 1800000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.2457,
    "fifty_two_week_high": 7.95,
    "fifty_two_week_low": 5.5,
    "percent_change_from_200_day_moving_average": -0.045727000000000004,
    "percent_change_from_50_day_moving_average": -0.001138,
    "shares_owned": "N/A",
    "short_ratio": 3.92,
    "two_hundred_day_moving_average": 6.5375,
    "volume": 209.0,
    "market_cap": 17380000.0,
    "price_to_sales_ttm": 0.74,
    "price_to_book_mrq": 2.32,
    "roa_ttm": 0.013500000000000002,
    "roe_ttm": 0.0032,
    "shares_outstanding": 2790000.0,
    "pcnt_held_by_insiders": 0.2965,
    "pcnt_held_by_institutions": 0.07400000000000001,
    "pcnt_short_of_float": 0.0064,
    "operating_cash_flow_ttm": 1270000.0,
    "levered_cash_flow_ttm": -594940.0,
    "book_value_per_share_mrq": 2.68,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Arrhythmia Research Technology Inc."
  },
  "HRTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.2,
    "earnings_per_share": -2.87,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.8,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 34.57,
    "fifty_two_week_high": 42.25,
    "fifty_two_week_low": 6.51,
    "percent_change_from_200_day_moving_average": 0.66,
    "percent_change_from_50_day_moving_average": 0.1804,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 24.58,
    "volume": 9046510.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": null,
    "industry": null
  },
  "HSGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.38,
    "ebitda": -35700000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 6.07,
    "fifty_two_week_high": 12.47,
    "fifty_two_week_low": 4.9,
    "percent_change_from_200_day_moving_average": -0.33409999999999995,
    "percent_change_from_50_day_moving_average": -0.18100000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.32,
    "two_hundred_day_moving_average": 7.46,
    "volume": 12007.0,
    "market_cap": 65790000.00000001,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.58,
    "roa_ttm": -0.6772,
    "roe_ttm": -2.2053,
    "shares_outstanding": 13240000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0091,
    "operating_cash_flow_ttm": -24090000.0,
    "levered_cash_flow_ttm": -24010000.0,
    "book_value_per_share_mrq": 3.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Histogenics Corporation"
  },
  "HSKA": {
    "p_e_ratio": 74.52,
    "peg_ratio": 2.65,
    "earnings_per_share": 0.47,
    "ebitda": 9110000.0,
    "eps_estimate_current_year": 0.53,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 34.03,
    "fifty_two_week_high": 35.72,
    "fifty_two_week_low": 11.89,
    "percent_change_from_200_day_moving_average": 0.17170000000000002,
    "percent_change_from_50_day_moving_average": 0.031400000000000004,
    "shares_owned": "N/A",
    "short_ratio": 3.09,
    "two_hundred_day_moving_average": 29.96,
    "volume": 49561.0,
    "market_cap": 229310000.0,
    "price_to_sales_ttm": 2.42,
    "price_to_book_mrq": 3.96,
    "roa_ttm": 0.030899999999999997,
    "roe_ttm": 0.041100000000000005,
    "shares_outstanding": 6530000.0,
    "pcnt_held_by_insiders": 0.12539999999999998,
    "pcnt_held_by_institutions": 0.268,
    "pcnt_short_of_float": 0.0334,
    "operating_cash_flow_ttm": 2340000.0,
    "levered_cash_flow_ttm": 6300000.0,
    "book_value_per_share_mrq": 8.67,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Heska Corporation"
  },
  "HTBX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.16,
    "ebitda": -15550000.0,
    "eps_estimate_current_year": -2.36,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 5.12,
    "fifty_two_week_high": 10.9,
    "fifty_two_week_low": 3.0,
    "percent_change_from_200_day_moving_average": -0.1525,
    "percent_change_from_50_day_moving_average": 0.0212,
    "shares_owned": "N/A",
    "short_ratio": 3.22,
    "two_hundred_day_moving_average": 6.17,
    "volume": 7597.0,
    "market_cap": 43960000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.96,
    "roa_ttm": -0.5015,
    "roe_ttm": -1.02,
    "shares_outstanding": 8410000.0,
    "pcnt_held_by_insiders": 0.4955,
    "pcnt_held_by_institutions": 0.129,
    "pcnt_short_of_float": 0.016,
    "operating_cash_flow_ttm": -13540000.0,
    "levered_cash_flow_ttm": -7680000.0,
    "book_value_per_share_mrq": 1.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Heat Biologics, Inc."
  },
  "HTGM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -18.57,
    "ebitda": -14690000.0,
    "eps_estimate_current_year": -3.08,
    "eps_estimate_next_quarter": -0.82,
    "fifty_day_moving_average": 7.03,
    "fifty_two_week_high": 19.75,
    "fifty_two_week_low": 4.64,
    "percent_change_from_200_day_moving_average": 0.048799999999999996,
    "percent_change_from_50_day_moving_average": 0.6077,
    "shares_owned": "N/A",
    "short_ratio": 2.15,
    "two_hundred_day_moving_average": 10.78,
    "volume": 8705.0,
    "market_cap": 77220000.0,
    "price_to_sales_ttm": 19.49,
    "price_to_book_mrq": 2.82,
    "roa_ttm": -0.3488,
    "roe_ttm": -1.7022,
    "shares_outstanding": 6830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0116,
    "operating_cash_flow_ttm": -16550000.0,
    "levered_cash_flow_ttm": -11650000.0,
    "book_value_per_share_mrq": 4.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "HTG Molecular Diagnostics, Inc."
  },
  "HTWR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.53,
    "earnings_per_share": -2.93,
    "ebitda": -6190000.0,
    "eps_estimate_current_year": -2.1,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 77.52,
    "fifty_two_week_high": 95.59,
    "fifty_two_week_low": 61.01,
    "percent_change_from_200_day_moving_average": -0.21780000000000002,
    "percent_change_from_50_day_moving_average": -0.2014,
    "shares_owned": "N/A",
    "short_ratio": 9.36,
    "two_hundred_day_moving_average": 79.14,
    "volume": 365406.0,
    "market_cap": 1070000000.0000001,
    "price_to_sales_ttm": 3.77,
    "price_to_book_mrq": 5.18,
    "roa_ttm": -0.020499999999999997,
    "roe_ttm": -0.244,
    "shares_outstanding": 17310000.0,
    "pcnt_held_by_insiders": 0.055099999999999996,
    "pcnt_held_by_institutions": 1.0390000000000001,
    "pcnt_short_of_float": 0.2775,
    "operating_cash_flow_ttm": -7390000.0,
    "levered_cash_flow_ttm": 12720000.0,
    "book_value_per_share_mrq": 12.02,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Heartware International Inc."
  },
  "HWAY": {
    "p_e_ratio": 207.59,
    "peg_ratio": -164.45,
    "earnings_per_share": 0.06,
    "ebitda": 49010000.0,
    "eps_estimate_current_year": 0.11,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 12.22,
    "fifty_two_week_high": 23.3,
    "fifty_two_week_low": 11.37,
    "percent_change_from_200_day_moving_average": -0.2163,
    "percent_change_from_50_day_moving_average": -0.0148,
    "shares_owned": "N/A",
    "short_ratio": 8.34,
    "two_hundred_day_moving_average": 15.36,
    "volume": 281824.0,
    "market_cap": 431420000.0,
    "price_to_sales_ttm": 0.57,
    "price_to_book_mrq": 1.44,
    "roa_ttm": 0.022400000000000003,
    "roe_ttm": 0.0058,
    "shares_outstanding": 35830000.0,
    "pcnt_held_by_insiders": 0.1507,
    "pcnt_held_by_institutions": 1.046,
    "pcnt_short_of_float": 0.0901,
    "operating_cash_flow_ttm": 61770000.0,
    "levered_cash_flow_ttm": 35060000.0,
    "book_value_per_share_mrq": 8.48,
    "next_earnings_announcement_date": "2015-10-29",
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Healthways Inc."
  },
  "HYH": {
    "p_e_ratio": 72.08,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.42,
    "ebitda": 218000000.0,
    "eps_estimate_current_year": 2.02,
    "eps_estimate_next_quarter": 0.52,
    "fifty_day_moving_average": 32.13,
    "fifty_two_week_high": 53.85,
    "fifty_two_week_low": 28.27,
    "percent_change_from_200_day_moving_average": -0.2619,
    "percent_change_from_50_day_moving_average": -0.0509,
    "shares_owned": "N/A",
    "short_ratio": 2.93,
    "two_hundred_day_moving_average": 41.31,
    "volume": 234098.0,
    "market_cap": 1420000000.0,
    "price_to_sales_ttm": 0.88,
    "price_to_book_mrq": 0.94,
    "roa_ttm": 0.036699999999999997,
    "roe_ttm": 0.0111,
    "shares_outstanding": 46610000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.069,
    "operating_cash_flow_ttm": 119900000.0,
    "levered_cash_flow_ttm": 132190000.0,
    "book_value_per_share_mrq": 32.67,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Halyard Health, Inc."
  },
  "HZNP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.15,
    "earnings_per_share": -0.15,
    "ebitda": 48060000.0,
    "eps_estimate_current_year": 1.39,
    "eps_estimate_next_quarter": 0.42,
    "fifty_day_moving_average": 30.37,
    "fifty_two_week_high": 39.49,
    "fifty_two_week_low": 10.15,
    "percent_change_from_200_day_moving_average": -0.1563,
    "percent_change_from_50_day_moving_average": -0.154,
    "shares_owned": "N/A",
    "short_ratio": 2.92,
    "two_hundred_day_moving_average": 30.45,
    "volume": 5056351.0,
    "market_cap": 4090000000.0,
    "price_to_sales_ttm": 8.74,
    "price_to_book_mrq": 3.22,
    "roa_ttm": 0.0024,
    "roe_ttm": -0.026000000000000002,
    "shares_outstanding": 159210000.0,
    "pcnt_held_by_insiders": 0.3085,
    "pcnt_held_by_institutions": 0.812,
    "pcnt_short_of_float": 0.06849999999999999,
    "operating_cash_flow_ttm": -17610000.0,
    "levered_cash_flow_ttm": 130870000.0,
    "book_value_per_share_mrq": 7.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Horizon Pharma plc"
  },
  "IART": {
    "p_e_ratio": 54.12,
    "peg_ratio": 2.05,
    "earnings_per_share": 1.21,
    "ebitda": 206610000.0,
    "eps_estimate_current_year": 3.07,
    "eps_estimate_next_quarter": 0.86,
    "fifty_day_moving_average": 62.03,
    "fifty_two_week_high": 68.46,
    "fifty_two_week_low": 42.09,
    "percent_change_from_200_day_moving_average": 0.0951,
    "percent_change_from_50_day_moving_average": 0.0592,
    "shares_owned": "N/A",
    "short_ratio": 3.04,
    "two_hundred_day_moving_average": 60.0,
    "volume": 320275.0,
    "market_cap": 2400000000.0,
    "price_to_sales_ttm": 2.24,
    "price_to_book_mrq": 3.02,
    "roa_ttm": 0.055999999999999994,
    "roe_ttm": 0.0576,
    "shares_outstanding": 36460000.0,
    "pcnt_held_by_insiders": 0.23070000000000002,
    "pcnt_held_by_institutions": 0.795,
    "pcnt_short_of_float": 0.0677,
    "operating_cash_flow_ttm": 101570000.0,
    "levered_cash_flow_ttm": 79810000.0,
    "book_value_per_share_mrq": 21.5,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Integra LifeSciences Holdings Corporation"
  },
  "IBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.085,
    "ebitda": -5560000.0,
    "eps_estimate_current_year": -0.15,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.717,
    "fifty_two_week_high": 3.48,
    "fifty_two_week_low": 0.4,
    "percent_change_from_200_day_moving_average": -0.19007000000000002,
    "percent_change_from_50_day_moving_average": -0.05801,
    "shares_owned": "N/A",
    "short_ratio": 3.67,
    "two_hundred_day_moving_average": 0.833,
    "volume": 188404.0,
    "market_cap": 51810000.0,
    "price_to_sales_ttm": 30.44,
    "price_to_book_mrq": 5.0,
    "roa_ttm": -0.3765,
    "roe_ttm": -0.6842,
    "shares_outstanding": 76760000.0,
    "pcnt_held_by_insiders": 0.5233,
    "pcnt_held_by_institutions": 0.022000000000000002,
    "pcnt_short_of_float": 0.049400000000000006,
    "operating_cash_flow_ttm": -4200000.0,
    "levered_cash_flow_ttm": -2670000.0,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "iBio, Inc."
  },
  "ICCC": {
    "p_e_ratio": 27.67,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.22,
    "ebitda": 1740000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.0,
    "fifty_two_week_high": 11.4,
    "fifty_two_week_low": 3.96,
    "percent_change_from_200_day_moving_average": -0.174,
    "percent_change_from_50_day_moving_average": -0.2286,
    "shares_owned": "N/A",
    "short_ratio": 0.05,
    "two_hundred_day_moving_average": 7.47,
    "volume": 26091.0,
    "market_cap": 18850000.0,
    "price_to_sales_ttm": 2.2,
    "price_to_book_mrq": 2.0,
    "roa_ttm": 0.0723,
    "roe_ttm": 0.0751,
    "shares_outstanding": 3060000.0,
    "pcnt_held_by_insiders": 0.2869,
    "pcnt_held_by_institutions": 0.078,
    "pcnt_short_of_float": 0.0006,
    "operating_cash_flow_ttm": 1490000.0,
    "levered_cash_flow_ttm": -1640000.0,
    "book_value_per_share_mrq": 3.26,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmuCell Corp."
  },
  "ICLR": {
    "p_e_ratio": 23.06,
    "peg_ratio": 1.12,
    "earnings_per_share": 3.36,
    "ebitda": 310910000.0,
    "eps_estimate_current_year": 3.93,
    "eps_estimate_next_quarter": 1.08,
    "fifty_day_moving_average": 79.12,
    "fifty_two_week_high": 84.14,
    "fifty_two_week_low": 49.75,
    "percent_change_from_200_day_moving_average": 0.08960000000000001,
    "percent_change_from_50_day_moving_average": -0.021400000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.95,
    "two_hundred_day_moving_average": 71.06,
    "volume": 303482.0,
    "market_cap": 4640000000.0,
    "price_to_sales_ttm": 2.99,
    "price_to_book_mrq": 4.55,
    "roa_ttm": 0.1007,
    "roe_ttm": 0.2078,
    "shares_outstanding": 59870000.0,
    "pcnt_held_by_insiders": 0.08220000000000001,
    "pcnt_held_by_institutions": 0.915,
    "pcnt_short_of_float": 0.04769999999999999,
    "operating_cash_flow_ttm": 275390000.0,
    "levered_cash_flow_ttm": 190900000.0,
    "book_value_per_share_mrq": 17.07,
    "next_earnings_announcement_date": [
      "2015-10-20",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "ICON Public Limited Company"
  },
  "ICPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.48,
    "earnings_per_share": -7.11,
    "ebitda": -158730000.0,
    "eps_estimate_current_year": -10.45,
    "eps_estimate_next_quarter": -3.77,
    "fifty_day_moving_average": 202.9,
    "fifty_two_week_high": 314.88,
    "fifty_two_week_low": 128.5,
    "percent_change_from_200_day_moving_average": -0.2736,
    "percent_change_from_50_day_moving_average": -0.1018,
    "shares_owned": "N/A",
    "short_ratio": 6.21,
    "two_hundred_day_moving_average": 250.89,
    "volume": 239758.0,
    "market_cap": 4410000000.0,
    "price_to_sales_ttm": 1577.61,
    "price_to_book_mrq": 5.37,
    "roa_ttm": -0.1875,
    "roe_ttm": -0.3119,
    "shares_outstanding": 24200000.0,
    "pcnt_held_by_insiders": 0.4086,
    "pcnt_held_by_institutions": 0.545,
    "pcnt_short_of_float": 0.1913,
    "operating_cash_flow_ttm": -119600000.0,
    "levered_cash_flow_ttm": -70930000.0,
    "book_value_per_share_mrq": 33.76,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intercept Pharmaceuticals, Inc."
  },
  "ICUI": {
    "p_e_ratio": 49.43,
    "peg_ratio": 2.91,
    "earnings_per_share": 2.31,
    "ebitda": 82710000.0,
    "eps_estimate_current_year": 3.62,
    "eps_estimate_next_quarter": 0.83,
    "fifty_day_moving_average": 112.7,
    "fifty_two_week_high": 124.69,
    "fifty_two_week_low": 61.7,
    "percent_change_from_200_day_moving_average": 0.15560000000000002,
    "percent_change_from_50_day_moving_average": 0.011899999999999999,
    "shares_owned": "N/A",
    "short_ratio": 2.83,
    "two_hundred_day_moving_average": 98.69,
    "volume": 88173.0,
    "market_cap": 1810000000.0,
    "price_to_sales_ttm": 5.58,
    "price_to_book_mrq": 3.32,
    "roa_ttm": 0.0733,
    "roe_ttm": 0.0724,
    "shares_outstanding": 15830000.0,
    "pcnt_held_by_insiders": 0.1195,
    "pcnt_held_by_institutions": 0.917,
    "pcnt_short_of_float": 0.0415,
    "operating_cash_flow_ttm": 57120000.0,
    "levered_cash_flow_ttm": 54510000.0,
    "book_value_per_share_mrq": 34.07,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ICU Medical, Inc."
  },
  "IDRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.47,
    "ebitda": -46410000.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.99,
    "fifty_two_week_high": 5.48,
    "fifty_two_week_low": 1.94,
    "percent_change_from_200_day_moving_average": 0.1283,
    "percent_change_from_50_day_moving_average": 0.2848,
    "shares_owned": "N/A",
    "short_ratio": 17.32,
    "two_hundred_day_moving_average": 3.4,
    "volume": 1916011.0,
    "market_cap": 453590000.0,
    "price_to_sales_ttm": 6305.39,
    "price_to_book_mrq": 4.37,
    "roa_ttm": -0.33130000000000004,
    "roe_ttm": -0.5722999999999999,
    "shares_outstanding": 118120000.0,
    "pcnt_held_by_insiders": 0.1818,
    "pcnt_held_by_institutions": 0.318,
    "pcnt_short_of_float": 0.34630000000000005,
    "operating_cash_flow_ttm": -40130000.0,
    "levered_cash_flow_ttm": -24070000.0,
    "book_value_per_share_mrq": 0.87,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Idera Pharmaceuticals, Inc."
  },
  "IDXX": {
    "p_e_ratio": 19.54,
    "peg_ratio": 2.58,
    "earnings_per_share": 3.92,
    "ebitda": 331840000.0,
    "eps_estimate_current_year": 2.11,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 75.13,
    "fifty_two_week_high": 84.25,
    "fifty_two_week_low": 57.56,
    "percent_change_from_200_day_moving_average": 0.0802,
    "percent_change_from_50_day_moving_average": 0.0202,
    "shares_owned": "N/A",
    "short_ratio": 11.37,
    "two_hundred_day_moving_average": 70.96,
    "volume": 414023.0,
    "market_cap": 7170000000.0,
    "price_to_sales_ttm": 4.58,
    "price_to_book_mrq": 836.92,
    "roa_ttm": 0.12140000000000001,
    "roe_ttm": 0.7872,
    "shares_outstanding": 93600000.0,
    "pcnt_held_by_insiders": 0.0111,
    "pcnt_held_by_institutions": 0.991,
    "pcnt_short_of_float": 0.09269999999999999,
    "operating_cash_flow_ttm": 186090000.0,
    "levered_cash_flow_ttm": 122430000.0,
    "book_value_per_share_mrq": 0.09,
    "next_earnings_announcement_date": [
      "2015-10-22",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "IDEXX Laboratories, Inc."
  },
  "IG": {
    "p_e_ratio": 135.59,
    "peg_ratio": -4.48,
    "earnings_per_share": 0.06,
    "ebitda": 3720000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 8.14,
    "fifty_two_week_high": 12.05,
    "fifty_two_week_low": 4.75,
    "percent_change_from_200_day_moving_average": 0.0796,
    "percent_change_from_50_day_moving_average": -0.0167,
    "shares_owned": "N/A",
    "short_ratio": 22.92,
    "two_hundred_day_moving_average": 7.41,
    "volume": 334243.0,
    "market_cap": 422910000.0,
    "price_to_sales_ttm": 10.57,
    "price_to_book_mrq": 5.66,
    "roa_ttm": 0.018799999999999997,
    "roe_ttm": 0.5173,
    "shares_outstanding": 52860000.0,
    "pcnt_held_by_insiders": 0.5847,
    "pcnt_held_by_institutions": 0.179,
    "pcnt_short_of_float": 0.2865,
    "operating_cash_flow_ttm": -9210000.0,
    "levered_cash_flow_ttm": -8400000.0,
    "book_value_per_share_mrq": 1.41,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "IGI Laboratories, Inc."
  },
  "IMDZ": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.79,
    "earnings_per_share": -2.42,
    "ebitda": -39380000.0,
    "eps_estimate_current_year": -2.0,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 16.8,
    "fifty_two_week_high": 40.13,
    "fifty_two_week_low": 12.73,
    "percent_change_from_200_day_moving_average": -0.29469999999999996,
    "percent_change_from_50_day_moving_average": -0.0729,
    "shares_owned": "N/A",
    "short_ratio": 8.0,
    "two_hundred_day_moving_average": 22.08,
    "volume": 56718.0,
    "market_cap": 313420000.0,
    "price_to_sales_ttm": 36.32,
    "price_to_book_mrq": 2.63,
    "roa_ttm": -0.32270000000000004,
    "roe_ttm": -0.5509000000000001,
    "shares_outstanding": 20130000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.17010000000000003,
    "operating_cash_flow_ttm": -31430000.0,
    "levered_cash_flow_ttm": -17500000.0,
    "book_value_per_share_mrq": 6.22,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Immune Design Corp."
  },
  "IMGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.71,
    "ebitda": -48940000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 13.9,
    "fifty_two_week_high": 19.43,
    "fifty_two_week_low": 5.34,
    "percent_change_from_200_day_moving_average": -0.07200000000000001,
    "percent_change_from_50_day_moving_average": -0.177,
    "shares_owned": "N/A",
    "short_ratio": 7.44,
    "two_hundred_day_moving_average": 12.33,
    "volume": 1794608.0,
    "market_cap": 994840000.0,
    "price_to_sales_ttm": 12.18,
    "price_to_book_mrq": 29.58,
    "roa_ttm": -0.1421,
    "roe_ttm": -1.0963,
    "shares_outstanding": 86960000.0,
    "pcnt_held_by_insiders": 0.0039000000000000003,
    "pcnt_held_by_institutions": 0.909,
    "pcnt_short_of_float": 0.1564,
    "operating_cash_flow_ttm": -55290000.0,
    "levered_cash_flow_ttm": -14650000.0,
    "book_value_per_share_mrq": 0.41,
    "next_earnings_announcement_date": "2015-10-23",
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmunoGen, Inc."
  },
  "IMMU": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -45640000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 2.02,
    "fifty_two_week_high": 5.48,
    "fifty_two_week_low": 1.69,
    "percent_change_from_200_day_moving_average": -0.467,
    "percent_change_from_50_day_moving_average": -0.0827,
    "shares_owned": "N/A",
    "short_ratio": 13.64,
    "two_hundred_day_moving_average": 3.47,
    "volume": 660452.0,
    "market_cap": 175060000.0,
    "price_to_sales_ttm": 31.8,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.377,
    "roe_ttm": -2.8032,
    "shares_outstanding": 94630000.0,
    "pcnt_held_by_insiders": 0.0725,
    "pcnt_held_by_institutions": 0.434,
    "pcnt_short_of_float": 0.20920000000000002,
    "operating_cash_flow_ttm": -39000000.0,
    "levered_cash_flow_ttm": -22830000.0,
    "book_value_per_share_mrq": -0.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Immunomedics Inc."
  },
  "IMMY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.33,
    "earnings_per_share": -1.29,
    "ebitda": -11470000.0,
    "eps_estimate_current_year": -1.44,
    "eps_estimate_next_quarter": -0.33,
    "fifty_day_moving_average": 7.54,
    "fifty_two_week_high": 9.24,
    "fifty_two_week_low": 6.65,
    "percent_change_from_200_day_moving_average": -0.1316,
    "percent_change_from_50_day_moving_average": -0.0781,
    "shares_owned": "N/A",
    "short_ratio": 4.03,
    "two_hundred_day_moving_average": 8.0,
    "volume": 7816.0,
    "market_cap": 66680000.00000001,
    "price_to_sales_ttm": 14.71,
    "price_to_book_mrq": 12.62,
    "roa_ttm": -0.4802,
    "roe_ttm": -1.3909,
    "shares_outstanding": 9590000.0,
    "pcnt_held_by_insiders": 0.48619999999999997,
    "pcnt_held_by_institutions": 0.05,
    "pcnt_short_of_float": 0.0126,
    "operating_cash_flow_ttm": -9290000.0,
    "levered_cash_flow_ttm": -4940000.0,
    "book_value_per_share_mrq": 0.55,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Imprimis Pharmaceuticals, Inc."
  },
  "IMNP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.25,
    "ebitda": -16210000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 1.44,
    "fifty_two_week_high": 3.59,
    "fifty_two_week_low": 1.05,
    "percent_change_from_200_day_moving_average": -0.1414,
    "percent_change_from_50_day_moving_average": 0.0755,
    "shares_owned": "N/A",
    "short_ratio": 3.37,
    "two_hundred_day_moving_average": 1.81,
    "volume": 82153.0,
    "market_cap": 42830000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.92,
    "roa_ttm": -0.3081,
    "roe_ttm": -2.5201,
    "shares_outstanding": 27630000.0,
    "pcnt_held_by_insiders": 0.4493,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.020499999999999997,
    "operating_cash_flow_ttm": -11820000.0,
    "levered_cash_flow_ttm": -7720000.0,
    "book_value_per_share_mrq": 0.51,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Immune Pharmaceuticals, Inc."
  },
  "IMUC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.121,
    "ebitda": -11130000.0,
    "eps_estimate_current_year": -0.17,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.431,
    "fifty_two_week_high": 1.03,
    "fifty_two_week_low": 0.35,
    "percent_change_from_200_day_moving_average": -0.02802,
    "percent_change_from_50_day_moving_average": 0.07853,
    "shares_owned": "N/A",
    "short_ratio": 0.16,
    "two_hundred_day_moving_average": 0.478,
    "volume": 332398.0,
    "market_cap": 41970000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.47,
    "roa_ttm": -0.2316,
    "roe_ttm": -0.3172,
    "shares_outstanding": 90250000.0,
    "pcnt_held_by_insiders": 0.038,
    "pcnt_held_by_institutions": 0.071,
    "pcnt_short_of_float": 0.0012,
    "operating_cash_flow_ttm": -11530000.0,
    "levered_cash_flow_ttm": -6840000.0,
    "book_value_per_share_mrq": 0.33,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmunoCellular Therapeutics, Ltd."
  },
  "INFI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -1.41,
    "ebitda": -60890000.0,
    "eps_estimate_current_year": -2.77,
    "eps_estimate_next_quarter": 0.65,
    "fifty_day_moving_average": 9.0,
    "fifty_two_week_high": 18.25,
    "fifty_two_week_low": 7.56,
    "percent_change_from_200_day_moving_average": -0.1991,
    "percent_change_from_50_day_moving_average": 0.0362,
    "shares_owned": "N/A",
    "short_ratio": 9.14,
    "two_hundred_day_moving_average": 11.65,
    "volume": 545266.0,
    "market_cap": 458930000.0,
    "price_to_sales_ttm": 2.68,
    "price_to_book_mrq": 5.34,
    "roa_ttm": -0.19260000000000002,
    "roe_ttm": -0.61,
    "shares_outstanding": 49190000.0,
    "pcnt_held_by_insiders": 0.0451,
    "pcnt_held_by_institutions": 1.023,
    "pcnt_short_of_float": 0.146,
    "operating_cash_flow_ttm": 59760000.0,
    "levered_cash_flow_ttm": 21080000.0,
    "book_value_per_share_mrq": 1.78,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Infinity Pharmaceuticals, Inc."
  },
  "INFU": {
    "p_e_ratio": 27.3,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.1,
    "ebitda": 16219999.999999998,
    "eps_estimate_current_year": 0.24,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.86,
    "fifty_two_week_high": 4.5,
    "fifty_two_week_low": 2.22,
    "percent_change_from_200_day_moving_average": -0.0929,
    "percent_change_from_50_day_moving_average": -0.0464,
    "shares_owned": "N/A",
    "short_ratio": 16.29,
    "two_hundred_day_moving_average": 3.01,
    "volume": 2012.0,
    "market_cap": 61250000.0,
    "price_to_sales_ttm": 0.98,
    "price_to_book_mrq": 1.28,
    "roa_ttm": 0.0692,
    "roe_ttm": 0.049100000000000005,
    "shares_outstanding": 22430000.0,
    "pcnt_held_by_insiders": 0.282,
    "pcnt_held_by_institutions": 0.35600000000000004,
    "pcnt_short_of_float": 0.0215,
    "operating_cash_flow_ttm": 9240000.0,
    "levered_cash_flow_ttm": -1790000.0,
    "book_value_per_share_mrq": 2.12,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "InfuSystem Holdings, Inc."
  },
  "INGN": {
    "p_e_ratio": 131.06,
    "peg_ratio": 4.81,
    "earnings_per_share": 0.41,
    "ebitda": 26260000.0,
    "eps_estimate_current_year": 0.3,
    "eps_estimate_next_quarter": 0.08,
    "fifty_day_moving_average": 49.86,
    "fifty_two_week_high": 55.98,
    "fifty_two_week_low": 19.16,
    "percent_change_from_200_day_moving_average": 0.31329999999999997,
    "percent_change_from_50_day_moving_average": 0.0908,
    "shares_owned": "N/A",
    "short_ratio": 2.94,
    "two_hundred_day_moving_average": 41.42,
    "volume": 185285.0,
    "market_cap": 1060000000.0,
    "price_to_sales_ttm": 7.57,
    "price_to_book_mrq": 8.07,
    "roa_ttm": 0.053099999999999994,
    "roe_ttm": 0.0727,
    "shares_outstanding": 19450000.0,
    "pcnt_held_by_insiders": 0.6748999999999999,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.060899999999999996,
    "operating_cash_flow_ttm": 21290000.0,
    "levered_cash_flow_ttm": -2170000.0,
    "book_value_per_share_mrq": 6.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Inogen, Inc."
  },
  "INNL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.89,
    "ebitda": -29940000.0,
    "eps_estimate_current_year": -2.19,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 13.27,
    "fifty_two_week_high": 16.46,
    "fifty_two_week_low": 4.45,
    "percent_change_from_200_day_moving_average": 0.0717,
    "percent_change_from_50_day_moving_average": -0.043,
    "shares_owned": "N/A",
    "short_ratio": 0.04,
    "two_hundred_day_moving_average": 11.85,
    "volume": 1037.0,
    "market_cap": 278560000.0,
    "price_to_sales_ttm": 82.76,
    "price_to_book_mrq": 13.18,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 21930000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -28890000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Innocoll AG"
  },
  "INO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -42090000.0,
    "eps_estimate_current_year": -0.58,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 7.26,
    "fifty_two_week_high": 13.04,
    "fifty_two_week_low": 6.19,
    "percent_change_from_200_day_moving_average": -0.1319,
    "percent_change_from_50_day_moving_average": -0.025099999999999997,
    "shares_owned": "N/A",
    "short_ratio": 6.09,
    "two_hundred_day_moving_average": 8.16,
    "volume": 760674.0,
    "market_cap": 510590000.0,
    "price_to_sales_ttm": 35.15,
    "price_to_book_mrq": 2.86,
    "roa_ttm": -0.1593,
    "roe_ttm": -0.20670000000000002,
    "shares_outstanding": 72120000.0,
    "pcnt_held_by_insiders": 0.0575,
    "pcnt_held_by_institutions": 0.188,
    "pcnt_short_of_float": 0.2523,
    "operating_cash_flow_ttm": -37210000.0,
    "levered_cash_flow_ttm": -21420000.0,
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Inovio Pharmaceuticals, Inc."
  },
  "INSM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.91,
    "ebitda": -99520000.0,
    "eps_estimate_current_year": -1.94,
    "eps_estimate_next_quarter": -0.48,
    "fifty_day_moving_average": 25.41,
    "fifty_two_week_high": 28.66,
    "fifty_two_week_low": 12.17,
    "percent_change_from_200_day_moving_average": 0.0032,
    "percent_change_from_50_day_moving_average": -0.0668,
    "shares_owned": "N/A",
    "short_ratio": 11.09,
    "two_hundred_day_moving_average": 23.63,
    "volume": 595907.0,
    "market_cap": 1460000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.07,
    "roa_ttm": -0.2263,
    "roe_ttm": -0.4094,
    "shares_outstanding": 61760000.0,
    "pcnt_held_by_insiders": 0.11810000000000001,
    "pcnt_held_by_institutions": 0.767,
    "pcnt_short_of_float": 0.1162,
    "operating_cash_flow_ttm": -82960000.0,
    "levered_cash_flow_ttm": -59090000.0,
    "book_value_per_share_mrq": 5.92,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Insmed Incorporated"
  },
  "INSY": {
    "p_e_ratio": 67.12,
    "peg_ratio": 1.4,
    "earnings_per_share": 0.49,
    "ebitda": 73910000.0,
    "eps_estimate_current_year": 0.93,
    "eps_estimate_next_quarter": 0.24,
    "fifty_day_moving_average": 35.54,
    "fifty_two_week_high": 46.17,
    "fifty_two_week_low": 16.5,
    "percent_change_from_200_day_moving_average": -0.023399999999999997,
    "percent_change_from_50_day_moving_average": -0.0766,
    "shares_owned": "N/A",
    "short_ratio": 18.18,
    "two_hundred_day_moving_average": 33.61,
    "volume": 593031.0,
    "market_cap": 2340000000.0,
    "price_to_sales_ttm": 8.49,
    "price_to_book_mrq": 11.37,
    "roa_ttm": 0.2061,
    "roe_ttm": 0.2224,
    "shares_outstanding": 71420000.0,
    "pcnt_held_by_insiders": 0.7088,
    "pcnt_held_by_institutions": 0.287,
    "pcnt_short_of_float": 0.7016,
    "operating_cash_flow_ttm": 60570000.0,
    "levered_cash_flow_ttm": 44240000.0,
    "book_value_per_share_mrq": 2.84,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "INSYS Therapeutics, Inc."
  },
  "IPCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.228,
    "ebitda": -4540000.0,
    "eps_estimate_current_year": -0.17,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 2.231,
    "fifty_two_week_high": 3.92,
    "fifty_two_week_low": 1.92,
    "percent_change_from_200_day_moving_average": -0.26883,
    "percent_change_from_50_day_moving_average": -0.0701,
    "shares_owned": "N/A",
    "short_ratio": 8.23,
    "two_hundred_day_moving_average": 2.838,
    "volume": 28277.0,
    "market_cap": 49570000.0,
    "price_to_sales_ttm": 9.9,
    "price_to_book_mrq": 16.64,
    "roa_ttm": -0.34979999999999994,
    "roe_ttm": -1.0552,
    "shares_outstanding": 23890000.0,
    "pcnt_held_by_insiders": 0.009300000000000001,
    "pcnt_held_by_institutions": 0.006,
    "pcnt_short_of_float": 0.0696,
    "operating_cash_flow_ttm": -4130000.0,
    "levered_cash_flow_ttm": -2750000.0,
    "book_value_per_share_mrq": 0.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "IntelliPharmaCeutics International Inc."
  },
  "IPCM": {
    "p_e_ratio": 42.36,
    "peg_ratio": 1.81,
    "earnings_per_share": 1.87,
    "ebitda": 70370000.0,
    "eps_estimate_current_year": 2.19,
    "eps_estimate_next_quarter": 0.59,
    "fifty_day_moving_average": 79.33,
    "fifty_two_week_high": 80.09,
    "fifty_two_week_low": 36.12,
    "percent_change_from_200_day_moving_average": 0.364,
    "percent_change_from_50_day_moving_average": -0.0013,
    "shares_owned": "N/A",
    "short_ratio": 0.92,
    "two_hundred_day_moving_average": 58.08,
    "volume": 216506.0,
    "market_cap": 1380000000.0,
    "price_to_sales_ttm": 1.93,
    "price_to_book_mrq": 3.54,
    "roa_ttm": 0.066,
    "roe_ttm": 0.0908,
    "shares_outstanding": 17420000.0,
    "pcnt_held_by_insiders": 0.0204,
    "pcnt_held_by_institutions": 1.07,
    "pcnt_short_of_float": 0.042199999999999994,
    "operating_cash_flow_ttm": 54210000.0,
    "levered_cash_flow_ttm": 67390000.0,
    "book_value_per_share_mrq": 22.36,
    "next_earnings_announcement_date": [
      "2015-10-20",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "IPC Healthcare, Inc."
  },
  "IPXL": {
    "p_e_ratio": 401.23,
    "peg_ratio": 1.28,
    "earnings_per_share": 0.11,
    "ebitda": 106210000.0,
    "eps_estimate_current_year": 1.3,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 43.96,
    "fifty_two_week_high": 52.1,
    "fifty_two_week_low": 23.31,
    "percent_change_from_200_day_moving_average": -0.0837,
    "percent_change_from_50_day_moving_average": -0.0325,
    "shares_owned": "N/A",
    "short_ratio": 11.95,
    "two_hundred_day_moving_average": 46.42,
    "volume": 707712.0,
    "market_cap": 3060000000.0,
    "price_to_sales_ttm": 4.56,
    "price_to_book_mrq": 2.99,
    "roa_ttm": 0.023399999999999997,
    "roe_ttm": 0.0083,
    "shares_outstanding": 72060000.0,
    "pcnt_held_by_insiders": 0.0599,
    "pcnt_held_by_institutions": 0.816,
    "pcnt_short_of_float": 0.1884,
    "operating_cash_flow_ttm": -12190000.0,
    "levered_cash_flow_ttm": -69030000.0,
    "book_value_per_share_mrq": 14.21,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Impax Laboratories Inc."
  },
  "IRIX": {
    "p_e_ratio": 8.02,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.88,
    "ebitda": 1720000.0,
    "eps_estimate_current_year": 0.18,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.98,
    "fifty_two_week_high": 11.28,
    "fifty_two_week_low": 6.41,
    "percent_change_from_200_day_moving_average": -0.1709,
    "percent_change_from_50_day_moving_average": 0.0148,
    "shares_owned": "N/A",
    "short_ratio": 0.81,
    "two_hundred_day_moving_average": 8.54,
    "volume": 37046.0,
    "market_cap": 70790000.0,
    "price_to_sales_ttm": 1.71,
    "price_to_book_mrq": 2.14,
    "roa_ttm": 0.0212,
    "roe_ttm": 0.3002,
    "shares_outstanding": 10000000.0,
    "pcnt_held_by_insiders": 0.344,
    "pcnt_held_by_institutions": 0.247,
    "pcnt_short_of_float": 0.0038,
    "operating_cash_flow_ttm": 2980000.0,
    "levered_cash_flow_ttm": 214750.0,
    "book_value_per_share_mrq": 3.32,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "IRIDEX Corporation"
  },
  "IRMD": {
    "p_e_ratio": 85.67,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.32,
    "ebitda": 5850000.0,
    "eps_estimate_current_year": 0.63,
    "eps_estimate_next_quarter": 0.17,
    "fifty_day_moving_average": 25.14,
    "fifty_two_week_high": 28.43,
    "fifty_two_week_low": 6.7,
    "percent_change_from_200_day_moving_average": 0.3638,
    "percent_change_from_50_day_moving_average": 0.09380000000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.14,
    "two_hundred_day_moving_average": 20.16,
    "volume": 38536.0,
    "market_cap": 304170000.0,
    "price_to_sales_ttm": 13.88,
    "price_to_book_mrq": 12.01,
    "roa_ttm": 0.18239999999999998,
    "roe_ttm": 0.23260000000000003,
    "shares_outstanding": 11060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0434,
    "operating_cash_flow_ttm": 3080000.0,
    "levered_cash_flow_ttm": 2200000.0,
    "book_value_per_share_mrq": 2.29,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "IRadimed Corporation"
  },
  "IRWD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -6.14,
    "earnings_per_share": -1.14,
    "ebitda": -127880000.0,
    "eps_estimate_current_year": -0.87,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 11.19,
    "fifty_two_week_high": 17.11,
    "fifty_two_week_low": 10.15,
    "percent_change_from_200_day_moving_average": -0.1582,
    "percent_change_from_50_day_moving_average": -0.022000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 9.81,
    "two_hundred_day_moving_average": 13.0,
    "volume": 858807.0,
    "market_cap": 1560000000.0,
    "price_to_sales_ttm": 14.07,
    "price_to_book_mrq": 11.2,
    "roa_ttm": -0.17079999999999998,
    "roe_ttm": -1.1405,
    "shares_outstanding": 126680000.0,
    "pcnt_held_by_insiders": 0.0207,
    "pcnt_held_by_institutions": 1.099,
    "pcnt_short_of_float": 0.23170000000000002,
    "operating_cash_flow_ttm": -122800000.0,
    "levered_cash_flow_ttm": -67320000.0,
    "book_value_per_share_mrq": 0.98,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Ironwood Pharmaceuticals, Inc."
  },
  "ISIS": {
    "p_e_ratio": 249.58,
    "peg_ratio": -4.11,
    "earnings_per_share": 0.19,
    "ebitda": 34980000.0,
    "eps_estimate_current_year": -0.52,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 51.27,
    "fifty_two_week_high": 77.8,
    "fifty_two_week_low": 35.26,
    "percent_change_from_200_day_moving_average": -0.205,
    "percent_change_from_50_day_moving_average": -0.0751,
    "shares_owned": "N/A",
    "short_ratio": 7.25,
    "two_hundred_day_moving_average": 59.65,
    "volume": 2236772.0,
    "market_cap": 5690000000.0,
    "price_to_sales_ttm": 18.55,
    "price_to_book_mrq": 19.25,
    "roa_ttm": 0.0176,
    "roe_ttm": 0.0699,
    "shares_outstanding": 119960000.0,
    "pcnt_held_by_insiders": 0.0079,
    "pcnt_held_by_institutions": 0.888,
    "pcnt_short_of_float": 0.12990000000000002,
    "operating_cash_flow_ttm": 95010000.0,
    "levered_cash_flow_ttm": 76230000.0,
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Isis Pharmaceuticals, Inc."
  },
  "ISR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.07,
    "ebitda": -3640000.0,
    "eps_estimate_current_year": 0.08,
    "eps_estimate_next_quarter": 0.02,
    "fifty_day_moving_average": 1.46,
    "fifty_two_week_high": 3.79,
    "fifty_two_week_low": 1.22,
    "percent_change_from_200_day_moving_average": -0.0471,
    "percent_change_from_50_day_moving_average": 0.0034999999999999996,
    "shares_owned": "N/A",
    "short_ratio": 12.17,
    "two_hundred_day_moving_average": 1.54,
    "volume": 288688.0,
    "market_cap": 80870000.0,
    "price_to_sales_ttm": 17.8,
    "price_to_book_mrq": 3.86,
    "roa_ttm": -0.1094,
    "roe_ttm": -0.1646,
    "shares_outstanding": 55010000.0,
    "pcnt_held_by_insiders": 0.0125,
    "pcnt_held_by_institutions": 0.04,
    "pcnt_short_of_float": 0.1251,
    "operating_cash_flow_ttm": -3520000.0,
    "levered_cash_flow_ttm": -2230000.0,
    "book_value_per_share_mrq": 0.38,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "IsoRay, Inc."
  },
  "ITCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.1,
    "ebitda": -65830000.0,
    "eps_estimate_current_year": -2.87,
    "eps_estimate_next_quarter": -0.82,
    "fifty_day_moving_average": 31.51,
    "fifty_two_week_high": 60.79,
    "fifty_two_week_low": 13.12,
    "percent_change_from_200_day_moving_average": 0.7101000000000001,
    "percent_change_from_50_day_moving_average": 0.5191,
    "shares_owned": "N/A",
    "short_ratio": 5.09,
    "two_hundred_day_moving_average": 27.99,
    "volume": 6517076.0,
    "market_cap": 1680000000.0,
    "price_to_sales_ttm": 6278.43,
    "price_to_book_mrq": 7.74,
    "roa_ttm": -0.2322,
    "roe_ttm": -0.3823,
    "shares_outstanding": 35060000.0,
    "pcnt_held_by_insiders": 0.3568,
    "pcnt_held_by_institutions": 0.41700000000000004,
    "pcnt_short_of_float": 0.1286,
    "operating_cash_flow_ttm": -57340000.0,
    "levered_cash_flow_ttm": -34950000.0,
    "book_value_per_share_mrq": 5.81,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intra-Cellular Therapies, Inc."
  },
  "ITEK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.65,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.54,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 13.48,
    "fifty_two_week_high": 19.45,
    "fifty_two_week_low": 4.68,
    "percent_change_from_200_day_moving_average": 0.5891,
    "percent_change_from_50_day_moving_average": -0.046900000000000004,
    "shares_owned": "N/A",
    "short_ratio": 0.56,
    "two_hundred_day_moving_average": 8.09,
    "volume": 311012.0,
    "market_cap": 339340000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.88,
    "roa_ttm": -0.21710000000000002,
    "roe_ttm": -0.5315,
    "shares_outstanding": 26410000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1153,
    "operating_cash_flow_ttm": -11880000.0,
    "levered_cash_flow_ttm": -5960000.0,
    "book_value_per_share_mrq": 1.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Inotek Pharmaceuticals Corporation"
  },
  "IVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.28,
    "earnings_per_share": -1.25,
    "ebitda": 1350000.0,
    "eps_estimate_current_year": -0.7,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 16.37,
    "fifty_two_week_high": 23.59,
    "fifty_two_week_low": 11.65,
    "percent_change_from_200_day_moving_average": -0.1787,
    "percent_change_from_50_day_moving_average": -0.0226,
    "shares_owned": "N/A",
    "short_ratio": 12.01,
    "two_hundred_day_moving_average": 19.48,
    "volume": 71664.0,
    "market_cap": 520350000.0,
    "price_to_sales_ttm": 0.43,
    "price_to_book_mrq": 1.05,
    "roa_ttm": -0.0147,
    "roe_ttm": -0.09,
    "shares_outstanding": 31440000.0,
    "pcnt_held_by_insiders": 0.0617,
    "pcnt_held_by_institutions": 0.877,
    "pcnt_short_of_float": 0.0687,
    "operating_cash_flow_ttm": -12600000.0,
    "levered_cash_flow_ttm": 32090000.000000004,
    "book_value_per_share_mrq": 15.18,
    "next_earnings_announcement_date": "2015-10-22",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Invacare Corporation"
  },
  "IVTY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.13,
    "earnings_per_share": -23.3,
    "ebitda": -26220000.0,
    "eps_estimate_current_year": -4.74,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 12.89,
    "fifty_two_week_high": 18.18,
    "fifty_two_week_low": 10.0,
    "percent_change_from_200_day_moving_average": 0.0269,
    "percent_change_from_50_day_moving_average": 0.058600000000000006,
    "shares_owned": "N/A",
    "short_ratio": 3.55,
    "two_hundred_day_moving_average": 13.28,
    "volume": 19560.0,
    "market_cap": 181480000.0,
    "price_to_sales_ttm": 10.21,
    "price_to_book_mrq": 2.91,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0146,
    "operating_cash_flow_ttm": -25260000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Invuity, Inc."
  },
  "JAGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -2.78,
    "ebitda": 0.0,
    "eps_estimate_current_year": -3.0,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 3.24,
    "fifty_two_week_high": 7.06,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": -0.17800000000000002,
    "percent_change_from_50_day_moving_average": 0.1868,
    "shares_owned": "N/A",
    "short_ratio": 0.67,
    "two_hundred_day_moving_average": 4.67,
    "volume": 2426.0,
    "market_cap": 31200000.0,
    "price_to_sales_ttm": 258.87,
    "price_to_book_mrq": 2.92,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 8119999.999999999,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0016,
    "operating_cash_flow_ttm": -10720000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Jaguar Animal Health, Inc."
  },
  "JAZZ": {
    "p_e_ratio": 36.2,
    "peg_ratio": 0.84,
    "earnings_per_share": 4.12,
    "ebitda": 668520000.0,
    "eps_estimate_current_year": 9.66,
    "eps_estimate_next_quarter": 2.7,
    "fifty_day_moving_average": 171.36,
    "fifty_two_week_high": 194.73,
    "fifty_two_week_low": 137.34,
    "percent_change_from_200_day_moving_average": -0.162,
    "percent_change_from_50_day_moving_average": -0.13019999999999998,
    "shares_owned": "N/A",
    "short_ratio": 5.07,
    "two_hundred_day_moving_average": 177.86,
    "volume": 646997.0,
    "market_cap": 9140000000.0,
    "price_to_sales_ttm": 7.21,
    "price_to_book_mrq": 6.37,
    "roa_ttm": 0.1048,
    "roe_ttm": 0.19519999999999998,
    "shares_outstanding": 61340000.0,
    "pcnt_held_by_insiders": 0.1425,
    "pcnt_held_by_institutions": 0.773,
    "pcnt_short_of_float": 0.057300000000000004,
    "operating_cash_flow_ttm": 499240000.0,
    "levered_cash_flow_ttm": 341520000.0,
    "book_value_per_share_mrq": 23.59,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Jazz Pharmaceuticals Public Limited Company"
  },
  "JNP": {
    "p_e_ratio": 66.21,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.21,
    "ebitda": 4750000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 11.5,
    "fifty_two_week_high": 15.44,
    "fifty_two_week_low": 5.09,
    "percent_change_from_200_day_moving_average": 0.5361,
    "percent_change_from_50_day_moving_average": 0.1864,
    "shares_owned": "N/A",
    "short_ratio": 3.03,
    "two_hundred_day_moving_average": 8.88,
    "volume": 136353.0,
    "market_cap": 147160000.0,
    "price_to_sales_ttm": 4.0,
    "price_to_book_mrq": 3.63,
    "roa_ttm": 0.031200000000000002,
    "roe_ttm": 0.0542,
    "shares_outstanding": 10790000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.012,
    "operating_cash_flow_ttm": 6020000.0,
    "levered_cash_flow_ttm": 4650000.0,
    "book_value_per_share_mrq": 3.81,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Juniper Pharmaceuticals, Inc."
  },
  "JUNO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -8.46,
    "ebitda": -327050000.0,
    "eps_estimate_current_year": -1.47,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 39.93,
    "fifty_two_week_high": 69.28,
    "fifty_two_week_low": 33.0,
    "percent_change_from_200_day_moving_average": -0.225,
    "percent_change_from_50_day_moving_average": -0.038,
    "shares_owned": "N/A",
    "short_ratio": 3.47,
    "two_hundred_day_moving_average": 49.56,
    "volume": 718230.0,
    "market_cap": 3860000000.0,
    "price_to_sales_ttm": 307.7,
    "price_to_book_mrq": 10.36,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 100560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1197,
    "operating_cash_flow_ttm": -129340000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Juno Therapeutics Inc."
  },
  "JYNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.26,
    "earnings_per_share": -0.835,
    "ebitda": -4210000.0,
    "eps_estimate_current_year": -0.9,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 8.2261,
    "fifty_two_week_high": 12.99,
    "fifty_two_week_low": 5.99,
    "percent_change_from_200_day_moving_average": -0.227012,
    "percent_change_from_50_day_moving_average": -0.139843,
    "shares_owned": "N/A",
    "short_ratio": 11.79,
    "two_hundred_day_moving_average": 9.1537,
    "volume": 6633.0,
    "market_cap": 69520000.0,
    "price_to_sales_ttm": 7.36,
    "price_to_book_mrq": 5.92,
    "roa_ttm": -0.17309999999999998,
    "roe_ttm": -1.2201,
    "shares_outstanding": 9830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0174,
    "operating_cash_flow_ttm": -3250000.0,
    "levered_cash_flow_ttm": -2900000.0,
    "book_value_per_share_mrq": 1.24,
    "next_earnings_announcement_date": [
      "2015-12-21",
      "2015-12-28"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "The Joint Corp."
  },
  "KANG": {
    "p_e_ratio": 28.21,
    "peg_ratio": 0.4,
    "earnings_per_share": 0.51,
    "ebitda": 72030000.0,
    "eps_estimate_current_year": 0.8,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 15.81,
    "fifty_two_week_high": 22.67,
    "fifty_two_week_low": 10.2,
    "percent_change_from_200_day_moving_average": -0.1643,
    "percent_change_from_50_day_moving_average": -0.08460000000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.51,
    "two_hundred_day_moving_average": 17.31,
    "volume": 451018.0,
    "market_cap": 934040000.0,
    "price_to_sales_ttm": 2.97,
    "price_to_book_mrq": 2.92,
    "roa_ttm": 0.0643,
    "roe_ttm": 0.109,
    "shares_outstanding": 64550000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.0,
    "next_earnings_announcement_date": [
      "2015-11-23",
      "2015-11-27"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "iKang Healthcare Group, Inc."
  },
  "KBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -8.11,
    "ebitda": -30190000.0,
    "eps_estimate_current_year": -6.49,
    "eps_estimate_next_quarter": -1.46,
    "fifty_day_moving_average": 2.5,
    "fifty_two_week_high": 17.2,
    "fifty_two_week_low": 1.71,
    "percent_change_from_200_day_moving_average": -0.2376,
    "percent_change_from_50_day_moving_average": 0.09539999999999998,
    "shares_owned": "N/A",
    "short_ratio": 0.34,
    "two_hundred_day_moving_average": 3.59,
    "volume": 278500.0,
    "market_cap": 11300000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.04,
    "roa_ttm": -0.4409,
    "roe_ttm": -1.29,
    "shares_outstanding": 4120000.0,
    "pcnt_held_by_insiders": 0.1894,
    "pcnt_held_by_institutions": 0.637,
    "pcnt_short_of_float": 0.006500000000000001,
    "operating_cash_flow_ttm": -30110000.0,
    "levered_cash_flow_ttm": -17430000.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "KaloBios Pharmaceuticals, Inc."
  },
  "KERX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -1.34,
    "ebitda": -126330000.0,
    "eps_estimate_current_year": -1.0,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 5.61,
    "fifty_two_week_high": 17.97,
    "fifty_two_week_low": 3.77,
    "percent_change_from_200_day_moving_average": -0.5859000000000001,
    "percent_change_from_50_day_moving_average": -0.3017,
    "shares_owned": "N/A",
    "short_ratio": 20.21,
    "two_hundred_day_moving_average": 9.47,
    "volume": 1332379.0,
    "market_cap": 412270000.0,
    "price_to_sales_ttm": 91.1,
    "price_to_book_mrq": 2.79,
    "roa_ttm": -0.4953,
    "roe_ttm": -0.9592,
    "shares_outstanding": 105170000.0,
    "pcnt_held_by_insiders": 0.1707,
    "pcnt_held_by_institutions": 0.679,
    "pcnt_short_of_float": 0.4107,
    "operating_cash_flow_ttm": -127430000.0,
    "levered_cash_flow_ttm": -79490000.0,
    "book_value_per_share_mrq": 1.4,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Keryx Biopharmaceuticals Inc."
  },
  "KIN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.24,
    "earnings_per_share": -1.34,
    "ebitda": -26470000.0,
    "eps_estimate_current_year": -1.68,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 5.94,
    "fifty_two_week_high": 10.18,
    "fifty_two_week_low": 4.18,
    "percent_change_from_200_day_moving_average": -0.1072,
    "percent_change_from_50_day_moving_average": 0.008,
    "shares_owned": "N/A",
    "short_ratio": 4.18,
    "two_hundred_day_moving_average": 6.71,
    "volume": 5900.0,
    "market_cap": 118560000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.36,
    "roa_ttm": -0.1632,
    "roe_ttm": -0.2682,
    "shares_outstanding": 19790000.0,
    "pcnt_held_by_insiders": 0.1117,
    "pcnt_held_by_institutions": 0.379,
    "pcnt_short_of_float": 0.0177,
    "operating_cash_flow_ttm": -22430000.0,
    "levered_cash_flow_ttm": -13110000.0,
    "book_value_per_share_mrq": 4.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Kindred Biosciences, Inc."
  },
  "KITE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.42,
    "ebitda": -58210000.0,
    "eps_estimate_current_year": -2.05,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 59.85,
    "fifty_two_week_high": 89.21,
    "fifty_two_week_low": 25.9,
    "percent_change_from_200_day_moving_average": 0.015,
    "percent_change_from_50_day_moving_average": 0.0291,
    "shares_owned": "N/A",
    "short_ratio": 5.47,
    "two_hundred_day_moving_average": 60.68,
    "volume": 392363.0,
    "market_cap": 2690000000.0,
    "price_to_sales_ttm": 368.29,
    "price_to_book_mrq": 7.1,
    "roa_ttm": -0.1116,
    "roe_ttm": -0.20190000000000002,
    "shares_outstanding": 43730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.25129999999999997,
    "operating_cash_flow_ttm": 13880000.0,
    "levered_cash_flow_ttm": 7520000.0,
    "book_value_per_share_mrq": 8.63,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Kite Pharma, Inc."
  },
  "KMDA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.43,
    "earnings_per_share": -0.26,
    "ebitda": -3040000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 3.58,
    "fifty_two_week_high": 5.15,
    "fifty_two_week_low": 3.02,
    "percent_change_from_200_day_moving_average": -0.1534,
    "percent_change_from_50_day_moving_average": -0.0331,
    "shares_owned": "N/A",
    "short_ratio": 0.74,
    "two_hundred_day_moving_average": 4.09,
    "volume": 2300.0,
    "market_cap": 135050000.0,
    "price_to_sales_ttm": 1.94,
    "price_to_book_mrq": 1.82,
    "roa_ttm": -0.0315,
    "roe_ttm": -0.1201,
    "shares_outstanding": 39030000.0,
    "pcnt_held_by_insiders": 0.1582,
    "pcnt_held_by_institutions": 0.084,
    "pcnt_short_of_float": 0.0005,
    "operating_cash_flow_ttm": -12310000.0,
    "levered_cash_flow_ttm": -10720000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Kamada Ltd."
  },
  "KMPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.33,
    "ebitda": -20800000.0,
    "eps_estimate_current_year": -3.33,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 19.95,
    "fifty_two_week_high": 26.15,
    "fifty_two_week_low": 10.9,
    "percent_change_from_200_day_moving_average": 0.355,
    "percent_change_from_50_day_moving_average": 0.11789999999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.17,
    "two_hundred_day_moving_average": 16.46,
    "volume": 58446.0,
    "market_cap": 317290000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 92.14,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 14230000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.010700000000000001,
    "operating_cash_flow_ttm": -20110000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "KemPharm, Inc."
  },
  "KND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.01,
    "earnings_per_share": -2.41,
    "ebitda": 444150000.0,
    "eps_estimate_current_year": 1.37,
    "eps_estimate_next_quarter": 0.39,
    "fifty_day_moving_average": 20.64,
    "fifty_two_week_high": 24.66,
    "fifty_two_week_low": 16.94,
    "percent_change_from_200_day_moving_average": -0.1422,
    "percent_change_from_50_day_moving_average": -0.0904,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 21.88,
    "volume": 375789.0,
    "market_cap": 1570000000.0,
    "price_to_sales_ttm": 0.26,
    "price_to_book_mrq": 1.07,
    "roa_ttm": 0.034,
    "roe_ttm": -0.0664,
    "shares_outstanding": 83880000.0,
    "pcnt_held_by_insiders": 0.0305,
    "pcnt_held_by_institutions": 0.8079999999999999,
    "pcnt_short_of_float": 0.0528,
    "operating_cash_flow_ttm": 131960000.00000001,
    "levered_cash_flow_ttm": 222620000.0,
    "book_value_per_share_mrq": 17.67,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Kindred Healthcare Inc."
  },
  "KOOL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.37,
    "ebitda": -13350000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 0.65,
    "fifty_two_week_high": 1.31,
    "fifty_two_week_low": 0.58,
    "percent_change_from_200_day_moving_average": -0.1772,
    "percent_change_from_50_day_moving_average": 0.0013,
    "shares_owned": "N/A",
    "short_ratio": 4.42,
    "two_hundred_day_moving_average": 0.79,
    "volume": 87012.0,
    "market_cap": 26400000.0,
    "price_to_sales_ttm": 1.67,
    "price_to_book_mrq": 0.77,
    "roa_ttm": -0.1617,
    "roe_ttm": -0.3553,
    "shares_outstanding": 40620000.0,
    "pcnt_held_by_insiders": 0.2369,
    "pcnt_held_by_institutions": 0.075,
    "pcnt_short_of_float": 0.0048,
    "operating_cash_flow_ttm": -10650000.0,
    "levered_cash_flow_ttm": -4990000.0,
    "book_value_per_share_mrq": 0.86,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cesca Therapeutics Inc."
  },
  "KPTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.33,
    "earnings_per_share": -3.06,
    "ebitda": -104320000.0,
    "eps_estimate_current_year": -3.45,
    "eps_estimate_next_quarter": -0.9,
    "fifty_day_moving_average": 14.84,
    "fifty_two_week_high": 49.01,
    "fifty_two_week_low": 11.58,
    "percent_change_from_200_day_moving_average": -0.4485,
    "percent_change_from_50_day_moving_average": -0.08539999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.81,
    "two_hundred_day_moving_average": 24.6,
    "volume": 161450.0,
    "market_cap": 484600000.0,
    "price_to_sales_ttm": 2639.93,
    "price_to_book_mrq": 1.98,
    "roa_ttm": -0.32689999999999997,
    "roe_ttm": -0.551,
    "shares_outstanding": 35710000.0,
    "pcnt_held_by_insiders": 0.2562,
    "pcnt_held_by_institutions": 0.195,
    "pcnt_short_of_float": 0.4556,
    "operating_cash_flow_ttm": -77320000.0,
    "levered_cash_flow_ttm": -45060000.0,
    "book_value_per_share_mrq": 6.93,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Karyopharm Therapeutics, Inc."
  },
  "KTWO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.2,
    "earnings_per_share": -1.25,
    "ebitda": -14150000.0,
    "eps_estimate_current_year": -0.88,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 21.38,
    "fifty_two_week_high": 26.29,
    "fifty_two_week_low": 12.31,
    "percent_change_from_200_day_moving_average": -0.087,
    "percent_change_from_50_day_moving_average": -0.0248,
    "shares_owned": "N/A",
    "short_ratio": 4.2,
    "two_hundred_day_moving_average": 22.84,
    "volume": 157508.0,
    "market_cap": 861890000.0,
    "price_to_sales_ttm": 4.33,
    "price_to_book_mrq": 3.05,
    "roa_ttm": -0.0767,
    "roe_ttm": -0.17170000000000002,
    "shares_outstanding": 41340000.0,
    "pcnt_held_by_insiders": 0.0092,
    "pcnt_held_by_institutions": 0.10400000000000001,
    "pcnt_short_of_float": 0.048799999999999996,
    "operating_cash_flow_ttm": -23340000.0,
    "levered_cash_flow_ttm": -12640000.0,
    "book_value_per_share_mrq": 6.93,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "K2M Group Holdings, Inc."
  },
  "KYTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.83,
    "earnings_per_share": -4.77,
    "ebitda": -107530000.0,
    "eps_estimate_current_year": -4.3,
    "eps_estimate_next_quarter": -0.76,
    "fifty_day_moving_average": 74.72,
    "fifty_two_week_high": 76.31,
    "fifty_two_week_low": 29.86,
    "percent_change_from_200_day_moving_average": 0.20989999999999998,
    "percent_change_from_50_day_moving_average": 0.0026,
    "shares_owned": "N/A",
    "short_ratio": 3.07,
    "two_hundred_day_moving_average": 61.92,
    "volume": 1039339.0,
    "market_cap": 1970000000.0,
    "price_to_sales_ttm": 6830.09,
    "price_to_book_mrq": 13.42,
    "roa_ttm": -0.4045,
    "roe_ttm": -0.9159999999999999,
    "shares_outstanding": 26300000.0,
    "pcnt_held_by_insiders": 0.3552,
    "pcnt_held_by_institutions": 0.8170000000000001,
    "pcnt_short_of_float": 0.0682,
    "operating_cash_flow_ttm": -77300000.0,
    "levered_cash_flow_ttm": -42620000.0,
    "book_value_per_share_mrq": 5.58,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Kythera Biopharmaceuticals, Inc."
  },
  "LAKE": {
    "p_e_ratio": 8.63,
    "peg_ratio": 1.04,
    "earnings_per_share": 1.73,
    "ebitda": 13650000.0,
    "eps_estimate_current_year": 1.29,
    "eps_estimate_next_quarter": 0.23,
    "fifty_day_moving_average": 10.12,
    "fifty_two_week_high": 29.55,
    "fifty_two_week_low": 6.85,
    "percent_change_from_200_day_moving_average": 0.4633,
    "percent_change_from_50_day_moving_average": 0.474,
    "shares_owned": "N/A",
    "short_ratio": 10.86,
    "two_hundred_day_moving_average": 10.2,
    "volume": 257656.0,
    "market_cap": 107930000.0,
    "price_to_sales_ttm": 0.92,
    "price_to_book_mrq": 1.49,
    "roa_ttm": 0.0862,
    "roe_ttm": 0.231,
    "shares_outstanding": 7230000.0,
    "pcnt_held_by_insiders": 0.1991,
    "pcnt_held_by_institutions": 0.304,
    "pcnt_short_of_float": 0.0664,
    "operating_cash_flow_ttm": -390090.0,
    "levered_cash_flow_ttm": 8240000.0,
    "book_value_per_share_mrq": 9.34,
    "next_earnings_announcement_date": [
      "2015-12-08",
      "2015-12-14"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Lakeland Industries Inc."
  },
  "LBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -18910000.0,
    "eps_estimate_current_year": -0.6,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 7.17,
    "fifty_two_week_high": 15.03,
    "fifty_two_week_low": 4.97,
    "percent_change_from_200_day_moving_average": -0.29510000000000003,
    "percent_change_from_50_day_moving_average": -0.0236,
    "shares_owned": "N/A",
    "short_ratio": 12.47,
    "two_hundred_day_moving_average": 9.93,
    "volume": 187640.0,
    "market_cap": 330340000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.98,
    "roa_ttm": -0.182,
    "roe_ttm": -0.2968,
    "shares_outstanding": 47190000.0,
    "pcnt_held_by_insiders": 0.728,
    "pcnt_held_by_institutions": 0.134,
    "pcnt_short_of_float": 0.162,
    "operating_cash_flow_ttm": -13000000.0,
    "levered_cash_flow_ttm": -8320000.0,
    "book_value_per_share_mrq": 2.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lion Biotechnologies, Inc."
  },
  "LBMH": {
    "p_e_ratio": 17.57,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.15,
    "ebitda": 13720000.0,
    "eps_estimate_current_year": 0.21,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.44,
    "fifty_two_week_high": 3.9,
    "fifty_two_week_low": 1.96,
    "percent_change_from_200_day_moving_average": -0.0584,
    "percent_change_from_50_day_moving_average": 0.0637,
    "shares_owned": "N/A",
    "short_ratio": 3.17,
    "two_hundred_day_moving_average": 2.76,
    "volume": 33213.0,
    "market_cap": 138980000.0,
    "price_to_sales_ttm": 1.72,
    "price_to_book_mrq": 4.09,
    "roa_ttm": 0.1512,
    "roe_ttm": 0.2402,
    "shares_outstanding": 53460000.0,
    "pcnt_held_by_insiders": 0.5114,
    "pcnt_held_by_institutions": 0.196,
    "pcnt_short_of_float": 0.0132,
    "operating_cash_flow_ttm": 5050000.0,
    "levered_cash_flow_ttm": 19060000.0,
    "book_value_per_share_mrq": 0.63,
    "next_earnings_announcement_date": [
      "2015-12-14",
      "2015-12-18"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Liberator Medical Holdings, Inc."
  },
  "LCI": {
    "p_e_ratio": 13.11,
    "peg_ratio": 0.8,
    "earnings_per_share": 4.04,
    "ebitda": 236070000.0,
    "eps_estimate_current_year": 4.12,
    "eps_estimate_next_quarter": 1.01,
    "fifty_day_moving_average": 53.42,
    "fifty_two_week_high": 72.44,
    "fifty_two_week_low": 39.05,
    "percent_change_from_200_day_moving_average": -0.1014,
    "percent_change_from_50_day_moving_average": -0.0083,
    "shares_owned": "N/A",
    "short_ratio": 9.78,
    "two_hundred_day_moving_average": 58.96,
    "volume": 841912.0,
    "market_cap": 1930000000.0,
    "price_to_sales_ttm": 4.76,
    "price_to_book_mrq": 4.16,
    "roa_ttm": 0.3383,
    "roe_ttm": 0.39549999999999996,
    "shares_outstanding": 36480000.0,
    "pcnt_held_by_insiders": 0.2785,
    "pcnt_held_by_institutions": 0.494,
    "pcnt_short_of_float": 0.3614,
    "operating_cash_flow_ttm": 128520000.00000001,
    "levered_cash_flow_ttm": 83580000.0,
    "book_value_per_share_mrq": 12.78,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Lannett Company, Inc."
  },
  "LDRH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.78,
    "earnings_per_share": -0.54,
    "ebitda": -10670000.0,
    "eps_estimate_current_year": -0.69,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 39.9,
    "fifty_two_week_high": 47.12,
    "fifty_two_week_low": 29.91,
    "percent_change_from_200_day_moving_average": -0.0371,
    "percent_change_from_50_day_moving_average": -0.0319,
    "shares_owned": "N/A",
    "short_ratio": 4.14,
    "two_hundred_day_moving_average": 40.12,
    "volume": 199955.0,
    "market_cap": 1110000000.0,
    "price_to_sales_ttm": 6.69,
    "price_to_book_mrq": 10.02,
    "roa_ttm": -0.0637,
    "roe_ttm": -0.1318,
    "shares_outstanding": 28690000.0,
    "pcnt_held_by_insiders": 0.0922,
    "pcnt_held_by_institutions": 0.423,
    "pcnt_short_of_float": 0.06280000000000001,
    "operating_cash_flow_ttm": -14920000.0,
    "levered_cash_flow_ttm": -17350000.0,
    "book_value_per_share_mrq": 3.88,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "LDR Holding Corporation"
  },
  "LENS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.46,
    "ebitda": -17870000.0,
    "eps_estimate_current_year": -1.62,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 6.83,
    "fifty_two_week_high": 9.38,
    "fifty_two_week_low": 5.52,
    "percent_change_from_200_day_moving_average": -0.2097,
    "percent_change_from_50_day_moving_average": -0.1213,
    "shares_owned": "N/A",
    "short_ratio": 33.45,
    "two_hundred_day_moving_average": 7.59,
    "volume": 9302.0,
    "market_cap": 80130000.0,
    "price_to_sales_ttm": 426.09,
    "price_to_book_mrq": 2.74,
    "roa_ttm": -0.6774,
    "roe_ttm": -2.8744,
    "shares_outstanding": 13360000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0559,
    "operating_cash_flow_ttm": -11980000.0,
    "levered_cash_flow_ttm": -10880000.0,
    "book_value_per_share_mrq": 2.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Presbia PLC"
  },
  "LGND": {
    "p_e_ratio": 63.31,
    "peg_ratio": 0.62,
    "earnings_per_share": 1.55,
    "ebitda": 24680000.0,
    "eps_estimate_current_year": 3.52,
    "eps_estimate_next_quarter": 0.95,
    "fifty_day_moving_average": 94.73,
    "fifty_two_week_high": 112.4,
    "fifty_two_week_low": 41.99,
    "percent_change_from_200_day_moving_average": 0.0882,
    "percent_change_from_50_day_moving_average": 0.0365,
    "shares_owned": "N/A",
    "short_ratio": 9.22,
    "two_hundred_day_moving_average": 90.23,
    "volume": 180712.0,
    "market_cap": 1950000000.0,
    "price_to_sales_ttm": 27.05,
    "price_to_book_mrq": 27.78,
    "roa_ttm": 0.0682,
    "roe_ttm": 0.4457,
    "shares_outstanding": 19850000.0,
    "pcnt_held_by_insiders": 0.0062,
    "pcnt_held_by_institutions": 0.941,
    "pcnt_short_of_float": 0.25329999999999997,
    "operating_cash_flow_ttm": 31610000.0,
    "levered_cash_flow_ttm": 19930000.0,
    "book_value_per_share_mrq": 3.48,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ligand Pharmaceuticals Incorporated"
  },
  "LHCG": {
    "p_e_ratio": 31.57,
    "peg_ratio": 1.79,
    "earnings_per_share": 1.57,
    "ebitda": 71840000.0,
    "eps_estimate_current_year": 1.8,
    "eps_estimate_next_quarter": 0.47,
    "fifty_day_moving_average": 46.27,
    "fifty_two_week_high": 51.83,
    "fifty_two_week_low": 22.37,
    "percent_change_from_200_day_moving_average": 0.2895,
    "percent_change_from_50_day_moving_average": 0.0717,
    "shares_owned": "N/A",
    "short_ratio": 2.46,
    "two_hundred_day_moving_average": 38.46,
    "volume": 159304.0,
    "market_cap": 890620000.0,
    "price_to_sales_ttm": 1.15,
    "price_to_book_mrq": 2.51,
    "roa_ttm": 0.0756,
    "roe_ttm": 0.1074,
    "shares_outstanding": 17960000.0,
    "pcnt_held_by_insiders": 0.1724,
    "pcnt_held_by_institutions": 0.805,
    "pcnt_short_of_float": 0.0329,
    "operating_cash_flow_ttm": 62810000.0,
    "levered_cash_flow_ttm": 44750000.0,
    "book_value_per_share_mrq": 19.29,
    "next_earnings_announcement_date": "2015-11-04",
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "LHC Group, Inc."
  },
  "LIFE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.49,
    "ebitda": -31250000.0,
    "eps_estimate_current_year": 4.19,
    "eps_estimate_next_quarter": -0.56,
    "fifty_day_moving_average": 16.28,
    "fifty_two_week_high": 28.29,
    "fifty_two_week_low": 12.05,
    "percent_change_from_200_day_moving_average": -0.187,
    "percent_change_from_50_day_moving_average": -0.0582,
    "shares_owned": "N/A",
    "short_ratio": 13.9,
    "two_hundred_day_moving_average": 18.86,
    "volume": 104190.0,
    "market_cap": 362390000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.64,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23640000.0,
    "pcnt_held_by_insiders": 0.005600000000000001,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.062400000000000004,
    "operating_cash_flow_ttm": -29070000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "aTyr Pharma Inc."
  },
  "LJPC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.12,
    "earnings_per_share": -2.12,
    "ebitda": -31190000.0,
    "eps_estimate_current_year": -2.64,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 32.53,
    "fifty_two_week_high": 44.99,
    "fifty_two_week_low": 7.2,
    "percent_change_from_200_day_moving_average": 0.42710000000000004,
    "percent_change_from_50_day_moving_average": 0.1134,
    "shares_owned": "N/A",
    "short_ratio": 6.84,
    "two_hundred_day_moving_average": 25.38,
    "volume": 320701.0,
    "market_cap": 658600000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 18.14,
    "roa_ttm": -0.9122,
    "roe_ttm": -1.604,
    "shares_outstanding": 18180000.0,
    "pcnt_held_by_insiders": 0.35090000000000005,
    "pcnt_held_by_institutions": 0.172,
    "pcnt_short_of_float": 0.1278,
    "operating_cash_flow_ttm": -19440000.0,
    "levered_cash_flow_ttm": -8930000.0,
    "book_value_per_share_mrq": 1.94,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "La Jolla Pharmaceutical Co."
  },
  "LMAT": {
    "p_e_ratio": 42.67,
    "peg_ratio": 2.94,
    "earnings_per_share": 0.33,
    "ebitda": 13090000.0,
    "eps_estimate_current_year": 0.33,
    "eps_estimate_next_quarter": 0.08,
    "fifty_day_moving_average": 13.49,
    "fifty_two_week_high": 14.82,
    "fifty_two_week_low": 6.48,
    "percent_change_from_200_day_moving_average": 0.2781,
    "percent_change_from_50_day_moving_average": 0.031400000000000004,
    "shares_owned": "N/A",
    "short_ratio": 3.1,
    "two_hundred_day_moving_average": 10.88,
    "volume": 81875.0,
    "market_cap": 246470000.0,
    "price_to_sales_ttm": 3.27,
    "price_to_book_mrq": 3.44,
    "roa_ttm": 0.0741,
    "roe_ttm": 0.0866,
    "shares_outstanding": 17720000.0,
    "pcnt_held_by_insiders": 0.3141,
    "pcnt_held_by_institutions": 0.363,
    "pcnt_short_of_float": 0.038599999999999995,
    "operating_cash_flow_ttm": 8880000.0,
    "levered_cash_flow_ttm": 8230000.0,
    "book_value_per_share_mrq": 3.99,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "LeMaitre Vascular, Inc."
  },
  "LMNS": {
    "p_e_ratio": 28.48,
    "peg_ratio": 0.9,
    "earnings_per_share": 0.48,
    "ebitda": 29420000.0,
    "eps_estimate_current_year": 0.62,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 13.88,
    "fifty_two_week_high": 13.97,
    "fifty_two_week_low": 8.45,
    "percent_change_from_200_day_moving_average": 0.07919999999999999,
    "percent_change_from_50_day_moving_average": -0.0127,
    "shares_owned": "N/A",
    "short_ratio": 0.45,
    "two_hundred_day_moving_average": 12.7,
    "volume": 295699.0,
    "market_cap": 493760000.0,
    "price_to_sales_ttm": 1.69,
    "price_to_book_mrq": 4.8,
    "roa_ttm": 0.0504,
    "roe_ttm": 0.1893,
    "shares_outstanding": 36040000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.004699999999999999,
    "operating_cash_flow_ttm": 9800000.0,
    "levered_cash_flow_ttm": 6400000.0,
    "book_value_per_share_mrq": 2.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Lumenis Ltd."
  },
  "LMNX": {
    "p_e_ratio": 19.53,
    "peg_ratio": 1.99,
    "earnings_per_share": 0.91,
    "ebitda": 49570000.0,
    "eps_estimate_current_year": 0.5,
    "eps_estimate_next_quarter": 0.16,
    "fifty_day_moving_average": 18.76,
    "fifty_two_week_high": 21.69,
    "fifty_two_week_low": 15.05,
    "percent_change_from_200_day_moving_average": 0.0291,
    "percent_change_from_50_day_moving_average": -0.0541,
    "shares_owned": "N/A",
    "short_ratio": 14.44,
    "two_hundred_day_moving_average": 17.25,
    "volume": 129228.0,
    "market_cap": 764090000.0,
    "price_to_sales_ttm": 3.32,
    "price_to_book_mrq": 2.26,
    "roa_ttm": 0.0667,
    "roe_ttm": 0.1243,
    "shares_outstanding": 43050000.0,
    "pcnt_held_by_insiders": 0.1343,
    "pcnt_held_by_institutions": 0.6809999999999999,
    "pcnt_short_of_float": 0.1408,
    "operating_cash_flow_ttm": 59080000.0,
    "levered_cash_flow_ttm": 25230000.0,
    "book_value_per_share_mrq": 7.89,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Luminex Corporation"
  },
  "LNTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.41,
    "earnings_per_share": -1.35,
    "ebitda": 58710000.0,
    "eps_estimate_current_year": 0.29,
    "eps_estimate_next_quarter": 0.03,
    "fifty_day_moving_average": 6.81,
    "fifty_two_week_high": 8.58,
    "fifty_two_week_low": 5.38,
    "percent_change_from_200_day_moving_average": -0.12789999999999999,
    "percent_change_from_50_day_moving_average": -0.1217,
    "shares_owned": "N/A",
    "short_ratio": 0.4,
    "two_hundred_day_moving_average": 6.86,
    "volume": 51978.0,
    "market_cap": 184550000.0,
    "price_to_sales_ttm": 0.59,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0964,
    "roe_ttm": "N/A",
    "shares_outstanding": 30860000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0045000000000000005,
    "operating_cash_flow_ttm": 20360000.0,
    "levered_cash_flow_ttm": 15190000.0,
    "book_value_per_share_mrq": -6.45,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Lantheus Holdings, Inc."
  },
  "LOXO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.88,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.93,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 20.62,
    "fifty_two_week_high": 23.37,
    "fifty_two_week_low": 9.9,
    "percent_change_from_200_day_moving_average": 0.2989,
    "percent_change_from_50_day_moving_average": 0.0149,
    "shares_owned": "N/A",
    "short_ratio": 7.69,
    "two_hundred_day_moving_average": 16.11,
    "volume": 80717.0,
    "market_cap": 349270000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.36,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 16690000.000000002,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0701,
    "operating_cash_flow_ttm": -22480000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Loxo Oncology, Inc."
  },
  "LPCN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.12,
    "ebitda": -15320000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 15.45,
    "fifty_two_week_high": 19.23,
    "fifty_two_week_low": 3.7,
    "percent_change_from_200_day_moving_average": 0.5600999999999999,
    "percent_change_from_50_day_moving_average": 0.0016,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 9.92,
    "volume": 132135.0,
    "market_cap": 282250000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.2,
    "roa_ttm": -0.2147,
    "roe_ttm": -0.3569,
    "shares_outstanding": 18240000.0,
    "pcnt_held_by_insiders": 0.4877,
    "pcnt_held_by_institutions": 0.003,
    "pcnt_short_of_float": 0.0441,
    "operating_cash_flow_ttm": -13330000.0,
    "levered_cash_flow_ttm": -7590000.0,
    "book_value_per_share_mrq": 2.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Lipocine Inc."
  },
  "LPNT": {
    "p_e_ratio": 26.88,
    "peg_ratio": 2.45,
    "earnings_per_share": 2.91,
    "ebitda": 627500000.0,
    "eps_estimate_current_year": 3.96,
    "eps_estimate_next_quarter": 1.08,
    "fifty_day_moving_average": 79.63,
    "fifty_two_week_high": 88.18,
    "fifty_two_week_low": 62.95,
    "percent_change_from_200_day_moving_average": 0.0024,
    "percent_change_from_50_day_moving_average": -0.0167,
    "shares_owned": "N/A",
    "short_ratio": 3.01,
    "two_hundred_day_moving_average": 78.12,
    "volume": 298944.0,
    "market_cap": 3480000000.0,
    "price_to_sales_ttm": 0.69,
    "price_to_book_mrq": 1.53,
    "roa_ttm": 0.0401,
    "roe_ttm": 0.0639,
    "shares_outstanding": 44410000.0,
    "pcnt_held_by_insiders": 0.023,
    "pcnt_held_by_institutions": 0.99,
    "pcnt_short_of_float": 0.0339,
    "operating_cash_flow_ttm": 603700000.0,
    "levered_cash_flow_ttm": 320940000.0,
    "book_value_per_share_mrq": 50.43,
    "next_earnings_announcement_date": [
      "2015-10-22",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "LifePoint Health, Inc."
  },
  "LPTN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.785,
    "ebitda": -16410000.0,
    "eps_estimate_current_year": 2.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.233,
    "fifty_two_week_high": 3.8,
    "fifty_two_week_low": 0.18,
    "percent_change_from_200_day_moving_average": -0.7905,
    "percent_change_from_50_day_moving_average": -0.032549999999999996,
    "shares_owned": "N/A",
    "short_ratio": 3.3,
    "two_hundred_day_moving_average": 1.074,
    "volume": 378514.0,
    "market_cap": 6620000.0,
    "price_to_sales_ttm": 1.85,
    "price_to_book_mrq": 0.45,
    "roa_ttm": -0.6156,
    "roe_ttm": -1.157,
    "shares_outstanding": 29400000.0,
    "pcnt_held_by_insiders": 0.2682,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.11720000000000001,
    "operating_cash_flow_ttm": -15520000.0,
    "levered_cash_flow_ttm": -9690000.0,
    "book_value_per_share_mrq": 0.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lpath Inc."
  },
  "LXRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.12,
    "earnings_per_share": -1.09,
    "ebitda": -75390000.0,
    "eps_estimate_current_year": -1.29,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 12.2,
    "fifty_two_week_high": 15.79,
    "fifty_two_week_low": 5.6,
    "percent_change_from_200_day_moving_average": 0.38079999999999997,
    "percent_change_from_50_day_moving_average": 0.0013,
    "shares_owned": "N/A",
    "short_ratio": 2.71,
    "two_hundred_day_moving_average": 8.85,
    "volume": 709555.0,
    "market_cap": 1270000000.0,
    "price_to_sales_ttm": 54.03,
    "price_to_book_mrq": 5.62,
    "roa_ttm": -0.14980000000000002,
    "roe_ttm": -0.5721,
    "shares_outstanding": 103610000.0,
    "pcnt_held_by_insiders": 0.005600000000000001,
    "pcnt_held_by_institutions": 0.856,
    "pcnt_short_of_float": 0.294,
    "operating_cash_flow_ttm": -81310000.0,
    "levered_cash_flow_ttm": -62520000.0,
    "book_value_per_share_mrq": 2.23,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lexicon Pharmaceuticals, Inc."
  },
  "MACK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.56,
    "earnings_per_share": -0.89,
    "ebitda": -74360000.0,
    "eps_estimate_current_year": -1.12,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 10.19,
    "fifty_two_week_high": 13.84,
    "fifty_two_week_low": 7.05,
    "percent_change_from_200_day_moving_average": -0.13449999999999998,
    "percent_change_from_50_day_moving_average": -0.0336,
    "shares_owned": "N/A",
    "short_ratio": 12.0,
    "two_hundred_day_moving_average": 11.38,
    "volume": 847724.0,
    "market_cap": 1100000000.0,
    "price_to_sales_ttm": 9.7,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.4121,
    "roe_ttm": "N/A",
    "shares_outstanding": 111420000.0,
    "pcnt_held_by_insiders": 0.1217,
    "pcnt_held_by_institutions": 0.536,
    "pcnt_short_of_float": 0.226,
    "operating_cash_flow_ttm": -30250000.0,
    "levered_cash_flow_ttm": -17780000.0,
    "book_value_per_share_mrq": -1.29,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Merrimack Pharmaceuticals, Inc."
  },
  "MASI": {
    "p_e_ratio": 30.21,
    "peg_ratio": 1.78,
    "earnings_per_share": 1.41,
    "ebitda": 122010000.0,
    "eps_estimate_current_year": 1.43,
    "eps_estimate_next_quarter": 0.38,
    "fifty_day_moving_average": 41.68,
    "fifty_two_week_high": 46.0,
    "fifty_two_week_low": 20.48,
    "percent_change_from_200_day_moving_average": 0.1387,
    "percent_change_from_50_day_moving_average": 0.0229,
    "shares_owned": "N/A",
    "short_ratio": 3.75,
    "two_hundred_day_moving_average": 37.44,
    "volume": 203162.0,
    "market_cap": 2170000000.0,
    "price_to_sales_ttm": 3.57,
    "price_to_book_mrq": 7.67,
    "roa_ttm": 0.1245,
    "roe_ttm": 0.25329999999999997,
    "shares_outstanding": 50990000.0,
    "pcnt_held_by_insiders": 0.0944,
    "pcnt_held_by_institutions": 0.878,
    "pcnt_short_of_float": 0.04019999999999999,
    "operating_cash_flow_ttm": 84910000.0,
    "levered_cash_flow_ttm": 53620000.0,
    "book_value_per_share_mrq": 5.56,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Masimo Corporation"
  },
  "MCRB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.61,
    "ebitda": -30960000.0,
    "eps_estimate_current_year": -1.69,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 42.2,
    "fifty_two_week_high": 52.0,
    "fifty_two_week_low": 28.11,
    "percent_change_from_200_day_moving_average": -0.0447,
    "percent_change_from_50_day_moving_average": -0.06,
    "shares_owned": "N/A",
    "short_ratio": 11.48,
    "two_hundred_day_moving_average": 41.52,
    "volume": 319040.0,
    "market_cap": 1550000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 12.37,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 38960000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1117,
    "operating_cash_flow_ttm": -24850000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Seres Therapeutics, Inc."
  },
  "MCUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -1.8,
    "ebitda": -26140000.0,
    "eps_estimate_current_year": -1.38,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 6.75,
    "fifty_two_week_high": 16.1,
    "fifty_two_week_low": 2.6,
    "percent_change_from_200_day_moving_average": -0.6368,
    "percent_change_from_50_day_moving_average": -0.44920000000000004,
    "shares_owned": "N/A",
    "short_ratio": 0.16,
    "two_hundred_day_moving_average": 10.24,
    "volume": 32506.0,
    "market_cap": 62160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.91,
    "roa_ttm": -0.6509999999999999,
    "roe_ttm": -1.3743,
    "shares_outstanding": 16710000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.011699999999999999,
    "operating_cash_flow_ttm": -22050000.0,
    "levered_cash_flow_ttm": -14810000.0,
    "book_value_per_share_mrq": 2.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Macrocure Ltd."
  },
  "MD": {
    "p_e_ratio": 24.96,
    "peg_ratio": 1.72,
    "earnings_per_share": 3.38,
    "ebitda": 589430000.0,
    "eps_estimate_current_year": 3.65,
    "eps_estimate_next_quarter": 1.03,
    "fifty_day_moving_average": 82.37,
    "fifty_two_week_high": 86.09,
    "fifty_two_week_low": 49.82,
    "percent_change_from_200_day_moving_average": 0.11599999999999999,
    "percent_change_from_50_day_moving_average": 0.0258,
    "shares_owned": "N/A",
    "short_ratio": 5.86,
    "two_hundred_day_moving_average": 75.71,
    "volume": 586338.0,
    "market_cap": 7930000000.0,
    "price_to_sales_ttm": 2.99,
    "price_to_book_mrq": 3.5,
    "roa_ttm": 0.0898,
    "roe_ttm": 0.14150000000000001,
    "shares_outstanding": 93860000.0,
    "pcnt_held_by_insiders": 0.0199,
    "pcnt_held_by_institutions": 1.022,
    "pcnt_short_of_float": 0.0452,
    "operating_cash_flow_ttm": 430670000.0,
    "levered_cash_flow_ttm": 353260000.0,
    "book_value_per_share_mrq": 24.0,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "MEDNAX, Inc."
  },
  "MDCO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.16,
    "earnings_per_share": -0.98,
    "ebitda": -100810000.0,
    "eps_estimate_current_year": -2.62,
    "eps_estimate_next_quarter": -1.03,
    "fifty_day_moving_average": 35.89,
    "fifty_two_week_high": 43.79,
    "fifty_two_week_low": 19.92,
    "percent_change_from_200_day_moving_average": 0.366,
    "percent_change_from_50_day_moving_average": 0.1743,
    "shares_owned": "N/A",
    "short_ratio": 6.25,
    "two_hundred_day_moving_average": 30.86,
    "volume": 1556596.0,
    "market_cap": 2850000000.0,
    "price_to_sales_ttm": 4.71,
    "price_to_book_mrq": 2.81,
    "roa_ttm": -0.0425,
    "roe_ttm": -0.0677,
    "shares_outstanding": 67710000.0,
    "pcnt_held_by_insiders": 0.17149999999999999,
    "pcnt_held_by_institutions": 0.865,
    "pcnt_short_of_float": 0.25730000000000003,
    "operating_cash_flow_ttm": -59240000.0,
    "levered_cash_flow_ttm": -64550000.0,
    "book_value_per_share_mrq": 14.75,
    "next_earnings_announcement_date": "2015-10-21",
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "The Medicines Company"
  },
  "MDGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.16,
    "ebitda": -24580000.0,
    "eps_estimate_current_year": -1.3,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 8.03,
    "fifty_two_week_high": 10.25,
    "fifty_two_week_low": 3.68,
    "percent_change_from_200_day_moving_average": 0.2164,
    "percent_change_from_50_day_moving_average": 0.1796,
    "shares_owned": "N/A",
    "short_ratio": 17.25,
    "two_hundred_day_moving_average": 7.79,
    "volume": 97191.0,
    "market_cap": 236090000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 11.24,
    "roa_ttm": -0.7251000000000001,
    "roe_ttm": -1.3978,
    "shares_outstanding": 24930000.0,
    "pcnt_held_by_insiders": 0.25379999999999997,
    "pcnt_held_by_institutions": 0.11900000000000001,
    "pcnt_short_of_float": 0.0886,
    "operating_cash_flow_ttm": -17150000.0,
    "levered_cash_flow_ttm": -7870000.0,
    "book_value_per_share_mrq": 0.84,
    "next_earnings_announcement_date": [
      "2015-10-13",
      "2015-10-19"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Medgenics, Inc."
  },
  "MDVN": {
    "p_e_ratio": 28.61,
    "peg_ratio": 0.37,
    "earnings_per_share": 1.63,
    "ebitda": 300730000.0,
    "eps_estimate_current_year": 1.07,
    "eps_estimate_next_quarter": 0.33,
    "fifty_day_moving_average": 47.87,
    "fifty_two_week_high": 70.79,
    "fifty_two_week_low": 40.01,
    "percent_change_from_200_day_moving_average": -0.1867,
    "percent_change_from_50_day_moving_average": -0.0256,
    "shares_owned": "N/A",
    "short_ratio": 2.94,
    "two_hundred_day_moving_average": 57.35,
    "volume": 1107945.0,
    "market_cap": 7620000000.0,
    "price_to_sales_ttm": 9.75,
    "price_to_book_mrq": 14.1,
    "roa_ttm": 0.26039999999999996,
    "roe_ttm": 0.7898000000000001,
    "shares_outstanding": 163390000.0,
    "pcnt_held_by_insiders": 0.0171,
    "pcnt_held_by_institutions": 0.9790000000000001,
    "pcnt_short_of_float": 0.053099999999999994,
    "operating_cash_flow_ttm": 251300000.0,
    "levered_cash_flow_ttm": 173660000.0,
    "book_value_per_share_mrq": 3.3,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Medivation, Inc."
  },
  "MDVX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -4600000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.71,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 2.02,
    "percent_change_from_200_day_moving_average": -0.31329999999999997,
    "percent_change_from_50_day_moving_average": -0.078,
    "shares_owned": "N/A",
    "short_ratio": 2.76,
    "two_hundred_day_moving_average": 3.64,
    "volume": 12647.0,
    "market_cap": 27060000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.21,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 10820000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0034000000000000002,
    "operating_cash_flow_ttm": -5020000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Medovex Corp."
  },
  "MDWD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -1.06,
    "ebitda": -20780000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": -0.33,
    "fifty_day_moving_average": 7.09,
    "fifty_two_week_high": 9.15,
    "fifty_two_week_low": 4.6,
    "percent_change_from_200_day_moving_average": 0.1253,
    "percent_change_from_50_day_moving_average": 0.0621,
    "shares_owned": "N/A",
    "short_ratio": 5.79,
    "two_hundred_day_moving_average": 6.69,
    "volume": 3319.0,
    "market_cap": 164230000.0,
    "price_to_sales_ttm": 406.48,
    "price_to_book_mrq": 4.86,
    "roa_ttm": -0.18760000000000002,
    "roe_ttm": -0.5166,
    "shares_outstanding": 21810000.0,
    "pcnt_held_by_insiders": 0.0642,
    "pcnt_held_by_institutions": 0.09300000000000001,
    "pcnt_short_of_float": 0.0108,
    "operating_cash_flow_ttm": -18180000.0,
    "levered_cash_flow_ttm": -11840000.0,
    "book_value_per_share_mrq": 1.55,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MediWound Ltd."
  },
  "MDXG": {
    "p_e_ratio": 76.67,
    "peg_ratio": 3.65,
    "earnings_per_share": 0.14,
    "ebitda": 20630000.0,
    "eps_estimate_current_year": 0.2,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 9.81,
    "fifty_two_week_high": 13.2,
    "fifty_two_week_low": 6.81,
    "percent_change_from_200_day_moving_average": -0.0070999999999999995,
    "percent_change_from_50_day_moving_average": 0.0554,
    "shares_owned": "N/A",
    "short_ratio": 11.64,
    "two_hundred_day_moving_average": 10.42,
    "volume": 582673.0,
    "market_cap": 1130000000.0,
    "price_to_sales_ttm": 7.07,
    "price_to_book_mrq": 12.09,
    "roa_ttm": 0.1143,
    "roe_ttm": 0.20329999999999998,
    "shares_outstanding": 108910000.0,
    "pcnt_held_by_insiders": 0.2182,
    "pcnt_held_by_institutions": 0.33899999999999997,
    "pcnt_short_of_float": 0.1649,
    "operating_cash_flow_ttm": 24380000.0,
    "levered_cash_flow_ttm": 14270000.0,
    "book_value_per_share_mrq": 0.86,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "MiMedx Group, Inc."
  },
  "MEIP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 21.2,
    "earnings_per_share": -1.16,
    "ebitda": -32710000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 1.75,
    "fifty_two_week_high": 8.33,
    "fifty_two_week_low": 1.47,
    "percent_change_from_200_day_moving_average": -0.159,
    "percent_change_from_50_day_moving_average": 0.0296,
    "shares_owned": "N/A",
    "short_ratio": 2.09,
    "two_hundred_day_moving_average": 2.14,
    "volume": 205334.0,
    "market_cap": 61480000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.03,
    "roa_ttm": -0.3576,
    "roe_ttm": -0.6228,
    "shares_outstanding": 34160000.0,
    "pcnt_held_by_insiders": 0.2623,
    "pcnt_held_by_institutions": 0.7170000000000001,
    "pcnt_short_of_float": 0.0687,
    "operating_cash_flow_ttm": -28070000.0,
    "levered_cash_flow_ttm": -15870000.0,
    "book_value_per_share_mrq": 1.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "MEI Pharma, Inc."
  },
  "MELA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -3.71,
    "ebitda": -17800000.0,
    "eps_estimate_current_year": -1.73,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.16,
    "fifty_two_week_high": 4.05,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.2432,
    "percent_change_from_50_day_moving_average": 0.0426,
    "shares_owned": "N/A",
    "short_ratio": 14.53,
    "two_hundred_day_moving_average": 1.6,
    "volume": 20017.0,
    "market_cap": 11960000.0,
    "price_to_sales_ttm": 9.16,
    "price_to_book_mrq": 0.39,
    "roa_ttm": -0.3615,
    "roe_ttm": -1.2741,
    "shares_outstanding": 9890000.0,
    "pcnt_held_by_insiders": 0.0131,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.1219,
    "operating_cash_flow_ttm": -12320000.0,
    "levered_cash_flow_ttm": -8000000.0,
    "book_value_per_share_mrq": 3.03,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "MELA Sciences, Inc."
  },
  "MGCD": {
    "p_e_ratio": 11.13,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.64,
    "ebitda": 2220000.0,
    "eps_estimate_current_year": 0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.63,
    "fifty_two_week_high": 7.7,
    "fifty_two_week_low": 5.0,
    "percent_change_from_200_day_moving_average": 0.17170000000000002,
    "percent_change_from_50_day_moving_average": 0.2589,
    "shares_owned": "N/A",
    "short_ratio": 2.36,
    "two_hundred_day_moving_average": 6.05,
    "volume": 5519.0,
    "market_cap": 30210000.0,
    "price_to_sales_ttm": 0.8,
    "price_to_book_mrq": 1.57,
    "roa_ttm": 0.028999999999999998,
    "roe_ttm": 0.1577,
    "shares_outstanding": 4260000.0,
    "pcnt_held_by_insiders": 0.16449999999999998,
    "pcnt_held_by_institutions": 0.20800000000000002,
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": -982000.0,
    "levered_cash_flow_ttm": -2990000.0,
    "book_value_per_share_mrq": 4.45,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "MGC Diagnostics Corporation"
  },
  "MGLN": {
    "p_e_ratio": 25.92,
    "peg_ratio": -1.98,
    "earnings_per_share": 2.27,
    "ebitda": 232660000.0,
    "eps_estimate_current_year": 1.77,
    "eps_estimate_next_quarter": 0.79,
    "fifty_day_moving_average": 57.25,
    "fifty_two_week_high": 73.0,
    "fifty_two_week_low": 52.37,
    "percent_change_from_200_day_moving_average": -0.0942,
    "percent_change_from_50_day_moving_average": 0.0277,
    "shares_owned": "N/A",
    "short_ratio": 2.49,
    "two_hundred_day_moving_average": 64.96,
    "volume": 120412.0,
    "market_cap": 1580000000.0,
    "price_to_sales_ttm": 0.39,
    "price_to_book_mrq": 1.36,
    "roa_ttm": 0.0548,
    "roe_ttm": 0.0487,
    "shares_outstanding": 26900000.0,
    "pcnt_held_by_insiders": 0.0137,
    "pcnt_held_by_institutions": 0.9640000000000001,
    "pcnt_short_of_float": 0.0296,
    "operating_cash_flow_ttm": 186670000.0,
    "levered_cash_flow_ttm": 143050000.0,
    "book_value_per_share_mrq": 42.74,
    "next_earnings_announcement_date": "2015-10-27",
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Magellan Health, Inc."
  },
  "MGNX": {
    "p_e_ratio": 945.0,
    "peg_ratio": 2.02,
    "earnings_per_share": 0.03,
    "ebitda": 3060000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 28.96,
    "fifty_two_week_high": 39.9,
    "fifty_two_week_low": 17.31,
    "percent_change_from_200_day_moving_average": -0.19190000000000002,
    "percent_change_from_50_day_moving_average": -0.08650000000000001,
    "shares_owned": "N/A",
    "short_ratio": 7.64,
    "two_hundred_day_moving_average": 32.75,
    "volume": 235024.0,
    "market_cap": 904820000.0,
    "price_to_sales_ttm": 8.73,
    "price_to_book_mrq": 3.7,
    "roa_ttm": 0.0024,
    "roe_ttm": 0.0046,
    "shares_outstanding": 34200000.0,
    "pcnt_held_by_insiders": 0.2716,
    "pcnt_held_by_institutions": 0.43700000000000006,
    "pcnt_short_of_float": 0.10869999999999999,
    "operating_cash_flow_ttm": -16370000.000000002,
    "levered_cash_flow_ttm": -6710000.0,
    "book_value_per_share_mrq": 7.03,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MacroGenics, Inc."
  },
  "MLAB": {
    "p_e_ratio": 39.17,
    "peg_ratio": 0.0,
    "earnings_per_share": 2.75,
    "ebitda": 22250000.0,
    "eps_estimate_current_year": 3.72,
    "eps_estimate_next_quarter": 1.01,
    "fifty_day_moving_average": 111.9,
    "fifty_two_week_high": 126.05,
    "fifty_two_week_low": 54.6,
    "percent_change_from_200_day_moving_average": 0.1728,
    "percent_change_from_50_day_moving_average": -0.0374,
    "shares_owned": "N/A",
    "short_ratio": 9.56,
    "two_hundred_day_moving_average": 91.85,
    "volume": 9239.0,
    "market_cap": 387170000.0,
    "price_to_sales_ttm": 5.27,
    "price_to_book_mrq": 5.04,
    "roa_ttm": 0.0904,
    "roe_ttm": 0.1402,
    "shares_outstanding": 3590000.0,
    "pcnt_held_by_insiders": 0.17989999999999998,
    "pcnt_held_by_institutions": 0.506,
    "pcnt_short_of_float": 0.0432,
    "operating_cash_flow_ttm": 13250000.0,
    "levered_cash_flow_ttm": 11190000.0,
    "book_value_per_share_mrq": 21.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mesa Laboratories Inc."
  },
  "MLSS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.19,
    "ebitda": -2550000.0,
    "eps_estimate_current_year": 0.08,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.88,
    "fifty_two_week_high": 4.0,
    "fifty_two_week_low": 1.76,
    "percent_change_from_200_day_moving_average": 0.0271,
    "percent_change_from_50_day_moving_average": 0.0682,
    "shares_owned": "N/A",
    "short_ratio": 0.54,
    "two_hundred_day_moving_average": 3.0,
    "volume": 39537.0,
    "market_cap": 66030000.0,
    "price_to_sales_ttm": 6.7,
    "price_to_book_mrq": 5.2,
    "roa_ttm": -0.1017,
    "roe_ttm": -0.2981,
    "shares_outstanding": 21440000.0,
    "pcnt_held_by_insiders": 0.4448,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0019,
    "operating_cash_flow_ttm": -2200000.0,
    "levered_cash_flow_ttm": -2840000.0,
    "book_value_per_share_mrq": 0.59,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Milestone Scientific Inc."
  },
  "MMSI": {
    "p_e_ratio": 37.48,
    "peg_ratio": 1.82,
    "earnings_per_share": 0.66,
    "ebitda": 87570000.0,
    "eps_estimate_current_year": 0.9,
    "eps_estimate_next_quarter": 0.23,
    "fifty_day_moving_average": 23.89,
    "fifty_two_week_high": 26.42,
    "fifty_two_week_low": 11.61,
    "percent_change_from_200_day_moving_average": 0.1469,
    "percent_change_from_50_day_moving_average": 0.0321,
    "shares_owned": "N/A",
    "short_ratio": 4.31,
    "two_hundred_day_moving_average": 21.5,
    "volume": 244379.0,
    "market_cap": 1090000000.0,
    "price_to_sales_ttm": 2.06,
    "price_to_book_mrq": 2.39,
    "roa_ttm": 0.0425,
    "roe_ttm": 0.0668,
    "shares_outstanding": 44160000.0,
    "pcnt_held_by_insiders": 0.055,
    "pcnt_held_by_institutions": 0.87,
    "pcnt_short_of_float": 0.0478,
    "operating_cash_flow_ttm": 73570000.0,
    "levered_cash_flow_ttm": 22960000.0,
    "book_value_per_share_mrq": 10.26,
    "next_earnings_announcement_date": "2015-10-22",
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Merit Medical Systems, Inc."
  },
  "MNK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.58,
    "earnings_per_share": -0.98,
    "ebitda": 1220000000.0,
    "eps_estimate_current_year": 7.33,
    "eps_estimate_next_quarter": 1.94,
    "fifty_day_moving_average": 89.29,
    "fifty_two_week_high": 134.26,
    "fifty_two_week_low": 71.44,
    "percent_change_from_200_day_moving_average": -0.3774,
    "percent_change_from_50_day_moving_average": -0.19760000000000003,
    "shares_owned": "N/A",
    "short_ratio": 3.16,
    "two_hundred_day_moving_average": 115.06,
    "volume": 1282160.0,
    "market_cap": 8410000000.0,
    "price_to_sales_ttm": 2.42,
    "price_to_book_mrq": 1.61,
    "roa_ttm": 0.0385,
    "roe_ttm": -0.0381,
    "shares_outstanding": 117340000.0,
    "pcnt_held_by_insiders": 0.0017000000000000001,
    "pcnt_held_by_institutions": 0.846,
    "pcnt_short_of_float": 0.0745,
    "operating_cash_flow_ttm": 764500000.0,
    "levered_cash_flow_ttm": 980090000.0,
    "book_value_per_share_mrq": 45.18,
    "next_earnings_announcement_date": [
      "2015-11-17",
      "2015-11-23"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Mallinckrodt Public Limited Company"
  },
  "MNKD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.46,
    "earnings_per_share": -0.33,
    "ebitda": -103950000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 3.82,
    "fifty_two_week_high": 7.88,
    "fifty_two_week_low": 3.2,
    "percent_change_from_200_day_moving_average": -0.3178,
    "percent_change_from_50_day_moving_average": -0.1398,
    "shares_owned": "N/A",
    "short_ratio": 23.55,
    "two_hundred_day_moving_average": 4.82,
    "volume": 4518626.0,
    "market_cap": 1360000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.24230000000000002,
    "roe_ttm": "N/A",
    "shares_outstanding": 414760000.0,
    "pcnt_held_by_insiders": 0.3923,
    "pcnt_held_by_institutions": 0.221,
    "pcnt_short_of_float": 0.494,
    "operating_cash_flow_ttm": 49710000.0,
    "levered_cash_flow_ttm": -10500000.0,
    "book_value_per_share_mrq": -0.29,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MannKind Corp."
  },
  "MNOV": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.43,
    "earnings_per_share": -0.38,
    "ebitda": -9180000.0,
    "eps_estimate_current_year": -0.38,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 3.27,
    "fifty_two_week_high": 5.9,
    "fifty_two_week_low": 2.53,
    "percent_change_from_200_day_moving_average": -0.15439999999999998,
    "percent_change_from_50_day_moving_average": -0.0481,
    "shares_owned": "N/A",
    "short_ratio": 2.96,
    "two_hundred_day_moving_average": 3.68,
    "volume": 9588.0,
    "market_cap": 92970000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.85,
    "roa_ttm": -0.21230000000000002,
    "roe_ttm": -0.4122,
    "shares_outstanding": 29890000.0,
    "pcnt_held_by_insiders": 0.203,
    "pcnt_held_by_institutions": 0.042,
    "pcnt_short_of_float": 0.0134,
    "operating_cash_flow_ttm": -7090000.0,
    "levered_cash_flow_ttm": -3620000.0,
    "book_value_per_share_mrq": 0.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MediciNova Inc."
  },
  "MNTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.26,
    "ebitda": -60880000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.13,
    "fifty_day_moving_average": 20.01,
    "fifty_two_week_high": 25.56,
    "fifty_two_week_low": 9.38,
    "percent_change_from_200_day_moving_average": -0.1173,
    "percent_change_from_50_day_moving_average": -0.1311,
    "shares_owned": "N/A",
    "short_ratio": 10.14,
    "two_hundred_day_moving_average": 19.7,
    "volume": 478415.0,
    "market_cap": 1200000000.0,
    "price_to_sales_ttm": 13.97,
    "price_to_book_mrq": 2.82,
    "roa_ttm": -0.1195,
    "roe_ttm": -0.2155,
    "shares_outstanding": 68810000.0,
    "pcnt_held_by_insiders": 0.2144,
    "pcnt_held_by_institutions": 0.735,
    "pcnt_short_of_float": 0.1578,
    "operating_cash_flow_ttm": -70580000.0,
    "levered_cash_flow_ttm": -45940000.0,
    "book_value_per_share_mrq": 6.14,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Momenta Pharmaceuticals Inc."
  },
  "MOH": {
    "p_e_ratio": 33.1,
    "peg_ratio": 0.91,
    "earnings_per_share": 2.33,
    "ebitda": 415940000.0,
    "eps_estimate_current_year": 2.6,
    "eps_estimate_next_quarter": 0.64,
    "fifty_day_moving_average": 76.76,
    "fifty_two_week_high": 82.37,
    "fifty_two_week_low": 40.79,
    "percent_change_from_200_day_moving_average": 0.106,
    "percent_change_from_50_day_moving_average": 0.0040999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 8.11,
    "two_hundred_day_moving_average": 69.69,
    "volume": 715727.0,
    "market_cap": 4320000000.0,
    "price_to_sales_ttm": 0.37,
    "price_to_book_mrq": 2.92,
    "roa_ttm": 0.0455,
    "roe_ttm": 0.0984,
    "shares_outstanding": 56060000.0,
    "pcnt_held_by_insiders": 0.34020000000000006,
    "pcnt_held_by_institutions": 0.7709999999999999,
    "pcnt_short_of_float": 0.2475,
    "operating_cash_flow_ttm": 1470000000.0,
    "levered_cash_flow_ttm": 608370000.0,
    "book_value_per_share_mrq": 26.1,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Molina Healthcare, Inc."
  },
  "MR": {
    "p_e_ratio": 16.47,
    "peg_ratio": 15.05,
    "earnings_per_share": 1.44,
    "ebitda": 230490000.0,
    "eps_estimate_current_year": 1.49,
    "eps_estimate_next_quarter": 0.36,
    "fifty_day_moving_average": 25.13,
    "fifty_two_week_high": 33.83,
    "fifty_two_week_low": 23.11,
    "percent_change_from_200_day_moving_average": -0.1377,
    "percent_change_from_50_day_moving_average": -0.0559,
    "shares_owned": "N/A",
    "short_ratio": 10.02,
    "two_hundred_day_moving_average": 27.51,
    "volume": 285109.0,
    "market_cap": 2790000000.0,
    "price_to_sales_ttm": 2.11,
    "price_to_book_mrq": 1.71,
    "roa_ttm": 0.0467,
    "roe_ttm": 0.1091,
    "shares_outstanding": 117830000.0,
    "pcnt_held_by_insiders": 0.019299999999999998,
    "pcnt_held_by_institutions": 1.167,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 325270000.0,
    "levered_cash_flow_ttm": -179140000.0,
    "book_value_per_share_mrq": 13.87,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mindray Medical International Limited"
  },
  "MRNS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.38,
    "ebitda": -18070000.0,
    "eps_estimate_current_year": -1.82,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 14.61,
    "fifty_two_week_high": 20.72,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": 0.1377,
    "percent_change_from_50_day_moving_average": -0.10220000000000001,
    "shares_owned": "N/A",
    "short_ratio": 0.81,
    "two_hundred_day_moving_average": 11.53,
    "volume": 68973.0,
    "market_cap": 187550000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.3,
    "roa_ttm": -0.4472,
    "roe_ttm": -1.0216,
    "shares_outstanding": 14300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0102,
    "operating_cash_flow_ttm": -14250000.0,
    "levered_cash_flow_ttm": -8520000.0,
    "book_value_per_share_mrq": 2.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Marinus Pharmaceuticals, Inc."
  },
  "MRTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.17,
    "ebitda": -48310000.0,
    "eps_estimate_current_year": -3.47,
    "eps_estimate_next_quarter": -0.89,
    "fifty_day_moving_average": 29.34,
    "fifty_two_week_high": 52.0,
    "fifty_two_week_low": 13.69,
    "percent_change_from_200_day_moving_average": 0.17800000000000002,
    "percent_change_from_50_day_moving_average": 0.1797,
    "shares_owned": "N/A",
    "short_ratio": 5.31,
    "two_hundred_day_moving_average": 29.38,
    "volume": 398453.0,
    "market_cap": 643670000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 10.46,
    "roa_ttm": -0.5435,
    "roe_ttm": -1.5582,
    "shares_outstanding": 18600000.0,
    "pcnt_held_by_insiders": 0.0023,
    "pcnt_held_by_institutions": 0.6940000000000001,
    "pcnt_short_of_float": 0.077,
    "operating_cash_flow_ttm": -37020000.0,
    "levered_cash_flow_ttm": -58630000.0,
    "book_value_per_share_mrq": 3.35,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Mirati Therapeutics, Inc."
  },
  "MSLI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.038,
    "ebitda": 18560000.0,
    "eps_estimate_current_year": 0.05,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 1.8083,
    "fifty_two_week_high": 2.85,
    "fifty_two_week_low": 1.15,
    "percent_change_from_200_day_moving_average": -0.317407,
    "percent_change_from_50_day_moving_average": -0.154007,
    "shares_owned": "N/A",
    "short_ratio": 29.89,
    "two_hundred_day_moving_average": 2.2412,
    "volume": 12910.0,
    "market_cap": 156500000.0,
    "price_to_sales_ttm": 5.43,
    "price_to_book_mrq": 1.28,
    "roa_ttm": 0.0095,
    "roe_ttm": -0.0311,
    "shares_outstanding": 102300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.002,
    "operating_cash_flow_ttm": 15840000.0,
    "levered_cash_flow_ttm": -107380000.0,
    "book_value_per_share_mrq": 1.22,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Merus Labs International Inc."
  },
  "MSON": {
    "p_e_ratio": 17.22,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.69,
    "ebitda": -274785.0,
    "eps_estimate_current_year": 0.35,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 10.28,
    "fifty_two_week_high": 14.9,
    "fifty_two_week_low": 8.2,
    "percent_change_from_200_day_moving_average": 0.0689,
    "percent_change_from_50_day_moving_average": 0.1609,
    "shares_owned": "N/A",
    "short_ratio": 1.85,
    "two_hundred_day_moving_average": 11.16,
    "volume": 27787.0,
    "market_cap": 92390000.0,
    "price_to_sales_ttm": 4.1,
    "price_to_book_mrq": 3.83,
    "roa_ttm": -0.0466,
    "roe_ttm": 0.2645,
    "shares_outstanding": 7740000.0,
    "pcnt_held_by_insiders": 0.2263,
    "pcnt_held_by_institutions": 0.128,
    "pcnt_short_of_float": 0.0036,
    "operating_cash_flow_ttm": 2390000.0,
    "levered_cash_flow_ttm": -2730000.0,
    "book_value_per_share_mrq": 3.07,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Misonix, Inc."
  },
  "MSTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.237,
    "ebitda": -33950000.0,
    "eps_estimate_current_year": -0.24,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.446,
    "fifty_two_week_high": 0.63,
    "fifty_two_week_low": 0.38,
    "percent_change_from_200_day_moving_average": -0.03707,
    "percent_change_from_50_day_moving_average": 0.041929999999999995,
    "shares_owned": "N/A",
    "short_ratio": 5.09,
    "two_hundred_day_moving_average": 0.483,
    "volume": 1119519.0,
    "market_cap": 76260000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.88,
    "roa_ttm": -0.3667,
    "roe_ttm": -0.7535,
    "shares_outstanding": 164000000.0,
    "pcnt_held_by_insiders": 0.037200000000000004,
    "pcnt_held_by_institutions": 0.196,
    "pcnt_short_of_float": 0.0304,
    "operating_cash_flow_ttm": -27260000.0,
    "levered_cash_flow_ttm": -13710000.0,
    "book_value_per_share_mrq": 0.26,
    "next_earnings_announcement_date": [
      "2015-10-29",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Mast Therapeutics, Inc."
  },
  "MTD": {
    "p_e_ratio": 23.49,
    "peg_ratio": 1.97,
    "earnings_per_share": 11.99,
    "ebitda": 528890000.0,
    "eps_estimate_current_year": 12.84,
    "eps_estimate_next_quarter": 4.62,
    "fifty_day_moving_average": 306.7,
    "fifty_two_week_high": 350.11,
    "fifty_two_week_low": 228.3,
    "percent_change_from_200_day_moving_average": -0.1309,
    "percent_change_from_50_day_moving_average": -0.0814,
    "shares_owned": "N/A",
    "short_ratio": 5.88,
    "two_hundred_day_moving_average": 324.18,
    "volume": 285825.0,
    "market_cap": 7800000000.0,
    "price_to_sales_ttm": 3.24,
    "price_to_book_mrq": 12.09,
    "roa_ttm": 0.14400000000000002,
    "roe_ttm": 0.444,
    "shares_outstanding": 27700000.0,
    "pcnt_held_by_insiders": 0.0217,
    "pcnt_held_by_institutions": 0.95,
    "pcnt_short_of_float": 0.0535,
    "operating_cash_flow_ttm": 431720000.0,
    "levered_cash_flow_ttm": 327170000.0,
    "book_value_per_share_mrq": 23.62,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mettler-Toledo International Inc."
  },
  "MYOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.83,
    "ebitda": -6000000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.26,
    "fifty_two_week_high": 14.96,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.3356,
    "percent_change_from_50_day_moving_average": 0.1057,
    "shares_owned": "N/A",
    "short_ratio": 5.57,
    "two_hundred_day_moving_average": 3.76,
    "volume": 38861.0,
    "market_cap": 8289999.999999999,
    "price_to_sales_ttm": 33.81,
    "price_to_book_mrq": 1.22,
    "roa_ttm": -0.5067,
    "roe_ttm": -0.8519,
    "shares_outstanding": 3320000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0172,
    "operating_cash_flow_ttm": -3960000.0,
    "levered_cash_flow_ttm": -2380000.0,
    "book_value_per_share_mrq": 1.73,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "MYOS Corporation"
  },
  "MZOR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.81,
    "earnings_per_share": -0.7,
    "ebitda": -13850000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 12.39,
    "fifty_two_week_high": 15.04,
    "fifty_two_week_low": 9.63,
    "percent_change_from_200_day_moving_average": -0.0635,
    "percent_change_from_50_day_moving_average": -0.033,
    "shares_owned": "N/A",
    "short_ratio": 23.91,
    "two_hundred_day_moving_average": 12.79,
    "volume": 10117.0,
    "market_cap": 253280000.0,
    "price_to_sales_ttm": 10.86,
    "price_to_book_mrq": 5.34,
    "roa_ttm": -0.145,
    "roe_ttm": -0.2726,
    "shares_outstanding": 21140000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -10540000.0,
    "levered_cash_flow_ttm": -5080000.0,
    "book_value_per_share_mrq": 2.3,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Mazor Robotics Ltd."
  },
  "NAII": {
    "p_e_ratio": 12.96,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.49,
    "ebitda": 8000000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.92,
    "fifty_two_week_high": 6.7,
    "fifty_two_week_low": 5.0,
    "percent_change_from_200_day_moving_average": 0.11199999999999999,
    "percent_change_from_50_day_moving_average": 0.0719,
    "shares_owned": "N/A",
    "short_ratio": 4.07,
    "two_hundred_day_moving_average": 5.71,
    "volume": 2604.0,
    "market_cap": 42630000.0,
    "price_to_sales_ttm": 0.52,
    "price_to_book_mrq": 0.94,
    "roa_ttm": 0.06559999999999999,
    "roe_ttm": 0.0775,
    "shares_outstanding": 6710000.0,
    "pcnt_held_by_insiders": 0.5049,
    "pcnt_held_by_institutions": 0.113,
    "pcnt_short_of_float": 0.0024,
    "operating_cash_flow_ttm": 2680000.0,
    "levered_cash_flow_ttm": 421120.0,
    "book_value_per_share_mrq": 6.71,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "Natural Alternatives International Inc."
  },
  "NATR": {
    "p_e_ratio": 42.84,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.28,
    "ebitda": 20580000.0,
    "eps_estimate_current_year": 0.8,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 12.38,
    "fifty_two_week_high": 15.96,
    "fifty_two_week_low": 11.3,
    "percent_change_from_200_day_moving_average": -0.0742,
    "percent_change_from_50_day_moving_average": -0.0484,
    "shares_owned": "N/A",
    "short_ratio": 14.59,
    "two_hundred_day_moving_average": 12.72,
    "volume": 14373.0,
    "market_cap": 220190000.0,
    "price_to_sales_ttm": 0.64,
    "price_to_book_mrq": 1.7,
    "roa_ttm": 0.0507,
    "roe_ttm": 0.09960000000000001,
    "shares_outstanding": 18690000.0,
    "pcnt_held_by_insiders": 0.1674,
    "pcnt_held_by_institutions": 0.617,
    "pcnt_short_of_float": 0.0232,
    "operating_cash_flow_ttm": 9170000.0,
    "levered_cash_flow_ttm": -10500000.0,
    "book_value_per_share_mrq": 6.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Nature's Sunshine Products Inc."
  },
  "NAVB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.2,
    "ebitda": -20360000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 1.93,
    "fifty_two_week_high": 2.5,
    "fifty_two_week_low": 0.97,
    "percent_change_from_200_day_moving_average": 0.4556,
    "percent_change_from_50_day_moving_average": 0.2413,
    "shares_owned": "N/A",
    "short_ratio": 63.27,
    "two_hundred_day_moving_average": 1.64,
    "volume": 557710.0,
    "market_cap": 360170000.0,
    "price_to_sales_ttm": 37.92,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5713,
    "roe_ttm": "N/A",
    "shares_outstanding": 150700000.0,
    "pcnt_held_by_insiders": 0.10830000000000001,
    "pcnt_held_by_institutions": 0.272,
    "pcnt_short_of_float": 0.21109999999999998,
    "operating_cash_flow_ttm": -22330000.0,
    "levered_cash_flow_ttm": -13750000.0,
    "book_value_per_share_mrq": -0.3,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Navidea Biopharmaceuticals, Inc"
  },
  "NBIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 7.2,
    "earnings_per_share": -0.76,
    "ebitda": -64000000.0,
    "eps_estimate_current_year": -0.83,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 48.33,
    "fifty_two_week_high": 56.97,
    "fifty_two_week_low": 15.15,
    "percent_change_from_200_day_moving_average": 0.050199999999999995,
    "percent_change_from_50_day_moving_average": -0.0216,
    "shares_owned": "N/A",
    "short_ratio": 7.1,
    "two_hundred_day_moving_average": 45.02,
    "volume": 899610.0,
    "market_cap": 4059999999.9999995,
    "price_to_sales_ttm": 210.85,
    "price_to_book_mrq": 8.91,
    "roa_ttm": -0.10400000000000001,
    "roe_ttm": -0.17190000000000003,
    "shares_outstanding": 85870000.0,
    "pcnt_held_by_insiders": 0.0115,
    "pcnt_held_by_institutions": 0.9359999999999999,
    "pcnt_short_of_float": 0.0816,
    "operating_cash_flow_ttm": -31630000.0,
    "levered_cash_flow_ttm": -24040000.0,
    "book_value_per_share_mrq": 5.45,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Neurocrine Biosciences Inc."
  },
  "NBY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.33,
    "ebitda": -18360000.0,
    "eps_estimate_current_year": -0.27,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.45,
    "fifty_two_week_high": 1.05,
    "fifty_two_week_low": 0.22,
    "percent_change_from_200_day_moving_average": -0.4215,
    "percent_change_from_50_day_moving_average": -0.2025,
    "shares_owned": "N/A",
    "short_ratio": 7.48,
    "two_hundred_day_moving_average": 0.62,
    "volume": 76277.0,
    "market_cap": 26930000.0,
    "price_to_sales_ttm": 11.49,
    "price_to_book_mrq": 5.09,
    "roa_ttm": -0.9781,
    "roe_ttm": -2.5792,
    "shares_outstanding": 74810000.0,
    "pcnt_held_by_insiders": 0.22760000000000002,
    "pcnt_held_by_institutions": 0.042,
    "pcnt_short_of_float": 0.0403,
    "operating_cash_flow_ttm": -16820000.0,
    "levered_cash_flow_ttm": -10550000.0,
    "book_value_per_share_mrq": 0.07,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NovaBay Pharmaceuticals, Inc."
  },
  "NDRM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.01,
    "ebitda": -15220000.0,
    "eps_estimate_current_year": -1.35,
    "eps_estimate_next_quarter": -0.46,
    "fifty_day_moving_average": 22.6,
    "fifty_two_week_high": 26.5,
    "fifty_two_week_low": 5.67,
    "percent_change_from_200_day_moving_average": 0.37070000000000003,
    "percent_change_from_50_day_moving_average": 0.008199999999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.82,
    "two_hundred_day_moving_average": 16.63,
    "volume": 166712.0,
    "market_cap": 477020000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 11.4,
    "roa_ttm": -0.4789,
    "roe_ttm": -2.5408,
    "shares_outstanding": 20930000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0767,
    "operating_cash_flow_ttm": -11980000.0,
    "levered_cash_flow_ttm": -4760000.0,
    "book_value_per_share_mrq": 2.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NeuroDerm Ltd."
  },
  "NEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.01,
    "ebitda": 7640000.0,
    "eps_estimate_current_year": 0.0,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 6.27,
    "fifty_two_week_high": 7.22,
    "fifty_two_week_low": 3.33,
    "percent_change_from_200_day_moving_average": 0.1894,
    "percent_change_from_50_day_moving_average": 0.053200000000000004,
    "shares_owned": "N/A",
    "short_ratio": 9.04,
    "two_hundred_day_moving_average": 5.55,
    "volume": 172570.0,
    "market_cap": 399370000.0,
    "price_to_sales_ttm": 4.21,
    "price_to_book_mrq": 6.62,
    "roa_ttm": 0.0106,
    "roe_ttm": -0.0043,
    "shares_outstanding": 60510000.0,
    "pcnt_held_by_insiders": 0.42460000000000003,
    "pcnt_held_by_institutions": 0.34299999999999997,
    "pcnt_short_of_float": 0.0499,
    "operating_cash_flow_ttm": 6050000.0,
    "levered_cash_flow_ttm": 2720000.0,
    "book_value_per_share_mrq": 1.01,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Neogenomics Inc."
  },
  "NEOG": {
    "p_e_ratio": 52.81,
    "peg_ratio": 2.63,
    "earnings_per_share": 0.9,
    "ebitda": 65370000.00000001,
    "eps_estimate_current_year": 1.09,
    "eps_estimate_next_quarter": 0.26,
    "fifty_day_moving_average": 53.64,
    "fifty_two_week_high": 62.7,
    "fifty_two_week_low": 38.74,
    "percent_change_from_200_day_moving_average": -0.0285,
    "percent_change_from_50_day_moving_average": -0.1041,
    "shares_owned": "N/A",
    "short_ratio": 8.92,
    "two_hundred_day_moving_average": 49.47,
    "volume": 294418.0,
    "market_cap": 1790000000.0,
    "price_to_sales_ttm": 6.19,
    "price_to_book_mrq": 4.91,
    "roa_ttm": 0.08900000000000001,
    "roe_ttm": 0.0992,
    "shares_outstanding": 37260000.0,
    "pcnt_held_by_insiders": 0.0451,
    "pcnt_held_by_institutions": 0.825,
    "pcnt_short_of_float": 0.0583,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 9.69,
    "next_earnings_announcement_date": [
      "2015-12-16",
      "2015-12-21"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Neogen Corp."
  },
  "NEOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -29.65,
    "ebitda": -17820000.0,
    "eps_estimate_current_year": -7.25,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 22.94,
    "fifty_two_week_high": 28.99,
    "fifty_two_week_low": 17.1,
    "percent_change_from_200_day_moving_average": -0.1362,
    "percent_change_from_50_day_moving_average": -0.1566,
    "shares_owned": "N/A",
    "short_ratio": 0.34,
    "two_hundred_day_moving_average": 22.4,
    "volume": 126499.0,
    "market_cap": 306430000.0,
    "price_to_sales_ttm": 135.05,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15840000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0029,
    "operating_cash_flow_ttm": -21180000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -104.81,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Neos Therapeutics, Inc."
  },
  "NEOT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.12,
    "earnings_per_share": -2.72,
    "ebitda": -20930000.0,
    "eps_estimate_current_year": -3.47,
    "eps_estimate_next_quarter": -1.13,
    "fifty_day_moving_average": 12.33,
    "fifty_two_week_high": 15.05,
    "fifty_two_week_low": 5.92,
    "percent_change_from_200_day_moving_average": 0.3191,
    "percent_change_from_50_day_moving_average": -0.0043,
    "shares_owned": "N/A",
    "short_ratio": 2.0,
    "two_hundred_day_moving_average": 9.31,
    "volume": 98357.0,
    "market_cap": 168270000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.5,
    "roa_ttm": -0.3436,
    "roe_ttm": -0.8270000000000001,
    "shares_outstanding": 13700000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0154,
    "operating_cash_flow_ttm": -17480000.0,
    "levered_cash_flow_ttm": -9710000.0,
    "book_value_per_share_mrq": 3.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Neothetics, Inc."
  },
  "NEPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.28,
    "ebitda": -26670000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 1.33,
    "fifty_two_week_high": 2.2,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": -0.191,
    "percent_change_from_50_day_moving_average": -0.1151,
    "shares_owned": "N/A",
    "short_ratio": 27.68,
    "two_hundred_day_moving_average": 1.46,
    "volume": 62114.0,
    "market_cap": 88930000.0,
    "price_to_sales_ttm": 8.49,
    "price_to_book_mrq": 2.32,
    "roa_ttm": -0.2122,
    "roe_ttm": -0.37270000000000003,
    "shares_outstanding": 75370000.0,
    "pcnt_held_by_insiders": 0.1522,
    "pcnt_held_by_institutions": 0.015,
    "pcnt_short_of_float": 0.0002,
    "operating_cash_flow_ttm": -20320000.0,
    "levered_cash_flow_ttm": -19780000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Neptune Technologies & Bioressources, Inc."
  },
  "NERV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.35,
    "ebitda": -46770000.0,
    "eps_estimate_current_year": -1.34,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 5.72,
    "fifty_two_week_high": 10.0,
    "fifty_two_week_low": 4.08,
    "percent_change_from_200_day_moving_average": 0.001,
    "percent_change_from_50_day_moving_average": -0.0318,
    "shares_owned": "N/A",
    "short_ratio": 5.31,
    "two_hundred_day_moving_average": 5.53,
    "volume": 10798.0,
    "market_cap": 136950000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.0,
    "roa_ttm": -0.3973,
    "roe_ttm": -0.9692000000000001,
    "shares_outstanding": 24720000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0092,
    "operating_cash_flow_ttm": -44120000.0,
    "levered_cash_flow_ttm": -40310000.0,
    "book_value_per_share_mrq": 2.77,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Minerva Neurosciences, Inc."
  },
  "NHC": {
    "p_e_ratio": 20.12,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.12,
    "ebitda": 106550000.0,
    "eps_estimate_current_year": 2.54,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 61.99,
    "fifty_two_week_high": 66.5,
    "fifty_two_week_low": 54.33,
    "percent_change_from_200_day_moving_average": -0.0069,
    "percent_change_from_50_day_moving_average": 0.0124,
    "shares_owned": "N/A",
    "short_ratio": 15.39,
    "two_hundred_day_moving_average": 63.2,
    "volume": 11252.0,
    "market_cap": 894440000.0,
    "price_to_sales_ttm": 0.99,
    "price_to_book_mrq": 1.55,
    "roa_ttm": 0.0416,
    "roe_ttm": 0.0729,
    "shares_outstanding": 14250000.0,
    "pcnt_held_by_insiders": 0.34450000000000003,
    "pcnt_held_by_institutions": 0.349,
    "pcnt_short_of_float": 0.027000000000000003,
    "operating_cash_flow_ttm": 88880000.0,
    "levered_cash_flow_ttm": 36870000.0,
    "book_value_per_share_mrq": 40.22,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "National Healthcare Corp."
  },
  "NK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 10.91,
    "earnings_per_share": -3.24,
    "ebitda": -118630000.0,
    "eps_estimate_current_year": -1.02,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 21.66,
    "fifty_two_week_high": 38.48,
    "fifty_two_week_low": 15.97,
    "percent_change_from_200_day_moving_average": -0.2489,
    "percent_change_from_50_day_moving_average": -0.2046,
    "shares_owned": "N/A",
    "short_ratio": 2.12,
    "two_hundred_day_moving_average": 22.94,
    "volume": 238906.0,
    "market_cap": 1400000000.0,
    "price_to_sales_ttm": 3282.36,
    "price_to_book_mrq": 9.83,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 81140000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.052000000000000005,
    "operating_cash_flow_ttm": -13300000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NantKwest, Inc."
  },
  "NKTR": {
    "p_e_ratio": 274.26,
    "peg_ratio": 3.03,
    "earnings_per_share": 0.05,
    "ebitda": 54650000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 11.52,
    "fifty_two_week_high": 17.53,
    "fifty_two_week_low": 9.16,
    "percent_change_from_200_day_moving_average": 0.1009,
    "percent_change_from_50_day_moving_average": 0.1186,
    "shares_owned": "N/A",
    "short_ratio": 16.1,
    "two_hundred_day_moving_average": 11.71,
    "volume": 1088886.0,
    "market_cap": 1710000000.0,
    "price_to_sales_ttm": 6.08,
    "price_to_book_mrq": 49.02,
    "roa_ttm": 0.0567,
    "roe_ttm": "N/A",
    "shares_outstanding": 132370000.0,
    "pcnt_held_by_insiders": 0.0036,
    "pcnt_held_by_institutions": 0.907,
    "pcnt_short_of_float": 0.2458,
    "operating_cash_flow_ttm": -54570000.0,
    "levered_cash_flow_ttm": -10680000.0,
    "book_value_per_share_mrq": 0.27,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nektar Therapeutics"
  },
  "NLNK": {
    "p_e_ratio": 13.83,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.78,
    "ebitda": 134120000.0,
    "eps_estimate_current_year": -1.55,
    "eps_estimate_next_quarter": -0.8,
    "fifty_day_moving_average": 48.75,
    "fifty_two_week_high": 58.73,
    "fifty_two_week_low": 17.32,
    "percent_change_from_200_day_moving_average": 0.0735,
    "percent_change_from_50_day_moving_average": 0.0719,
    "shares_owned": "N/A",
    "short_ratio": 8.48,
    "two_hundred_day_moving_average": 48.68,
    "volume": 209169.0,
    "market_cap": 1500000000.0,
    "price_to_sales_ttm": 6.86,
    "price_to_book_mrq": 6.63,
    "roa_ttm": 0.5065999999999999,
    "roe_ttm": 0.7934,
    "shares_outstanding": 28760000.0,
    "pcnt_held_by_insiders": 0.2904,
    "pcnt_held_by_institutions": 0.511,
    "pcnt_short_of_float": 0.2205,
    "operating_cash_flow_ttm": 113460000.0,
    "levered_cash_flow_ttm": 73830000.0,
    "book_value_per_share_mrq": 7.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NewLink Genetics Corporation"
  },
  "NNVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.09,
    "ebitda": -6910000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.18,
    "fifty_two_week_high": 3.99,
    "fifty_two_week_low": 0.89,
    "percent_change_from_200_day_moving_average": -0.31170000000000003,
    "percent_change_from_50_day_moving_average": 0.013000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.6,
    "two_hundred_day_moving_average": 1.74,
    "volume": 107929.0,
    "market_cap": 68690000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.29,
    "roa_ttm": -0.1024,
    "roe_ttm": -0.0797,
    "shares_outstanding": 57240000.0,
    "pcnt_held_by_insiders": 0.2446,
    "pcnt_held_by_institutions": 0.081,
    "pcnt_short_of_float": 0.0213,
    "operating_cash_flow_ttm": -6210000.0,
    "levered_cash_flow_ttm": -10840000.0,
    "book_value_per_share_mrq": 0.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "NanoViricides, Inc."
  },
  "NRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.39,
    "ebitda": -20930000.0,
    "eps_estimate_current_year": -2.56,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 4.05,
    "fifty_two_week_high": 17.98,
    "fifty_two_week_low": 3.4,
    "percent_change_from_200_day_moving_average": -0.36939999999999995,
    "percent_change_from_50_day_moving_average": -0.0171,
    "shares_owned": "N/A",
    "short_ratio": 4.12,
    "two_hundred_day_moving_average": 6.31,
    "volume": 72522.0,
    "market_cap": 41700000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.23,
    "roa_ttm": -0.5118,
    "roe_ttm": -1.1561,
    "shares_outstanding": 10480000.0,
    "pcnt_held_by_insiders": 0.5586,
    "pcnt_held_by_institutions": 0.264,
    "pcnt_short_of_float": 0.0434,
    "operating_cash_flow_ttm": -17680000.0,
    "levered_cash_flow_ttm": -9610000.0,
    "book_value_per_share_mrq": 0.94,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "NephroGenex, Inc."
  },
  "NSPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -7.66,
    "ebitda": -31230000.0,
    "eps_estimate_current_year": -5.19,
    "eps_estimate_next_quarter": -1.13,
    "fifty_day_moving_average": 2.46,
    "fifty_two_week_high": 25.4,
    "fifty_two_week_low": 1.91,
    "percent_change_from_200_day_moving_average": -0.4218,
    "percent_change_from_50_day_moving_average": -0.18,
    "shares_owned": "N/A",
    "short_ratio": 3.65,
    "two_hundred_day_moving_average": 3.49,
    "volume": 148262.0,
    "market_cap": 14910000.0,
    "price_to_sales_ttm": 0.86,
    "price_to_book_mrq": 0.72,
    "roa_ttm": -0.4648,
    "roe_ttm": -1.4477000000000002,
    "shares_outstanding": 7380000.0,
    "pcnt_held_by_insiders": 0.2043,
    "pcnt_held_by_institutions": 0.373,
    "pcnt_short_of_float": 0.03,
    "operating_cash_flow_ttm": -30060000.0,
    "levered_cash_flow_ttm": -21420000.0,
    "book_value_per_share_mrq": 2.9,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Nanosphere, Inc."
  },
  "NSPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.41,
    "ebitda": -18720000.0,
    "eps_estimate_current_year": -0.26,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.2,
    "fifty_two_week_high": 2.23,
    "fifty_two_week_low": 0.18,
    "percent_change_from_200_day_moving_average": -0.2494,
    "percent_change_from_50_day_moving_average": -0.0647,
    "shares_owned": "N/A",
    "short_ratio": 0.27,
    "two_hundred_day_moving_average": 0.25,
    "volume": 175105.0,
    "market_cap": 14790000.0,
    "price_to_sales_ttm": 6.42,
    "price_to_book_mrq": 6.13,
    "roa_ttm": -0.8628,
    "roe_ttm": "N/A",
    "shares_outstanding": 77860000.0,
    "pcnt_held_by_insiders": 0.1961,
    "pcnt_held_by_institutions": 0.295,
    "pcnt_short_of_float": 0.0028000000000000004,
    "operating_cash_flow_ttm": -18050000.0,
    "levered_cash_flow_ttm": -10750000.0,
    "book_value_per_share_mrq": 0.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "InspireMD, Inc."
  },
  "NSTG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.82,
    "ebitda": -46220000.0,
    "eps_estimate_current_year": -1.96,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 15.6,
    "fifty_two_week_high": 19.81,
    "fifty_two_week_low": 7.8,
    "percent_change_from_200_day_moving_average": 0.2829,
    "percent_change_from_50_day_moving_average": 0.1542,
    "shares_owned": "N/A",
    "short_ratio": 11.42,
    "two_hundred_day_moving_average": 14.04,
    "volume": 78679.0,
    "market_cap": 349160000.0,
    "price_to_sales_ttm": 6.61,
    "price_to_book_mrq": 10.25,
    "roa_ttm": -0.30870000000000003,
    "roe_ttm": -1.0384,
    "shares_outstanding": 19390000.0,
    "pcnt_held_by_insiders": 0.4426,
    "pcnt_held_by_institutions": 0.46299999999999997,
    "pcnt_short_of_float": 0.1199,
    "operating_cash_flow_ttm": -48650000.0,
    "levered_cash_flow_ttm": -34920000.0,
    "book_value_per_share_mrq": 1.75,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NanoString Technologies, Inc."
  },
  "NTRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.78,
    "ebitda": -6780000.0,
    "eps_estimate_current_year": -2.17,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 15.67,
    "fifty_two_week_high": 23.24,
    "fifty_two_week_low": 12.77,
    "percent_change_from_200_day_moving_average": -0.2547,
    "percent_change_from_50_day_moving_average": -0.174,
    "shares_owned": "N/A",
    "short_ratio": 7.22,
    "two_hundred_day_moving_average": 17.36,
    "volume": 299935.0,
    "market_cap": 633820000.0,
    "price_to_sales_ttm": 3.41,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 48980000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0646,
    "operating_cash_flow_ttm": 111000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -27.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Natera, Inc."
  },
  "NURO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.25,
    "earnings_per_share": -1.34,
    "ebitda": -10830000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.9,
    "fifty_two_week_high": 2.05,
    "fifty_two_week_low": 0.71,
    "percent_change_from_200_day_moving_average": -0.1777,
    "percent_change_from_50_day_moving_average": 0.0219,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 1.12,
    "volume": 21320.0,
    "market_cap": 10160000.0,
    "price_to_sales_ttm": 1.91,
    "price_to_book_mrq": 0.87,
    "roa_ttm": -0.43829999999999997,
    "roe_ttm": -0.7951,
    "shares_outstanding": 11040000.0,
    "pcnt_held_by_insiders": 0.1155,
    "pcnt_held_by_institutions": 0.069,
    "pcnt_short_of_float": 0.07730000000000001,
    "operating_cash_flow_ttm": -10420000.0,
    "levered_cash_flow_ttm": -6980000.0,
    "book_value_per_share_mrq": 1.06,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "NeuroMetrix Inc."
  },
  "NUVA": {
    "p_e_ratio": 56.23,
    "peg_ratio": 3.05,
    "earnings_per_share": 0.96,
    "ebitda": 150120000.0,
    "eps_estimate_current_year": 1.19,
    "eps_estimate_next_quarter": 0.32,
    "fifty_day_moving_average": 53.21,
    "fifty_two_week_high": 56.61,
    "fifty_two_week_low": 33.33,
    "percent_change_from_200_day_moving_average": 0.1042,
    "percent_change_from_50_day_moving_average": 0.0113,
    "shares_owned": "N/A",
    "short_ratio": 5.21,
    "two_hundred_day_moving_average": 48.73,
    "volume": 309184.0,
    "market_cap": 2630000000.0,
    "price_to_sales_ttm": 3.34,
    "price_to_book_mrq": 3.94,
    "roa_ttm": 0.0466,
    "roe_ttm": 0.0717,
    "shares_outstanding": 48940000.0,
    "pcnt_held_by_insiders": 0.0154,
    "pcnt_held_by_institutions": 0.99,
    "pcnt_short_of_float": 0.057999999999999996,
    "operating_cash_flow_ttm": 102420000.0,
    "levered_cash_flow_ttm": -59190000.0,
    "book_value_per_share_mrq": 13.67,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "NuVasive, Inc."
  },
  "NVAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.39,
    "ebitda": -90230000.0,
    "eps_estimate_current_year": -0.38,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 11.31,
    "fifty_two_week_high": 15.01,
    "fifty_two_week_low": 3.92,
    "percent_change_from_200_day_moving_average": -0.047400000000000005,
    "percent_change_from_50_day_moving_average": -0.1612,
    "shares_owned": "N/A",
    "short_ratio": 4.3,
    "two_hundred_day_moving_average": 9.96,
    "volume": 5927460.0,
    "market_cap": 2550000000.0,
    "price_to_sales_ttm": 67.62,
    "price_to_book_mrq": 6.77,
    "roa_ttm": -0.16390000000000002,
    "roe_ttm": -0.2877,
    "shares_outstanding": 269180000.0,
    "pcnt_held_by_insiders": 0.0452,
    "pcnt_held_by_institutions": 0.527,
    "pcnt_short_of_float": 0.1137,
    "operating_cash_flow_ttm": -78450000.0,
    "levered_cash_flow_ttm": -54960000.0,
    "book_value_per_share_mrq": 1.44,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Novavax, Inc."
  },
  "NVCN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.34,
    "ebitda": -20190000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.51,
    "fifty_two_week_high": 10.12,
    "fifty_two_week_low": 3.66,
    "percent_change_from_200_day_moving_average": -0.1804,
    "percent_change_from_50_day_moving_average": 0.0538,
    "shares_owned": "N/A",
    "short_ratio": 1.27,
    "two_hundred_day_moving_average": 7.09,
    "volume": 2733.0,
    "market_cap": 386660000.0,
    "price_to_sales_ttm": 37.05,
    "price_to_book_mrq": 5.35,
    "roa_ttm": -0.2584,
    "roe_ttm": -0.42579999999999996,
    "shares_outstanding": 66550000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -13210000.0,
    "levered_cash_flow_ttm": -7550000.0,
    "book_value_per_share_mrq": 1.11,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Neovasc Inc."
  },
  "NVDQ": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.5,
    "earnings_per_share": -0.68,
    "ebitda": -30030000.0,
    "eps_estimate_current_year": -0.8,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 11.64,
    "fifty_two_week_high": 18.24,
    "fifty_two_week_low": 9.4,
    "percent_change_from_200_day_moving_average": 0.0165,
    "percent_change_from_50_day_moving_average": 0.0718,
    "shares_owned": "N/A",
    "short_ratio": 24.62,
    "two_hundred_day_moving_average": 12.27,
    "volume": 261388.0,
    "market_cap": 700750000.0,
    "price_to_sales_ttm": 15.26,
    "price_to_book_mrq": 4.81,
    "roa_ttm": -0.1159,
    "roe_ttm": -0.1936,
    "shares_outstanding": 56200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -30150000.0,
    "levered_cash_flow_ttm": -25460000.0,
    "book_value_per_share_mrq": 2.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Novadaq Technologies Inc."
  },
  "NVET": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.27,
    "ebitda": -15830000.0,
    "eps_estimate_current_year": -2.04,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 4.69,
    "fifty_two_week_high": 11.3,
    "fifty_two_week_low": 3.54,
    "percent_change_from_200_day_moving_average": -0.3104,
    "percent_change_from_50_day_moving_average": -0.0857,
    "shares_owned": "N/A",
    "short_ratio": 2.37,
    "two_hundred_day_moving_average": 6.22,
    "volume": 24495.0,
    "market_cap": 49130000.0,
    "price_to_sales_ttm": 1974.15,
    "price_to_book_mrq": 0.92,
    "roa_ttm": -0.2213,
    "roe_ttm": -0.3023,
    "shares_outstanding": 11450000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0039000000000000003,
    "operating_cash_flow_ttm": -10850000.0,
    "levered_cash_flow_ttm": -9090000.0,
    "book_value_per_share_mrq": 4.7,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nexvet Biopharma Public Limited Company"
  },
  "NVGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.55,
    "ebitda": -5380000.0,
    "eps_estimate_current_year": -0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.76,
    "fifty_two_week_high": 9.5,
    "fifty_two_week_low": 1.51,
    "percent_change_from_200_day_moving_average": -0.4219,
    "percent_change_from_50_day_moving_average": -0.0732,
    "shares_owned": "N/A",
    "short_ratio": 0.41,
    "two_hundred_day_moving_average": 4.43,
    "volume": 100711.0,
    "market_cap": 43330000.0,
    "price_to_sales_ttm": 37.27,
    "price_to_book_mrq": 1.43,
    "roa_ttm": -0.19820000000000002,
    "roe_ttm": -0.31920000000000004,
    "shares_outstanding": 16920000.0,
    "pcnt_held_by_insiders": 0.0479,
    "pcnt_held_by_institutions": 0.006,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -4139999.9999999995,
    "levered_cash_flow_ttm": -2520000.0,
    "book_value_per_share_mrq": 1.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Novogen Limited"
  },
  "NVIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.43,
    "ebitda": -19190000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 10.97,
    "fifty_two_week_high": 19.68,
    "fifty_two_week_low": 2.94,
    "percent_change_from_200_day_moving_average": -0.2183,
    "percent_change_from_50_day_moving_average": -0.0123,
    "shares_owned": "N/A",
    "short_ratio": 7.52,
    "two_hundred_day_moving_average": 13.87,
    "volume": 79505.0,
    "market_cap": 292730000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 19.14,
    "roa_ttm": -0.4885,
    "roe_ttm": -2.4459999999999997,
    "shares_outstanding": 27000000.0,
    "pcnt_held_by_insiders": 0.26940000000000003,
    "pcnt_held_by_institutions": 0.015,
    "pcnt_short_of_float": 0.10439999999999999,
    "operating_cash_flow_ttm": -14590000.0,
    "levered_cash_flow_ttm": -5740000.0,
    "book_value_per_share_mrq": 0.57,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "InVivo Therapeutics Holdings Corp."
  },
  "NVLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.281,
    "ebitda": -16239999.999999998,
    "eps_estimate_current_year": 2.92,
    "eps_estimate_next_quarter": -0.46,
    "fifty_day_moving_average": 16.477,
    "fifty_two_week_high": 20.43,
    "fifty_two_week_low": 13.7,
    "percent_change_from_200_day_moving_average": -0.12075,
    "percent_change_from_50_day_moving_average": -0.12150999999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.72,
    "two_hundred_day_moving_average": 16.463,
    "volume": 50453.0,
    "market_cap": 223660000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.48,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15450000.0,
    "pcnt_held_by_insiders": 0.006500000000000001,
    "pcnt_held_by_institutions": 1.032,
    "pcnt_short_of_float": 0.0042,
    "operating_cash_flow_ttm": -14370000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nivalis Therapeutics, Inc."
  },
  "NVRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -358.8,
    "earnings_per_share": -3.03,
    "ebitda": -44930000.0,
    "eps_estimate_current_year": -2.77,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 47.08,
    "fifty_two_week_high": 65.5,
    "fifty_two_week_low": 23.13,
    "percent_change_from_200_day_moving_average": -0.027200000000000002,
    "percent_change_from_50_day_moving_average": 0.0216,
    "shares_owned": "N/A",
    "short_ratio": 5.67,
    "two_hundred_day_moving_average": 49.44,
    "volume": 251756.0,
    "market_cap": 1340000000.0,
    "price_to_sales_ttm": 34.27,
    "price_to_book_mrq": 5.16,
    "roa_ttm": -0.1566,
    "roe_ttm": -0.3164,
    "shares_outstanding": 27880000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1646,
    "operating_cash_flow_ttm": -56680000.0,
    "levered_cash_flow_ttm": -36260000.0,
    "book_value_per_share_mrq": 9.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Nevro Corp."
  },
  "NVTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.58,
    "ebitda": -66900000.00000001,
    "eps_estimate_current_year": -3.11,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 9.76,
    "fifty_two_week_high": 22.35,
    "fifty_two_week_low": 8.0,
    "percent_change_from_200_day_moving_average": -0.2475,
    "percent_change_from_50_day_moving_average": 0.0196,
    "shares_owned": "N/A",
    "short_ratio": 4.97,
    "two_hundred_day_moving_average": 13.22,
    "volume": 97273.0,
    "market_cap": 316540000.0,
    "price_to_sales_ttm": 77.36,
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.3851,
    "roe_ttm": -0.6655,
    "shares_outstanding": 31810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.077,
    "operating_cash_flow_ttm": -62240000.0,
    "levered_cash_flow_ttm": -42660000.0,
    "book_value_per_share_mrq": 5.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Invitae Corporation"
  },
  "NWBO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.6,
    "ebitda": -113700000.0,
    "eps_estimate_current_year": -1.85,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.6,
    "fifty_two_week_high": 12.55,
    "fifty_two_week_low": 3.79,
    "percent_change_from_200_day_moving_average": -0.1813,
    "percent_change_from_50_day_moving_average": -0.1425,
    "shares_owned": "N/A",
    "short_ratio": 12.3,
    "two_hundred_day_moving_average": 9.0,
    "volume": 234805.0,
    "market_cap": 576110000.0,
    "price_to_sales_ttm": 285.99,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.8503,
    "roe_ttm": "N/A",
    "shares_outstanding": 78170000.0,
    "pcnt_held_by_insiders": 0.4694,
    "pcnt_held_by_institutions": 0.155,
    "pcnt_short_of_float": 0.2797,
    "operating_cash_flow_ttm": -71760000.0,
    "levered_cash_flow_ttm": -2240000.0,
    "book_value_per_share_mrq": -0.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Northwest Biotherapeutics, Inc."
  },
  "NXTM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.68,
    "earnings_per_share": -0.361,
    "ebitda": -5110000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 17.096,
    "fifty_two_week_high": 19.63,
    "fifty_two_week_low": 12.71,
    "percent_change_from_200_day_moving_average": 0.0452,
    "percent_change_from_50_day_moving_average": 0.01221,
    "shares_owned": "N/A",
    "short_ratio": 5.17,
    "two_hundred_day_moving_average": 16.557,
    "volume": 710816.0,
    "market_cap": 1100000000.0,
    "price_to_sales_ttm": 3.44,
    "price_to_book_mrq": 5.78,
    "roa_ttm": -0.0436,
    "roe_ttm": -0.1229,
    "shares_outstanding": 63450000.0,
    "pcnt_held_by_insiders": 0.1208,
    "pcnt_held_by_institutions": 0.912,
    "pcnt_short_of_float": 0.062,
    "operating_cash_flow_ttm": -8440000.0,
    "levered_cash_flow_ttm": 9810000.0,
    "book_value_per_share_mrq": 2.95,
    "next_earnings_announcement_date": "2015-11-03",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Nxstage Medical, Inc."
  },
  "NYMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": -22940000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.54,
    "fifty_two_week_high": 5.55,
    "fifty_two_week_low": 0.33,
    "percent_change_from_200_day_moving_average": 1.2755,
    "percent_change_from_50_day_moving_average": 0.45539999999999997,
    "shares_owned": "N/A",
    "short_ratio": 2.52,
    "two_hundred_day_moving_average": 1.63,
    "volume": 1426260.0,
    "market_cap": 137590000.0,
    "price_to_sales_ttm": 29.72,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "-1,382.64%",
    "roe_ttm": "N/A",
    "shares_outstanding": 37190000.0,
    "pcnt_held_by_insiders": 0.5221,
    "pcnt_held_by_institutions": 0.038,
    "pcnt_short_of_float": 0.0593,
    "operating_cash_flow_ttm": -4040000.0,
    "levered_cash_flow_ttm": 5690000.0,
    "book_value_per_share_mrq": -0.06,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Nymox Pharmaceutical Corporation"
  },
  "OCAT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.73,
    "ebitda": -24300000.0,
    "eps_estimate_current_year": -0.61,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 4.08,
    "fifty_two_week_high": 9.45,
    "fifty_two_week_low": 3.06,
    "percent_change_from_200_day_moving_average": -0.2186,
    "percent_change_from_50_day_moving_average": 0.0611,
    "shares_owned": "N/A",
    "short_ratio": 4.8,
    "two_hundred_day_moving_average": 5.54,
    "volume": 1639986.0,
    "market_cap": 182840000.0,
    "price_to_sales_ttm": 1198.22,
    "price_to_book_mrq": 11.67,
    "roa_ttm": -0.7889,
    "roe_ttm": -4.8003,
    "shares_outstanding": 42230000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0691,
    "operating_cash_flow_ttm": -24570000.0,
    "levered_cash_flow_ttm": -38440000.0,
    "book_value_per_share_mrq": 0.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocata Therapeutics, Inc."
  },
  "OCLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.92,
    "ebitda": -7200000.0,
    "eps_estimate_current_year": -0.45,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 1.18,
    "fifty_two_week_high": 2.35,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": 0.0787,
    "percent_change_from_50_day_moving_average": 0.0354,
    "shares_owned": "N/A",
    "short_ratio": 3.09,
    "two_hundred_day_moving_average": 1.13,
    "volume": 39982.0,
    "market_cap": 20010000.0,
    "price_to_sales_ttm": 1.39,
    "price_to_book_mrq": 1.69,
    "roa_ttm": -0.2734,
    "roe_ttm": -0.8534999999999999,
    "shares_outstanding": 16410000.0,
    "pcnt_held_by_insiders": 0.0815,
    "pcnt_held_by_institutions": 0.107,
    "pcnt_short_of_float": 0.08689999999999999,
    "operating_cash_flow_ttm": -7930000.0,
    "levered_cash_flow_ttm": -6520000.0,
    "book_value_per_share_mrq": 0.71,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Oculus Innovative Sciences, Inc."
  },
  "OCRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.27,
    "ebitda": -24940000.0,
    "eps_estimate_current_year": -1.43,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 3.79,
    "fifty_two_week_high": 8.1,
    "fifty_two_week_low": 3.3,
    "percent_change_from_200_day_moving_average": -0.0391,
    "percent_change_from_50_day_moving_average": 0.003,
    "shares_owned": "N/A",
    "short_ratio": 2.04,
    "two_hundred_day_moving_average": 3.95,
    "volume": 429709.0,
    "market_cap": 75560000.0,
    "price_to_sales_ttm": 213.87,
    "price_to_book_mrq": 1.82,
    "roa_ttm": -0.38079999999999997,
    "roe_ttm": -0.6589,
    "shares_outstanding": 19880000.0,
    "pcnt_held_by_insiders": 0.26890000000000003,
    "pcnt_held_by_institutions": 0.21100000000000002,
    "pcnt_short_of_float": 0.0106,
    "operating_cash_flow_ttm": -20050000.0,
    "levered_cash_flow_ttm": -11480000.0,
    "book_value_per_share_mrq": 1.99,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocera Therapeutics, Inc."
  },
  "OCUL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.64,
    "ebitda": -30410000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 18.39,
    "fifty_two_week_high": 44.19,
    "fifty_two_week_low": 13.0,
    "percent_change_from_200_day_moving_average": -0.2742,
    "percent_change_from_50_day_moving_average": -0.008100000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.53,
    "two_hundred_day_moving_average": 25.13,
    "volume": 140621.0,
    "market_cap": 450890000.0,
    "price_to_sales_ttm": 296.36,
    "price_to_book_mrq": 4.16,
    "roa_ttm": -0.2531,
    "roe_ttm": -0.5716,
    "shares_outstanding": 24720000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1295,
    "operating_cash_flow_ttm": -27370000.0,
    "levered_cash_flow_ttm": -15870000.0,
    "book_value_per_share_mrq": 4.42,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocular Therapeutix, Inc."
  },
  "OFIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.86,
    "earnings_per_share": -0.54,
    "ebitda": 18830000.0,
    "eps_estimate_current_year": 0.69,
    "eps_estimate_next_quarter": 0.22,
    "fifty_day_moving_average": 37.41,
    "fifty_two_week_high": 42.1,
    "fifty_two_week_low": 26.96,
    "percent_change_from_200_day_moving_average": 0.0338,
    "percent_change_from_50_day_moving_average": -0.0415,
    "shares_owned": "N/A",
    "short_ratio": 5.88,
    "two_hundred_day_moving_average": 34.69,
    "volume": 66664.0,
    "market_cap": 675980000.0,
    "price_to_sales_ttm": 1.71,
    "price_to_book_mrq": 2.25,
    "roa_ttm": 0.013999999999999999,
    "roe_ttm": -0.028900000000000002,
    "shares_outstanding": 18850000.0,
    "pcnt_held_by_insiders": 0.0336,
    "pcnt_held_by_institutions": 0.875,
    "pcnt_short_of_float": 0.0374,
    "operating_cash_flow_ttm": 42040000.0,
    "levered_cash_flow_ttm": 78030000.0,
    "book_value_per_share_mrq": 15.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Orthofix International N.V."
  },
  "OGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.27,
    "ebitda": -9850000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.56,
    "fifty_two_week_high": 3.87,
    "fifty_two_week_low": 0.66,
    "percent_change_from_200_day_moving_average": 0.6375,
    "percent_change_from_50_day_moving_average": -0.0046,
    "shares_owned": "N/A",
    "short_ratio": 0.85,
    "two_hundred_day_moving_average": 1.56,
    "volume": 145081.0,
    "market_cap": 93020000.0,
    "price_to_sales_ttm": 97.11,
    "price_to_book_mrq": 32.18,
    "roa_ttm": -0.5615,
    "roe_ttm": -1.2625,
    "shares_outstanding": 36480000.0,
    "pcnt_held_by_insiders": 0.3296,
    "pcnt_held_by_institutions": 0.414,
    "pcnt_short_of_float": 0.0398,
    "operating_cash_flow_ttm": -4510000.0,
    "levered_cash_flow_ttm": -6170000.0,
    "book_value_per_share_mrq": 0.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oragenics Inc."
  },
  "OGXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.95,
    "ebitda": -24530000.0,
    "eps_estimate_current_year": -0.84,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 2.79,
    "fifty_two_week_high": 4.1,
    "fifty_two_week_low": 1.38,
    "percent_change_from_200_day_moving_average": 0.0097,
    "percent_change_from_50_day_moving_average": -0.1039,
    "shares_owned": "N/A",
    "short_ratio": 2.05,
    "two_hundred_day_moving_average": 2.48,
    "volume": 2398611.0,
    "market_cap": 74480000.0,
    "price_to_sales_ttm": 5.49,
    "price_to_book_mrq": 2.53,
    "roa_ttm": -0.2737,
    "roe_ttm": -0.7726999999999999,
    "shares_outstanding": 29790000.0,
    "pcnt_held_by_insiders": 0.1058,
    "pcnt_held_by_institutions": 0.26899999999999996,
    "pcnt_short_of_float": 0.0861,
    "operating_cash_flow_ttm": -2490000.0,
    "levered_cash_flow_ttm": 9820000.0,
    "book_value_per_share_mrq": 1.15,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoGenex Pharmaceuticals, Inc."
  },
  "OHRP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -0.53,
    "ebitda": -15900000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 2.81,
    "fifty_two_week_high": 12.31,
    "fifty_two_week_low": 2.02,
    "percent_change_from_200_day_moving_average": -0.0978,
    "percent_change_from_50_day_moving_average": 0.1139,
    "shares_owned": "N/A",
    "short_ratio": 3.46,
    "two_hundred_day_moving_average": 3.47,
    "volume": 245399.0,
    "market_cap": 94940000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.06,
    "roa_ttm": -0.2516,
    "roe_ttm": -0.38659999999999994,
    "shares_outstanding": 30330000.0,
    "pcnt_held_by_insiders": 0.4111,
    "pcnt_held_by_institutions": 0.134,
    "pcnt_short_of_float": 0.13720000000000002,
    "operating_cash_flow_ttm": -10060000.0,
    "levered_cash_flow_ttm": -12250000.0,
    "book_value_per_share_mrq": 1.5,
    "next_earnings_announcement_date": [
      "2015-12-21",
      "2015-12-28"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ohr Pharmaceutical, Inc."
  },
  "OMED": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.9,
    "ebitda": -55770000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 20.0,
    "fifty_two_week_high": 29.83,
    "fifty_two_week_low": 16.54,
    "percent_change_from_200_day_moving_average": -0.2779,
    "percent_change_from_50_day_moving_average": -0.16210000000000002,
    "shares_owned": "N/A",
    "short_ratio": 16.24,
    "two_hundred_day_moving_average": 23.21,
    "volume": 161343.0,
    "market_cap": 503840000.0,
    "price_to_sales_ttm": 12.2,
    "price_to_book_mrq": 11.03,
    "roa_ttm": -0.1452,
    "roe_ttm": -0.818,
    "shares_outstanding": 30060000.0,
    "pcnt_held_by_insiders": 0.7356999999999999,
    "pcnt_held_by_institutions": 0.21100000000000002,
    "pcnt_short_of_float": 0.1177,
    "operating_cash_flow_ttm": -66370000.00000001,
    "levered_cash_flow_ttm": -38530000.0,
    "book_value_per_share_mrq": 1.54,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoMed Pharmaceuticals, Inc."
  },
  "OMER": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.09,
    "earnings_per_share": -2.09,
    "ebitda": -70740000.0,
    "eps_estimate_current_year": -1.83,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 15.13,
    "fifty_two_week_high": 30.23,
    "fifty_two_week_low": 11.18,
    "percent_change_from_200_day_moving_average": -0.36219999999999997,
    "percent_change_from_50_day_moving_average": -0.1778,
    "shares_owned": "N/A",
    "short_ratio": 3.74,
    "two_hundred_day_moving_average": 19.5,
    "volume": 525346.0,
    "market_cap": 471300000.0,
    "price_to_sales_ttm": 122.75,
    "price_to_book_mrq": 61.53,
    "roa_ttm": -0.8909,
    "roe_ttm": "N/A",
    "shares_outstanding": 37890000.0,
    "pcnt_held_by_insiders": 0.06849999999999999,
    "pcnt_held_by_institutions": 0.408,
    "pcnt_short_of_float": 0.2838,
    "operating_cash_flow_ttm": -65650000.00000001,
    "levered_cash_flow_ttm": -38480000.0,
    "book_value_per_share_mrq": 0.21,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Omeros Corporation"
  },
  "ONCE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.09,
    "ebitda": -38200000.0,
    "eps_estimate_current_year": -2.08,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 47.12,
    "fifty_two_week_high": 79.5,
    "fifty_two_week_low": 36.96,
    "percent_change_from_200_day_moving_average": -0.2763,
    "percent_change_from_50_day_moving_average": -0.066,
    "shares_owned": "N/A",
    "short_ratio": 6.93,
    "two_hundred_day_moving_average": 60.81,
    "volume": 232175.0,
    "market_cap": 1080000000.0,
    "price_to_sales_ttm": 254.36,
    "price_to_book_mrq": 5.17,
    "roa_ttm": -0.1535,
    "roe_ttm": -0.29059999999999997,
    "shares_outstanding": 24560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.2147,
    "operating_cash_flow_ttm": -4950000.0,
    "levered_cash_flow_ttm": -23520000.0,
    "book_value_per_share_mrq": 8.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Spark Therapeutics, Inc."
  },
  "ONCS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.5,
    "ebitda": -17410000.0,
    "eps_estimate_current_year": -1.26,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 5.83,
    "fifty_two_week_high": 13.2,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": 0.0981,
    "percent_change_from_50_day_moving_average": 0.1723,
    "shares_owned": "N/A",
    "short_ratio": 0.2,
    "two_hundred_day_moving_average": 6.23,
    "volume": 55520.0,
    "market_cap": 101390000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.29,
    "roa_ttm": -0.4267,
    "roe_ttm": -0.7225,
    "shares_outstanding": 14820000.0,
    "pcnt_held_by_insiders": 0.1709,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": -15140000.0,
    "levered_cash_flow_ttm": -9340000.0,
    "book_value_per_share_mrq": 2.1,
    "next_earnings_announcement_date": [
      "2015-10-08",
      "2015-10-12"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoSec Medical Incorporated"
  },
  "ONCY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.122,
    "ebitda": -11960000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.5571,
    "fifty_two_week_high": 1.4,
    "fifty_two_week_low": 0.4,
    "percent_change_from_200_day_moving_average": -0.16886500000000002,
    "percent_change_from_50_day_moving_average": -0.029154,
    "shares_owned": "N/A",
    "short_ratio": 4.39,
    "two_hundred_day_moving_average": 0.6508,
    "volume": 123249.0,
    "market_cap": 63820000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.78,
    "roa_ttm": -0.37549999999999994,
    "roe_ttm": -0.6801999999999999,
    "shares_outstanding": 117980000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0089,
    "operating_cash_flow_ttm": -11800000.0,
    "levered_cash_flow_ttm": -7630000.0,
    "book_value_per_share_mrq": 0.19,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Oncolytics Biotech Inc."
  },
  "ONTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.283,
    "ebitda": -49260000.0,
    "eps_estimate_current_year": -1.63,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 1.6463,
    "fifty_two_week_high": 5.0,
    "fifty_two_week_low": 1.35,
    "percent_change_from_200_day_moving_average": -0.385511,
    "percent_change_from_50_day_moving_average": -0.149542,
    "shares_owned": "N/A",
    "short_ratio": 0.35,
    "two_hundred_day_moving_average": 2.2785,
    "volume": 61667.0,
    "market_cap": 30510000.0,
    "price_to_sales_ttm": 68.8,
    "price_to_book_mrq": 8.53,
    "roa_ttm": -0.6053999999999999,
    "roe_ttm": -1.8552000000000002,
    "shares_outstanding": 21790000.0,
    "pcnt_held_by_insiders": 0.6256,
    "pcnt_held_by_institutions": 0.135,
    "pcnt_short_of_float": 0.0277,
    "operating_cash_flow_ttm": -45790000.0,
    "levered_cash_flow_ttm": -26820000.0,
    "book_value_per_share_mrq": 0.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Onconova Therapeutics, Inc."
  },
  "ONTY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.58,
    "ebitda": -51230000.0,
    "eps_estimate_current_year": -0.38,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 3.34,
    "fifty_two_week_high": 4.69,
    "fifty_two_week_low": 1.41,
    "percent_change_from_200_day_moving_average": 0.1591,
    "percent_change_from_50_day_moving_average": -0.0051,
    "shares_owned": "N/A",
    "short_ratio": 6.11,
    "two_hundred_day_moving_average": 2.86,
    "volume": 779463.0,
    "market_cap": 315100000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.15,
    "roa_ttm": -0.3739,
    "roe_ttm": -0.6931,
    "shares_outstanding": 94910000.0,
    "pcnt_held_by_insiders": 0.0794,
    "pcnt_held_by_institutions": 0.562,
    "pcnt_short_of_float": 0.08779999999999999,
    "operating_cash_flow_ttm": -50200000.0,
    "levered_cash_flow_ttm": -28630000.0,
    "book_value_per_share_mrq": 1.01,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oncothyreon Inc"
  },
  "ONVO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.4,
    "ebitda": -31830000.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 2.83,
    "fifty_two_week_high": 7.68,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": -0.0736,
    "percent_change_from_50_day_moving_average": 0.3036,
    "shares_owned": "N/A",
    "short_ratio": 13.44,
    "two_hundred_day_moving_average": 3.98,
    "volume": 855934.0,
    "market_cap": 341050000.0,
    "price_to_sales_ttm": 446.69,
    "price_to_book_mrq": 4.07,
    "roa_ttm": -0.29410000000000003,
    "roe_ttm": -0.4978,
    "shares_outstanding": 92430000.0,
    "pcnt_held_by_insiders": 0.10769999999999999,
    "pcnt_held_by_institutions": 0.19699999999999998,
    "pcnt_short_of_float": 0.3099,
    "operating_cash_flow_ttm": -22530000.0,
    "levered_cash_flow_ttm": -12540000.0,
    "book_value_per_share_mrq": 0.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Organovo Holdings, Inc."
  },
  "OPGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.74,
    "ebitda": -8050000.000000001,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.64,
    "fifty_two_week_high": 5.44,
    "fifty_two_week_low": 2.21,
    "percent_change_from_200_day_moving_average": -0.1142,
    "percent_change_from_50_day_moving_average": 0.16649999999999998,
    "shares_owned": "N/A",
    "short_ratio": 0.84,
    "two_hundred_day_moving_average": 3.48,
    "volume": 7582.0,
    "market_cap": 38620000.0,
    "price_to_sales_ttm": 13.81,
    "price_to_book_mrq": 3.75,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 12540000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0037,
    "operating_cash_flow_ttm": -7360000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "OpGen, Inc."
  },
  "OPHT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.58,
    "ebitda": -51850000.0,
    "eps_estimate_current_year": -3.15,
    "eps_estimate_next_quarter": -1.14,
    "fifty_day_moving_average": 49.29,
    "fifty_two_week_high": 72.51,
    "fifty_two_week_low": 36.46,
    "percent_change_from_200_day_moving_average": -0.20420000000000002,
    "percent_change_from_50_day_moving_average": -0.1629,
    "shares_owned": "N/A",
    "short_ratio": 5.5,
    "two_hundred_day_moving_average": 51.85,
    "volume": 491244.0,
    "market_cap": 1430000000.0,
    "price_to_sales_ttm": 17.26,
    "price_to_book_mrq": 12.8,
    "roa_ttm": -0.069,
    "roe_ttm": -0.3923,
    "shares_outstanding": 34740000.0,
    "pcnt_held_by_insiders": 0.6469,
    "pcnt_held_by_institutions": 0.23800000000000002,
    "pcnt_short_of_float": 0.1272,
    "operating_cash_flow_ttm": -49530000.0,
    "levered_cash_flow_ttm": -34170000.0,
    "book_value_per_share_mrq": 3.28,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ophthotech Corporation"
  },
  "OPK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.98,
    "earnings_per_share": -0.59,
    "ebitda": -94770000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 11.78,
    "fifty_two_week_high": 19.2,
    "fifty_two_week_low": 8.02,
    "percent_change_from_200_day_moving_average": -0.3471,
    "percent_change_from_50_day_moving_average": -0.18899999999999997,
    "shares_owned": "N/A",
    "short_ratio": 8.59,
    "two_hundred_day_moving_average": 14.63,
    "volume": 4414371.0,
    "market_cap": 5160000000.0,
    "price_to_sales_ttm": 38.37,
    "price_to_book_mrq": 5.41,
    "roa_ttm": -0.0481,
    "roe_ttm": -0.3044,
    "shares_outstanding": 540420000.0,
    "pcnt_held_by_insiders": 0.5118,
    "pcnt_held_by_institutions": 0.185,
    "pcnt_short_of_float": 0.804,
    "operating_cash_flow_ttm": 158900000.0,
    "levered_cash_flow_ttm": 53660000.0,
    "book_value_per_share_mrq": 1.8,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Opko Health, Inc."
  },
  "OPXA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -13730000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 0.41,
    "fifty_two_week_high": 1.08,
    "fifty_two_week_low": 0.3,
    "percent_change_from_200_day_moving_average": 0.024,
    "percent_change_from_50_day_moving_average": 0.165,
    "shares_owned": "N/A",
    "short_ratio": 2.47,
    "two_hundred_day_moving_average": 0.47,
    "volume": 462920.0,
    "market_cap": 25630000.0,
    "price_to_sales_ttm": 14.48,
    "price_to_book_mrq": 1.88,
    "roa_ttm": -0.4556,
    "roe_ttm": -1.0519,
    "shares_outstanding": 53390000.0,
    "pcnt_held_by_insiders": 0.09970000000000001,
    "pcnt_held_by_institutions": 0.049,
    "pcnt_short_of_float": 0.0166,
    "operating_cash_flow_ttm": -10600000.0,
    "levered_cash_flow_ttm": -5120000.0,
    "book_value_per_share_mrq": 0.25,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Opexa Therapeutics, Inc."
  },
  "OREX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.05,
    "earnings_per_share": -0.22,
    "ebitda": -20570000.0,
    "eps_estimate_current_year": -0.67,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 3.0,
    "fifty_two_week_high": 9.37,
    "fifty_two_week_low": 2.19,
    "percent_change_from_200_day_moving_average": -0.5276,
    "percent_change_from_50_day_moving_average": -0.1935,
    "shares_owned": "N/A",
    "short_ratio": 13.52,
    "two_hundred_day_moving_average": 5.12,
    "volume": 2527907.0,
    "market_cap": 303450000.0,
    "price_to_sales_ttm": 4.75,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0782,
    "roe_ttm": "N/A",
    "shares_outstanding": 125390000.0,
    "pcnt_held_by_insiders": 0.09050000000000001,
    "pcnt_held_by_institutions": 0.7959999999999999,
    "pcnt_short_of_float": 0.32380000000000003,
    "operating_cash_flow_ttm": 36510000.0,
    "levered_cash_flow_ttm": 7040000.0,
    "book_value_per_share_mrq": -0.03,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Orexigen Therapeutics, Inc."
  },
  "ORMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.64,
    "ebitda": -6850000.0,
    "eps_estimate_current_year": -0.72,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.92,
    "fifty_two_week_high": 9.84,
    "fifty_two_week_low": 3.71,
    "percent_change_from_200_day_moving_average": -0.0875,
    "percent_change_from_50_day_moving_average": -0.0125,
    "shares_owned": "N/A",
    "short_ratio": 13.53,
    "two_hundred_day_moving_average": 6.41,
    "volume": 9879.0,
    "market_cap": 67570000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.98,
    "roa_ttm": -0.19210000000000002,
    "roe_ttm": -0.3116,
    "shares_outstanding": 11550000.0,
    "pcnt_held_by_insiders": 0.2372,
    "pcnt_held_by_institutions": 0.13,
    "pcnt_short_of_float": 0.08070000000000001,
    "operating_cash_flow_ttm": -4720000.0,
    "levered_cash_flow_ttm": -2130000.0,
    "book_value_per_share_mrq": 1.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oramed Pharmaceuticals Inc."
  },
  "ORPN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.88,
    "ebitda": -12370000.0,
    "eps_estimate_current_year": -1.13,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 5.78,
    "fifty_two_week_high": 8.85,
    "fifty_two_week_low": 4.5,
    "percent_change_from_200_day_moving_average": -0.024,
    "percent_change_from_50_day_moving_average": 0.046900000000000004,
    "shares_owned": "N/A",
    "short_ratio": 0.96,
    "two_hundred_day_moving_average": 6.2,
    "volume": 11073.0,
    "market_cap": 86090000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.43,
    "roa_ttm": -0.4927,
    "roe_ttm": -0.8467,
    "shares_outstanding": 14230000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.004699999999999999,
    "operating_cash_flow_ttm": -9580000.0,
    "levered_cash_flow_ttm": -5040000.0,
    "book_value_per_share_mrq": 1.77,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bio Blast Pharma Ltd."
  },
  "OSIR": {
    "p_e_ratio": 170.97,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.11,
    "ebitda": 7020000.0,
    "eps_estimate_current_year": 0.21,
    "eps_estimate_next_quarter": 0.08,
    "fifty_day_moving_average": 18.46,
    "fifty_two_week_high": 23.67,
    "fifty_two_week_low": 11.87,
    "percent_change_from_200_day_moving_average": 0.049800000000000004,
    "percent_change_from_50_day_moving_average": 0.046799999999999994,
    "shares_owned": "N/A",
    "short_ratio": 14.1,
    "two_hundred_day_moving_average": 18.4,
    "volume": 81024.0,
    "market_cap": 665370000.0,
    "price_to_sales_ttm": 8.03,
    "price_to_book_mrq": 7.34,
    "roa_ttm": 0.038900000000000004,
    "roe_ttm": 0.051100000000000007,
    "shares_outstanding": 34440000.0,
    "pcnt_held_by_insiders": 0.5297,
    "pcnt_held_by_institutions": 0.266,
    "pcnt_short_of_float": 0.18230000000000002,
    "operating_cash_flow_ttm": 5960000.0,
    "levered_cash_flow_ttm": -8750000.0,
    "book_value_per_share_mrq": 2.58,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Osiris Therapeutics, Inc."
  },
  "OSUR": {
    "p_e_ratio": 515.0,
    "peg_ratio": 6.59,
    "earnings_per_share": 0.01,
    "ebitda": 6800000.0,
    "eps_estimate_current_year": 0.04,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 5.31,
    "fifty_two_week_high": 10.93,
    "fifty_two_week_low": 4.42,
    "percent_change_from_200_day_moving_average": -0.1247,
    "percent_change_from_50_day_moving_average": -0.029300000000000003,
    "shares_owned": "N/A",
    "short_ratio": 3.23,
    "two_hundred_day_moving_average": 5.88,
    "volume": 562103.0,
    "market_cap": 290880000.0,
    "price_to_sales_ttm": 2.61,
    "price_to_book_mrq": 1.86,
    "roa_ttm": 0.0026,
    "roe_ttm": 0.0036,
    "shares_outstanding": 56480000.0,
    "pcnt_held_by_insiders": 0.0292,
    "pcnt_held_by_institutions": 0.7909999999999999,
    "pcnt_short_of_float": 0.0455,
    "operating_cash_flow_ttm": 14500000.0,
    "levered_cash_flow_ttm": 12790000.0,
    "book_value_per_share_mrq": 2.83,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "OraSure Technologies, Inc."
  },
  "OTIC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.33,
    "earnings_per_share": -2.36,
    "ebitda": -43770000.0,
    "eps_estimate_current_year": -2.87,
    "eps_estimate_next_quarter": -0.92,
    "fifty_day_moving_average": 23.29,
    "fifty_two_week_high": 41.99,
    "fifty_two_week_low": 19.86,
    "percent_change_from_200_day_moving_average": -0.1223,
    "percent_change_from_50_day_moving_average": 0.0327,
    "shares_owned": "N/A",
    "short_ratio": 11.82,
    "two_hundred_day_moving_average": 27.4,
    "volume": 106236.0,
    "market_cap": 582010000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.71,
    "roa_ttm": -0.1894,
    "roe_ttm": -0.33270000000000005,
    "shares_outstanding": 24200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1419,
    "operating_cash_flow_ttm": -40980000.0,
    "levered_cash_flow_ttm": -25830000.0,
    "book_value_per_share_mrq": 8.79,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Otonomy, Inc."
  },
  "OVAS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.62,
    "ebitda": -63960000.0,
    "eps_estimate_current_year": -2.55,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 20.81,
    "fifty_two_week_high": 55.69,
    "fifty_two_week_low": 13.25,
    "percent_change_from_200_day_moving_average": -0.3926,
    "percent_change_from_50_day_moving_average": -0.1293,
    "shares_owned": "N/A",
    "short_ratio": 12.97,
    "two_hundred_day_moving_average": 29.83,
    "volume": 447866.0,
    "market_cap": 494070000.0,
    "price_to_sales_ttm": 11391.13,
    "price_to_book_mrq": 3.27,
    "roa_ttm": -0.32299999999999995,
    "roe_ttm": -0.5650999999999999,
    "shares_outstanding": 27270000.0,
    "pcnt_held_by_insiders": 0.29760000000000003,
    "pcnt_held_by_institutions": 0.581,
    "pcnt_short_of_float": 0.49079999999999996,
    "operating_cash_flow_ttm": -45500000.0,
    "levered_cash_flow_ttm": -24210000.0,
    "book_value_per_share_mrq": 5.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OvaScience, Inc."
  },
  "OXFD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.37,
    "ebitda": -23920000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 13.74,
    "fifty_two_week_high": 15.61,
    "fifty_two_week_low": 10.01,
    "percent_change_from_200_day_moving_average": 0.0208,
    "percent_change_from_50_day_moving_average": 0.0111,
    "shares_owned": "N/A",
    "short_ratio": 11.64,
    "two_hundred_day_moving_average": 13.61,
    "volume": 26874.0,
    "market_cap": 312970000.0,
    "price_to_sales_ttm": 5.81,
    "price_to_book_mrq": 3.03,
    "roa_ttm": -0.16140000000000002,
    "roe_ttm": -0.3009,
    "shares_outstanding": 22530000.0,
    "pcnt_held_by_insiders": 0.1099,
    "pcnt_held_by_institutions": 0.595,
    "pcnt_short_of_float": 0.0315,
    "operating_cash_flow_ttm": -23220000.0,
    "levered_cash_flow_ttm": -16940000.0,
    "book_value_per_share_mrq": 4.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Oxford Immunotec Global PLC"
  },
  "OXGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.55,
    "ebitda": -12140000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 1.28,
    "fifty_two_week_high": 2.53,
    "fifty_two_week_low": 1.01,
    "percent_change_from_200_day_moving_average": -0.122,
    "percent_change_from_50_day_moving_average": -0.025,
    "shares_owned": "N/A",
    "short_ratio": 6.07,
    "two_hundred_day_moving_average": 1.42,
    "volume": 100944.0,
    "market_cap": 33180000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.03,
    "roa_ttm": -0.2164,
    "roe_ttm": -0.3617,
    "shares_outstanding": 26540000.0,
    "pcnt_held_by_insiders": 0.20379999999999998,
    "pcnt_held_by_institutions": 0.057,
    "pcnt_short_of_float": 0.04650000000000001,
    "operating_cash_flow_ttm": -12340000.0,
    "levered_cash_flow_ttm": -7820000.0,
    "book_value_per_share_mrq": 1.22,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OXiGENE, Inc."
  },
  "PACB": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.18,
    "earnings_per_share": -0.82,
    "ebitda": -53240000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 4.71,
    "fifty_two_week_high": 8.78,
    "fifty_two_week_low": 4.16,
    "percent_change_from_200_day_moving_average": -0.2065,
    "percent_change_from_50_day_moving_average": -0.0827,
    "shares_owned": "N/A",
    "short_ratio": 23.76,
    "two_hundred_day_moving_average": 5.44,
    "volume": 203566.0,
    "market_cap": 323860000.0,
    "price_to_sales_ttm": 4.03,
    "price_to_book_mrq": 9.56,
    "roa_ttm": -0.3166,
    "roe_ttm": -1.2977,
    "shares_outstanding": 74970000.0,
    "pcnt_held_by_insiders": 0.18969999999999998,
    "pcnt_held_by_institutions": 0.5429999999999999,
    "pcnt_short_of_float": 0.318,
    "operating_cash_flow_ttm": -53000000.0,
    "levered_cash_flow_ttm": -14690000.0,
    "book_value_per_share_mrq": 0.45,
    "next_earnings_announcement_date": [
      "2015-10-12",
      "2015-10-22"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pacific Biosciences of California, Inc."
  },
  "PAHC": {
    "p_e_ratio": 23.58,
    "peg_ratio": 1.46,
    "earnings_per_share": 1.51,
    "ebitda": 107110000.0,
    "eps_estimate_current_year": 1.7,
    "eps_estimate_next_quarter": 0.41,
    "fifty_day_moving_average": 36.24,
    "fifty_two_week_high": 40.54,
    "fifty_two_week_low": 21.01,
    "percent_change_from_200_day_moving_average": 0.0002,
    "percent_change_from_50_day_moving_average": -0.0174,
    "shares_owned": "N/A",
    "short_ratio": 2.95,
    "two_hundred_day_moving_average": 35.6,
    "volume": 139794.0,
    "market_cap": 1390000000.0,
    "price_to_sales_ttm": 1.82,
    "price_to_book_mrq": 45.88,
    "roa_ttm": 0.11449999999999999,
    "roe_ttm": 2.6925,
    "shares_outstanding": 17950000.0,
    "pcnt_held_by_insiders": 0.3583,
    "pcnt_held_by_institutions": 0.264,
    "pcnt_short_of_float": 0.0388,
    "operating_cash_flow_ttm": 68700000.0,
    "levered_cash_flow_ttm": 50690000.0,
    "book_value_per_share_mrq": 0.76,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Phibro Animal Health Corporation"
  },
  "PARN": {
    "p_e_ratio": 11.5003,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.32,
    "ebitda": -6260000.0,
    "eps_estimate_current_year": -0.69,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 4.2049,
    "fifty_two_week_high": 6.38,
    "fifty_two_week_low": 3.29,
    "percent_change_from_200_day_moving_average": -0.167967,
    "percent_change_from_50_day_moving_average": -0.124809,
    "shares_owned": "N/A",
    "short_ratio": 1.0,
    "two_hundred_day_moving_average": 4.423,
    "volume": 18199.0,
    "market_cap": 48890000.0,
    "price_to_sales_ttm": 9.01,
    "price_to_book_mrq": 2.47,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13280000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": -4139999.9999999995,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Parnell Pharmaceuticals Holdings Ltd."
  },
  "PBMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.45,
    "ebitda": -9340000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.2,
    "fifty_two_week_high": 6.48,
    "fifty_two_week_low": 0.42,
    "percent_change_from_200_day_moving_average": -0.06280000000000001,
    "percent_change_from_50_day_moving_average": -0.032400000000000005,
    "shares_owned": "N/A",
    "short_ratio": 0.38,
    "two_hundred_day_moving_average": 1.24,
    "volume": 401329.0,
    "market_cap": 76340000.0,
    "price_to_sales_ttm": 80.89,
    "price_to_book_mrq": 3.93,
    "roa_ttm": -0.3179,
    "roe_ttm": -1.36,
    "shares_outstanding": 65810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -5600000.0,
    "levered_cash_flow_ttm": -4760000.0,
    "book_value_per_share_mrq": 0.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Prima Biomed Ltd."
  },
  "PBYI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.35,
    "earnings_per_share": -6.46,
    "ebitda": -200350000.0,
    "eps_estimate_current_year": -7.28,
    "eps_estimate_next_quarter": -1.81,
    "fifty_day_moving_average": 92.92,
    "fifty_two_week_high": 266.75,
    "fifty_two_week_low": 79.29,
    "percent_change_from_200_day_moving_average": -0.4188,
    "percent_change_from_50_day_moving_average": -0.0501,
    "shares_owned": "N/A",
    "short_ratio": 7.06,
    "two_hundred_day_moving_average": 151.88,
    "volume": 627083.0,
    "market_cap": 2850000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 11.05,
    "roa_ttm": -0.5042,
    "roe_ttm": -0.9075,
    "shares_outstanding": 32310000.000000004,
    "pcnt_held_by_insiders": 0.18239999999999998,
    "pcnt_held_by_institutions": 0.8640000000000001,
    "pcnt_short_of_float": 0.20829999999999999,
    "operating_cash_flow_ttm": -127350000.0,
    "levered_cash_flow_ttm": -53550000.0,
    "book_value_per_share_mrq": 8.53,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Puma Biotechnology, Inc."
  },
  "PCRX": {
    "p_e_ratio": 523.27,
    "peg_ratio": 1.06,
    "earnings_per_share": 0.11,
    "ebitda": 22580000.0,
    "eps_estimate_current_year": 0.83,
    "eps_estimate_next_quarter": 0.24,
    "fifty_day_moving_average": 61.45,
    "fifty_two_week_high": 121.95,
    "fifty_two_week_low": 54.0,
    "percent_change_from_200_day_moving_average": -0.24239999999999998,
    "percent_change_from_50_day_moving_average": -0.0889,
    "shares_owned": "N/A",
    "short_ratio": 7.54,
    "two_hundred_day_moving_average": 73.9,
    "volume": 2810984.0,
    "market_cap": 2049999999.9999998,
    "price_to_sales_ttm": 9.61,
    "price_to_book_mrq": 11.37,
    "roa_ttm": 0.023399999999999997,
    "roe_ttm": 0.023700000000000002,
    "shares_outstanding": 36650000.0,
    "pcnt_held_by_insiders": 0.07150000000000001,
    "pcnt_held_by_institutions": 1.0270000000000001,
    "pcnt_short_of_float": 0.1745,
    "operating_cash_flow_ttm": 31130000.0,
    "levered_cash_flow_ttm": -4240000.0,
    "book_value_per_share_mrq": 5.33,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Pacira Pharmaceuticals, Inc."
  },
  "PDEX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.088,
    "ebitda": -324000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.3451,
    "fifty_two_week_high": 3.07,
    "fifty_two_week_low": 1.99,
    "percent_change_from_200_day_moving_average": 0.121356,
    "percent_change_from_50_day_moving_average": 0.074477,
    "shares_owned": "N/A",
    "short_ratio": 0.7,
    "two_hundred_day_moving_average": 2.2471,
    "volume": 10974.0,
    "market_cap": 10430000.0,
    "price_to_sales_ttm": 0.78,
    "price_to_book_mrq": 1.23,
    "roa_ttm": -0.04650000000000001,
    "roe_ttm": -0.0454,
    "shares_outstanding": 4139999.9999999995,
    "pcnt_held_by_insiders": 0.4263,
    "pcnt_held_by_institutions": 0.017,
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": -775000.0,
    "levered_cash_flow_ttm": -742500.0,
    "book_value_per_share_mrq": 2.05,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Pro-Dex Inc."
  },
  "PDLI": {
    "p_e_ratio": 2.91,
    "peg_ratio": 0.17,
    "earnings_per_share": 1.89,
    "ebitda": 450670000.0,
    "eps_estimate_current_year": 2.26,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 5.54,
    "fifty_two_week_high": 8.6,
    "fifty_two_week_low": 4.58,
    "percent_change_from_200_day_moving_average": -0.1378,
    "percent_change_from_50_day_moving_average": -0.0091,
    "shares_owned": "N/A",
    "short_ratio": 15.63,
    "two_hundred_day_moving_average": 6.37,
    "volume": 3660233.0,
    "market_cap": 901340000.0,
    "price_to_sales_ttm": 1.73,
    "price_to_book_mrq": 1.63,
    "roa_ttm": 0.302,
    "roe_ttm": 0.777,
    "shares_outstanding": 164180000.0,
    "pcnt_held_by_insiders": 0.10490000000000001,
    "pcnt_held_by_institutions": 0.8909999999999999,
    "pcnt_short_of_float": 0.3059,
    "operating_cash_flow_ttm": 302030000.0,
    "levered_cash_flow_ttm": 209980000.0,
    "book_value_per_share_mrq": 3.22,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PDL BioPharma, Inc."
  },
  "PETS": {
    "p_e_ratio": 18.01,
    "peg_ratio": 3.36,
    "earnings_per_share": 0.91,
    "ebitda": 31270000.0,
    "eps_estimate_current_year": 0.99,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 16.56,
    "fifty_two_week_high": 18.42,
    "fifty_two_week_low": 12.07,
    "percent_change_from_200_day_moving_average": -0.018000000000000002,
    "percent_change_from_50_day_moving_average": -0.0105,
    "shares_owned": "N/A",
    "short_ratio": 31.99,
    "two_hundred_day_moving_average": 16.69,
    "volume": 174931.0,
    "market_cap": 333220000.0,
    "price_to_sales_ttm": 1.44,
    "price_to_book_mrq": 4.22,
    "roa_ttm": 0.213,
    "roe_ttm": 0.24309999999999998,
    "shares_outstanding": 20330000.0,
    "pcnt_held_by_insiders": 0.045899999999999996,
    "pcnt_held_by_institutions": 0.6970000000000001,
    "pcnt_short_of_float": 0.3056,
    "operating_cash_flow_ttm": 28600000.0,
    "levered_cash_flow_ttm": 26230000.0,
    "book_value_per_share_mrq": 3.88,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "PetMed Express, Inc."
  },
  "PETX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.96,
    "earnings_per_share": -1.13,
    "ebitda": -43760000.0,
    "eps_estimate_current_year": -1.37,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 17.72,
    "fifty_two_week_high": 20.63,
    "fifty_two_week_low": 9.2,
    "percent_change_from_200_day_moving_average": 0.0499,
    "percent_change_from_50_day_moving_average": -0.0425,
    "shares_owned": "N/A",
    "short_ratio": 8.46,
    "two_hundred_day_moving_average": 16.16,
    "volume": 377621.0,
    "market_cap": 593360000.0,
    "price_to_sales_ttm": 893.98,
    "price_to_book_mrq": 3.6,
    "roa_ttm": -0.1523,
    "roe_ttm": -0.2285,
    "shares_outstanding": 34960000.0,
    "pcnt_held_by_insiders": 0.1673,
    "pcnt_held_by_institutions": 0.7390000000000001,
    "pcnt_short_of_float": 0.1137,
    "operating_cash_flow_ttm": -34050000.0,
    "levered_cash_flow_ttm": -23790000.0,
    "book_value_per_share_mrq": 4.81,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aratana Therapeutics, Inc."
  },
  "PFNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.88,
    "ebitda": -16980000.0,
    "eps_estimate_current_year": -1.52,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 20.35,
    "fifty_two_week_high": 24.41,
    "fifty_two_week_low": 6.27,
    "percent_change_from_200_day_moving_average": 0.0111,
    "percent_change_from_50_day_moving_average": -0.0949,
    "shares_owned": "N/A",
    "short_ratio": 5.27,
    "two_hundred_day_moving_average": 18.22,
    "volume": 75949.0,
    "market_cap": 427210000.0,
    "price_to_sales_ttm": 47.41,
    "price_to_book_mrq": 5.0,
    "roa_ttm": -0.1258,
    "roe_ttm": -0.35590000000000005,
    "shares_outstanding": 23190000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.069,
    "operating_cash_flow_ttm": 31900000.0,
    "levered_cash_flow_ttm": -7290000.0,
    "book_value_per_share_mrq": 3.72,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pfenex Inc."
  },
  "PGND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.57,
    "earnings_per_share": -0.86,
    "ebitda": 27600000.0,
    "eps_estimate_current_year": 0.89,
    "eps_estimate_next_quarter": 0.22,
    "fifty_day_moving_average": 31.84,
    "fifty_two_week_high": 35.09,
    "fifty_two_week_low": 25.0,
    "percent_change_from_200_day_moving_average": 0.0754,
    "percent_change_from_50_day_moving_average": -0.009000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.5,
    "two_hundred_day_moving_average": 29.34,
    "volume": 140880.0,
    "market_cap": 1660000000.0,
    "price_to_sales_ttm": 5.3,
    "price_to_book_mrq": 2.93,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 52600000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0298,
    "operating_cash_flow_ttm": 65170000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 10.31,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Press Ganey Holdings, Inc."
  },
  "PGNX": {
    "p_e_ratio": 196.94,
    "peg_ratio": -0.08,
    "earnings_per_share": 0.04,
    "ebitda": -537000.0,
    "eps_estimate_current_year": -0.56,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 7.62,
    "fifty_two_week_high": 11.15,
    "fifty_two_week_low": 4.26,
    "percent_change_from_200_day_moving_average": 0.0401,
    "percent_change_from_50_day_moving_average": -0.0697,
    "shares_owned": "N/A",
    "short_ratio": 10.54,
    "two_hundred_day_moving_average": 6.82,
    "volume": 556361.0,
    "market_cap": 494060000.0,
    "price_to_sales_ttm": 11.4,
    "price_to_book_mrq": 4.69,
    "roa_ttm": -0.0049,
    "roe_ttm": 0.027999999999999997,
    "shares_outstanding": 69680000.0,
    "pcnt_held_by_insiders": 0.1535,
    "pcnt_held_by_institutions": 0.669,
    "pcnt_short_of_float": 0.26839999999999997,
    "operating_cash_flow_ttm": 11810000.0,
    "levered_cash_flow_ttm": 4110000.0000000005,
    "book_value_per_share_mrq": 1.51,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Progenics Pharmaceuticals, Inc."
  },
  "PHMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -5.96,
    "ebitda": -18590000.0,
    "eps_estimate_current_year": -0.73,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 0.88,
    "fifty_two_week_high": 6.99,
    "fifty_two_week_low": 0.43,
    "percent_change_from_200_day_moving_average": -0.643,
    "percent_change_from_50_day_moving_average": -0.40700000000000003,
    "shares_owned": "N/A",
    "short_ratio": 37.38,
    "two_hundred_day_moving_average": 1.46,
    "volume": 667866.0,
    "market_cap": 11480000.0,
    "price_to_sales_ttm": 0.13,
    "price_to_book_mrq": 0.39,
    "roa_ttm": -0.0859,
    "roe_ttm": -0.6372,
    "shares_outstanding": 22080000.0,
    "pcnt_held_by_insiders": 0.4033,
    "pcnt_held_by_institutions": 0.489,
    "pcnt_short_of_float": 0.1841,
    "operating_cash_flow_ttm": 47000.0,
    "levered_cash_flow_ttm": 11550000.0,
    "book_value_per_share_mrq": 2.04,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "PhotoMedex, Inc."
  },
  "PIP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.13,
    "ebitda": -5180000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.5,
    "fifty_two_week_high": 2.1,
    "fifty_two_week_low": 1.37,
    "percent_change_from_200_day_moving_average": -0.1076,
    "percent_change_from_50_day_moving_average": -0.02,
    "shares_owned": "N/A",
    "short_ratio": 21.38,
    "two_hundred_day_moving_average": 1.65,
    "volume": 112440.0,
    "market_cap": 94410000.0,
    "price_to_sales_ttm": 8.58,
    "price_to_book_mrq": 5.12,
    "roa_ttm": -0.17600000000000002,
    "roe_ttm": -0.5572,
    "shares_outstanding": 64220000.0,
    "pcnt_held_by_insiders": 0.025099999999999997,
    "pcnt_held_by_institutions": 0.107,
    "pcnt_short_of_float": 0.039,
    "operating_cash_flow_ttm": -5710000.0,
    "levered_cash_flow_ttm": -1300000.0,
    "book_value_per_share_mrq": 0.29,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PharmAthene, Inc."
  },
  "PIRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.59,
    "ebitda": -10660000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 2.9,
    "fifty_two_week_high": 4.4,
    "fifty_two_week_low": 2.36,
    "percent_change_from_200_day_moving_average": -0.175,
    "percent_change_from_50_day_moving_average": -0.1401,
    "shares_owned": "N/A",
    "short_ratio": 0.21,
    "two_hundred_day_moving_average": 3.02,
    "volume": 150202.0,
    "market_cap": 98930000.0,
    "price_to_sales_ttm": 27.7,
    "price_to_book_mrq": 6.75,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 39730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0025,
    "operating_cash_flow_ttm": -8340000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pieris Pharmaceuticals, Inc."
  },
  "PKI": {
    "p_e_ratio": 32.31,
    "peg_ratio": 2.26,
    "earnings_per_share": 1.44,
    "ebitda": 350060000.0,
    "eps_estimate_current_year": 2.58,
    "eps_estimate_next_quarter": 0.89,
    "fifty_day_moving_average": 48.91,
    "fifty_two_week_high": 54.45,
    "fifty_two_week_low": 38.96,
    "percent_change_from_200_day_moving_average": -0.0861,
    "percent_change_from_50_day_moving_average": -0.048799999999999996,
    "shares_owned": "N/A",
    "short_ratio": 3.23,
    "two_hundred_day_moving_average": 50.9,
    "volume": 475278.0,
    "market_cap": 5270000000.0,
    "price_to_sales_ttm": 2.35,
    "price_to_book_mrq": 2.48,
    "roa_ttm": 0.0366,
    "roe_ttm": 0.0783,
    "shares_outstanding": 113380000.0,
    "pcnt_held_by_insiders": 0.0097,
    "pcnt_held_by_institutions": 0.9520000000000001,
    "pcnt_short_of_float": 0.0275,
    "operating_cash_flow_ttm": 260620000.0,
    "levered_cash_flow_ttm": 221280000.0,
    "book_value_per_share_mrq": 18.71,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PerkinElmer Inc."
  },
  "PLX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.18,
    "earnings_per_share": -0.29,
    "ebitda": -19870000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 1.5,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 1.33,
    "percent_change_from_200_day_moving_average": -0.23579999999999998,
    "percent_change_from_50_day_moving_average": -0.059500000000000004,
    "shares_owned": "N/A",
    "short_ratio": 27.73,
    "two_hundred_day_moving_average": 1.85,
    "volume": 4900.0,
    "market_cap": 132210000.00000001,
    "price_to_sales_ttm": 9.04,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.17379999999999998,
    "roe_ttm": "N/A",
    "shares_outstanding": 93770000.0,
    "pcnt_held_by_insiders": 0.0635,
    "pcnt_held_by_institutions": 0.312,
    "pcnt_short_of_float": 0.0318,
    "operating_cash_flow_ttm": -26190000.0,
    "levered_cash_flow_ttm": -13340000.0,
    "book_value_per_share_mrq": -0.7,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-18"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Protalix BioTherapeutics, Inc."
  },
  "PMD": {
    "p_e_ratio": 27.11,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.39,
    "ebitda": 4050000.0,
    "eps_estimate_current_year": 0.93,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 11.14,
    "fifty_two_week_high": 17.83,
    "fifty_two_week_low": 9.82,
    "percent_change_from_200_day_moving_average": -0.23879999999999998,
    "percent_change_from_50_day_moving_average": -0.041299999999999996,
    "shares_owned": "N/A",
    "short_ratio": 2.94,
    "two_hundred_day_moving_average": 14.03,
    "volume": 4919.0,
    "market_cap": 57910000.0,
    "price_to_sales_ttm": 2.07,
    "price_to_book_mrq": 4.85,
    "roa_ttm": 0.0827,
    "roe_ttm": 0.1724,
    "shares_outstanding": 5420000.0,
    "pcnt_held_by_insiders": 0.0684,
    "pcnt_held_by_institutions": 0.509,
    "pcnt_short_of_float": 0.0076,
    "operating_cash_flow_ttm": 6030000.0,
    "levered_cash_flow_ttm": 1430000.0,
    "book_value_per_share_mrq": 2.22,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Psychemedics Corp."
  },
  "PODD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.12,
    "earnings_per_share": -0.77,
    "ebitda": 3210000.0,
    "eps_estimate_current_year": -0.99,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 30.29,
    "fifty_two_week_high": 47.97,
    "fifty_two_week_low": 24.95,
    "percent_change_from_200_day_moving_average": -0.0521,
    "percent_change_from_50_day_moving_average": -0.0451,
    "shares_owned": "N/A",
    "short_ratio": 8.2,
    "two_hundred_day_moving_average": 30.51,
    "volume": 294647.0,
    "market_cap": 1650000000.0,
    "price_to_sales_ttm": 5.82,
    "price_to_book_mrq": 23.56,
    "roa_ttm": -0.02,
    "roe_ttm": -0.5874,
    "shares_outstanding": 56900000.0,
    "pcnt_held_by_insiders": 0.0085,
    "pcnt_held_by_institutions": 1.1520000000000001,
    "pcnt_short_of_float": 0.0898,
    "operating_cash_flow_ttm": 6730000.0,
    "levered_cash_flow_ttm": 10550000.0,
    "book_value_per_share_mrq": 1.23,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Insulet Corporation"
  },
  "POZN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.93,
    "earnings_per_share": -0.08,
    "ebitda": 8369999.999999999,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 9.32,
    "fifty_two_week_high": 12.69,
    "fifty_two_week_low": 6.38,
    "percent_change_from_200_day_moving_average": -0.0547,
    "percent_change_from_50_day_moving_average": -0.0955,
    "shares_owned": "N/A",
    "short_ratio": 4.2,
    "two_hundred_day_moving_average": 8.92,
    "volume": 360907.0,
    "market_cap": 273310000.0,
    "price_to_sales_ttm": 10.58,
    "price_to_book_mrq": 8.12,
    "roa_ttm": 0.12269999999999999,
    "roe_ttm": -0.0794,
    "shares_outstanding": 32420000.0,
    "pcnt_held_by_insiders": 0.1757,
    "pcnt_held_by_institutions": 0.523,
    "pcnt_short_of_float": 0.0984,
    "operating_cash_flow_ttm": 2630000.0,
    "levered_cash_flow_ttm": 11970000.0,
    "book_value_per_share_mrq": 1.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "POZEN Inc."
  },
  "PPHM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.29,
    "ebitda": -50080000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 1.16,
    "fifty_two_week_high": 1.75,
    "fifty_two_week_low": 1.0,
    "percent_change_from_200_day_moving_average": -0.1841,
    "percent_change_from_50_day_moving_average": -0.0801,
    "shares_owned": "N/A",
    "short_ratio": 7.74,
    "two_hundred_day_moving_average": 1.31,
    "volume": 945072.0,
    "market_cap": 216270000.0,
    "price_to_sales_ttm": 6.86,
    "price_to_book_mrq": 3.8,
    "roa_ttm": -0.3555,
    "roe_ttm": -0.8419,
    "shares_outstanding": 202120000.0,
    "pcnt_held_by_insiders": 0.0501,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.0454,
    "operating_cash_flow_ttm": -40610000.0,
    "levered_cash_flow_ttm": -24230000.0,
    "book_value_per_share_mrq": 0.28,
    "next_earnings_announcement_date": [
      "2015-12-08",
      "2015-12-14"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Peregrine Pharmaceuticals, Inc."
  },
  "PRAH": {
    "p_e_ratio": 283.78,
    "peg_ratio": 1.14,
    "earnings_per_share": 0.15,
    "ebitda": 186820000.0,
    "eps_estimate_current_year": 1.81,
    "eps_estimate_next_quarter": 0.47,
    "fifty_day_moving_average": 40.66,
    "fifty_two_week_high": 46.35,
    "fifty_two_week_low": 19.1,
    "percent_change_from_200_day_moving_average": 0.2025,
    "percent_change_from_50_day_moving_average": 0.0331,
    "shares_owned": "N/A",
    "short_ratio": 12.34,
    "two_hundred_day_moving_average": 34.93,
    "volume": 356911.0,
    "market_cap": 2530000000.0,
    "price_to_sales_ttm": 2.0,
    "price_to_book_mrq": 3.78,
    "roa_ttm": 0.0274,
    "roe_ttm": 0.0138,
    "shares_outstanding": 60170000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1182,
    "operating_cash_flow_ttm": 55960000.0,
    "levered_cash_flow_ttm": 47970000.0,
    "book_value_per_share_mrq": 11.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PRA Health Sciences, Inc."
  },
  "PRAN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.08,
    "ebitda": -7660000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.0,
    "fifty_two_week_high": 2.29,
    "fifty_two_week_low": 0.8,
    "percent_change_from_200_day_moving_average": -0.16649999999999998,
    "percent_change_from_50_day_moving_average": -0.0322,
    "shares_owned": "N/A",
    "short_ratio": 7.03,
    "two_hundred_day_moving_average": 1.16,
    "volume": 11339.0,
    "market_cap": 51790000.0,
    "price_to_sales_ttm": 10.88,
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.16010000000000002,
    "roe_ttm": -0.1533,
    "shares_outstanding": 53390000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -7810000.0,
    "levered_cash_flow_ttm": -4960000.0,
    "book_value_per_share_mrq": 0.53,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Prana Biotechnology Limited"
  },
  "PRPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -2950000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.54,
    "fifty_two_week_high": 1.75,
    "fifty_two_week_low": 1.21,
    "percent_change_from_200_day_moving_average": 0.08289999999999999,
    "percent_change_from_50_day_moving_average": -0.0159,
    "shares_owned": "N/A",
    "short_ratio": 0.26,
    "two_hundred_day_moving_average": 1.4,
    "volume": 9644.0,
    "market_cap": 24820000.0,
    "price_to_sales_ttm": 1.18,
    "price_to_book_mrq": 3.12,
    "roa_ttm": -0.128,
    "roe_ttm": -0.6225,
    "shares_outstanding": 16329999.999999998,
    "pcnt_held_by_insiders": 0.41009999999999996,
    "pcnt_held_by_institutions": 0.069,
    "pcnt_short_of_float": 0.003,
    "operating_cash_flow_ttm": -3450000.0,
    "levered_cash_flow_ttm": -2880000.0,
    "book_value_per_share_mrq": 0.51,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "ProPhase Labs, Inc."
  },
  "PRQR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.81,
    "ebitda": -25630000.0,
    "eps_estimate_current_year": -0.92,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 16.65,
    "fifty_two_week_high": 27.6,
    "fifty_two_week_low": 11.0,
    "percent_change_from_200_day_moving_average": 0.0347,
    "percent_change_from_50_day_moving_average": 0.1558,
    "shares_owned": "N/A",
    "short_ratio": 8.84,
    "two_hundred_day_moving_average": 18.6,
    "volume": 81002.0,
    "market_cap": 449260000.0,
    "price_to_sales_ttm": 283.83,
    "price_to_book_mrq": 3.9,
    "roa_ttm": -0.19149999999999998,
    "roe_ttm": -0.20350000000000001,
    "shares_outstanding": 23340000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0187,
    "operating_cash_flow_ttm": -23120000.0,
    "levered_cash_flow_ttm": -16270000.0,
    "book_value_per_share_mrq": 4.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ProQR Therapeutics N.V."
  },
  "PRSC": {
    "p_e_ratio": 45.06,
    "peg_ratio": 1.57,
    "earnings_per_share": 1.03,
    "ebitda": 110720000.0,
    "eps_estimate_current_year": 1.9,
    "eps_estimate_next_quarter": 0.34,
    "fifty_day_moving_average": 46.04,
    "fifty_two_week_high": 55.99,
    "fifty_two_week_low": 34.03,
    "percent_change_from_200_day_moving_average": -0.0097,
    "percent_change_from_50_day_moving_average": 0.011200000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.57,
    "two_hundred_day_moving_average": 47.01,
    "volume": 52212.0,
    "market_cap": 747270000.0,
    "price_to_sales_ttm": 0.4,
    "price_to_book_mrq": 3.03,
    "roa_ttm": 0.0414,
    "roe_ttm": 0.08109999999999999,
    "shares_outstanding": 16050000.0,
    "pcnt_held_by_insiders": 0.0106,
    "pcnt_held_by_institutions": 0.866,
    "pcnt_short_of_float": 0.0452,
    "operating_cash_flow_ttm": 60520000.0,
    "levered_cash_flow_ttm": 41420000.0,
    "book_value_per_share_mrq": 15.14,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Providence Service Corp."
  },
  "PRSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.131,
    "ebitda": -12220000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.503,
    "fifty_two_week_high": 7.6,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.7989400000000001,
    "percent_change_from_50_day_moving_average": -0.06985000000000001,
    "shares_owned": "N/A",
    "short_ratio": 0.27,
    "two_hundred_day_moving_average": 2.328,
    "volume": 94858.0,
    "market_cap": 4570000.0,
    "price_to_sales_ttm": 0.7,
    "price_to_book_mrq": 1.06,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 9770000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0134,
    "operating_cash_flow_ttm": -10160000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Perseon Corporation"
  },
  "PRTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.18,
    "earnings_per_share": -2.12,
    "ebitda": -58530000.0,
    "eps_estimate_current_year": -2.59,
    "eps_estimate_next_quarter": -0.78,
    "fifty_day_moving_average": 59.17,
    "fifty_two_week_high": 70.52,
    "fifty_two_week_low": 17.0,
    "percent_change_from_200_day_moving_average": 0.2,
    "percent_change_from_50_day_moving_average": -0.0484,
    "shares_owned": "N/A",
    "short_ratio": 5.99,
    "two_hundred_day_moving_average": 46.92,
    "volume": 215136.0,
    "market_cap": 1770000000.0,
    "price_to_sales_ttm": 404.34,
    "price_to_book_mrq": 4.47,
    "roa_ttm": -0.1026,
    "roe_ttm": -0.1723,
    "shares_outstanding": 31380000.0,
    "pcnt_held_by_insiders": 0.0463,
    "pcnt_held_by_institutions": 0.8320000000000001,
    "pcnt_short_of_float": 0.1557,
    "operating_cash_flow_ttm": -50650000.0,
    "levered_cash_flow_ttm": -28090000.0,
    "book_value_per_share_mrq": 12.6,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Prothena Corporation plc"
  },
  "PRTK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -4.09,
    "ebitda": -29420000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": -0.99,
    "fifty_day_moving_average": 24.62,
    "fifty_two_week_high": 39.8,
    "fifty_two_week_low": 16.0,
    "percent_change_from_200_day_moving_average": -0.0803,
    "percent_change_from_50_day_moving_average": 0.019,
    "shares_owned": "N/A",
    "short_ratio": 9.07,
    "two_hundred_day_moving_average": 27.28,
    "volume": 67876.0,
    "market_cap": 440610000.0,
    "price_to_sales_ttm": 109.93,
    "price_to_book_mrq": 3.12,
    "roa_ttm": -0.2336,
    "roe_ttm": -0.6496999999999999,
    "shares_outstanding": 17560000.0,
    "pcnt_held_by_insiders": 0.2086,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1307,
    "operating_cash_flow_ttm": -29990000.0,
    "levered_cash_flow_ttm": -17350000.0,
    "book_value_per_share_mrq": 8.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Paratek Pharmaceuticals, Inc."
  },
  "PRTO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.94,
    "ebitda": -12710000.0,
    "eps_estimate_current_year": -1.28,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 14.37,
    "fifty_two_week_high": 20.0,
    "fifty_two_week_low": 8.57,
    "percent_change_from_200_day_moving_average": -0.043899999999999995,
    "percent_change_from_50_day_moving_average": 0.0008,
    "shares_owned": "N/A",
    "short_ratio": 13.31,
    "two_hundred_day_moving_average": 15.04,
    "volume": 4949.0,
    "market_cap": 236680000.0,
    "price_to_sales_ttm": 80.89,
    "price_to_book_mrq": 3.23,
    "roa_ttm": -0.1535,
    "roe_ttm": -0.16010000000000002,
    "shares_outstanding": 16460000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0546,
    "operating_cash_flow_ttm": -14230000.0,
    "levered_cash_flow_ttm": -10470000.0,
    "book_value_per_share_mrq": 4.48,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Proteon Therapeutics Inc"
  },
  "PRXL": {
    "p_e_ratio": 25.86,
    "peg_ratio": 1.31,
    "earnings_per_share": 2.65,
    "ebitda": 297220000.0,
    "eps_estimate_current_year": 3.22,
    "eps_estimate_next_quarter": 0.75,
    "fifty_day_moving_average": 68.33,
    "fifty_two_week_high": 76.17,
    "fifty_two_week_low": 52.19,
    "percent_change_from_200_day_moving_average": 0.0148,
    "percent_change_from_50_day_moving_average": 0.003,
    "shares_owned": "N/A",
    "short_ratio": 5.43,
    "two_hundred_day_moving_average": 67.53,
    "volume": 473828.0,
    "market_cap": 3790000000.0,
    "price_to_sales_ttm": 1.9,
    "price_to_book_mrq": 5.75,
    "roa_ttm": 0.0717,
    "roe_ttm": 0.2379,
    "shares_outstanding": 55340000.0,
    "pcnt_held_by_insiders": 0.0206,
    "pcnt_held_by_institutions": 0.9890000000000001,
    "pcnt_short_of_float": 0.0967,
    "operating_cash_flow_ttm": 157840000.0,
    "levered_cash_flow_ttm": 77510000.0,
    "book_value_per_share_mrq": 12.04,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PAREXEL International Corporation"
  },
  "PSDV": {
    "p_e_ratio": 17.52,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.21,
    "ebitda": 7300000.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 3.9,
    "fifty_two_week_high": 4.68,
    "fifty_two_week_low": 3.23,
    "percent_change_from_200_day_moving_average": -0.0806,
    "percent_change_from_50_day_moving_average": -0.0553,
    "shares_owned": "N/A",
    "short_ratio": 9.2,
    "two_hundred_day_moving_average": 4.0,
    "volume": 36795.0,
    "market_cap": 108260000.0,
    "price_to_sales_ttm": 4.1,
    "price_to_book_mrq": 4.66,
    "roa_ttm": 0.1458,
    "roe_ttm": 0.33149999999999996,
    "shares_outstanding": 29420000.0,
    "pcnt_held_by_insiders": 0.16760000000000003,
    "pcnt_held_by_institutions": 0.251,
    "pcnt_short_of_float": 0.022099999999999998,
    "operating_cash_flow_ttm": 10300000.0,
    "levered_cash_flow_ttm": 7680000.0,
    "book_value_per_share_mrq": 0.79,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "pSivida Corp."
  },
  "PSTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.35,
    "ebitda": -23190000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 2.07,
    "fifty_two_week_high": 3.78,
    "fifty_two_week_low": 1.84,
    "percent_change_from_200_day_moving_average": -0.21170000000000003,
    "percent_change_from_50_day_moving_average": -0.0323,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 2.54,
    "volume": 45923.0,
    "market_cap": 158210000.0,
    "price_to_sales_ttm": 421.62,
    "price_to_book_mrq": 2.74,
    "roa_ttm": -0.22210000000000002,
    "roe_ttm": -0.4104,
    "shares_outstanding": 79110000.0,
    "pcnt_held_by_insiders": 0.0861,
    "pcnt_held_by_institutions": 0.015,
    "pcnt_short_of_float": 0.008199999999999999,
    "operating_cash_flow_ttm": -20600000.0,
    "levered_cash_flow_ttm": -8450000.0,
    "book_value_per_share_mrq": 0.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pluristem Therapeutics, Inc."
  },
  "PTCT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.87,
    "earnings_per_share": -3.82,
    "ebitda": -134130000.0,
    "eps_estimate_current_year": -4.61,
    "eps_estimate_next_quarter": -1.17,
    "fifty_day_moving_average": 38.8,
    "fifty_two_week_high": 78.72,
    "fifty_two_week_low": 29.08,
    "percent_change_from_200_day_moving_average": -0.3945,
    "percent_change_from_50_day_moving_average": -0.1617,
    "shares_owned": "N/A",
    "short_ratio": 6.45,
    "two_hundred_day_moving_average": 53.73,
    "volume": 577052.0,
    "market_cap": 1110000000.0,
    "price_to_sales_ttm": 39.75,
    "price_to_book_mrq": 4.57,
    "roa_ttm": -0.3337,
    "roe_ttm": -0.5539999999999999,
    "shares_outstanding": 34270000.0,
    "pcnt_held_by_insiders": 0.3993,
    "pcnt_held_by_institutions": 0.62,
    "pcnt_short_of_float": 0.19079999999999997,
    "operating_cash_flow_ttm": -91270000.0,
    "levered_cash_flow_ttm": -52930000.0,
    "book_value_per_share_mrq": 7.34,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PTC Therapeutics, Inc."
  },
  "PTIE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -0.26,
    "ebitda": -11670000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.84,
    "fifty_two_week_high": 4.27,
    "fifty_two_week_low": 1.53,
    "percent_change_from_200_day_moving_average": 0.032,
    "percent_change_from_50_day_moving_average": 0.051699999999999996,
    "shares_owned": "N/A",
    "short_ratio": 6.34,
    "two_hundred_day_moving_average": 1.87,
    "volume": 117872.0,
    "market_cap": 88310000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.52,
    "roa_ttm": -0.17579999999999998,
    "roe_ttm": -0.2927,
    "shares_outstanding": 45760000.0,
    "pcnt_held_by_insiders": 0.265,
    "pcnt_held_by_institutions": 0.504,
    "pcnt_short_of_float": 0.023,
    "operating_cash_flow_ttm": -7330000.0,
    "levered_cash_flow_ttm": -3190000.0,
    "book_value_per_share_mrq": 0.79,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pain Therapeutics Inc."
  },
  "PTLA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.77,
    "ebitda": -178940000.0,
    "eps_estimate_current_year": -4.58,
    "eps_estimate_next_quarter": -1.36,
    "fifty_day_moving_average": 48.36,
    "fifty_two_week_high": 57.96,
    "fifty_two_week_low": 24.75,
    "percent_change_from_200_day_moving_average": 0.1189,
    "percent_change_from_50_day_moving_average": 0.0118,
    "shares_owned": "N/A",
    "short_ratio": 8.73,
    "two_hundred_day_moving_average": 43.73,
    "volume": 522704.0,
    "market_cap": 2570000000.0,
    "price_to_sales_ttm": 272.11,
    "price_to_book_mrq": 7.06,
    "roa_ttm": -0.3063,
    "roe_ttm": -0.5912,
    "shares_outstanding": 52560000.0,
    "pcnt_held_by_insiders": 0.1821,
    "pcnt_held_by_institutions": 0.79,
    "pcnt_short_of_float": 0.1094,
    "operating_cash_flow_ttm": -163390000.0,
    "levered_cash_flow_ttm": -96940000.0,
    "book_value_per_share_mrq": 7.02,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Portola Pharmaceuticals, Inc."
  },
  "PTN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.309,
    "ebitda": -17170000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 0.9086,
    "fifty_two_week_high": 1.58,
    "fifty_two_week_low": 0.59,
    "percent_change_from_200_day_moving_average": -0.07251,
    "percent_change_from_50_day_moving_average": -0.023191000000000003,
    "shares_owned": "N/A",
    "short_ratio": 1.15,
    "two_hundred_day_moving_average": 0.9569,
    "volume": 204512.0,
    "market_cap": 50700000.0,
    "price_to_sales_ttm": 4.54,
    "price_to_book_mrq": 4.04,
    "roa_ttm": -0.5141,
    "roe_ttm": -1.6065,
    "shares_outstanding": 57130000.0,
    "pcnt_held_by_insiders": 0.0178,
    "pcnt_held_by_institutions": 0.28,
    "pcnt_short_of_float": 0.0697,
    "operating_cash_flow_ttm": -13360000.0,
    "levered_cash_flow_ttm": -7110000.0,
    "book_value_per_share_mrq": 0.21,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Palatin Technologies Inc."
  },
  "PTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -13.72,
    "earnings_per_share": -1.8,
    "ebitda": 37900000.0,
    "eps_estimate_current_year": -0.07,
    "eps_estimate_next_quarter": 0.06,
    "fifty_day_moving_average": 4.61,
    "fifty_two_week_high": 12.88,
    "fifty_two_week_low": 1.91,
    "percent_change_from_200_day_moving_average": -0.4251,
    "percent_change_from_50_day_moving_average": -0.17850000000000002,
    "shares_owned": "N/A",
    "short_ratio": 5.58,
    "two_hundred_day_moving_average": 6.59,
    "volume": 1027078.0,
    "market_cap": 231330000.0,
    "price_to_sales_ttm": 1.41,
    "price_to_book_mrq": 1.9,
    "roa_ttm": -0.045599999999999995,
    "roe_ttm": -0.6859999999999999,
    "shares_outstanding": 61040000.0,
    "pcnt_held_by_insiders": 0.3538,
    "pcnt_held_by_institutions": 0.447,
    "pcnt_short_of_float": 0.226,
    "operating_cash_flow_ttm": 9170000.0,
    "levered_cash_flow_ttm": 36840000.0,
    "book_value_per_share_mrq": 2.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Pernix Therapeutics Holdings, Inc."
  },
  "PULM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.35,
    "ebitda": -11110000.0,
    "eps_estimate_current_year": -4.13,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.72,
    "fifty_two_week_high": 14.55,
    "fifty_two_week_low": 4.3,
    "percent_change_from_200_day_moving_average": -0.3736,
    "percent_change_from_50_day_moving_average": -0.0888,
    "shares_owned": "N/A",
    "short_ratio": 0.43,
    "two_hundred_day_moving_average": 8.32,
    "volume": 5776.0,
    "market_cap": 75630000.0,
    "price_to_sales_ttm": 117.49,
    "price_to_book_mrq": 1.87,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 14520000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0032,
    "operating_cash_flow_ttm": -10470000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pulmatrix, Inc."
  },
  "PVCT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.07,
    "ebitda": -16800000.0,
    "eps_estimate_current_year": -0.12,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.5,
    "fifty_two_week_high": 1.11,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.12619999999999998,
    "percent_change_from_50_day_moving_average": 0.19820000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.63,
    "two_hundred_day_moving_average": 0.69,
    "volume": 382676.0,
    "market_cap": 122760000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.19,
    "roa_ttm": -0.4097,
    "roe_ttm": -0.4779,
    "shares_outstanding": 204610000.0,
    "pcnt_held_by_insiders": 0.0726,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0074,
    "operating_cash_flow_ttm": -15800000.0,
    "levered_cash_flow_ttm": -10120000.0,
    "book_value_per_share_mrq": 0.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Provectus Biopharmaceuticals, Inc."
  },
  "Q": {
    "p_e_ratio": 27.63,
    "peg_ratio": 1.93,
    "earnings_per_share": 2.75,
    "ebitda": 750690000.0,
    "eps_estimate_current_year": 3.16,
    "eps_estimate_next_quarter": 0.86,
    "fifty_day_moving_average": 75.02,
    "fifty_two_week_high": 80.45,
    "fifty_two_week_low": 51.09,
    "percent_change_from_200_day_moving_average": 0.0696,
    "percent_change_from_50_day_moving_average": 0.0131,
    "shares_owned": "N/A",
    "short_ratio": 2.55,
    "two_hundred_day_moving_average": 71.07,
    "volume": 388403.0,
    "market_cap": 9330000000.0,
    "price_to_sales_ttm": 2.19,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.1243,
    "roe_ttm": "N/A",
    "shares_outstanding": 122710000.0,
    "pcnt_held_by_insiders": 0.1572,
    "pcnt_held_by_institutions": 0.8590000000000001,
    "pcnt_short_of_float": 0.045700000000000005,
    "operating_cash_flow_ttm": 379490000.0,
    "levered_cash_flow_ttm": 220290000.0,
    "book_value_per_share_mrq": -5.72,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Quintiles Transnational Holdings Inc."
  },
  "QDEL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -8.58,
    "earnings_per_share": -0.11,
    "ebitda": 30400000.0,
    "eps_estimate_current_year": -0.12,
    "eps_estimate_next_quarter": 0.16,
    "fifty_day_moving_average": 20.75,
    "fifty_two_week_high": 29.38,
    "fifty_two_week_low": 18.23,
    "percent_change_from_200_day_moving_average": -0.11689999999999999,
    "percent_change_from_50_day_moving_average": -0.0246,
    "shares_owned": "N/A",
    "short_ratio": 25.67,
    "two_hundred_day_moving_average": 22.92,
    "volume": 115225.0,
    "market_cap": 678590000.0,
    "price_to_sales_ttm": 3.39,
    "price_to_book_mrq": 2.96,
    "roa_ttm": 0.009399999999999999,
    "roe_ttm": -0.016,
    "shares_outstanding": 33530000.0,
    "pcnt_held_by_insiders": 0.26890000000000003,
    "pcnt_held_by_institutions": 0.836,
    "pcnt_short_of_float": 0.2536,
    "operating_cash_flow_ttm": 41660000.0,
    "levered_cash_flow_ttm": 35840000.0,
    "book_value_per_share_mrq": 6.79,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Quidel Corp."
  },
  "QLTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.36,
    "earnings_per_share": -0.11,
    "ebitda": -24830000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 3.51,
    "fifty_two_week_high": 4.92,
    "fifty_two_week_low": 3.22,
    "percent_change_from_200_day_moving_average": -0.1009,
    "percent_change_from_50_day_moving_average": -0.025099999999999997,
    "shares_owned": "N/A",
    "short_ratio": 3.31,
    "two_hundred_day_moving_average": 3.8,
    "volume": 137633.0,
    "market_cap": 180680000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.21,
    "roa_ttm": -0.10490000000000001,
    "roe_ttm": -0.0385,
    "shares_outstanding": 52830000.0,
    "pcnt_held_by_insiders": 0.4533,
    "pcnt_held_by_institutions": 0.508,
    "pcnt_short_of_float": 0.0111,
    "operating_cash_flow_ttm": 2009999.9999999998,
    "levered_cash_flow_ttm": -4370000.0,
    "book_value_per_share_mrq": 2.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "QLT Inc."
  },
  "QTNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.21,
    "ebitda": -34390000.0,
    "eps_estimate_current_year": -3.0,
    "eps_estimate_next_quarter": -0.76,
    "fifty_day_moving_average": 15.92,
    "fifty_two_week_high": 19.95,
    "fifty_two_week_low": 9.02,
    "percent_change_from_200_day_moving_average": -0.1597,
    "percent_change_from_50_day_moving_average": -0.1734,
    "shares_owned": "N/A",
    "short_ratio": 4.16,
    "two_hundred_day_moving_average": 15.66,
    "volume": 11018.0,
    "market_cap": 224110000.0,
    "price_to_sales_ttm": 11.61,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3389,
    "roe_ttm": -8.8625,
    "shares_outstanding": 17030000.0,
    "pcnt_held_by_insiders": 0.0519,
    "pcnt_held_by_institutions": 0.095,
    "pcnt_short_of_float": 0.006999999999999999,
    "operating_cash_flow_ttm": -32780000.0,
    "levered_cash_flow_ttm": -16770000.0,
    "book_value_per_share_mrq": -0.49,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Quotient Limited"
  },
  "QURE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.12,
    "ebitda": -52180000.0,
    "eps_estimate_current_year": -2.65,
    "eps_estimate_next_quarter": -0.66,
    "fifty_day_moving_average": 26.51,
    "fifty_two_week_high": 36.38,
    "fifty_two_week_low": 9.0,
    "percent_change_from_200_day_moving_average": 0.0063,
    "percent_change_from_50_day_moving_average": 0.0382,
    "shares_owned": "N/A",
    "short_ratio": 3.04,
    "two_hundred_day_moving_average": 27.35,
    "volume": 292233.0,
    "market_cap": 589750000.0,
    "price_to_sales_ttm": 106.83,
    "price_to_book_mrq": 4.73,
    "roa_ttm": -0.1856,
    "roe_ttm": -0.5991,
    "shares_outstanding": 21430000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0721,
    "operating_cash_flow_ttm": 12890000.0,
    "levered_cash_flow_ttm": -30940000.0,
    "book_value_per_share_mrq": 5.84,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "uniQure N.V."
  },
  "RARE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.51,
    "ebitda": -83550000.0,
    "eps_estimate_current_year": -3.29,
    "eps_estimate_next_quarter": -0.91,
    "fifty_day_moving_average": 114.73,
    "fifty_two_week_high": 137.05,
    "fifty_two_week_low": 38.01,
    "percent_change_from_200_day_moving_average": 0.1611,
    "percent_change_from_50_day_moving_average": -0.0725,
    "shares_owned": "N/A",
    "short_ratio": 4.74,
    "two_hundred_day_moving_average": 91.64,
    "volume": 370011.0,
    "market_cap": 4120000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 12.16,
    "roa_ttm": -0.2087,
    "roe_ttm": -0.3546,
    "shares_outstanding": 38680000.0,
    "pcnt_held_by_insiders": 0.0002,
    "pcnt_held_by_institutions": 0.441,
    "pcnt_short_of_float": 0.1001,
    "operating_cash_flow_ttm": -58420000.0,
    "levered_cash_flow_ttm": -34150000.0,
    "book_value_per_share_mrq": 8.85,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ultragenyx Pharmaceutical Inc."
  },
  "RCPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.17,
    "ebitda": -15990000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.01,
    "fifty_two_week_high": 9.25,
    "fifty_two_week_low": 0.76,
    "percent_change_from_200_day_moving_average": -0.43439999999999995,
    "percent_change_from_50_day_moving_average": 0.07200000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.14,
    "two_hundred_day_moving_average": 1.91,
    "volume": 278990.0,
    "market_cap": 11740000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.4606999999999999,
    "roe_ttm": "N/A",
    "shares_outstanding": 10870000.0,
    "pcnt_held_by_insiders": 0.2325,
    "pcnt_held_by_institutions": 0.152,
    "pcnt_short_of_float": 0.1069,
    "operating_cash_flow_ttm": -10970000.0,
    "levered_cash_flow_ttm": -3790000.0,
    "book_value_per_share_mrq": -0.62,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Rock Creek Pharmaceuticals, Inc."
  },
  "RDHL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.31,
    "ebitda": -20440000.0,
    "eps_estimate_current_year": -2.37,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 13.7,
    "fifty_two_week_high": 22.22,
    "fifty_two_week_low": 6.89,
    "percent_change_from_200_day_moving_average": -0.09140000000000001,
    "percent_change_from_50_day_moving_average": 0.0111,
    "shares_owned": "N/A",
    "short_ratio": 2.56,
    "two_hundred_day_moving_average": 15.24,
    "volume": 17124.0,
    "market_cap": 137710000.0,
    "price_to_sales_ttm": 19147.38,
    "price_to_book_mrq": 4.85,
    "roa_ttm": -0.3475,
    "roe_ttm": -0.6787000000000001,
    "shares_outstanding": 9940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -17790000.0,
    "levered_cash_flow_ttm": -11930000.0,
    "book_value_per_share_mrq": 2.78,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "RedHill Biopharma Ltd."
  },
  "RDNT": {
    "p_e_ratio": 37.07,
    "peg_ratio": 2.01,
    "earnings_per_share": 0.16,
    "ebitda": 100640000.0,
    "eps_estimate_current_year": 0.31,
    "eps_estimate_next_quarter": 0.17,
    "fifty_day_moving_average": 6.49,
    "fifty_two_week_high": 10.35,
    "fifty_two_week_low": 5.66,
    "percent_change_from_200_day_moving_average": -0.1628,
    "percent_change_from_50_day_moving_average": -0.063,
    "shares_owned": "N/A",
    "short_ratio": 4.0,
    "two_hundred_day_moving_average": 7.26,
    "volume": 366852.0,
    "market_cap": 270360000.0,
    "price_to_sales_ttm": 0.35,
    "price_to_book_mrq": 25.65,
    "roa_ttm": 0.0351,
    "roe_ttm": 1.6743000000000001,
    "shares_outstanding": 44470000.0,
    "pcnt_held_by_insiders": 0.4048,
    "pcnt_held_by_institutions": 0.29,
    "pcnt_short_of_float": 0.0378,
    "operating_cash_flow_ttm": 69280000.0,
    "levered_cash_flow_ttm": -30890000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "RadNet, Inc."
  },
  "RDUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -12.13,
    "earnings_per_share": -2.2,
    "ebitda": -72320000.0,
    "eps_estimate_current_year": -2.22,
    "eps_estimate_next_quarter": -0.58,
    "fifty_day_moving_average": 66.62,
    "fifty_two_week_high": 84.64,
    "fifty_two_week_low": 16.55,
    "percent_change_from_200_day_moving_average": 0.2727,
    "percent_change_from_50_day_moving_average": 0.0747,
    "shares_owned": "N/A",
    "short_ratio": 4.21,
    "two_hundred_day_moving_average": 56.26,
    "volume": 1262341.0,
    "market_cap": 3060000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 13.26,
    "roa_ttm": -0.2927,
    "roe_ttm": -0.6618999999999999,
    "shares_outstanding": 42790000.0,
    "pcnt_held_by_insiders": 0.374,
    "pcnt_held_by_institutions": 0.363,
    "pcnt_short_of_float": 0.14,
    "operating_cash_flow_ttm": -68270000.0,
    "levered_cash_flow_ttm": -43760000.0,
    "book_value_per_share_mrq": 4.96,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Radius Health, Inc."
  },
  "REPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.97,
    "ebitda": -7230000.0,
    "eps_estimate_current_year": -1.55,
    "eps_estimate_next_quarter": -0.78,
    "fifty_day_moving_average": 14.23,
    "fifty_two_week_high": 18.3,
    "fifty_two_week_low": 2.36,
    "percent_change_from_200_day_moving_average": 0.3439,
    "percent_change_from_50_day_moving_average": 0.10460000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.54,
    "two_hundred_day_moving_average": 11.7,
    "volume": 19252.0,
    "market_cap": 144960000.0,
    "price_to_sales_ttm": 7.72,
    "price_to_book_mrq": 8.32,
    "roa_ttm": -0.07200000000000001,
    "roe_ttm": -0.6577,
    "shares_outstanding": 9220000.0,
    "pcnt_held_by_insiders": 0.4113,
    "pcnt_held_by_institutions": 0.27899999999999997,
    "pcnt_short_of_float": 0.0613,
    "operating_cash_flow_ttm": -6450000.0,
    "levered_cash_flow_ttm": -26110000.0,
    "book_value_per_share_mrq": 1.88,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Recro Pharma, Inc."
  },
  "RGEN": {
    "p_e_ratio": 163.33,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.22,
    "ebitda": 20040000.0,
    "eps_estimate_current_year": 0.35,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 35.06,
    "fifty_two_week_high": 42.48,
    "fifty_two_week_low": 18.55,
    "percent_change_from_200_day_moving_average": 0.0144,
    "percent_change_from_50_day_moving_average": 0.0341,
    "shares_owned": "N/A",
    "short_ratio": 8.82,
    "two_hundred_day_moving_average": 35.75,
    "volume": 242965.0,
    "market_cap": 1190000000.0,
    "price_to_sales_ttm": 15.43,
    "price_to_book_mrq": 9.65,
    "roa_ttm": 0.0731,
    "roe_ttm": 0.06509999999999999,
    "shares_outstanding": 32909999.999999996,
    "pcnt_held_by_insiders": 0.062,
    "pcnt_held_by_institutions": 0.8540000000000001,
    "pcnt_short_of_float": 0.09949999999999999,
    "operating_cash_flow_ttm": 13190000.0,
    "levered_cash_flow_ttm": 11400000.0,
    "book_value_per_share_mrq": 3.59,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Repligen Corporation"
  },
  "RGLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.17,
    "earnings_per_share": -1.41,
    "ebitda": -49060000.0,
    "eps_estimate_current_year": -1.35,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 7.98,
    "fifty_two_week_high": 25.6,
    "fifty_two_week_low": 6.23,
    "percent_change_from_200_day_moving_average": -0.32439999999999997,
    "percent_change_from_50_day_moving_average": 0.0195,
    "shares_owned": "N/A",
    "short_ratio": 11.17,
    "two_hundred_day_moving_average": 12.05,
    "volume": 374643.0,
    "market_cap": 422620000.0,
    "price_to_sales_ttm": 31.88,
    "price_to_book_mrq": 3.18,
    "roa_ttm": -0.2396,
    "roe_ttm": -0.6286,
    "shares_outstanding": 51920000.0,
    "pcnt_held_by_insiders": 0.7401000000000001,
    "pcnt_held_by_institutions": 0.32899999999999996,
    "pcnt_short_of_float": 0.3615,
    "operating_cash_flow_ttm": -41470000.0,
    "levered_cash_flow_ttm": -15090000.0,
    "book_value_per_share_mrq": 2.57,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Regulus Therapeutics Inc."
  },
  "RGNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.92,
    "ebitda": 0.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 25.79,
    "fifty_two_week_low": 22.65,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 0.0,
    "volume": 440837.0,
    "market_cap": 603100000.0,
    "price_to_sales_ttm": 19.69,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 24610000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": -13090000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -10.45,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Regenxbio Inc."
  },
  "RIGL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.86,
    "ebitda": -73730000.0,
    "eps_estimate_current_year": -0.71,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 2.98,
    "fifty_two_week_high": 5.2,
    "fifty_two_week_low": 1.56,
    "percent_change_from_200_day_moving_average": -0.1421,
    "percent_change_from_50_day_moving_average": -0.011399999999999999,
    "shares_owned": "N/A",
    "short_ratio": 6.2,
    "two_hundred_day_moving_average": 3.44,
    "volume": 333580.0,
    "market_cap": 261089999.99999997,
    "price_to_sales_ttm": 17.29,
    "price_to_book_mrq": 2.67,
    "roa_ttm": -0.2858,
    "roe_ttm": -0.5644,
    "shares_outstanding": 88500000.0,
    "pcnt_held_by_insiders": 0.0049,
    "pcnt_held_by_institutions": 0.9129999999999999,
    "pcnt_short_of_float": 0.0408,
    "operating_cash_flow_ttm": -33540000.0,
    "levered_cash_flow_ttm": -12340000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Rigel Pharmaceuticals, Inc."
  },
  "RLYP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.15,
    "earnings_per_share": -3.14,
    "ebitda": -106710000.0,
    "eps_estimate_current_year": -4.21,
    "eps_estimate_next_quarter": -1.56,
    "fifty_day_moving_average": 25.0,
    "fifty_two_week_high": 42.26,
    "fifty_two_week_low": 17.6,
    "percent_change_from_200_day_moving_average": -0.32159999999999994,
    "percent_change_from_50_day_moving_average": -0.12369999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.16,
    "two_hundred_day_moving_average": 32.3,
    "volume": 442816.0,
    "market_cap": 911170000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.3,
    "roa_ttm": -0.2903,
    "roe_ttm": -0.5596,
    "shares_outstanding": 41590000.0,
    "pcnt_held_by_insiders": 0.5737,
    "pcnt_held_by_institutions": 0.253,
    "pcnt_short_of_float": 0.1213,
    "operating_cash_flow_ttm": -88730000.0,
    "levered_cash_flow_ttm": -45580000.0,
    "book_value_per_share_mrq": 6.58,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Relypsa, Inc."
  },
  "RMD": {
    "p_e_ratio": 20.14,
    "peg_ratio": 2.01,
    "earnings_per_share": 2.47,
    "ebitda": 482290000.0,
    "eps_estimate_current_year": 2.65,
    "eps_estimate_next_quarter": 0.65,
    "fifty_day_moving_average": 52.63,
    "fifty_two_week_high": 75.33,
    "fifty_two_week_low": 45.74,
    "percent_change_from_200_day_moving_average": -0.1743,
    "percent_change_from_50_day_moving_average": -0.055,
    "shares_owned": "N/A",
    "short_ratio": 12.32,
    "two_hundred_day_moving_average": 60.24,
    "volume": 364263.0,
    "market_cap": 6990000000.0,
    "price_to_sales_ttm": 4.17,
    "price_to_book_mrq": 4.41,
    "roa_ttm": 0.11259999999999999,
    "roe_ttm": 0.21100000000000002,
    "shares_outstanding": 140520000.0,
    "pcnt_held_by_insiders": 0.0113,
    "pcnt_held_by_institutions": 0.568,
    "pcnt_short_of_float": 0.0799,
    "operating_cash_flow_ttm": 383180000.0,
    "levered_cash_flow_ttm": 222390000.0,
    "book_value_per_share_mrq": 11.3,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ResMed Inc."
  },
  "RMTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.43,
    "earnings_per_share": -0.36,
    "ebitda": -13720000.0,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 12.02,
    "fifty_two_week_high": 18.9,
    "fifty_two_week_low": 8.1,
    "percent_change_from_200_day_moving_average": -0.2132,
    "percent_change_from_50_day_moving_average": -0.1949,
    "shares_owned": "N/A",
    "short_ratio": 12.39,
    "two_hundred_day_moving_average": 12.3,
    "volume": 461090.0,
    "market_cap": 486160000.0,
    "price_to_sales_ttm": 8.95,
    "price_to_book_mrq": 7.47,
    "roa_ttm": -0.1557,
    "roe_ttm": -0.5344,
    "shares_outstanding": 50220000.0,
    "pcnt_held_by_insiders": 0.1855,
    "pcnt_held_by_institutions": 0.28,
    "pcnt_short_of_float": 0.22190000000000001,
    "operating_cash_flow_ttm": 8170000.0,
    "levered_cash_flow_ttm": -2620000.0,
    "book_value_per_share_mrq": 1.31,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Rockwell Medical, Inc."
  },
  "RNN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.06,
    "ebitda": -16210000.0,
    "eps_estimate_current_year": -0.09,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 0.56,
    "fifty_two_week_high": 0.96,
    "fifty_two_week_low": 0.5,
    "percent_change_from_200_day_moving_average": -0.0941,
    "percent_change_from_50_day_moving_average": 0.056799999999999996,
    "shares_owned": "N/A",
    "short_ratio": 13.77,
    "two_hundred_day_moving_average": 0.65,
    "volume": 204360.0,
    "market_cap": 106610000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.04,
    "roa_ttm": -0.3046,
    "roe_ttm": -0.44920000000000004,
    "shares_outstanding": 180700000.0,
    "pcnt_held_by_insiders": 0.1705,
    "pcnt_held_by_institutions": 0.069,
    "pcnt_short_of_float": 0.0229,
    "operating_cash_flow_ttm": -13960000.0,
    "levered_cash_flow_ttm": -7880000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Rexahn Pharmaceuticals, Inc."
  },
  "ROKA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.05,
    "earnings_per_share": -1.79,
    "ebitda": -28070000.0,
    "eps_estimate_current_year": -2.1,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 2.68,
    "fifty_two_week_high": 11.19,
    "fifty_two_week_low": 2.2,
    "percent_change_from_200_day_moving_average": -0.2087,
    "percent_change_from_50_day_moving_average": -0.1084,
    "shares_owned": "N/A",
    "short_ratio": 5.17,
    "two_hundred_day_moving_average": 3.02,
    "volume": 5114.0,
    "market_cap": 43130000.0,
    "price_to_sales_ttm": 7.45,
    "price_to_book_mrq": 0.7,
    "roa_ttm": -0.30579999999999996,
    "roe_ttm": -0.731,
    "shares_outstanding": 18040000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.016200000000000003,
    "operating_cash_flow_ttm": -25670000.0,
    "levered_cash_flow_ttm": -26510000.0,
    "book_value_per_share_mrq": 3.45,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Roka Bioscience, Inc."
  },
  "ROSG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.29,
    "ebitda": -13950000.0,
    "eps_estimate_current_year": -1.37,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.65,
    "fifty_two_week_high": 5.55,
    "fifty_two_week_low": 2.07,
    "percent_change_from_200_day_moving_average": -0.08220000000000001,
    "percent_change_from_50_day_moving_average": 0.1099,
    "shares_owned": "N/A",
    "short_ratio": 5.43,
    "two_hundred_day_moving_average": 3.2,
    "volume": 85999.0,
    "market_cap": 34580000.0,
    "price_to_sales_ttm": 25.44,
    "price_to_book_mrq": 2.24,
    "roa_ttm": -0.4128,
    "roe_ttm": -0.7506999999999999,
    "shares_outstanding": 11760000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.081,
    "pcnt_short_of_float": 0.0373,
    "operating_cash_flow_ttm": -13600000.0,
    "levered_cash_flow_ttm": -7960000.0,
    "book_value_per_share_mrq": 1.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Rosetta Genomics, Ltd."
  },
  "RPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.3,
    "earnings_per_share": -1.3,
    "ebitda": -31280000.0,
    "eps_estimate_current_year": -1.29,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 7.73,
    "fifty_two_week_high": 11.21,
    "fifty_two_week_low": 5.92,
    "percent_change_from_200_day_moving_average": 0.121,
    "percent_change_from_50_day_moving_average": 0.1411,
    "shares_owned": "N/A",
    "short_ratio": 6.55,
    "two_hundred_day_moving_average": 7.87,
    "volume": 378412.0,
    "market_cap": 214160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.03,
    "roa_ttm": -0.40409999999999996,
    "roe_ttm": -0.6962999999999999,
    "shares_outstanding": 24280000.0,
    "pcnt_held_by_insiders": 0.0363,
    "pcnt_held_by_institutions": 0.924,
    "pcnt_short_of_float": 0.0978,
    "operating_cash_flow_ttm": -28600000.0,
    "levered_cash_flow_ttm": -16870000.0,
    "book_value_per_share_mrq": 1.23,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Repros Therapeutics Inc."
  },
  "RPTP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.85,
    "ebitda": -42370000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 11.73,
    "fifty_two_week_high": 16.28,
    "fifty_two_week_low": 6.22,
    "percent_change_from_200_day_moving_average": -0.46649999999999997,
    "percent_change_from_50_day_moving_average": -0.4365,
    "shares_owned": "N/A",
    "short_ratio": 10.8,
    "two_hundred_day_moving_average": 12.39,
    "volume": 2037238.0,
    "market_cap": 536600000.0,
    "price_to_sales_ttm": 6.18,
    "price_to_book_mrq": 4.32,
    "roa_ttm": -0.1557,
    "roe_ttm": -0.8443999999999999,
    "shares_outstanding": 81180000.0,
    "pcnt_held_by_insiders": 0.0716,
    "pcnt_held_by_institutions": 0.493,
    "pcnt_short_of_float": 0.18100000000000002,
    "operating_cash_flow_ttm": -42900000.0,
    "levered_cash_flow_ttm": -30020000.0,
    "book_value_per_share_mrq": 1.49,
    "next_earnings_announcement_date": "2015-11-02",
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Raptor Pharmaceuticals Corp."
  },
  "RTIX": {
    "p_e_ratio": 52.31,
    "peg_ratio": 1.98,
    "earnings_per_share": 0.12,
    "ebitda": 37770000.0,
    "eps_estimate_current_year": 0.21,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 6.37,
    "fifty_two_week_high": 7.48,
    "fifty_two_week_low": 3.5,
    "percent_change_from_200_day_moving_average": -0.009000000000000001,
    "percent_change_from_50_day_moving_average": -0.0397,
    "shares_owned": "N/A",
    "short_ratio": 6.23,
    "two_hundred_day_moving_average": 6.18,
    "volume": 120596.0,
    "market_cap": 352630000.0,
    "price_to_sales_ttm": 1.28,
    "price_to_book_mrq": 2.02,
    "roa_ttm": 0.036000000000000004,
    "roe_ttm": 0.044199999999999996,
    "shares_outstanding": 57620000.0,
    "pcnt_held_by_insiders": 0.1056,
    "pcnt_held_by_institutions": 0.654,
    "pcnt_short_of_float": 0.0471,
    "operating_cash_flow_ttm": 14300000.0,
    "levered_cash_flow_ttm": 7310000.0,
    "book_value_per_share_mrq": 3.03,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "RTI Surgical Inc."
  },
  "RTRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.84,
    "earnings_per_share": -1.16,
    "ebitda": -39870000.0,
    "eps_estimate_current_year": 0.76,
    "eps_estimate_next_quarter": 0.17,
    "fifty_day_moving_average": 28.58,
    "fifty_two_week_high": 37.04,
    "fifty_two_week_low": 7.85,
    "percent_change_from_200_day_moving_average": -0.1387,
    "percent_change_from_50_day_moving_average": -0.16510000000000002,
    "shares_owned": "N/A",
    "short_ratio": 7.45,
    "two_hundred_day_moving_average": 27.7,
    "volume": 1437991.0,
    "market_cap": 852900000.0,
    "price_to_sales_ttm": 12.67,
    "price_to_book_mrq": 5.27,
    "roa_ttm": -0.1057,
    "roe_ttm": -0.43310000000000004,
    "shares_outstanding": 35750000.0,
    "pcnt_held_by_insiders": 0.4459,
    "pcnt_held_by_institutions": 0.325,
    "pcnt_short_of_float": 0.1285,
    "operating_cash_flow_ttm": -24030000.0,
    "levered_cash_flow_ttm": -26040000.0,
    "book_value_per_share_mrq": 4.3,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Retrophin, Inc."
  },
  "RTTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -12.45,
    "ebitda": -5100000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.2,
    "fifty_two_week_high": 5.5,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.18710000000000002,
    "percent_change_from_50_day_moving_average": -0.07629999999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.06,
    "two_hundred_day_moving_average": 3.64,
    "volume": 22137.0,
    "market_cap": 23070000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.35,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 7790000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0013,
    "operating_cash_flow_ttm": -1470000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ritter Pharmaceuticals, Inc."
  },
  "RVNC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.57,
    "ebitda": -57330000.0,
    "eps_estimate_current_year": -3.55,
    "eps_estimate_next_quarter": -1.15,
    "fifty_day_moving_average": 30.16,
    "fifty_two_week_high": 35.72,
    "fifty_two_week_low": 14.02,
    "percent_change_from_200_day_moving_average": 0.0287,
    "percent_change_from_50_day_moving_average": -0.07919999999999999,
    "shares_owned": "N/A",
    "short_ratio": 11.74,
    "two_hundred_day_moving_average": 26.99,
    "volume": 116753.0,
    "market_cap": 665110000.0,
    "price_to_sales_ttm": 2252.1,
    "price_to_book_mrq": 4.54,
    "roa_ttm": -0.1883,
    "roe_ttm": -0.3478,
    "shares_outstanding": 23950000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.3406,
    "operating_cash_flow_ttm": -47330000.0,
    "levered_cash_flow_ttm": -31490000.0,
    "book_value_per_share_mrq": 6.22,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Revance Therapeutics, Inc."
  },
  "RVP": {
    "p_e_ratio": 21.9,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.17,
    "ebitda": -645645.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.83,
    "fifty_two_week_high": 5.7,
    "fifty_two_week_low": 2.78,
    "percent_change_from_200_day_moving_average": -0.029300000000000003,
    "percent_change_from_50_day_moving_average": -0.005600000000000001,
    "shares_owned": "N/A",
    "short_ratio": 1.23,
    "two_hundred_day_moving_average": 3.93,
    "volume": 1921.0,
    "market_cap": 106160000.0,
    "price_to_sales_ttm": 3.11,
    "price_to_book_mrq": 3.39,
    "roa_ttm": -0.0225,
    "roe_ttm": 0.20850000000000002,
    "shares_outstanding": 27860000.0,
    "pcnt_held_by_insiders": 0.6542,
    "pcnt_held_by_institutions": 0.051,
    "pcnt_short_of_float": 0.0021,
    "operating_cash_flow_ttm": -1870000.0,
    "levered_cash_flow_ttm": -9700000.0,
    "book_value_per_share_mrq": 1.11,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Retractable Technologies, Inc."
  },
  "RWLK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.5,
    "ebitda": -23850000.0,
    "eps_estimate_current_year": -1.93,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 9.13,
    "fifty_two_week_high": 35.55,
    "fifty_two_week_low": 7.31,
    "percent_change_from_200_day_moving_average": -0.2115,
    "percent_change_from_50_day_moving_average": -0.0341,
    "shares_owned": "N/A",
    "short_ratio": 7.78,
    "two_hundred_day_moving_average": 11.19,
    "volume": 17120.0,
    "market_cap": 105650000.0,
    "price_to_sales_ttm": 25.7,
    "price_to_book_mrq": 3.25,
    "roa_ttm": -0.6754000000000001,
    "roe_ttm": -1.3030000000000002,
    "shares_outstanding": 11980000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0929,
    "operating_cash_flow_ttm": -20050000.0,
    "levered_cash_flow_ttm": -10310000.0,
    "book_value_per_share_mrq": 2.77,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ReWalk Robotics Ltd."
  },
  "RXDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.13,
    "ebitda": -64700000.0,
    "eps_estimate_current_year": -2.69,
    "eps_estimate_next_quarter": -0.65,
    "fifty_day_moving_average": 14.41,
    "fifty_two_week_high": 19.4,
    "fifty_two_week_low": 6.25,
    "percent_change_from_200_day_moving_average": 0.20559999999999998,
    "percent_change_from_50_day_moving_average": 0.0643,
    "shares_owned": "N/A",
    "short_ratio": 5.74,
    "two_hundred_day_moving_average": 12.72,
    "volume": 225563.0,
    "market_cap": 454050000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.21,
    "roa_ttm": -0.2989,
    "roe_ttm": -0.5838,
    "shares_outstanding": 29600000.0,
    "pcnt_held_by_insiders": 0.2275,
    "pcnt_held_by_institutions": 0.496,
    "pcnt_short_of_float": 0.0706,
    "operating_cash_flow_ttm": -44920000.0,
    "levered_cash_flow_ttm": -37210000.0,
    "book_value_per_share_mrq": 4.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ignyta, Inc."
  },
  "RXII": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.411,
    "ebitda": -9540000.0,
    "eps_estimate_current_year": -0.22,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.412,
    "fifty_two_week_high": 2.3,
    "fifty_two_week_low": 0.342,
    "percent_change_from_200_day_moving_average": -0.21428,
    "percent_change_from_50_day_moving_average": 0.08647,
    "shares_owned": "N/A",
    "short_ratio": 6.02,
    "two_hundred_day_moving_average": 0.57,
    "volume": 637508.0,
    "market_cap": 29100000.0,
    "price_to_sales_ttm": 447.13,
    "price_to_book_mrq": 2.18,
    "roa_ttm": -0.4375,
    "roe_ttm": -0.7813,
    "shares_outstanding": 64950000.0,
    "pcnt_held_by_insiders": 0.3389,
    "pcnt_held_by_institutions": 0.12,
    "pcnt_short_of_float": 0.1435,
    "operating_cash_flow_ttm": -7130000.0,
    "levered_cash_flow_ttm": -3790000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "RXi Pharmaceuticals Corporation"
  },
  "SAGE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.88,
    "ebitda": -63710000.0,
    "eps_estimate_current_year": -3.24,
    "eps_estimate_next_quarter": -0.87,
    "fifty_day_moving_average": 57.64,
    "fifty_two_week_high": 89.04,
    "fifty_two_week_low": 27.36,
    "percent_change_from_200_day_moving_average": -0.1668,
    "percent_change_from_50_day_moving_average": -0.1054,
    "shares_owned": "N/A",
    "short_ratio": 5.36,
    "two_hundred_day_moving_average": 61.88,
    "volume": 255480.0,
    "market_cap": 1490000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.88,
    "roa_ttm": -0.2846,
    "roe_ttm": -0.4807,
    "shares_outstanding": 28820000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.2834,
    "operating_cash_flow_ttm": -49200000.0,
    "levered_cash_flow_ttm": -24990000.0,
    "book_value_per_share_mrq": 7.6,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sage Therapeutics, Inc."
  },
  "SCAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.48,
    "earnings_per_share": "N/A",
    "ebitda": 0.0,
    "eps_estimate_current_year": 2.03,
    "eps_estimate_next_quarter": 0.7,
    "fifty_day_moving_average": 37.21,
    "fifty_two_week_high": 40.99,
    "fifty_two_week_low": 26.55,
    "percent_change_from_200_day_moving_average": 0.0054,
    "percent_change_from_50_day_moving_average": 0.0116,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 37.44,
    "volume": 70415.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": null,
    "industry": null
  },
  "SCLN": {
    "p_e_ratio": 23.42,
    "peg_ratio": 1.67,
    "earnings_per_share": 0.31,
    "ebitda": 28050000.0,
    "eps_estimate_current_year": 0.33,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 8.04,
    "fifty_two_week_high": 11.71,
    "fifty_two_week_low": 6.59,
    "percent_change_from_200_day_moving_average": -0.183,
    "percent_change_from_50_day_moving_average": -0.0965,
    "shares_owned": "N/A",
    "short_ratio": 7.56,
    "two_hundred_day_moving_average": 8.89,
    "volume": 181140.0,
    "market_cap": 364820000.0,
    "price_to_sales_ttm": 2.49,
    "price_to_book_mrq": 2.29,
    "roa_ttm": 0.0908,
    "roe_ttm": 0.1041,
    "shares_outstanding": 50250000.0,
    "pcnt_held_by_insiders": 0.1333,
    "pcnt_held_by_institutions": 0.516,
    "pcnt_short_of_float": 0.08199999999999999,
    "operating_cash_flow_ttm": 33830000.0,
    "levered_cash_flow_ttm": 32520000.000000004,
    "book_value_per_share_mrq": 3.2,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "SciClone Pharmaceuticals, Inc."
  },
  "SCMP": {
    "p_e_ratio": 42.91,
    "peg_ratio": 2.86,
    "earnings_per_share": 0.59,
    "ebitda": 48140000.0,
    "eps_estimate_current_year": 0.74,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 25.31,
    "fifty_two_week_high": 29.67,
    "fifty_two_week_low": 6.12,
    "percent_change_from_200_day_moving_average": 0.2774,
    "percent_change_from_50_day_moving_average": -0.004699999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.25,
    "two_hundred_day_moving_average": 19.72,
    "volume": 739453.0,
    "market_cap": 1120000000.0,
    "price_to_sales_ttm": 8.42,
    "price_to_book_mrq": 10.36,
    "roa_ttm": 0.19649999999999998,
    "roe_ttm": 0.3038,
    "shares_outstanding": 44660000.0,
    "pcnt_held_by_insiders": 0.6481,
    "pcnt_held_by_institutions": 0.243,
    "pcnt_short_of_float": 0.23420000000000002,
    "operating_cash_flow_ttm": 41870000.0,
    "levered_cash_flow_ttm": 72820000.0,
    "book_value_per_share_mrq": 2.39,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Sucampo Pharmaceuticals, Inc."
  },
  "SCYX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.38,
    "ebitda": -17160000.0,
    "eps_estimate_current_year": -2.69,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 7.15,
    "fifty_two_week_high": 15.0,
    "fifty_two_week_low": 5.7,
    "percent_change_from_200_day_moving_average": -0.1533,
    "percent_change_from_50_day_moving_average": 0.0043,
    "shares_owned": "N/A",
    "short_ratio": 3.69,
    "two_hundred_day_moving_average": 8.48,
    "volume": 3516.0,
    "market_cap": 99830000.0,
    "price_to_sales_ttm": 5.09,
    "price_to_book_mrq": 1.71,
    "roa_ttm": -0.2059,
    "roe_ttm": -0.37549999999999994,
    "shares_outstanding": 13900000.0,
    "pcnt_held_by_insiders": 0.6431,
    "pcnt_held_by_institutions": 0.013999999999999999,
    "pcnt_short_of_float": 0.0111,
    "operating_cash_flow_ttm": -18220000.0,
    "levered_cash_flow_ttm": -11290000.0,
    "book_value_per_share_mrq": 4.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "SCYNEXIS, Inc."
  },
  "SEM": {
    "p_e_ratio": 12.54,
    "peg_ratio": 1.09,
    "earnings_per_share": 0.95,
    "ebitda": 366960000.0,
    "eps_estimate_current_year": 0.93,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 13.03,
    "fifty_two_week_high": 17.2,
    "fifty_two_week_low": 11.46,
    "percent_change_from_200_day_moving_average": -0.19440000000000002,
    "percent_change_from_50_day_moving_average": -0.0876,
    "shares_owned": "N/A",
    "short_ratio": 6.74,
    "two_hundred_day_moving_average": 14.76,
    "volume": 639290.0,
    "market_cap": 1560000000.0,
    "price_to_sales_ttm": 0.5,
    "price_to_book_mrq": 1.95,
    "roa_ttm": 0.050499999999999996,
    "roe_ttm": 0.1426,
    "shares_outstanding": 131380000.0,
    "pcnt_held_by_insiders": 0.4144,
    "pcnt_held_by_institutions": 0.703,
    "pcnt_short_of_float": 0.1025,
    "operating_cash_flow_ttm": 203530000.0,
    "levered_cash_flow_ttm": 4480000.0,
    "book_value_per_share_mrq": 6.14,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Select Medical Holdings Corporation"
  },
  "SGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.91,
    "earnings_per_share": -0.9,
    "ebitda": -99030000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 43.67,
    "fifty_two_week_high": 52.33,
    "fifty_two_week_low": 30.05,
    "percent_change_from_200_day_moving_average": 0.030699999999999998,
    "percent_change_from_50_day_moving_average": 0.0051,
    "shares_owned": "N/A",
    "short_ratio": 19.46,
    "two_hundred_day_moving_average": 42.58,
    "volume": 632135.0,
    "market_cap": 6010000000.0,
    "price_to_sales_ttm": 18.09,
    "price_to_book_mrq": 31.17,
    "roa_ttm": -0.1605,
    "roe_ttm": -0.5497,
    "shares_outstanding": 137010000.0,
    "pcnt_held_by_insiders": 0.1827,
    "pcnt_held_by_institutions": 0.8759999999999999,
    "pcnt_short_of_float": 0.2741,
    "operating_cash_flow_ttm": -106260000.0,
    "levered_cash_flow_ttm": -33189999.999999996,
    "book_value_per_share_mrq": 1.43,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Seattle Genetics, Inc."
  },
  "SGMO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.43,
    "ebitda": -29590000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 7.65,
    "fifty_two_week_high": 19.25,
    "fifty_two_week_low": 6.22,
    "percent_change_from_200_day_moving_average": -0.3979,
    "percent_change_from_50_day_moving_average": -0.0956,
    "shares_owned": "N/A",
    "short_ratio": 9.99,
    "two_hundred_day_moving_average": 11.49,
    "volume": 599335.0,
    "market_cap": 483440000.0,
    "price_to_sales_ttm": 9.89,
    "price_to_book_mrq": 2.43,
    "roa_ttm": -0.0788,
    "roe_ttm": -0.14150000000000001,
    "shares_outstanding": 69860000.0,
    "pcnt_held_by_insiders": 0.0308,
    "pcnt_held_by_institutions": 0.772,
    "pcnt_short_of_float": 0.1673,
    "operating_cash_flow_ttm": -18900000.0,
    "levered_cash_flow_ttm": -2660000.0,
    "book_value_per_share_mrq": 2.86,
    "next_earnings_announcement_date": [
      "2015-10-20",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sangamo Biosciences Inc."
  },
  "SGNL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.67,
    "ebitda": -8930000.0,
    "eps_estimate_current_year": -1.5,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 1.46,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 1.28,
    "percent_change_from_200_day_moving_average": -0.2426,
    "percent_change_from_50_day_moving_average": -0.0669,
    "shares_owned": "N/A",
    "short_ratio": 2.08,
    "two_hundred_day_moving_average": 1.8,
    "volume": 15303563.0,
    "market_cap": 10700000.0,
    "price_to_sales_ttm": 3.14,
    "price_to_book_mrq": 0.95,
    "roa_ttm": -0.4783,
    "roe_ttm": -0.9369,
    "shares_outstanding": 7870000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0667,
    "operating_cash_flow_ttm": -5120000.0,
    "levered_cash_flow_ttm": -2520000.0,
    "book_value_per_share_mrq": 1.4,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Signal Genetics, Inc."
  },
  "SGNT": {
    "p_e_ratio": 18.9,
    "peg_ratio": -19.73,
    "earnings_per_share": 0.91,
    "ebitda": 26900000.0,
    "eps_estimate_current_year": -0.04,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 19.95,
    "fifty_two_week_high": 33.6,
    "fifty_two_week_low": 17.04,
    "percent_change_from_200_day_moving_average": -0.2693,
    "percent_change_from_50_day_moving_average": -0.1377,
    "shares_owned": "N/A",
    "short_ratio": 6.55,
    "two_hundred_day_moving_average": 23.54,
    "volume": 376173.0,
    "market_cap": 562260000.0,
    "price_to_sales_ttm": 1.84,
    "price_to_book_mrq": 2.04,
    "roa_ttm": 0.0288,
    "roe_ttm": 0.1124,
    "shares_outstanding": 32689999.999999996,
    "pcnt_held_by_insiders": 0.514,
    "pcnt_held_by_institutions": 0.593,
    "pcnt_short_of_float": 0.18109999999999998,
    "operating_cash_flow_ttm": 1870000.0,
    "levered_cash_flow_ttm": -16379999.999999998,
    "book_value_per_share_mrq": 8.54,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Sagent Pharmaceuticals, Inc."
  },
  "SGYP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.18,
    "ebitda": -100640000.0,
    "eps_estimate_current_year": -1.16,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 7.35,
    "fifty_two_week_high": 10.15,
    "fifty_two_week_low": 2.45,
    "percent_change_from_200_day_moving_average": 0.0728,
    "percent_change_from_50_day_moving_average": -0.1199,
    "shares_owned": "N/A",
    "short_ratio": 8.2,
    "two_hundred_day_moving_average": 6.03,
    "volume": 7437735.0,
    "market_cap": 727660000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5686,
    "roe_ttm": "-1,404.92%",
    "shares_outstanding": 112470000.0,
    "pcnt_held_by_insiders": 0.09539999999999998,
    "pcnt_held_by_institutions": 0.287,
    "pcnt_short_of_float": 0.2242,
    "operating_cash_flow_ttm": -98590000.0,
    "levered_cash_flow_ttm": -56310000.0,
    "book_value_per_share_mrq": -0.21,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Synergy Pharmaceuticals, Inc."
  },
  "SIEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.99,
    "earnings_per_share": -1.11,
    "ebitda": -7550000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 23.3,
    "fifty_two_week_high": 26.67,
    "fifty_two_week_low": 12.53,
    "percent_change_from_200_day_moving_average": -0.050499999999999996,
    "percent_change_from_50_day_moving_average": -0.1167,
    "shares_owned": "N/A",
    "short_ratio": 3.46,
    "two_hundred_day_moving_average": 21.67,
    "volume": 199920.0,
    "market_cap": 369260000.0,
    "price_to_sales_ttm": 6.16,
    "price_to_book_mrq": 3.36,
    "roa_ttm": -0.049699999999999994,
    "roe_ttm": -0.19469999999999998,
    "shares_outstanding": 17940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0298,
    "operating_cash_flow_ttm": -8330000.0,
    "levered_cash_flow_ttm": -5680000.0,
    "book_value_per_share_mrq": 6.05,
    "next_earnings_announcement_date": [
      "2015-11-18",
      "2015-11-23"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Sientra, Inc."
  },
  "SIRO": {
    "p_e_ratio": 30.28,
    "peg_ratio": 2.18,
    "earnings_per_share": 3.26,
    "ebitda": 280200000.0,
    "eps_estimate_current_year": 3.97,
    "eps_estimate_next_quarter": 1.05,
    "fifty_day_moving_average": 98.28,
    "fifty_two_week_high": 105.37,
    "fifty_two_week_low": 74.38,
    "percent_change_from_200_day_moving_average": 0.0216,
    "percent_change_from_50_day_moving_average": 0.0043,
    "shares_owned": "N/A",
    "short_ratio": 6.51,
    "two_hundred_day_moving_average": 96.62,
    "volume": 322150.0,
    "market_cap": 5520000000.0,
    "price_to_sales_ttm": 4.81,
    "price_to_book_mrq": 4.29,
    "roa_ttm": 0.0823,
    "roe_ttm": 0.1432,
    "shares_outstanding": 55900000.0,
    "pcnt_held_by_insiders": 0.002,
    "pcnt_held_by_institutions": 1.095,
    "pcnt_short_of_float": 0.049800000000000004,
    "operating_cash_flow_ttm": 249400000.0,
    "levered_cash_flow_ttm": 147640000.0,
    "book_value_per_share_mrq": 22.99,
    "next_earnings_announcement_date": [
      "2015-11-19",
      "2015-11-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Sirona Dental Systems Inc."
  },
  "SKBI": {
    "p_e_ratio": 0.84,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.37,
    "ebitda": 14480000.0,
    "eps_estimate_current_year": 2.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.27,
    "fifty_two_week_high": 4.97,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.5827,
    "percent_change_from_50_day_moving_average": -0.0975,
    "shares_owned": "N/A",
    "short_ratio": 1.83,
    "two_hundred_day_moving_average": 2.76,
    "volume": 15455.0,
    "market_cap": 10000000.0,
    "price_to_sales_ttm": 0.2,
    "price_to_book_mrq": 0.08,
    "roa_ttm": 0.051100000000000007,
    "roe_ttm": 0.09609999999999999,
    "shares_outstanding": 8700000.0,
    "pcnt_held_by_insiders": 0.469,
    "pcnt_held_by_institutions": 0.046,
    "pcnt_short_of_float": 0.005,
    "operating_cash_flow_ttm": 18910000.0,
    "levered_cash_flow_ttm": -1920000.0,
    "book_value_per_share_mrq": 14.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Skystar Bio Pharmaceutical Company"
  },
  "SKLN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.58,
    "ebitda": -4130000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.92,
    "fifty_two_week_high": 7.15,
    "fifty_two_week_low": 2.0,
    "percent_change_from_200_day_moving_average": -0.10830000000000001,
    "percent_change_from_50_day_moving_average": -0.10769999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.66,
    "two_hundred_day_moving_average": 3.93,
    "volume": 12181.0,
    "market_cap": 11600000.0,
    "price_to_sales_ttm": 11.18,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -3.0585000000000004,
    "roe_ttm": "N/A",
    "shares_outstanding": 3310000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0131,
    "operating_cash_flow_ttm": -1640000.0,
    "levered_cash_flow_ttm": 429360.0,
    "book_value_per_share_mrq": -1.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Skyline Medical Inc."
  },
  "SMLR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.12,
    "ebitda": -4970000.0,
    "eps_estimate_current_year": -0.78,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.96,
    "fifty_two_week_high": 6.9,
    "fifty_two_week_low": 1.81,
    "percent_change_from_200_day_moving_average": -0.2341,
    "percent_change_from_50_day_moving_average": -0.1081,
    "shares_owned": "N/A",
    "short_ratio": 2.07,
    "two_hundred_day_moving_average": 3.45,
    "volume": 19791.0,
    "market_cap": 13160000.0,
    "price_to_sales_ttm": 2.71,
    "price_to_book_mrq": 7.1,
    "roa_ttm": -0.4878,
    "roe_ttm": -1.4143999999999999,
    "shares_outstanding": 4980000.0,
    "pcnt_held_by_insiders": 0.4363,
    "pcnt_held_by_institutions": 0.138,
    "pcnt_short_of_float": 0.005699999999999999,
    "operating_cash_flow_ttm": -4350000.0,
    "levered_cash_flow_ttm": -4940000.0,
    "book_value_per_share_mrq": 0.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Semler Scientific Inc"
  },
  "SNSS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -0.59,
    "ebitda": -43820000.0,
    "eps_estimate_current_year": -0.49,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 1.18,
    "fifty_two_week_high": 7.78,
    "fifty_two_week_low": 0.84,
    "percent_change_from_200_day_moving_average": -0.4929,
    "percent_change_from_50_day_moving_average": -0.047400000000000005,
    "shares_owned": "N/A",
    "short_ratio": 2.65,
    "two_hundred_day_moving_average": 2.21,
    "volume": 664466.0,
    "market_cap": 84530000.0,
    "price_to_sales_ttm": 24.66,
    "price_to_book_mrq": 4.96,
    "roa_ttm": -0.5457,
    "roe_ttm": -2.1033,
    "shares_outstanding": 75470000.0,
    "pcnt_held_by_insiders": 0.1815,
    "pcnt_held_by_institutions": 0.821,
    "pcnt_short_of_float": 0.0556,
    "operating_cash_flow_ttm": -41360000.0,
    "levered_cash_flow_ttm": -36190000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sunesis Pharmaceuticals, Inc."
  },
  "SNTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.71,
    "ebitda": -78510000.0,
    "eps_estimate_current_year": -0.65,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 2.03,
    "fifty_two_week_high": 3.44,
    "fifty_two_week_low": 1.75,
    "percent_change_from_200_day_moving_average": -0.1161,
    "percent_change_from_50_day_moving_average": -0.016,
    "shares_owned": "N/A",
    "short_ratio": 10.51,
    "two_hundred_day_moving_average": 2.26,
    "volume": 628332.0,
    "market_cap": 272880000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.91,
    "roa_ttm": -0.4551,
    "roe_ttm": -1.1306,
    "shares_outstanding": 136440000.0,
    "pcnt_held_by_insiders": 0.3763,
    "pcnt_held_by_institutions": 0.213,
    "pcnt_short_of_float": 0.11220000000000001,
    "operating_cash_flow_ttm": -74290000.0,
    "levered_cash_flow_ttm": -44180000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Synta Pharmaceuticals Corp."
  },
  "SPAN": {
    "p_e_ratio": 15.69,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.12,
    "ebitda": 5530000.0,
    "eps_estimate_current_year": 0.86,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 18.12,
    "fifty_two_week_high": 21.62,
    "fifty_two_week_low": 16.44,
    "percent_change_from_200_day_moving_average": -0.0525,
    "percent_change_from_50_day_moving_average": -0.030299999999999997,
    "shares_owned": "N/A",
    "short_ratio": 0.24,
    "two_hundred_day_moving_average": 18.54,
    "volume": 351.0,
    "market_cap": 52510000.0,
    "price_to_sales_ttm": 0.88,
    "price_to_book_mrq": 1.84,
    "roa_ttm": 0.0754,
    "roe_ttm": 0.1131,
    "shares_outstanding": 2990000.0,
    "pcnt_held_by_insiders": 0.2827,
    "pcnt_held_by_institutions": 0.354,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": 4600000.0,
    "levered_cash_flow_ttm": 3330000.0,
    "book_value_per_share_mrq": 9.55,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Span-America Medical Systems Inc."
  },
  "SPHS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.28,
    "ebitda": -20840000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.9,
    "fifty_two_week_high": 3.25,
    "fifty_two_week_low": 0.42,
    "percent_change_from_200_day_moving_average": 0.11470000000000001,
    "percent_change_from_50_day_moving_average": 0.0274,
    "shares_owned": "N/A",
    "short_ratio": 1.36,
    "two_hundred_day_moving_average": 0.83,
    "volume": 220522.0,
    "market_cap": 15500000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.29,
    "roa_ttm": -0.4803,
    "roe_ttm": -1.258,
    "shares_outstanding": 16840000.0,
    "pcnt_held_by_insiders": 0.08449999999999999,
    "pcnt_held_by_institutions": 0.40700000000000003,
    "pcnt_short_of_float": 0.0155,
    "operating_cash_flow_ttm": -22280000.0,
    "levered_cash_flow_ttm": -14350000.0,
    "book_value_per_share_mrq": 0.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Sophiris Bio, Inc."
  },
  "SPNC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.95,
    "earnings_per_share": -1.54,
    "ebitda": -8510000.0,
    "eps_estimate_current_year": -1.02,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 16.04,
    "fifty_two_week_high": 37.04,
    "fifty_two_week_low": 13.46,
    "percent_change_from_200_day_moving_average": -0.4471,
    "percent_change_from_50_day_moving_average": -0.1435,
    "shares_owned": "N/A",
    "short_ratio": 7.32,
    "two_hundred_day_moving_average": 24.85,
    "volume": 1129160.0,
    "market_cap": 583920000.0,
    "price_to_sales_ttm": 2.6,
    "price_to_book_mrq": 4.53,
    "roa_ttm": -0.0435,
    "roe_ttm": -0.40369999999999995,
    "shares_outstanding": 42500000.0,
    "pcnt_held_by_insiders": 0.1075,
    "pcnt_held_by_institutions": 0.938,
    "pcnt_short_of_float": 0.1567,
    "operating_cash_flow_ttm": -43520000.0,
    "levered_cash_flow_ttm": 8830000.0,
    "book_value_per_share_mrq": 3.21,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "The Spectranetics Corporation"
  },
  "SPNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.7,
    "ebitda": -4260000.0,
    "eps_estimate_current_year": -3.64,
    "eps_estimate_next_quarter": -0.56,
    "fifty_day_moving_average": 16.13,
    "fifty_two_week_high": 26.0,
    "fifty_two_week_low": 13.56,
    "percent_change_from_200_day_moving_average": 0.044800000000000006,
    "percent_change_from_50_day_moving_average": 0.1057,
    "shares_owned": "N/A",
    "short_ratio": 2.09,
    "two_hundred_day_moving_average": 17.08,
    "volume": 115583.0,
    "market_cap": 198280000.0,
    "price_to_sales_ttm": 1.41,
    "price_to_book_mrq": 1.38,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11110000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -25820000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 12.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "SeaSpine Holdings Corporation"
  },
  "SPPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.65,
    "ebitda": -12890000.0,
    "eps_estimate_current_year": -0.89,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 6.93,
    "fifty_two_week_high": 8.34,
    "fifty_two_week_low": 5.45,
    "percent_change_from_200_day_moving_average": 0.0579,
    "percent_change_from_50_day_moving_average": 0.006500000000000001,
    "shares_owned": "N/A",
    "short_ratio": 13.61,
    "two_hundred_day_moving_average": 6.6,
    "volume": 730781.0,
    "market_cap": 469830000.0,
    "price_to_sales_ttm": 2.46,
    "price_to_book_mrq": 1.93,
    "roa_ttm": -0.0541,
    "roe_ttm": -0.1698,
    "shares_outstanding": 67310000.0,
    "pcnt_held_by_insiders": 0.1193,
    "pcnt_held_by_institutions": 0.687,
    "pcnt_short_of_float": 0.3851,
    "operating_cash_flow_ttm": 33690000.0,
    "levered_cash_flow_ttm": 32560000.000000004,
    "book_value_per_share_mrq": 3.58,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Spectrum Pharmaceuticals, Inc."
  },
  "SQNM": {
    "p_e_ratio": 13.96,
    "peg_ratio": -0.4,
    "earnings_per_share": 0.15,
    "ebitda": 4920000.0,
    "eps_estimate_current_year": -0.24,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 2.19,
    "fifty_two_week_high": 4.8,
    "fifty_two_week_low": 1.82,
    "percent_change_from_200_day_moving_average": -0.359,
    "percent_change_from_50_day_moving_average": -0.0516,
    "shares_owned": "N/A",
    "short_ratio": 13.23,
    "two_hundred_day_moving_average": 3.25,
    "volume": 683621.0,
    "market_cap": 246440000.0,
    "price_to_sales_ttm": 1.73,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0311,
    "roe_ttm": "N/A",
    "shares_outstanding": 118480000.0,
    "pcnt_held_by_insiders": 0.0636,
    "pcnt_held_by_institutions": 0.43,
    "pcnt_short_of_float": 0.1535,
    "operating_cash_flow_ttm": -18250000.0,
    "levered_cash_flow_ttm": 23830000.0,
    "book_value_per_share_mrq": -0.18,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sequenom Inc."
  },
  "SRDX": {
    "p_e_ratio": 24.05,
    "peg_ratio": 1.81,
    "earnings_per_share": 0.96,
    "ebitda": 23000000.0,
    "eps_estimate_current_year": 0.97,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 23.5,
    "fifty_two_week_high": 27.68,
    "fifty_two_week_low": 18.0,
    "percent_change_from_200_day_moving_average": -0.0593,
    "percent_change_from_50_day_moving_average": -0.0175,
    "shares_owned": "N/A",
    "short_ratio": 16.83,
    "two_hundred_day_moving_average": 24.55,
    "volume": 31876.0,
    "market_cap": 298600000.0,
    "price_to_sales_ttm": 4.92,
    "price_to_book_mrq": 3.3,
    "roa_ttm": 0.12869999999999998,
    "roe_ttm": 0.1414,
    "shares_outstanding": 12930000.0,
    "pcnt_held_by_insiders": 0.0118,
    "pcnt_held_by_institutions": 0.857,
    "pcnt_short_of_float": 0.1093,
    "operating_cash_flow_ttm": 17990000.0,
    "levered_cash_flow_ttm": 15170000.0,
    "book_value_per_share_mrq": 6.89,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "SurModics, Inc."
  },
  "SRNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.15,
    "ebitda": -34540000.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 14.28,
    "fifty_two_week_high": 26.8,
    "fifty_two_week_low": 3.1,
    "percent_change_from_200_day_moving_average": -0.2493,
    "percent_change_from_50_day_moving_average": -0.2409,
    "shares_owned": "N/A",
    "short_ratio": 2.47,
    "two_hundred_day_moving_average": 14.44,
    "volume": 380964.0,
    "market_cap": 409340000.0,
    "price_to_sales_ttm": 99.23,
    "price_to_book_mrq": 4.43,
    "roa_ttm": -0.1932,
    "roe_ttm": -0.44310000000000005,
    "shares_outstanding": 37760000.0,
    "pcnt_held_by_insiders": 0.3342,
    "pcnt_held_by_institutions": 0.228,
    "pcnt_short_of_float": 0.0706,
    "operating_cash_flow_ttm": -20800000.0,
    "levered_cash_flow_ttm": -17620000.0,
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sorrento Therapeutics, Inc."
  },
  "SRPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 41.1,
    "earnings_per_share": -4.29,
    "ebitda": -168290000.0,
    "eps_estimate_current_year": -4.86,
    "eps_estimate_next_quarter": -1.16,
    "fifty_day_moving_average": 35.32,
    "fifty_two_week_high": 41.47,
    "fifty_two_week_low": 11.33,
    "percent_change_from_200_day_moving_average": 0.5294,
    "percent_change_from_50_day_moving_average": 0.0916,
    "shares_owned": "N/A",
    "short_ratio": 7.9,
    "two_hundred_day_moving_average": 25.21,
    "volume": 629076.0,
    "market_cap": 1600000000.0,
    "price_to_sales_ttm": 1486.21,
    "price_to_book_mrq": 9.76,
    "roa_ttm": -0.38020000000000004,
    "roe_ttm": -0.7609999999999999,
    "shares_outstanding": 41510000.0,
    "pcnt_held_by_insiders": 0.131,
    "pcnt_held_by_institutions": 0.654,
    "pcnt_short_of_float": 0.2928,
    "operating_cash_flow_ttm": -132650000.0,
    "levered_cash_flow_ttm": -86780000.0,
    "book_value_per_share_mrq": 3.98,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sarepta Therapeutics, Inc."
  },
  "SSH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.51,
    "ebitda": -25790000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 2.8,
    "fifty_two_week_high": 6.9,
    "fifty_two_week_low": 1.99,
    "percent_change_from_200_day_moving_average": -0.2772,
    "percent_change_from_50_day_moving_average": -0.0467,
    "shares_owned": "N/A",
    "short_ratio": 13.43,
    "two_hundred_day_moving_average": 3.69,
    "volume": 24512.0,
    "market_cap": 48950000.0,
    "price_to_sales_ttm": 164.69,
    "price_to_book_mrq": 1.98,
    "roa_ttm": -0.4167,
    "roe_ttm": -0.8085,
    "shares_outstanding": 18330000.0,
    "pcnt_held_by_insiders": 0.1875,
    "pcnt_held_by_institutions": 0.20600000000000002,
    "pcnt_short_of_float": 0.0623,
    "operating_cash_flow_ttm": -23530000.0,
    "levered_cash_flow_ttm": -13380000.0,
    "book_value_per_share_mrq": 1.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Sunshine Heart Inc."
  },
  "SSRG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.94,
    "ebitda": 7320000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.65,
    "fifty_two_week_high": 9.21,
    "fifty_two_week_low": 6.42,
    "percent_change_from_200_day_moving_average": 0.0378,
    "percent_change_from_50_day_moving_average": -0.0031,
    "shares_owned": "N/A",
    "short_ratio": 1.24,
    "two_hundred_day_moving_average": 8.31,
    "volume": 4155.0,
    "market_cap": 89000000.0,
    "price_to_sales_ttm": 1.11,
    "price_to_book_mrq": 0.65,
    "roa_ttm": 0.0033,
    "roe_ttm": -0.1882,
    "shares_outstanding": 10320000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0077,
    "operating_cash_flow_ttm": -2110000.0,
    "levered_cash_flow_ttm": -2580000.0,
    "book_value_per_share_mrq": 13.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Symmetry Surgical Inc."
  },
  "SSY": {
    "p_e_ratio": 10.69,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.16,
    "ebitda": 4680000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.72,
    "fifty_two_week_high": 2.01,
    "fifty_two_week_low": 1.12,
    "percent_change_from_200_day_moving_average": 0.0722,
    "percent_change_from_50_day_moving_average": -0.0121,
    "shares_owned": "N/A",
    "short_ratio": 0.16,
    "two_hundred_day_moving_average": 1.59,
    "volume": 14022.0,
    "market_cap": 16050000.0,
    "price_to_sales_ttm": 0.16,
    "price_to_book_mrq": 0.49,
    "roa_ttm": 0.0152,
    "roe_ttm": 0.0054,
    "shares_outstanding": 9440000.0,
    "pcnt_held_by_insiders": 0.5939,
    "pcnt_held_by_institutions": 0.07400000000000001,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": 1870000.0,
    "levered_cash_flow_ttm": 1130000.0,
    "book_value_per_share_mrq": 3.55,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "SunLink Health Systems Inc."
  },
  "STAA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.07,
    "earnings_per_share": -0.24,
    "ebitda": -6190000.0,
    "eps_estimate_current_year": -0.16,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 7.79,
    "fifty_two_week_high": 11.64,
    "fifty_two_week_low": 4.84,
    "percent_change_from_200_day_moving_average": -0.14150000000000001,
    "percent_change_from_50_day_moving_average": -0.0483,
    "shares_owned": "N/A",
    "short_ratio": 22.77,
    "two_hundred_day_moving_average": 8.63,
    "volume": 123627.0,
    "market_cap": 294950000.0,
    "price_to_sales_ttm": 4.26,
    "price_to_book_mrq": 7.72,
    "roa_ttm": -0.0858,
    "roe_ttm": -0.225,
    "shares_outstanding": 39800000.0,
    "pcnt_held_by_insiders": 0.0184,
    "pcnt_held_by_institutions": 0.7959999999999999,
    "pcnt_short_of_float": 0.132,
    "operating_cash_flow_ttm": -5290000.0,
    "levered_cash_flow_ttm": -3140000.0,
    "book_value_per_share_mrq": 1.0,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "STAAR Surgical Company"
  },
  "STDY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -2.23,
    "ebitda": -21220000.0,
    "eps_estimate_current_year": -2.51,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 4.2,
    "fifty_two_week_high": 11.14,
    "fifty_two_week_low": 3.14,
    "percent_change_from_200_day_moving_average": -0.4815,
    "percent_change_from_50_day_moving_average": -0.1909,
    "shares_owned": "N/A",
    "short_ratio": 2.0,
    "two_hundred_day_moving_average": 6.56,
    "volume": 18329.0,
    "market_cap": 46180000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.13,
    "roa_ttm": -0.41859999999999997,
    "roe_ttm": -0.8447,
    "shares_outstanding": 13580000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0085,
    "operating_cash_flow_ttm": -18750000.0,
    "levered_cash_flow_ttm": -10420000.0,
    "book_value_per_share_mrq": 2.99,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "SteadyMed Ltd."
  },
  "STE": {
    "p_e_ratio": 28.12,
    "peg_ratio": 1.96,
    "earnings_per_share": 2.24,
    "ebitda": 354560000.0,
    "eps_estimate_current_year": 3.25,
    "eps_estimate_next_quarter": 0.86,
    "fifty_day_moving_average": 65.35,
    "fifty_two_week_high": 71.39,
    "fifty_two_week_low": 52.29,
    "percent_change_from_200_day_moving_average": -0.0591,
    "percent_change_from_50_day_moving_average": -0.0365,
    "shares_owned": "N/A",
    "short_ratio": 13.83,
    "two_hundred_day_moving_average": 66.91,
    "volume": 344602.0,
    "market_cap": 3770000000.0,
    "price_to_sales_ttm": 2.02,
    "price_to_book_mrq": 3.43,
    "roa_ttm": 0.0787,
    "roe_ttm": 0.1245,
    "shares_outstanding": 59840000.0,
    "pcnt_held_by_insiders": 0.0089,
    "pcnt_held_by_institutions": 0.9570000000000001,
    "pcnt_short_of_float": 0.11320000000000001,
    "operating_cash_flow_ttm": 240840000.0,
    "levered_cash_flow_ttm": 181980000.0,
    "book_value_per_share_mrq": 18.34,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Steris Corp."
  },
  "STEM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.411,
    "ebitda": -33159999.999999996,
    "eps_estimate_current_year": -0.39,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 0.4574,
    "fifty_two_week_high": 1.39,
    "fifty_two_week_low": 0.31,
    "percent_change_from_200_day_moving_average": -0.232865,
    "percent_change_from_50_day_moving_average": 0.114271,
    "shares_owned": "N/A",
    "short_ratio": 4.05,
    "two_hundred_day_moving_average": 0.6644,
    "volume": 288346.0,
    "market_cap": 55310000.0,
    "price_to_sales_ttm": 56.58,
    "price_to_book_mrq": 3.76,
    "roa_ttm": -0.657,
    "roe_ttm": -4.8031,
    "shares_outstanding": 108520000.0,
    "pcnt_held_by_insiders": 0.2377,
    "pcnt_held_by_institutions": 0.09,
    "pcnt_short_of_float": 0.0256,
    "operating_cash_flow_ttm": -29560000.0,
    "levered_cash_flow_ttm": -16440000.000000002,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "StemCells Inc."
  },
  "STML": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.11,
    "ebitda": -31690000.0,
    "eps_estimate_current_year": -2.22,
    "eps_estimate_next_quarter": -0.58,
    "fifty_day_moving_average": 9.72,
    "fifty_two_week_high": 18.94,
    "fifty_two_week_low": 8.31,
    "percent_change_from_200_day_moving_average": -0.163,
    "percent_change_from_50_day_moving_average": 0.0977,
    "shares_owned": "N/A",
    "short_ratio": 5.97,
    "two_hundred_day_moving_average": 12.75,
    "volume": 46754.0,
    "market_cap": 191790000.0,
    "price_to_sales_ttm": 426.86,
    "price_to_book_mrq": 1.78,
    "roa_ttm": -0.21760000000000002,
    "roe_ttm": -0.369,
    "shares_outstanding": 17970000.0,
    "pcnt_held_by_insiders": 0.1938,
    "pcnt_held_by_institutions": 0.6629999999999999,
    "pcnt_short_of_float": 0.0351,
    "operating_cash_flow_ttm": -24810000.0,
    "levered_cash_flow_ttm": -13550000.0,
    "book_value_per_share_mrq": 5.98,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Stemline Therapeutics, Inc."
  },
  "STXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.184,
    "ebitda": -3390000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.0483,
    "fifty_two_week_high": 2.97,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": -0.36221600000000004,
    "percent_change_from_50_day_moving_average": -0.027082000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.8,
    "two_hundred_day_moving_average": 1.5991,
    "volume": 383772.0,
    "market_cap": 21490000.0,
    "price_to_sales_ttm": 0.53,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1059,
    "roe_ttm": "N/A",
    "shares_outstanding": 21070000.0,
    "pcnt_held_by_insiders": 0.1576,
    "pcnt_held_by_institutions": 0.17300000000000001,
    "pcnt_short_of_float": 0.027999999999999997,
    "operating_cash_flow_ttm": -7840000.0,
    "levered_cash_flow_ttm": -9090000.0,
    "book_value_per_share_mrq": -0.75,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Stereotaxis Inc."
  },
  "SUPN": {
    "p_e_ratio": 32.49,
    "peg_ratio": 2.32,
    "earnings_per_share": 0.59,
    "ebitda": 41300000.0,
    "eps_estimate_current_year": 0.12,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 18.62,
    "fifty_two_week_high": 23.3,
    "fifty_two_week_low": 7.31,
    "percent_change_from_200_day_moving_average": 0.2126,
    "percent_change_from_50_day_moving_average": 0.0294,
    "shares_owned": "N/A",
    "short_ratio": 4.54,
    "two_hundred_day_moving_average": 15.81,
    "volume": 641741.0,
    "market_cap": 928720000.0,
    "price_to_sales_ttm": 6.38,
    "price_to_book_mrq": 9.12,
    "roa_ttm": 0.2034,
    "roe_ttm": 0.5177,
    "shares_outstanding": 48450000.0,
    "pcnt_held_by_insiders": 0.1653,
    "pcnt_held_by_institutions": 0.767,
    "pcnt_short_of_float": 0.11320000000000001,
    "operating_cash_flow_ttm": 48950000.0,
    "levered_cash_flow_ttm": 34100000.0,
    "book_value_per_share_mrq": 2.11,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Supernus Pharmaceuticals, Inc."
  },
  "SURG": {
    "p_e_ratio": 38.76,
    "peg_ratio": 2.58,
    "earnings_per_share": 0.17,
    "ebitda": 10110000.0,
    "eps_estimate_current_year": 0.17,
    "eps_estimate_next_quarter": 0.06,
    "fifty_day_moving_average": 5.3,
    "fifty_two_week_high": 6.7,
    "fifty_two_week_low": 3.18,
    "percent_change_from_200_day_moving_average": 0.32539999999999997,
    "percent_change_from_50_day_moving_average": 0.2432,
    "shares_owned": "N/A",
    "short_ratio": 0.83,
    "two_hundred_day_moving_average": 4.97,
    "volume": 752853.0,
    "market_cap": 168660000.0,
    "price_to_sales_ttm": 2.32,
    "price_to_book_mrq": 2.5,
    "roa_ttm": 0.0521,
    "roe_ttm": 0.0674,
    "shares_outstanding": 25590000.0,
    "pcnt_held_by_insiders": 0.1039,
    "pcnt_held_by_institutions": 0.418,
    "pcnt_short_of_float": 0.0016,
    "operating_cash_flow_ttm": 11080000.0,
    "levered_cash_flow_ttm": 10570000.0,
    "book_value_per_share_mrq": 2.63,
    "next_earnings_announcement_date": [
      "2015-10-12",
      "2015-10-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Synergetics USA, Inc."
  },
  "SVA": {
    "p_e_ratio": 255.5,
    "peg_ratio": -8.62,
    "earnings_per_share": 0.02,
    "ebitda": 11700000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 5.37,
    "fifty_two_week_high": 6.0,
    "fifty_two_week_low": 4.51,
    "percent_change_from_200_day_moving_average": -0.028399999999999998,
    "percent_change_from_50_day_moving_average": -0.0484,
    "shares_owned": "N/A",
    "short_ratio": 8.47,
    "two_hundred_day_moving_average": 5.26,
    "volume": 28392.0,
    "market_cap": 285190000.0,
    "price_to_sales_ttm": 4.44,
    "price_to_book_mrq": 2.27,
    "roa_ttm": 0.0129,
    "roe_ttm": 0.0202,
    "shares_outstanding": 55810000.0,
    "pcnt_held_by_insiders": 0.099,
    "pcnt_held_by_institutions": 0.267,
    "pcnt_short_of_float": 0.0273,
    "operating_cash_flow_ttm": -5010000.0,
    "levered_cash_flow_ttm": -11950000.0,
    "book_value_per_share_mrq": 2.28,
    "next_earnings_announcement_date": [
      "2015-11-13",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sinovac Biotech Ltd."
  },
  "SYN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.54,
    "ebitda": -29920000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.59,
    "fifty_two_week_high": 4.32,
    "fifty_two_week_low": 1.34,
    "percent_change_from_200_day_moving_average": 0.16579999999999998,
    "percent_change_from_50_day_moving_average": 0.1482,
    "shares_owned": "N/A",
    "short_ratio": 3.1,
    "two_hundred_day_moving_average": 2.55,
    "volume": 1092298.0,
    "market_cap": 262890000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.7721,
    "roe_ttm": "N/A",
    "shares_outstanding": 88520000.0,
    "pcnt_held_by_insiders": 0.0379,
    "pcnt_held_by_institutions": 0.354,
    "pcnt_short_of_float": 0.09179999999999999,
    "operating_cash_flow_ttm": -22020000.0,
    "levered_cash_flow_ttm": 2600000.0,
    "book_value_per_share_mrq": -0.19,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Synthetic Biologics Inc."
  },
  "TARO": {
    "p_e_ratio": 11.96,
    "peg_ratio": 0.81,
    "earnings_per_share": 12.64,
    "ebitda": 625560000.0,
    "eps_estimate_current_year": 11.92,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 137.96,
    "fifty_two_week_high": 173.0,
    "fifty_two_week_low": 124.35,
    "percent_change_from_200_day_moving_average": 0.0678,
    "percent_change_from_50_day_moving_average": 0.0964,
    "shares_owned": "N/A",
    "short_ratio": 0.24,
    "two_hundred_day_moving_average": 141.66,
    "volume": 42850.0,
    "market_cap": 6480000000.0,
    "price_to_sales_ttm": 6.74,
    "price_to_book_mrq": 4.19,
    "roa_ttm": 0.24309999999999998,
    "roe_ttm": 0.4152,
    "shares_outstanding": 42830000.0,
    "pcnt_held_by_insiders": 0.6887000000000001,
    "pcnt_held_by_institutions": 0.12300000000000001,
    "pcnt_short_of_float": 0.0014000000000000002,
    "operating_cash_flow_ttm": 439320000.0,
    "levered_cash_flow_ttm": 253700000.0,
    "book_value_per_share_mrq": 35.59,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Taro Pharmaceutical Industries Ltd."
  },
  "TBPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.26,
    "earnings_per_share": -6.43,
    "ebitda": -196420000.0,
    "eps_estimate_current_year": -5.47,
    "eps_estimate_next_quarter": -1.35,
    "fifty_day_moving_average": 13.14,
    "fifty_two_week_high": 26.04,
    "fifty_two_week_low": 11.36,
    "percent_change_from_200_day_moving_average": -0.0892,
    "percent_change_from_50_day_moving_average": 0.022099999999999998,
    "shares_owned": "N/A",
    "short_ratio": 15.41,
    "two_hundred_day_moving_average": 14.75,
    "volume": 165827.0,
    "market_cap": 455800000.0,
    "price_to_sales_ttm": 13.09,
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.3452,
    "roe_ttm": -0.6503,
    "shares_outstanding": 33940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1732,
    "operating_cash_flow_ttm": -182040000.0,
    "levered_cash_flow_ttm": -101720000.0,
    "book_value_per_share_mrq": 7.59,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-10"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Theravance Biopharma, Inc."
  },
  "TBRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -10.65,
    "ebitda": -26770000.0,
    "eps_estimate_current_year": -15.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 13.25,
    "fifty_two_week_high": 24.31,
    "fifty_two_week_low": 7.2,
    "percent_change_from_200_day_moving_average": -0.0493,
    "percent_change_from_50_day_moving_average": 0.021400000000000002,
    "shares_owned": "N/A",
    "short_ratio": 1.92,
    "two_hundred_day_moving_average": 14.23,
    "volume": 17695.0,
    "market_cap": 235960000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.06,
    "roa_ttm": -0.31329999999999997,
    "roe_ttm": -2.2641,
    "shares_outstanding": 17440000.0,
    "pcnt_held_by_insiders": 0.6657,
    "pcnt_held_by_institutions": 0.175,
    "pcnt_short_of_float": 0.0242,
    "operating_cash_flow_ttm": -29580000.0,
    "levered_cash_flow_ttm": -21380000.0,
    "book_value_per_share_mrq": 3.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tobira Therapeutics, Inc."
  },
  "TCON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.98,
    "ebitda": -10320000.0,
    "eps_estimate_current_year": -1.75,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 11.53,
    "fifty_two_week_high": 21.0,
    "fifty_two_week_low": 9.02,
    "percent_change_from_200_day_moving_average": 0.0478,
    "percent_change_from_50_day_moving_average": 0.1075,
    "shares_owned": "N/A",
    "short_ratio": 2.63,
    "two_hundred_day_moving_average": 12.19,
    "volume": 189784.0,
    "market_cap": 154560000.0,
    "price_to_sales_ttm": 21.83,
    "price_to_book_mrq": 3.5,
    "roa_ttm": -0.16260000000000002,
    "roe_ttm": -0.5279,
    "shares_outstanding": 12100000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0226,
    "operating_cash_flow_ttm": -12820000.0,
    "levered_cash_flow_ttm": -5450000.0,
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TRACON Pharmaceuticals, Inc."
  },
  "TEAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -0.86,
    "ebitda": -25740000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 2.49,
    "fifty_two_week_high": 3.86,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.1552,
    "percent_change_from_50_day_moving_average": -0.1881,
    "shares_owned": "N/A",
    "short_ratio": 12.15,
    "two_hundred_day_moving_average": 2.39,
    "volume": 139941.0,
    "market_cap": 68100000.0,
    "price_to_sales_ttm": 3.0,
    "price_to_book_mrq": 6.35,
    "roa_ttm": -0.5091,
    "roe_ttm": -1.272,
    "shares_outstanding": 33710000.0,
    "pcnt_held_by_insiders": 0.1377,
    "pcnt_held_by_institutions": 0.695,
    "pcnt_short_of_float": 0.08039999999999999,
    "operating_cash_flow_ttm": -22730000.0,
    "levered_cash_flow_ttm": -14050000.0,
    "book_value_per_share_mrq": 0.31,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "TearLab Corporation"
  },
  "TECH": {
    "p_e_ratio": 32.74,
    "peg_ratio": 2.16,
    "earnings_per_share": 2.89,
    "ebitda": 186230000.0,
    "eps_estimate_current_year": 3.56,
    "eps_estimate_next_quarter": 0.85,
    "fifty_day_moving_average": 99.55,
    "fifty_two_week_high": 114.56,
    "fifty_two_week_low": 86.01,
    "percent_change_from_200_day_moving_average": -0.0562,
    "percent_change_from_50_day_moving_average": -0.049400000000000006,
    "shares_owned": "N/A",
    "short_ratio": 7.21,
    "two_hundred_day_moving_average": 100.26,
    "volume": 152997.0,
    "market_cap": 3520000000.0,
    "price_to_sales_ttm": 7.83,
    "price_to_book_mrq": 4.17,
    "roa_ttm": 0.10289999999999999,
    "roe_ttm": 0.13119999999999998,
    "shares_outstanding": 37180000.0,
    "pcnt_held_by_insiders": 0.0053,
    "pcnt_held_by_institutions": 0.961,
    "pcnt_short_of_float": 0.0487,
    "operating_cash_flow_ttm": 139360000.0,
    "levered_cash_flow_ttm": 105380000.0,
    "book_value_per_share_mrq": 22.8,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bio-Techne Corp."
  },
  "TENX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -14120000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 3.53,
    "fifty_two_week_high": 4.76,
    "fifty_two_week_low": 2.88,
    "percent_change_from_200_day_moving_average": 0.021099999999999997,
    "percent_change_from_50_day_moving_average": 0.019799999999999998,
    "shares_owned": "N/A",
    "short_ratio": 28.49,
    "two_hundred_day_moving_average": 3.53,
    "volume": 17280.0,
    "market_cap": 101230000.0,
    "price_to_sales_ttm": 1985.43,
    "price_to_book_mrq": 1.45,
    "roa_ttm": -0.1047,
    "roe_ttm": -0.2007,
    "shares_outstanding": 28120000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0394,
    "operating_cash_flow_ttm": -11610000.0,
    "levered_cash_flow_ttm": -6430000.0,
    "book_value_per_share_mrq": 2.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tenax Therapeutics, Inc."
  },
  "TFX": {
    "p_e_ratio": 33.3,
    "peg_ratio": 1.91,
    "earnings_per_share": 3.99,
    "ebitda": 409950000.0,
    "eps_estimate_current_year": 6.22,
    "eps_estimate_next_quarter": 1.94,
    "fifty_day_moving_average": 132.69,
    "fifty_two_week_high": 140.5,
    "fifty_two_week_low": 101.95,
    "percent_change_from_200_day_moving_average": 0.0287,
    "percent_change_from_50_day_moving_average": 0.0018,
    "shares_owned": "N/A",
    "short_ratio": 12.08,
    "two_hundred_day_moving_average": 129.23,
    "volume": 499146.0,
    "market_cap": 5530000000.0,
    "price_to_sales_ttm": 3.08,
    "price_to_book_mrq": 2.89,
    "roa_ttm": 0.0479,
    "roe_ttm": 0.0983,
    "shares_outstanding": 41600000.0,
    "pcnt_held_by_insiders": 0.0031,
    "pcnt_held_by_institutions": 0.924,
    "pcnt_short_of_float": 0.0643,
    "operating_cash_flow_ttm": 276160000.0,
    "levered_cash_flow_ttm": 196350000.0,
    "book_value_per_share_mrq": 46.11,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Teleflex Incorporated"
  },
  "TGTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.7,
    "ebitda": -67870000.0,
    "eps_estimate_current_year": -1.44,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 13.71,
    "fifty_two_week_high": 20.0,
    "fifty_two_week_low": 9.16,
    "percent_change_from_200_day_moving_average": -0.243,
    "percent_change_from_50_day_moving_average": -0.1313,
    "shares_owned": "N/A",
    "short_ratio": 11.69,
    "two_hundred_day_moving_average": 15.73,
    "volume": 390857.0,
    "market_cap": 625840000.0,
    "price_to_sales_ttm": 4091.64,
    "price_to_book_mrq": 5.52,
    "roa_ttm": -0.47159999999999996,
    "roe_ttm": -0.8231999999999999,
    "shares_outstanding": 52550000.0,
    "pcnt_held_by_insiders": 0.43799999999999994,
    "pcnt_held_by_institutions": 0.263,
    "pcnt_short_of_float": 0.2097,
    "operating_cash_flow_ttm": -44290000.0,
    "levered_cash_flow_ttm": -19120000.0,
    "book_value_per_share_mrq": 2.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TG Therapeutics, Inc."
  },
  "THC": {
    "p_e_ratio": 79.78,
    "peg_ratio": 0.91,
    "earnings_per_share": 0.56,
    "ebitda": 2190000000.0,
    "eps_estimate_current_year": 2.17,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 49.32,
    "fifty_two_week_high": 63.23,
    "fifty_two_week_low": 41.47,
    "percent_change_from_200_day_moving_average": -0.1392,
    "percent_change_from_50_day_moving_average": -0.099,
    "shares_owned": "N/A",
    "short_ratio": 3.92,
    "two_hundred_day_moving_average": 51.63,
    "volume": 2316746.0,
    "market_cap": 4420000000.0,
    "price_to_sales_ttm": 0.25,
    "price_to_book_mrq": 5.39,
    "roa_ttm": 0.0421,
    "roe_ttm": 0.0787,
    "shares_outstanding": 99560000.0,
    "pcnt_held_by_insiders": 0.012199999999999999,
    "pcnt_held_by_institutions": 1.025,
    "pcnt_short_of_float": 0.0902,
    "operating_cash_flow_ttm": 793000000.0,
    "levered_cash_flow_ttm": -498750000.0,
    "book_value_per_share_mrq": 8.09,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Tenet Healthcare Corp."
  },
  "THLD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -32650000.0,
    "eps_estimate_current_year": -0.53,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 4.39,
    "fifty_two_week_high": 5.28,
    "fifty_two_week_low": 2.58,
    "percent_change_from_200_day_moving_average": 0.1475,
    "percent_change_from_50_day_moving_average": 0.0901,
    "shares_owned": "N/A",
    "short_ratio": 7.54,
    "two_hundred_day_moving_average": 4.17,
    "volume": 628921.0,
    "market_cap": 341690000.0,
    "price_to_sales_ttm": 22.68,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2669,
    "roe_ttm": "N/A",
    "shares_outstanding": 71330000.0,
    "pcnt_held_by_insiders": 0.1736,
    "pcnt_held_by_institutions": 0.508,
    "pcnt_short_of_float": 0.08289999999999999,
    "operating_cash_flow_ttm": -40990000.0,
    "levered_cash_flow_ttm": -13850000.0,
    "book_value_per_share_mrq": -0.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Threshold Pharmaceuticals Inc."
  },
  "THOR": {
    "p_e_ratio": 89.87,
    "peg_ratio": 4.39,
    "earnings_per_share": 0.7,
    "ebitda": 70480000.0,
    "eps_estimate_current_year": 1.34,
    "eps_estimate_next_quarter": 0.37,
    "fifty_day_moving_average": 62.96,
    "fifty_two_week_high": 63.51,
    "fifty_two_week_low": 25.04,
    "percent_change_from_200_day_moving_average": 0.27149999999999996,
    "percent_change_from_50_day_moving_average": 0.0049,
    "shares_owned": "N/A",
    "short_ratio": 1.23,
    "two_hundred_day_moving_average": 49.76,
    "volume": 449074.0,
    "market_cap": 3470000000.0,
    "price_to_sales_ttm": 7.15,
    "price_to_book_mrq": 5.08,
    "roa_ttm": 0.043,
    "roe_ttm": 0.0571,
    "shares_outstanding": 54790000.0,
    "pcnt_held_by_insiders": 0.005600000000000001,
    "pcnt_held_by_institutions": 0.903,
    "pcnt_short_of_float": 0.0424,
    "operating_cash_flow_ttm": 105660000.0,
    "levered_cash_flow_ttm": 80510000.0,
    "book_value_per_share_mrq": 12.43,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Thoratec Corp."
  },
  "THRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.39,
    "earnings_per_share": -0.49,
    "ebitda": -4210000.0,
    "eps_estimate_current_year": -0.14,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 13.0,
    "fifty_two_week_high": 21.16,
    "fifty_two_week_low": 8.78,
    "percent_change_from_200_day_moving_average": -0.43689999999999996,
    "percent_change_from_50_day_moving_average": -0.3079,
    "shares_owned": "N/A",
    "short_ratio": 46.24,
    "two_hundred_day_moving_average": 15.98,
    "volume": 1243032.0,
    "market_cap": 1050000000.0,
    "price_to_sales_ttm": 41.81,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0042,
    "roe_ttm": "N/A",
    "shares_outstanding": 117130000.0,
    "pcnt_held_by_insiders": 0.3126,
    "pcnt_held_by_institutions": 0.8079999999999999,
    "pcnt_short_of_float": 0.8108,
    "operating_cash_flow_ttm": -25120000.0,
    "levered_cash_flow_ttm": -76030000.0,
    "book_value_per_share_mrq": -2.51,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Theravance Inc."
  },
  "TKAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.0,
    "ebitda": -34940000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 12.46,
    "fifty_two_week_high": 17.87,
    "fifty_two_week_low": 9.67,
    "percent_change_from_200_day_moving_average": 0.0313,
    "percent_change_from_50_day_moving_average": 0.0356,
    "shares_owned": "N/A",
    "short_ratio": 28.39,
    "two_hundred_day_moving_average": 12.51,
    "volume": 53274.0,
    "market_cap": 290870000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.49,
    "roa_ttm": -0.3944,
    "roe_ttm": -0.6794,
    "shares_outstanding": 22550000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.3135,
    "operating_cash_flow_ttm": -33030000.0,
    "levered_cash_flow_ttm": -21030000.0,
    "book_value_per_share_mrq": 3.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tokai Pharmaceuticals, Inc."
  },
  "TLOG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.03,
    "ebitda": -37320000.0,
    "eps_estimate_current_year": -1.98,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 2.3294,
    "fifty_two_week_high": 6.3,
    "fifty_two_week_low": 0.72,
    "percent_change_from_200_day_moving_average": -0.29791,
    "percent_change_from_50_day_moving_average": -0.100401,
    "shares_owned": "N/A",
    "short_ratio": 12.12,
    "two_hundred_day_moving_average": 2.9847,
    "volume": 68511.0,
    "market_cap": 48900000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.44,
    "roa_ttm": -0.20620000000000002,
    "roe_ttm": -1.3722,
    "shares_outstanding": 23330000.0,
    "pcnt_held_by_insiders": 0.4286,
    "pcnt_held_by_institutions": 0.29,
    "pcnt_short_of_float": 0.0575,
    "operating_cash_flow_ttm": -37170000.0,
    "levered_cash_flow_ttm": -20490000.0,
    "book_value_per_share_mrq": 0.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TetraLogic Pharmaceuticals Corporation"
  },
  "TNDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.28,
    "earnings_per_share": -3.09,
    "ebitda": -70700000.0,
    "eps_estimate_current_year": -2.83,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 12.07,
    "fifty_two_week_high": 17.98,
    "fifty_two_week_low": 10.14,
    "percent_change_from_200_day_moving_average": -0.1247,
    "percent_change_from_50_day_moving_average": -0.1099,
    "shares_owned": "N/A",
    "short_ratio": 18.92,
    "two_hundred_day_moving_average": 12.27,
    "volume": 170302.0,
    "market_cap": 322350000.0,
    "price_to_sales_ttm": 5.75,
    "price_to_book_mrq": 3.9,
    "roa_ttm": -0.3482,
    "roe_ttm": -0.9236,
    "shares_outstanding": 30010000.0,
    "pcnt_held_by_insiders": 0.4576,
    "pcnt_held_by_institutions": 0.47600000000000003,
    "pcnt_short_of_float": 0.22519999999999998,
    "operating_cash_flow_ttm": -61300000.0,
    "levered_cash_flow_ttm": -34830000.0,
    "book_value_per_share_mrq": 2.92,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Tandem Diabetes Care, Inc."
  },
  "TNXP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.96,
    "ebitda": -37850000.0,
    "eps_estimate_current_year": -2.68,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 7.16,
    "fifty_two_week_high": 14.35,
    "fifty_two_week_low": 5.33,
    "percent_change_from_200_day_moving_average": -0.1151,
    "percent_change_from_50_day_moving_average": -0.09269999999999999,
    "shares_owned": "N/A",
    "short_ratio": 4.43,
    "two_hundred_day_moving_average": 7.35,
    "volume": 119976.0,
    "market_cap": 122200000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.41,
    "roa_ttm": -0.4938,
    "roe_ttm": -0.8515,
    "shares_outstanding": 18800000.0,
    "pcnt_held_by_insiders": 0.129,
    "pcnt_held_by_institutions": 0.294,
    "pcnt_short_of_float": 0.056600000000000004,
    "operating_cash_flow_ttm": -31370000.0,
    "levered_cash_flow_ttm": -17650000.0,
    "book_value_per_share_mrq": 2.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Tonix Pharmaceuticals Holding Corp"
  },
  "TPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.14,
    "ebitda": 3120000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.27,
    "fifty_two_week_high": 0.78,
    "fifty_two_week_low": 0.22,
    "percent_change_from_200_day_moving_average": -0.3935,
    "percent_change_from_50_day_moving_average": -0.1223,
    "shares_owned": "N/A",
    "short_ratio": 0.71,
    "two_hundred_day_moving_average": 0.4,
    "volume": 0.0,
    "market_cap": 7060000.0,
    "price_to_sales_ttm": 0.24,
    "price_to_book_mrq": 0.07,
    "roa_ttm": -0.0124,
    "roe_ttm": -0.041100000000000005,
    "shares_outstanding": 29430000.0,
    "pcnt_held_by_insiders": 0.2967,
    "pcnt_held_by_institutions": 0.106,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": -1250000.0,
    "levered_cash_flow_ttm": -10240000.0,
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Tianyin Pharmaceutical Co., Inc."
  },
  "TRIB": {
    "p_e_ratio": 21.56,
    "peg_ratio": 1.44,
    "earnings_per_share": 0.6,
    "ebitda": 18660000.0,
    "eps_estimate_current_year": 0.48,
    "eps_estimate_next_quarter": 0.11,
    "fifty_day_moving_average": 15.48,
    "fifty_two_week_high": 20.24,
    "fifty_two_week_low": 12.73,
    "percent_change_from_200_day_moving_average": -0.24350000000000002,
    "percent_change_from_50_day_moving_average": -0.1613,
    "shares_owned": "N/A",
    "short_ratio": 21.56,
    "two_hundred_day_moving_average": 17.16,
    "volume": 242940.0,
    "market_cap": 301070000.0,
    "price_to_sales_ttm": 2.94,
    "price_to_book_mrq": 1.47,
    "roa_ttm": 0.029900000000000003,
    "roe_ttm": 0.0757,
    "shares_outstanding": 23200000.0,
    "pcnt_held_by_insiders": 0.050300000000000004,
    "pcnt_held_by_institutions": 0.58,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 16810000.0,
    "levered_cash_flow_ttm": -17650000.0,
    "book_value_per_share_mrq": 8.84,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Trinity Biotech plc"
  },
  "TRIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -2.9,
    "ebitda": -50500000.0,
    "eps_estimate_current_year": -2.88,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 5.13,
    "fifty_two_week_high": 16.62,
    "fifty_two_week_low": 3.98,
    "percent_change_from_200_day_moving_average": -0.2394,
    "percent_change_from_50_day_moving_average": 0.0021,
    "shares_owned": "N/A",
    "short_ratio": 12.69,
    "two_hundred_day_moving_average": 6.76,
    "volume": 9439.0,
    "market_cap": 105470000.0,
    "price_to_sales_ttm": 2.86,
    "price_to_book_mrq": 7.79,
    "roa_ttm": -0.31,
    "roe_ttm": -1.4978,
    "shares_outstanding": 20520000.0,
    "pcnt_held_by_insiders": 0.3243,
    "pcnt_held_by_institutions": 0.40399999999999997,
    "pcnt_short_of_float": 0.0443,
    "operating_cash_flow_ttm": -53750000.0,
    "levered_cash_flow_ttm": -33070000.0,
    "book_value_per_share_mrq": 0.62,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "TriVascular Technologies, Inc."
  },
  "TRNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.84,
    "earnings_per_share": -0.57,
    "ebitda": 27200000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 23.55,
    "fifty_two_week_high": 28.53,
    "fifty_two_week_low": 21.43,
    "percent_change_from_200_day_moving_average": -0.0626,
    "percent_change_from_50_day_moving_average": 0.0063,
    "shares_owned": "N/A",
    "short_ratio": 12.84,
    "two_hundred_day_moving_average": 25.28,
    "volume": 110093.0,
    "market_cap": 1170000000.0,
    "price_to_sales_ttm": 3.45,
    "price_to_book_mrq": 2.61,
    "roa_ttm": -0.0128,
    "roe_ttm": -0.0588,
    "shares_outstanding": 49270000.0,
    "pcnt_held_by_insiders": 0.04769999999999999,
    "pcnt_held_by_institutions": 0.935,
    "pcnt_short_of_float": 0.0575,
    "operating_cash_flow_ttm": 2510000.0,
    "levered_cash_flow_ttm": 6650000.0,
    "book_value_per_share_mrq": 9.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Tornier N.V."
  },
  "TROV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.32,
    "ebitda": -19650000.0,
    "eps_estimate_current_year": -1.29,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 6.24,
    "fifty_two_week_high": 13.58,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": -0.2076,
    "percent_change_from_50_day_moving_average": 0.0726,
    "shares_owned": "N/A",
    "short_ratio": 4.57,
    "two_hundred_day_moving_average": 8.44,
    "volume": 435520.0,
    "market_cap": 198180000.0,
    "price_to_sales_ttm": 702.97,
    "price_to_book_mrq": 9.45,
    "roa_ttm": -0.3119,
    "roe_ttm": -1.5467,
    "shares_outstanding": 29620000.0,
    "pcnt_held_by_insiders": 0.1167,
    "pcnt_held_by_institutions": 0.22,
    "pcnt_short_of_float": 0.1649,
    "operating_cash_flow_ttm": -17450000.0,
    "levered_cash_flow_ttm": -10040000.0,
    "book_value_per_share_mrq": 0.73,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "TrovaGene, Inc."
  },
  "TRVN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.57,
    "ebitda": -53160000.0,
    "eps_estimate_current_year": -1.33,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 8.34,
    "fifty_two_week_high": 13.57,
    "fifty_two_week_low": 3.8,
    "percent_change_from_200_day_moving_average": 0.7909,
    "percent_change_from_50_day_moving_average": 0.5238,
    "shares_owned": "N/A",
    "short_ratio": 3.25,
    "two_hundred_day_moving_average": 7.1,
    "volume": 629703.0,
    "market_cap": 617200000.0,
    "price_to_sales_ttm": 215.83,
    "price_to_book_mrq": 5.69,
    "roa_ttm": -0.34619999999999995,
    "roe_ttm": -0.6204,
    "shares_outstanding": 48560000.0,
    "pcnt_held_by_insiders": 0.5299,
    "pcnt_held_by_institutions": 0.429,
    "pcnt_short_of_float": 0.054299999999999994,
    "operating_cash_flow_ttm": -40280000.0,
    "levered_cash_flow_ttm": -21420000.0,
    "book_value_per_share_mrq": 2.2,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Trevena, Inc."
  },
  "TRXC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.61,
    "ebitda": -36490000.0,
    "eps_estimate_current_year": -0.53,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.74,
    "fifty_two_week_high": 4.87,
    "fifty_two_week_low": 1.4,
    "percent_change_from_200_day_moving_average": -0.16649999999999998,
    "percent_change_from_50_day_moving_average": -0.0329,
    "shares_owned": "N/A",
    "short_ratio": 5.92,
    "two_hundred_day_moving_average": 3.18,
    "volume": 644294.0,
    "market_cap": 224080000.0,
    "price_to_sales_ttm": 1214.16,
    "price_to_book_mrq": 1.47,
    "roa_ttm": -0.14679999999999999,
    "roe_ttm": -0.2626,
    "shares_outstanding": 84560000.0,
    "pcnt_held_by_insiders": 0.5964,
    "pcnt_held_by_institutions": 0.145,
    "pcnt_short_of_float": 0.1208,
    "operating_cash_flow_ttm": -35990000.0,
    "levered_cash_flow_ttm": -23200000.0,
    "book_value_per_share_mrq": 1.9,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "TransEnterix, Inc."
  },
  "TSRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.66,
    "earnings_per_share": -5.17,
    "ebitda": -173480000.0,
    "eps_estimate_current_year": -6.01,
    "eps_estimate_next_quarter": -1.67,
    "fifty_day_moving_average": 52.68,
    "fifty_two_week_high": 66.95,
    "fifty_two_week_low": 23.0,
    "percent_change_from_200_day_moving_average": -0.09179999999999999,
    "percent_change_from_50_day_moving_average": -0.0222,
    "shares_owned": "N/A",
    "short_ratio": 14.84,
    "two_hundred_day_moving_average": 56.72,
    "volume": 520568.0,
    "market_cap": 2060000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 10.21,
    "roa_ttm": -0.41840000000000005,
    "roe_ttm": -1.1206,
    "shares_outstanding": 40030000.0,
    "pcnt_held_by_insiders": 0.1649,
    "pcnt_held_by_institutions": 0.887,
    "pcnt_short_of_float": 0.3346,
    "operating_cash_flow_ttm": -146830000.0,
    "levered_cash_flow_ttm": -90860000.0,
    "book_value_per_share_mrq": 5.19,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tesaro, Inc."
  },
  "TTHI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.07,
    "ebitda": -41020000.0,
    "eps_estimate_current_year": -1.47,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.13,
    "fifty_two_week_high": 9.3,
    "fifty_two_week_low": 1.77,
    "percent_change_from_200_day_moving_average": -0.598,
    "percent_change_from_50_day_moving_average": -0.0637,
    "shares_owned": "N/A",
    "short_ratio": 2.06,
    "two_hundred_day_moving_average": 4.95,
    "volume": 42944.0,
    "market_cap": 77160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.77,
    "roa_ttm": -0.5770000000000001,
    "roe_ttm": -1.0715000000000001,
    "shares_outstanding": 38780000.0,
    "pcnt_held_by_insiders": 0.419,
    "pcnt_held_by_institutions": 0.405,
    "pcnt_short_of_float": 0.0148,
    "operating_cash_flow_ttm": -36270000.0,
    "levered_cash_flow_ttm": -21430000.0,
    "book_value_per_share_mrq": 0.72,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Transition Therapeutics Inc."
  },
  "TTOO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.19,
    "ebitda": -36310000.0,
    "eps_estimate_current_year": -2.26,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 12.41,
    "fifty_two_week_high": 24.04,
    "fifty_two_week_low": 10.52,
    "percent_change_from_200_day_moving_average": -0.2837,
    "percent_change_from_50_day_moving_average": -0.0993,
    "shares_owned": "N/A",
    "short_ratio": 6.31,
    "two_hundred_day_moving_average": 15.61,
    "volume": 124232.0,
    "market_cap": 227390000.0,
    "price_to_sales_ttm": 262.67,
    "price_to_book_mrq": 6.72,
    "roa_ttm": -0.5566,
    "roe_ttm": -1.7265000000000001,
    "shares_outstanding": 20340000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0688,
    "operating_cash_flow_ttm": -33380000.000000004,
    "levered_cash_flow_ttm": -25180000.0,
    "book_value_per_share_mrq": 1.68,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "T2 Biosystems, Inc."
  },
  "TTPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -2.65,
    "ebitda": -81040000.0,
    "eps_estimate_current_year": -2.64,
    "eps_estimate_next_quarter": -0.59,
    "fifty_day_moving_average": 33.52,
    "fifty_two_week_high": 52.9,
    "fifty_two_week_low": 8.31,
    "percent_change_from_200_day_moving_average": -0.7349,
    "percent_change_from_50_day_moving_average": -0.6844,
    "shares_owned": "N/A",
    "short_ratio": 5.87,
    "two_hundred_day_moving_average": 39.91,
    "volume": 1491480.0,
    "market_cap": 385330000.0,
    "price_to_sales_ttm": 33.76,
    "price_to_book_mrq": 1.69,
    "roa_ttm": -0.30879999999999996,
    "roe_ttm": -0.5596,
    "shares_outstanding": 36420000.0,
    "pcnt_held_by_insiders": 0.2796,
    "pcnt_held_by_institutions": 0.514,
    "pcnt_short_of_float": 0.1119,
    "operating_cash_flow_ttm": -72380000.0,
    "levered_cash_flow_ttm": -42330000.0,
    "book_value_per_share_mrq": 6.43,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Tetraphase Pharmaceuticals, Inc."
  },
  "TXMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -82290000.0,
    "eps_estimate_current_year": -0.49,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 6.61,
    "fifty_two_week_high": 8.83,
    "fifty_two_week_low": 3.44,
    "percent_change_from_200_day_moving_average": 0.048499999999999995,
    "percent_change_from_50_day_moving_average": 0.1038,
    "shares_owned": "N/A",
    "short_ratio": 14.81,
    "two_hundred_day_moving_average": 6.96,
    "volume": 963311.0,
    "market_cap": 1300000000.0,
    "price_to_sales_ttm": 72.13,
    "price_to_book_mrq": 19.84,
    "roa_ttm": -0.8569,
    "roe_ttm": -1.6371,
    "shares_outstanding": 177500000.0,
    "pcnt_held_by_insiders": 0.4401,
    "pcnt_held_by_institutions": 0.519,
    "pcnt_short_of_float": 0.2194,
    "operating_cash_flow_ttm": -70740000.0,
    "levered_cash_flow_ttm": -41350000.0,
    "book_value_per_share_mrq": 0.36,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "TherapeuticsMD, Inc."
  },
  "UAM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.1,
    "earnings_per_share": -0.24,
    "ebitda": -7430000.0,
    "eps_estimate_current_year": 0.15,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 7.44,
    "fifty_two_week_high": 11.16,
    "fifty_two_week_low": 6.73,
    "percent_change_from_200_day_moving_average": -0.2066,
    "percent_change_from_50_day_moving_average": 0.008100000000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.85,
    "two_hundred_day_moving_average": 9.45,
    "volume": 180481.0,
    "market_cap": 605680000.0,
    "price_to_sales_ttm": 0.3,
    "price_to_book_mrq": 0.96,
    "roa_ttm": -0.0058,
    "roe_ttm": -0.018600000000000002,
    "shares_outstanding": 80760000.0,
    "pcnt_held_by_insiders": 0.4576,
    "pcnt_held_by_institutions": 0.42200000000000004,
    "pcnt_short_of_float": 0.0276,
    "operating_cash_flow_ttm": -1590000.0,
    "levered_cash_flow_ttm": 47540000.0,
    "book_value_per_share_mrq": 7.53,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Universal American Corp"
  },
  "UNIS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.8084,
    "ebitda": -75510000.0,
    "eps_estimate_current_year": -0.43,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 1.3,
    "fifty_two_week_high": 4.9,
    "fifty_two_week_low": 0.94,
    "percent_change_from_200_day_moving_average": -0.6140019999999999,
    "percent_change_from_50_day_moving_average": -0.261462,
    "shares_owned": "N/A",
    "short_ratio": 19.19,
    "two_hundred_day_moving_average": 2.4873,
    "volume": 1197631.0,
    "market_cap": 116610000.0,
    "price_to_sales_ttm": 9.69,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5716,
    "roe_ttm": "N/A",
    "shares_outstanding": 121460000.0,
    "pcnt_held_by_insiders": 0.0895,
    "pcnt_held_by_institutions": 0.47600000000000003,
    "pcnt_short_of_float": 0.2192,
    "operating_cash_flow_ttm": -55200000.0,
    "levered_cash_flow_ttm": -46990000.0,
    "book_value_per_share_mrq": -0.15,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Unilife Corporation"
  },
  "USMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.918,
    "ebitda": -2830000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.529,
    "fifty_two_week_high": 18.0,
    "fifty_two_week_low": 6.5,
    "percent_change_from_200_day_moving_average": -0.12246,
    "percent_change_from_50_day_moving_average": 0.06178,
    "shares_owned": "N/A",
    "short_ratio": 0.81,
    "two_hundred_day_moving_average": 9.11,
    "volume": 2022.0,
    "market_cap": 82920000.0,
    "price_to_sales_ttm": 0.27,
    "price_to_book_mrq": 0.61,
    "roa_ttm": -0.026699999999999998,
    "roe_ttm": -0.1304,
    "shares_outstanding": 10370000.0,
    "pcnt_held_by_insiders": 0.8708,
    "pcnt_held_by_institutions": 0.004,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": 12910000.0,
    "levered_cash_flow_ttm": 535250.0,
    "book_value_per_share_mrq": 13.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "USMD Holdings, Inc."
  },
  "USNA": {
    "p_e_ratio": 21.65,
    "peg_ratio": 2.04,
    "earnings_per_share": 6.56,
    "ebitda": 139480000.0,
    "eps_estimate_current_year": 7.18,
    "eps_estimate_next_quarter": 1.99,
    "fifty_day_moving_average": 148.46,
    "fifty_two_week_high": 176.88,
    "fifty_two_week_low": 69.76,
    "percent_change_from_200_day_moving_average": 0.0882,
    "percent_change_from_50_day_moving_average": -0.0435,
    "shares_owned": "N/A",
    "short_ratio": 5.13,
    "two_hundred_day_moving_average": 130.49,
    "volume": 96532.0,
    "market_cap": 1820000000.0,
    "price_to_sales_ttm": 2.1,
    "price_to_book_mrq": 6.42,
    "roa_ttm": 0.21359999999999998,
    "roe_ttm": 0.3189,
    "shares_outstanding": 12810000.0,
    "pcnt_held_by_insiders": 0.5437,
    "pcnt_held_by_institutions": 0.591,
    "pcnt_short_of_float": 0.1441,
    "operating_cash_flow_ttm": 120100000.0,
    "levered_cash_flow_ttm": 91060000.0,
    "book_value_per_share_mrq": 22.22,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "USANA Health Sciences Inc."
  },
  "USPH": {
    "p_e_ratio": 27.77,
    "peg_ratio": 1.89,
    "earnings_per_share": 1.65,
    "ebitda": 52550000.0,
    "eps_estimate_current_year": 1.78,
    "eps_estimate_next_quarter": 0.47,
    "fifty_day_moving_average": 48.15,
    "fifty_two_week_high": 56.37,
    "fifty_two_week_low": 34.0,
    "percent_change_from_200_day_moving_average": -0.0779,
    "percent_change_from_50_day_moving_average": -0.049400000000000006,
    "shares_owned": "N/A",
    "short_ratio": 7.09,
    "two_hundred_day_moving_average": 49.63,
    "volume": 41319.0,
    "market_cap": 568510000.0,
    "price_to_sales_ttm": 1.78,
    "price_to_book_mrq": 3.59,
    "roa_ttm": 0.1104,
    "roe_ttm": 0.1673,
    "shares_outstanding": 12420000.0,
    "pcnt_held_by_insiders": 0.047599999999999996,
    "pcnt_held_by_institutions": 0.887,
    "pcnt_short_of_float": 0.039900000000000005,
    "operating_cash_flow_ttm": 43380000.0,
    "levered_cash_flow_ttm": 28310000.0,
    "book_value_per_share_mrq": 12.5,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "US Physical Therapy Inc."
  },
  "UTHR": {
    "p_e_ratio": 43.43,
    "peg_ratio": 1.18,
    "earnings_per_share": 3.27,
    "ebitda": 336970000.0,
    "eps_estimate_current_year": 6.97,
    "eps_estimate_next_quarter": 2.55,
    "fifty_day_moving_average": 157.29,
    "fifty_two_week_high": 190.29,
    "fifty_two_week_low": 118.47,
    "percent_change_from_200_day_moving_average": -0.1728,
    "percent_change_from_50_day_moving_average": -0.0973,
    "shares_owned": "N/A",
    "short_ratio": 11.65,
    "two_hundred_day_moving_average": 171.65,
    "volume": 685024.0,
    "market_cap": 6470000000.0,
    "price_to_sales_ttm": 4.88,
    "price_to_book_mrq": 6.36,
    "roa_ttm": 0.1027,
    "roe_ttm": 0.1565,
    "shares_outstanding": 45540000.0,
    "pcnt_held_by_insiders": 0.0127,
    "pcnt_held_by_institutions": 1.129,
    "pcnt_short_of_float": 0.1679,
    "operating_cash_flow_ttm": 449080000.0,
    "levered_cash_flow_ttm": 877230000.0,
    "book_value_per_share_mrq": 22.77,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "United Therapeutics Corporation"
  },
  "UTMD": {
    "p_e_ratio": 17.44,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.03,
    "ebitda": 19450000.0,
    "eps_estimate_current_year": 2.81,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 52.76,
    "fifty_two_week_high": 63.98,
    "fifty_two_week_low": 47.33,
    "percent_change_from_200_day_moving_average": -0.058499999999999996,
    "percent_change_from_50_day_moving_average": 0.0001,
    "shares_owned": "N/A",
    "short_ratio": 12.2,
    "two_hundred_day_moving_average": 56.04,
    "volume": 2065.0,
    "market_cap": 198290000.0,
    "price_to_sales_ttm": 4.8,
    "price_to_book_mrq": 2.91,
    "roa_ttm": 0.1235,
    "roe_ttm": 0.17129999999999998,
    "shares_outstanding": 3760000.0,
    "pcnt_held_by_insiders": 0.17579999999999998,
    "pcnt_held_by_institutions": 0.5589999999999999,
    "pcnt_short_of_float": 0.030699999999999998,
    "operating_cash_flow_ttm": 15360000.0,
    "levered_cash_flow_ttm": 14170000.0,
    "book_value_per_share_mrq": 18.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Utah Medical Products Inc."
  },
  "VAR": {
    "p_e_ratio": 18.63,
    "peg_ratio": 2.23,
    "earnings_per_share": 4.12,
    "ebitda": 658730000.0,
    "eps_estimate_current_year": 4.38,
    "eps_estimate_next_quarter": 1.02,
    "fifty_day_moving_average": 82.23,
    "fifty_two_week_high": 96.67,
    "fifty_two_week_low": 76.58,
    "percent_change_from_200_day_moving_average": -0.1242,
    "percent_change_from_50_day_moving_average": -0.0662,
    "shares_owned": "N/A",
    "short_ratio": 8.83,
    "two_hundred_day_moving_average": 87.68,
    "volume": 861233.0,
    "market_cap": 7580000000.0,
    "price_to_sales_ttm": 2.47,
    "price_to_book_mrq": 4.45,
    "roa_ttm": 0.1057,
    "roe_ttm": 0.2422,
    "shares_outstanding": 98720000.0,
    "pcnt_held_by_insiders": 0.0027,
    "pcnt_held_by_institutions": 0.937,
    "pcnt_short_of_float": 0.0725,
    "operating_cash_flow_ttm": 509560000.0,
    "levered_cash_flow_ttm": 420620000.0,
    "book_value_per_share_mrq": 17.37,
    "next_earnings_announcement_date": "2015-10-28",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Varian Medical Systems, Inc."
  },
  "VASC": {
    "p_e_ratio": 49.93,
    "peg_ratio": 1.72,
    "earnings_per_share": 0.71,
    "ebitda": 29740000.0,
    "eps_estimate_current_year": 1.03,
    "eps_estimate_next_quarter": 0.28,
    "fifty_day_moving_average": 36.1,
    "fifty_two_week_high": 40.33,
    "fifty_two_week_low": 22.31,
    "percent_change_from_200_day_moving_average": 0.051699999999999996,
    "percent_change_from_50_day_moving_average": -0.018000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.65,
    "two_hundred_day_moving_average": 33.71,
    "volume": 65051.0,
    "market_cap": 614060000.0,
    "price_to_sales_ttm": 4.5,
    "price_to_book_mrq": 5.09,
    "roa_ttm": 0.1197,
    "roe_ttm": 0.1127,
    "shares_outstanding": 17320000.0,
    "pcnt_held_by_insiders": 0.08130000000000001,
    "pcnt_held_by_institutions": 0.59,
    "pcnt_short_of_float": 0.0461,
    "operating_cash_flow_ttm": 18300000.0,
    "levered_cash_flow_ttm": 932870.0,
    "book_value_per_share_mrq": 6.95,
    "next_earnings_announcement_date": "2015-10-20",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Vascular Solutions Inc."
  },
  "VBIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.84,
    "ebitda": -14770000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.64,
    "fifty_two_week_high": 3.97,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": 0.10640000000000001,
    "percent_change_from_50_day_moving_average": 0.12710000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.01,
    "two_hundred_day_moving_average": 2.69,
    "volume": 1561.0,
    "market_cap": 68630000.0,
    "price_to_sales_ttm": 234.65,
    "price_to_book_mrq": 10.14,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23030000.0,
    "pcnt_held_by_insiders": 0.2792,
    "pcnt_held_by_institutions": 0.013000000000000001,
    "pcnt_short_of_float": 0.0014000000000000002,
    "operating_cash_flow_ttm": -10310000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "VBI Vaccines Inc"
  },
  "VBLT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.97,
    "ebitda": -14240000.0,
    "eps_estimate_current_year": -0.64,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 5.57,
    "fifty_two_week_high": 17.02,
    "fifty_two_week_low": 3.09,
    "percent_change_from_200_day_moving_average": 0.6742,
    "percent_change_from_50_day_moving_average": 0.6631,
    "shares_owned": "N/A",
    "short_ratio": 2.32,
    "two_hundred_day_moving_average": 5.53,
    "volume": 935108.0,
    "market_cap": 184380000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.65,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 19910000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.028399999999999998,
    "operating_cash_flow_ttm": -12720000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.49,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Vascular Biogenics Ltd."
  },
  "VCEL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.11,
    "ebitda": -16030000.000000002,
    "eps_estimate_current_year": -0.8,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 3.24,
    "fifty_two_week_high": 4.35,
    "fifty_two_week_low": 2.56,
    "percent_change_from_200_day_moving_average": -0.13570000000000002,
    "percent_change_from_50_day_moving_average": -0.08650000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.33,
    "two_hundred_day_moving_average": 3.42,
    "volume": 45069.0,
    "market_cap": 70410000.0,
    "price_to_sales_ttm": 1.5,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3522,
    "roe_ttm": -0.9871,
    "shares_outstanding": 23790000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0059,
    "operating_cash_flow_ttm": -23260000.0,
    "levered_cash_flow_ttm": -20160000.0,
    "book_value_per_share_mrq": -0.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vericel Corporation"
  },
  "VCYT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.41,
    "ebitda": -31050000.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 9.1,
    "fifty_two_week_high": 12.47,
    "fifty_two_week_low": 6.01,
    "percent_change_from_200_day_moving_average": -0.195,
    "percent_change_from_50_day_moving_average": -0.1534,
    "shares_owned": "N/A",
    "short_ratio": 20.04,
    "two_hundred_day_moving_average": 9.57,
    "volume": 71464.0,
    "market_cap": 213010000.0,
    "price_to_sales_ttm": 4.8,
    "price_to_book_mrq": 3.32,
    "roa_ttm": -0.2704,
    "roe_ttm": -0.5956,
    "shares_outstanding": 27660000.0,
    "pcnt_held_by_insiders": 0.5095000000000001,
    "pcnt_held_by_institutions": 0.397,
    "pcnt_short_of_float": 0.1366,
    "operating_cash_flow_ttm": -35300000.0,
    "levered_cash_flow_ttm": -23790000.0,
    "book_value_per_share_mrq": 2.36,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Veracyte, Inc."
  },
  "VICL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.171,
    "ebitda": -14060000.0,
    "eps_estimate_current_year": -0.15,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 0.6,
    "fifty_two_week_high": 1.55,
    "fifty_two_week_low": 0.515,
    "percent_change_from_200_day_moving_average": -0.37387,
    "percent_change_from_50_day_moving_average": -0.12792,
    "shares_owned": "N/A",
    "short_ratio": 2.74,
    "two_hundred_day_moving_average": 0.835,
    "volume": 283771.0,
    "market_cap": 47830000.0,
    "price_to_sales_ttm": 2.86,
    "price_to_book_mrq": 1.05,
    "roa_ttm": -0.1686,
    "roe_ttm": -0.2998,
    "shares_outstanding": 91460000.0,
    "pcnt_held_by_insiders": 0.1375,
    "pcnt_held_by_institutions": 0.33299999999999996,
    "pcnt_short_of_float": 0.0059,
    "operating_cash_flow_ttm": -10300000.0,
    "levered_cash_flow_ttm": -5450000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vical Incorporated"
  },
  "VIVO": {
    "p_e_ratio": 20.77,
    "peg_ratio": 1.3,
    "earnings_per_share": 0.84,
    "ebitda": 60040000.0,
    "eps_estimate_current_year": 0.86,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 18.21,
    "fifty_two_week_high": 20.28,
    "fifty_two_week_low": 15.56,
    "percent_change_from_200_day_moving_average": -0.061900000000000004,
    "percent_change_from_50_day_moving_average": -0.042,
    "shares_owned": "N/A",
    "short_ratio": 24.07,
    "two_hundred_day_moving_average": 18.6,
    "volume": 205507.0,
    "market_cap": 727920000.0,
    "price_to_sales_ttm": 3.79,
    "price_to_book_mrq": 4.45,
    "roa_ttm": 0.1912,
    "roe_ttm": 0.2165,
    "shares_outstanding": 41710000.0,
    "pcnt_held_by_insiders": 0.0204,
    "pcnt_held_by_institutions": 0.932,
    "pcnt_short_of_float": 0.1348,
    "operating_cash_flow_ttm": 45850000.0,
    "levered_cash_flow_ttm": 37960000.0,
    "book_value_per_share_mrq": 3.93,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Meridian Bioscience, Inc."
  },
  "VKTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.34,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.5,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 6.34,
    "fifty_two_week_high": 10.23,
    "fifty_two_week_low": 5.3,
    "percent_change_from_200_day_moving_average": -0.2373,
    "percent_change_from_50_day_moving_average": -0.1258,
    "shares_owned": "N/A",
    "short_ratio": 0.59,
    "two_hundred_day_moving_average": 7.26,
    "volume": 3249.0,
    "market_cap": 54200000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.16,
    "roa_ttm": -0.23629999999999998,
    "roe_ttm": "N/A",
    "shares_outstanding": 9780000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0028000000000000004,
    "operating_cash_flow_ttm": -3080000.0,
    "levered_cash_flow_ttm": -22190000.0,
    "book_value_per_share_mrq": 1.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Viking Therapeutics, Inc."
  },
  "VNDA": {
    "p_e_ratio": 10.3,
    "peg_ratio": -1.19,
    "earnings_per_share": 1.29,
    "ebitda": -15830000.0,
    "eps_estimate_current_year": -0.7,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 12.35,
    "fifty_two_week_high": 15.51,
    "fifty_two_week_low": 8.34,
    "percent_change_from_200_day_moving_average": 0.1819,
    "percent_change_from_50_day_moving_average": 0.0786,
    "shares_owned": "N/A",
    "short_ratio": 14.62,
    "two_hundred_day_moving_average": 11.27,
    "volume": 620731.0,
    "market_cap": 563240000.0,
    "price_to_sales_ttm": 6.9,
    "price_to_book_mrq": 3.68,
    "roa_ttm": -0.0989,
    "roe_ttm": 0.6995,
    "shares_outstanding": 42290000.0,
    "pcnt_held_by_insiders": 0.17920000000000003,
    "pcnt_held_by_institutions": 0.9670000000000001,
    "pcnt_short_of_float": 0.25739999999999996,
    "operating_cash_flow_ttm": -3330000.0,
    "levered_cash_flow_ttm": -14120000.0,
    "book_value_per_share_mrq": 3.54,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vanda Pharmaceuticals, Inc."
  },
  "VNRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.69,
    "ebitda": -7850000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 3.81,
    "fifty_two_week_high": 5.3,
    "fifty_two_week_low": 2.81,
    "percent_change_from_200_day_moving_average": 0.2278,
    "percent_change_from_50_day_moving_average": 0.23379999999999998,
    "shares_owned": "N/A",
    "short_ratio": 1.61,
    "two_hundred_day_moving_average": 3.83,
    "volume": 20070.0,
    "market_cap": 84880000.0,
    "price_to_sales_ttm": 5911.77,
    "price_to_book_mrq": 9.27,
    "roa_ttm": -0.6966,
    "roe_ttm": -2.4134,
    "shares_outstanding": 18060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0014000000000000002,
    "operating_cash_flow_ttm": -5990000.0,
    "levered_cash_flow_ttm": -5790000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "VolitionRX Ltd"
  },
  "VRML": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.47,
    "ebitda": -17330000.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 1.99,
    "fifty_two_week_high": 2.5,
    "fifty_two_week_low": 1.2,
    "percent_change_from_200_day_moving_average": 0.0403,
    "percent_change_from_50_day_moving_average": 0.0287,
    "shares_owned": "N/A",
    "short_ratio": 27.57,
    "two_hundred_day_moving_average": 1.97,
    "volume": 16445.0,
    "market_cap": 106530000.0,
    "price_to_sales_ttm": 30.77,
    "price_to_book_mrq": 9.17,
    "roa_ttm": -0.6112,
    "roe_ttm": -1.3836000000000002,
    "shares_outstanding": 51960000.0,
    "pcnt_held_by_insiders": 0.1184,
    "pcnt_held_by_institutions": 0.231,
    "pcnt_short_of_float": 0.0621,
    "operating_cash_flow_ttm": -19020000.0,
    "levered_cash_flow_ttm": -11420000.0,
    "book_value_per_share_mrq": 0.22,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Vermillion, Inc."
  },
  "VSAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.83,
    "ebitda": -69210000.0,
    "eps_estimate_current_year": -2.9,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 14.28,
    "fifty_two_week_high": 23.99,
    "fifty_two_week_low": 9.97,
    "percent_change_from_200_day_moving_average": -0.2597,
    "percent_change_from_50_day_moving_average": -0.1247,
    "shares_owned": "N/A",
    "short_ratio": 9.55,
    "two_hundred_day_moving_average": 16.88,
    "volume": 263416.0,
    "market_cap": 366900000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.67,
    "roa_ttm": -0.2075,
    "roe_ttm": -0.3508,
    "shares_outstanding": 29350000.0,
    "pcnt_held_by_insiders": 0.294,
    "pcnt_held_by_institutions": 0.08900000000000001,
    "pcnt_short_of_float": 0.1333,
    "operating_cash_flow_ttm": -58380000.0,
    "levered_cash_flow_ttm": -30840000.0,
    "book_value_per_share_mrq": 7.24,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Versartis, Inc."
  },
  "VSCP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.106,
    "ebitda": -2780000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.2203,
    "fifty_two_week_high": 4.82,
    "fifty_two_week_low": 1.91,
    "percent_change_from_200_day_moving_average": -0.216357,
    "percent_change_from_50_day_moving_average": -0.067915,
    "shares_owned": "N/A",
    "short_ratio": 0.54,
    "two_hundred_day_moving_average": 2.6409,
    "volume": 4432.0,
    "market_cap": 6200000.0,
    "price_to_sales_ttm": 0.59,
    "price_to_book_mrq": 1.66,
    "roa_ttm": -0.2526,
    "roe_ttm": -0.5916,
    "shares_outstanding": 2990000.0,
    "pcnt_held_by_insiders": 0.3271,
    "pcnt_held_by_institutions": 0.065,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": -3400000.0,
    "levered_cash_flow_ttm": -2560000.0,
    "book_value_per_share_mrq": 1.25,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "VirtualScopics Inc."
  },
  "VSTM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.93,
    "earnings_per_share": -1.9,
    "ebitda": -57430000.0,
    "eps_estimate_current_year": -1.76,
    "eps_estimate_next_quarter": -0.45,
    "fifty_day_moving_average": 6.58,
    "fifty_two_week_high": 12.35,
    "fifty_two_week_low": 4.35,
    "percent_change_from_200_day_moving_average": -0.2949,
    "percent_change_from_50_day_moving_average": -0.12050000000000001,
    "shares_owned": "N/A",
    "short_ratio": 8.01,
    "two_hundred_day_moving_average": 8.21,
    "volume": 368627.0,
    "market_cap": 213640000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.74,
    "roa_ttm": -0.2988,
    "roe_ttm": -0.5154,
    "shares_outstanding": 36900000.0,
    "pcnt_held_by_insiders": 0.2052,
    "pcnt_held_by_institutions": 0.597,
    "pcnt_short_of_float": 0.12369999999999999,
    "operating_cash_flow_ttm": -42650000.0,
    "levered_cash_flow_ttm": -24710000.0,
    "book_value_per_share_mrq": 3.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Verastem, Inc."
  },
  "VTAE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.83,
    "ebitda": -27950000.0,
    "eps_estimate_current_year": -1.89,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 10.01,
    "fifty_two_week_high": 23.35,
    "fifty_two_week_low": 5.41,
    "percent_change_from_200_day_moving_average": 0.3804,
    "percent_change_from_50_day_moving_average": 0.6456000000000001,
    "shares_owned": "N/A",
    "short_ratio": 11.13,
    "two_hundred_day_moving_average": 11.94,
    "volume": 530963.0,
    "market_cap": 360120000.0,
    "price_to_sales_ttm": 51.08,
    "price_to_book_mrq": 4.45,
    "roa_ttm": -0.3382,
    "roe_ttm": -0.6652,
    "shares_outstanding": 21850000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0842,
    "operating_cash_flow_ttm": -22630000.0,
    "levered_cash_flow_ttm": -12900000.0,
    "book_value_per_share_mrq": 3.5,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vitae Pharmaceuticals, Inc."
  },
  "VTL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -2.42,
    "ebitda": -55560000.0,
    "eps_estimate_current_year": -2.37,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 8.95,
    "fifty_two_week_high": 29.67,
    "fifty_two_week_low": 2.81,
    "percent_change_from_200_day_moving_average": -0.8062,
    "percent_change_from_50_day_moving_average": -0.5732,
    "shares_owned": "N/A",
    "short_ratio": 2.36,
    "two_hundred_day_moving_average": 19.71,
    "volume": 276184.0,
    "market_cap": 91740000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.32,
    "roa_ttm": -0.4008,
    "roe_ttm": -0.7126,
    "shares_outstanding": 24020000.0,
    "pcnt_held_by_insiders": 0.0141,
    "pcnt_held_by_institutions": 0.07200000000000001,
    "pcnt_short_of_float": 0.1643,
    "operating_cash_flow_ttm": -50210000.0,
    "levered_cash_flow_ttm": -31860000.0,
    "book_value_per_share_mrq": 2.9,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vital Therapies, Inc."
  },
  "VTVT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.57,
    "ebitda": -29140000.0,
    "eps_estimate_current_year": -4.91,
    "eps_estimate_next_quarter": -1.24,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 7.43,
    "fifty_two_week_low": 6.51,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 1.22,
    "two_hundred_day_moving_average": 0.0,
    "volume": 51802.0,
    "market_cap": 65470000.0,
    "price_to_sales_ttm": 44.62,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 9160000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.028300000000000002,
    "operating_cash_flow_ttm": -30690000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -115.39,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "vTv Therapeutics Inc."
  },
  "VVUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.08,
    "earnings_per_share": -1.02,
    "ebitda": -40440000.0,
    "eps_estimate_current_year": -0.97,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 1.28,
    "fifty_two_week_high": 4.47,
    "fifty_two_week_low": 0.94,
    "percent_change_from_200_day_moving_average": -0.2376,
    "percent_change_from_50_day_moving_average": 0.26280000000000003,
    "shares_owned": "N/A",
    "short_ratio": 16.58,
    "two_hundred_day_moving_average": 2.12,
    "volume": 3174174.0,
    "market_cap": 168540000.0,
    "price_to_sales_ttm": 1.56,
    "price_to_book_mrq": 8.34,
    "roa_ttm": -0.0735,
    "roe_ttm": -1.5212999999999999,
    "shares_outstanding": 104040000.0,
    "pcnt_held_by_insiders": 0.11,
    "pcnt_held_by_institutions": 0.7170000000000001,
    "pcnt_short_of_float": 0.3582,
    "operating_cash_flow_ttm": -40730000.0,
    "levered_cash_flow_ttm": 17640000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "VIVUS Inc."
  },
  "VWR": {
    "p_e_ratio": 14.97,
    "peg_ratio": 1.51,
    "earnings_per_share": 1.77,
    "ebitda": 455800000.0,
    "eps_estimate_current_year": 1.46,
    "eps_estimate_next_quarter": 0.42,
    "fifty_day_moving_average": 26.31,
    "fifty_two_week_high": 28.83,
    "fifty_two_week_low": 20.6,
    "percent_change_from_200_day_moving_average": 0.0055000000000000005,
    "percent_change_from_50_day_moving_average": 0.005699999999999999,
    "shares_owned": "N/A",
    "short_ratio": 10.65,
    "two_hundred_day_moving_average": 26.32,
    "volume": 761398.0,
    "market_cap": 3480000000.0,
    "price_to_sales_ttm": 0.8,
    "price_to_book_mrq": 2.65,
    "roa_ttm": 0.0409,
    "roe_ttm": 0.156,
    "shares_outstanding": 131360000.00000001,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1267,
    "operating_cash_flow_ttm": 219700000.0,
    "levered_cash_flow_ttm": 219410000.0,
    "book_value_per_share_mrq": 9.95,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "VWR Corporation"
  },
  "WAT": {
    "p_e_ratio": 21.65,
    "peg_ratio": 2.21,
    "earnings_per_share": 5.54,
    "ebitda": 675470000.0,
    "eps_estimate_current_year": 5.85,
    "eps_estimate_next_quarter": 1.94,
    "fifty_day_moving_average": 125.37,
    "fifty_two_week_high": 137.39,
    "fifty_two_week_low": 93.56,
    "percent_change_from_200_day_moving_average": -0.0621,
    "percent_change_from_50_day_moving_average": -0.0434,
    "shares_owned": "N/A",
    "short_ratio": 6.15,
    "two_hundred_day_moving_average": 127.88,
    "volume": 298684.0,
    "market_cap": 9870000000.0,
    "price_to_sales_ttm": 4.85,
    "price_to_book_mrq": 5.1,
    "roa_ttm": 0.09300000000000001,
    "roe_ttm": 0.24710000000000001,
    "shares_outstanding": 82270000.0,
    "pcnt_held_by_insiders": 0.0415,
    "pcnt_held_by_institutions": 0.955,
    "pcnt_short_of_float": 0.0466,
    "operating_cash_flow_ttm": 557110000.0,
    "levered_cash_flow_ttm": 337100000.0,
    "book_value_per_share_mrq": 23.49,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Waters Corporation"
  },
  "WCG": {
    "p_e_ratio": 43.2,
    "peg_ratio": 1.7,
    "earnings_per_share": 2.17,
    "ebitda": 407800000.0,
    "eps_estimate_current_year": 3.45,
    "eps_estimate_next_quarter": 0.66,
    "fifty_day_moving_average": 90.2,
    "fifty_two_week_high": 98.79,
    "fifty_two_week_low": 55.43,
    "percent_change_from_200_day_moving_average": 0.08289999999999999,
    "percent_change_from_50_day_moving_average": 0.0401,
    "shares_owned": "N/A",
    "short_ratio": 5.14,
    "two_hundred_day_moving_average": 86.63,
    "volume": 293328.0,
    "market_cap": 4139999999.9999995,
    "price_to_sales_ttm": 0.3,
    "price_to_book_mrq": 2.48,
    "roa_ttm": 0.0508,
    "roe_ttm": 0.059699999999999996,
    "shares_outstanding": 44070000.0,
    "pcnt_held_by_insiders": 0.004699999999999999,
    "pcnt_held_by_institutions": 0.965,
    "pcnt_short_of_float": 0.0625,
    "operating_cash_flow_ttm": 471200000.0,
    "levered_cash_flow_ttm": -283770000.0,
    "book_value_per_share_mrq": 37.87,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "WellCare Health Plans, Inc."
  },
  "WGBS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.97,
    "ebitda": -14140000.0,
    "eps_estimate_current_year": -2.71,
    "eps_estimate_next_quarter": -1.68,
    "fifty_day_moving_average": 1.45,
    "fifty_two_week_high": 5.89,
    "fifty_two_week_low": 0.97,
    "percent_change_from_200_day_moving_average": -0.3045,
    "percent_change_from_50_day_moving_average": 0.5274,
    "shares_owned": "N/A",
    "short_ratio": 1.1,
    "two_hundred_day_moving_average": 3.19,
    "volume": 2711922.0,
    "market_cap": 12670000.0,
    "price_to_sales_ttm": 2.08,
    "price_to_book_mrq": 2.01,
    "roa_ttm": -0.8238,
    "roe_ttm": -3.6513999999999998,
    "shares_outstanding": 5710000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0171,
    "operating_cash_flow_ttm": -12330000.0,
    "levered_cash_flow_ttm": -6580000.0,
    "book_value_per_share_mrq": 1.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "WaferGen Bio-systems, Inc."
  },
  "WMGI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.94,
    "earnings_per_share": -5.27,
    "ebitda": -55910000.0,
    "eps_estimate_current_year": -1.74,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 24.45,
    "fifty_two_week_high": 32.65,
    "fifty_two_week_low": 22.17,
    "percent_change_from_200_day_moving_average": -0.0527,
    "percent_change_from_50_day_moving_average": 0.002,
    "shares_owned": "N/A",
    "short_ratio": 16.94,
    "two_hundred_day_moving_average": 25.86,
    "volume": 525038.0,
    "market_cap": 1250000000.0,
    "price_to_sales_ttm": 4.06,
    "price_to_book_mrq": 5.95,
    "roa_ttm": -0.049800000000000004,
    "roe_ttm": -0.7356,
    "shares_outstanding": 50930000.0,
    "pcnt_held_by_insiders": 0.0158,
    "pcnt_held_by_institutions": 1.034,
    "pcnt_short_of_float": 0.15109999999999998,
    "operating_cash_flow_ttm": -115410000.0,
    "levered_cash_flow_ttm": -1330000.0,
    "book_value_per_share_mrq": 4.14,
    "next_earnings_announcement_date": "2015-11-04",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Wright Medical Group Inc."
  },
  "WST": {
    "p_e_ratio": 33.52,
    "peg_ratio": 2.35,
    "earnings_per_share": 1.69,
    "ebitda": 263000000.0,
    "eps_estimate_current_year": 1.81,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 57.55,
    "fifty_two_week_high": 61.73,
    "fifty_two_week_low": 43.49,
    "percent_change_from_200_day_moving_average": -0.0075,
    "percent_change_from_50_day_moving_average": -0.015600000000000001,
    "shares_owned": "N/A",
    "short_ratio": 10.94,
    "two_hundred_day_moving_average": 57.08,
    "volume": 337673.0,
    "market_cap": 4080000000.0,
    "price_to_sales_ttm": 2.89,
    "price_to_book_mrq": 4.09,
    "roa_ttm": 0.0645,
    "roe_ttm": 0.1255,
    "shares_outstanding": 72000000.0,
    "pcnt_held_by_insiders": 0.0174,
    "pcnt_held_by_institutions": 0.903,
    "pcnt_short_of_float": 0.0451,
    "operating_cash_flow_ttm": 185500000.0,
    "levered_cash_flow_ttm": 127490000.0,
    "book_value_per_share_mrq": 13.74,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "West Pharmaceutical Services, Inc."
  },
  "WX": {
    "p_e_ratio": 31.86,
    "peg_ratio": 2.75,
    "earnings_per_share": 1.36,
    "ebitda": 133530000.0,
    "eps_estimate_current_year": 1.57,
    "eps_estimate_next_quarter": 0.44,
    "fifty_day_moving_average": 42.59,
    "fifty_two_week_high": 46.14,
    "fifty_two_week_low": 32.4,
    "percent_change_from_200_day_moving_average": 0.044500000000000005,
    "percent_change_from_50_day_moving_average": 0.0173,
    "shares_owned": "N/A",
    "short_ratio": 0.41,
    "two_hundred_day_moving_average": 41.49,
    "volume": 480750.0,
    "market_cap": 3070000000.0,
    "price_to_sales_ttm": 4.16,
    "price_to_book_mrq": 3.64,
    "roa_ttm": 0.046,
    "roe_ttm": 0.1331,
    "shares_outstanding": 70930000.0,
    "pcnt_held_by_insiders": 0.0678,
    "pcnt_held_by_institutions": 0.904,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 11.9,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "WuXi PharmaTech (Cayman) Inc."
  },
  "XBIT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.04,
    "ebitda": -27280000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 17.21,
    "fifty_two_week_high": 32.5,
    "fifty_two_week_low": 13.64,
    "percent_change_from_200_day_moving_average": -0.10369999999999999,
    "percent_change_from_50_day_moving_average": -0.0044,
    "shares_owned": "N/A",
    "short_ratio": 13.4,
    "two_hundred_day_moving_average": 19.11,
    "volume": 18535.0,
    "market_cap": 549070000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.36,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 32049999.999999996,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0707,
    "operating_cash_flow_ttm": -22070000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "XBiotech, Inc."
  },
  "XENE": {
    "p_e_ratio": 17.91,
    "peg_ratio": -1.6,
    "earnings_per_share": 0.48,
    "ebitda": 3640000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 9.77,
    "fifty_two_week_high": 23.5,
    "fifty_two_week_low": 8.58,
    "percent_change_from_200_day_moving_average": -0.3196,
    "percent_change_from_50_day_moving_average": -0.11289999999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.82,
    "two_hundred_day_moving_average": 12.74,
    "volume": 26513.0,
    "market_cap": 123870000.0,
    "price_to_sales_ttm": 4.98,
    "price_to_book_mrq": 2.02,
    "roa_ttm": 0.0271,
    "roe_ttm": 0.053099999999999994,
    "shares_outstanding": 14290000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.004,
    "operating_cash_flow_ttm": -4640000.0,
    "levered_cash_flow_ttm": -155250.0,
    "book_value_per_share_mrq": 4.51,
    "next_earnings_announcement_date": [
      "2015-12-14",
      "2015-12-18"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xenon Pharmaceuticals Inc."
  },
  "XENT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.52,
    "earnings_per_share": -0.92,
    "ebitda": -20180000.0,
    "eps_estimate_current_year": -0.88,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 26.77,
    "fifty_two_week_high": 32.85,
    "fifty_two_week_low": 15.0,
    "percent_change_from_200_day_moving_average": -0.1027,
    "percent_change_from_50_day_moving_average": -0.10210000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.21,
    "two_hundred_day_moving_average": 26.79,
    "volume": 199871.0,
    "market_cap": 672880000.0,
    "price_to_sales_ttm": 13.49,
    "price_to_book_mrq": 4.73,
    "roa_ttm": -0.1549,
    "roe_ttm": -0.2805,
    "shares_outstanding": 27990000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0705,
    "operating_cash_flow_ttm": -16760000.000000002,
    "levered_cash_flow_ttm": -13000000.0,
    "book_value_per_share_mrq": 5.08,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Intersect ENT, Inc."
  },
  "XLRN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.56,
    "ebitda": -52950000.0,
    "eps_estimate_current_year": -1.22,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 30.44,
    "fifty_two_week_high": 48.5,
    "fifty_two_week_low": 20.0,
    "percent_change_from_200_day_moving_average": -0.046900000000000004,
    "percent_change_from_50_day_moving_average": 0.016200000000000003,
    "shares_owned": "N/A",
    "short_ratio": 8.97,
    "two_hundred_day_moving_average": 32.45,
    "volume": 190459.0,
    "market_cap": 1020000000.0,
    "price_to_sales_ttm": 61.7,
    "price_to_book_mrq": 7.68,
    "roa_ttm": -0.1769,
    "roe_ttm": -0.32689999999999997,
    "shares_outstanding": 33060000.000000004,
    "pcnt_held_by_insiders": 0.7737,
    "pcnt_held_by_institutions": 0.249,
    "pcnt_short_of_float": 0.11789999999999999,
    "operating_cash_flow_ttm": -52750000.0,
    "levered_cash_flow_ttm": -30970000.0,
    "book_value_per_share_mrq": 4.23,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acceleron Pharma, Inc."
  },
  "XNCR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.67,
    "ebitda": -21700000.0,
    "eps_estimate_current_year": -0.74,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 18.11,
    "fifty_two_week_high": 24.82,
    "fifty_two_week_low": 9.0,
    "percent_change_from_200_day_moving_average": -0.1057,
    "percent_change_from_50_day_moving_average": -0.1051,
    "shares_owned": "N/A",
    "short_ratio": 7.86,
    "two_hundred_day_moving_average": 18.13,
    "volume": 161269.0,
    "market_cap": 656050000.0,
    "price_to_sales_ttm": 73.48,
    "price_to_book_mrq": 4.09,
    "roa_ttm": -0.1134,
    "roe_ttm": -0.2016,
    "shares_outstanding": 40470000.0,
    "pcnt_held_by_insiders": 0.3357,
    "pcnt_held_by_institutions": 0.48,
    "pcnt_short_of_float": 0.0663,
    "operating_cash_flow_ttm": -19590000.0,
    "levered_cash_flow_ttm": -11810000.0,
    "book_value_per_share_mrq": 4.01,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xencor, Inc."
  },
  "XNPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.57,
    "earnings_per_share": -0.87,
    "ebitda": -52260000.0,
    "eps_estimate_current_year": -1.45,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 6.25,
    "fifty_two_week_high": 9.6,
    "fifty_two_week_low": 3.98,
    "percent_change_from_200_day_moving_average": -0.387,
    "percent_change_from_50_day_moving_average": -0.3436,
    "shares_owned": "N/A",
    "short_ratio": 8.4,
    "two_hundred_day_moving_average": 6.69,
    "volume": 1448253.0,
    "market_cap": 258620000.0,
    "price_to_sales_ttm": 4.84,
    "price_to_book_mrq": 5.01,
    "roa_ttm": -0.1945,
    "roe_ttm": -0.7347,
    "shares_outstanding": 63080000.0,
    "pcnt_held_by_insiders": 0.0917,
    "pcnt_held_by_institutions": 0.9259999999999999,
    "pcnt_short_of_float": 0.1133,
    "operating_cash_flow_ttm": -64840000.0,
    "levered_cash_flow_ttm": -49150000.0,
    "book_value_per_share_mrq": 0.82,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xenoport, Inc."
  },
  "XOMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -0.707,
    "ebitda": -82550000.0,
    "eps_estimate_current_year": -0.64,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 0.8203,
    "fifty_two_week_high": 5.95,
    "fifty_two_week_low": 0.69,
    "percent_change_from_200_day_moving_average": -0.697954,
    "percent_change_from_50_day_moving_average": 0.034273,
    "shares_owned": "N/A",
    "short_ratio": 8.36,
    "two_hundred_day_moving_average": 2.8088,
    "volume": 2696228.0,
    "market_cap": 100610000.0,
    "price_to_sales_ttm": 6.67,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6995,
    "roe_ttm": "N/A",
    "shares_outstanding": 118580000.0,
    "pcnt_held_by_insiders": 0.284,
    "pcnt_held_by_institutions": 0.552,
    "pcnt_short_of_float": 0.3837,
    "operating_cash_flow_ttm": -73810000.0,
    "levered_cash_flow_ttm": -40350000.0,
    "book_value_per_share_mrq": -0.27,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "XOMA Corporation"
  },
  "XON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.46,
    "ebitda": -123510000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 48.1,
    "fifty_two_week_high": 69.45,
    "fifty_two_week_low": 16.13,
    "percent_change_from_200_day_moving_average": -0.028999999999999998,
    "percent_change_from_50_day_moving_average": -0.056600000000000004,
    "shares_owned": "N/A",
    "short_ratio": 5.69,
    "two_hundred_day_moving_average": 46.73,
    "volume": 1306410.0,
    "market_cap": 5200000000.0,
    "price_to_sales_ttm": 38.52,
    "price_to_book_mrq": 10.63,
    "roa_ttm": -0.1329,
    "roe_ttm": -0.11800000000000001,
    "shares_outstanding": 114610000.0,
    "pcnt_held_by_insiders": 0.0044,
    "pcnt_held_by_institutions": 0.858,
    "pcnt_short_of_float": 0.26289999999999997,
    "operating_cash_flow_ttm": -45240000.0,
    "levered_cash_flow_ttm": -131889999.99999999,
    "book_value_per_share_mrq": 4.33,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intrexon Corporation"
  },
  "XRAY": {
    "p_e_ratio": 28.3,
    "peg_ratio": 2.44,
    "earnings_per_share": 1.87,
    "ebitda": 572690000.0,
    "eps_estimate_current_year": 2.59,
    "eps_estimate_next_quarter": 0.65,
    "fifty_day_moving_average": 53.96,
    "fifty_two_week_high": 57.61,
    "fifty_two_week_low": 43.83,
    "percent_change_from_200_day_moving_average": 0.010700000000000001,
    "percent_change_from_50_day_moving_average": -0.0183,
    "shares_owned": "N/A",
    "short_ratio": 5.87,
    "two_hundred_day_moving_average": 52.41,
    "volume": 1048195.0,
    "market_cap": 7410000000.0,
    "price_to_sales_ttm": 2.64,
    "price_to_book_mrq": 3.17,
    "roa_ttm": 0.0588,
    "roe_ttm": 0.1094,
    "shares_outstanding": 139810000.0,
    "pcnt_held_by_insiders": 0.12269999999999999,
    "pcnt_held_by_institutions": 0.7979999999999999,
    "pcnt_short_of_float": 0.047,
    "operating_cash_flow_ttm": 551400000.0,
    "levered_cash_flow_ttm": 401640000.0,
    "book_value_per_share_mrq": 16.56,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "DENTSPLY International Inc."
  },
  "XTLB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.24,
    "ebitda": -1840000.0,
    "eps_estimate_current_year": -0.02,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.819,
    "fifty_two_week_high": 5.0,
    "fifty_two_week_low": 1.48,
    "percent_change_from_200_day_moving_average": -0.1402,
    "percent_change_from_50_day_moving_average": -0.037309999999999996,
    "shares_owned": "N/A",
    "short_ratio": 0.97,
    "two_hundred_day_moving_average": 2.037,
    "volume": 351.0,
    "market_cap": 21960000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.54,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 12540000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.011000000000000001,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "XTL Biopharmaceuticals Ltd."
  },
  "XXII": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.22,
    "ebitda": -14300000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 0.77,
    "fifty_two_week_high": 2.78,
    "fifty_two_week_low": 0.56,
    "percent_change_from_200_day_moving_average": 0.0202,
    "percent_change_from_50_day_moving_average": 0.20440000000000003,
    "shares_owned": "N/A",
    "short_ratio": 7.78,
    "two_hundred_day_moving_average": 0.91,
    "volume": 103945.0,
    "market_cap": 65680000.00000001,
    "price_to_sales_ttm": 20.15,
    "price_to_book_mrq": 3.63,
    "roa_ttm": -0.5424,
    "roe_ttm": -1.0678,
    "shares_outstanding": 70620000.0,
    "pcnt_held_by_insiders": 0.384,
    "pcnt_held_by_institutions": 0.065,
    "pcnt_short_of_float": 0.0387,
    "operating_cash_flow_ttm": -7950000.0,
    "levered_cash_flow_ttm": -5540000.0,
    "book_value_per_share_mrq": 0.25,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "22nd Century Group, Inc."
  },
  "ZFGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.31,
    "ebitda": -55850000.0,
    "eps_estimate_current_year": -2.9,
    "eps_estimate_next_quarter": -0.88,
    "fifty_day_moving_average": 38.13,
    "fifty_two_week_high": 55.36,
    "fifty_two_week_low": 16.01,
    "percent_change_from_200_day_moving_average": 0.17809999999999998,
    "percent_change_from_50_day_moving_average": 0.1482,
    "shares_owned": "N/A",
    "short_ratio": 7.94,
    "two_hundred_day_moving_average": 37.16,
    "volume": 391427.0,
    "market_cap": 1190000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.69,
    "roa_ttm": -0.1942,
    "roe_ttm": -0.3429,
    "shares_outstanding": 27120000.0,
    "pcnt_held_by_insiders": 0.10210000000000001,
    "pcnt_held_by_institutions": 0.027999999999999997,
    "pcnt_short_of_float": 0.1578,
    "operating_cash_flow_ttm": -43470000.0,
    "levered_cash_flow_ttm": -25770000.0,
    "book_value_per_share_mrq": 7.6,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Zafgen, Inc."
  },
  "ZGNX": {
    "p_e_ratio": 19.66,
    "peg_ratio": -0.45,
    "earnings_per_share": 0.87,
    "ebitda": -99890000.0,
    "eps_estimate_current_year": -1.61,
    "eps_estimate_next_quarter": -0.81,
    "fifty_day_moving_average": 18.79,
    "fifty_two_week_high": 21.65,
    "fifty_two_week_low": 8.56,
    "percent_change_from_200_day_moving_average": 0.1648,
    "percent_change_from_50_day_moving_average": -0.09,
    "shares_owned": "N/A",
    "short_ratio": 5.28,
    "two_hundred_day_moving_average": 14.68,
    "volume": 232032.0,
    "market_cap": 327810000.0,
    "price_to_sales_ttm": 8.54,
    "price_to_book_mrq": 3.03,
    "roa_ttm": -0.33390000000000003,
    "roe_ttm": -0.9168000000000001,
    "shares_outstanding": 23920000.0,
    "pcnt_held_by_insiders": 0.1197,
    "pcnt_held_by_institutions": 0.71,
    "pcnt_short_of_float": 0.1617,
    "operating_cash_flow_ttm": -82990000.0,
    "levered_cash_flow_ttm": -76010000.0,
    "book_value_per_share_mrq": 5.63,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Zogenix, Inc."
  },
  "ZIOP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.98,
    "ebitda": -114510000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 10.28,
    "fifty_two_week_high": 14.4,
    "fifty_two_week_low": 2.31,
    "percent_change_from_200_day_moving_average": 0.1855,
    "percent_change_from_50_day_moving_average": 0.2608,
    "shares_owned": "N/A",
    "short_ratio": 8.66,
    "two_hundred_day_moving_average": 10.93,
    "volume": 2682574.0,
    "market_cap": 1700000000.0,
    "price_to_sales_ttm": 1068.71,
    "price_to_book_mrq": 14.67,
    "roa_ttm": -0.8012999999999999,
    "roe_ttm": -1.4706000000000001,
    "shares_outstanding": 130850000.0,
    "pcnt_held_by_insiders": 0.0297,
    "pcnt_held_by_institutions": 0.555,
    "pcnt_short_of_float": 0.3233,
    "operating_cash_flow_ttm": -41770000.0,
    "levered_cash_flow_ttm": -65800000.0,
    "book_value_per_share_mrq": 0.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ZIOPHARM Oncology, Inc."
  },
  "ZLTQ": {
    "p_e_ratio": 267.6,
    "peg_ratio": 24.83,
    "earnings_per_share": 0.13,
    "ebitda": 8480000.0,
    "eps_estimate_current_year": 0.05,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 34.71,
    "fifty_two_week_high": 38.49,
    "fifty_two_week_low": 20.54,
    "percent_change_from_200_day_moving_average": 0.09,
    "percent_change_from_50_day_moving_average": -0.0054,
    "shares_owned": "N/A",
    "short_ratio": 8.52,
    "two_hundred_day_moving_average": 31.67,
    "volume": 981286.0,
    "market_cap": 1340000000.0,
    "price_to_sales_ttm": 6.44,
    "price_to_book_mrq": 18.4,
    "roa_ttm": 0.0397,
    "roe_ttm": 0.0761,
    "shares_outstanding": 38760000.0,
    "pcnt_held_by_insiders": 0.2808,
    "pcnt_held_by_institutions": 0.703,
    "pcnt_short_of_float": 0.18,
    "operating_cash_flow_ttm": 16700000.0,
    "levered_cash_flow_ttm": 12520000.0,
    "book_value_per_share_mrq": 1.92,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ZELTIQ Aesthetics, Inc."
  },
  "ZSAN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.51,
    "ebitda": -14710000.0,
    "eps_estimate_current_year": -2.36,
    "eps_estimate_next_quarter": -0.64,
    "fifty_day_moving_average": 8.08,
    "fifty_two_week_high": 12.4,
    "fifty_two_week_low": 7.01,
    "percent_change_from_200_day_moving_average": -0.1124,
    "percent_change_from_50_day_moving_average": -0.0356,
    "shares_owned": "N/A",
    "short_ratio": 14.12,
    "two_hundred_day_moving_average": 8.78,
    "volume": 20880.0,
    "market_cap": 93210000.0,
    "price_to_sales_ttm": 86.74,
    "price_to_book_mrq": 2.18,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11970000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0176,
    "operating_cash_flow_ttm": -15960000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Zosano Pharma Corporation"
  },
  "ZSPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.17,
    "ebitda": -82680000.0,
    "eps_estimate_current_year": -4.44,
    "eps_estimate_next_quarter": -1.13,
    "fifty_day_moving_average": 59.04,
    "fifty_two_week_high": 84.85,
    "fifty_two_week_low": 31.07,
    "percent_change_from_200_day_moving_average": 0.36310000000000003,
    "percent_change_from_50_day_moving_average": 0.22769999999999999,
    "shares_owned": "N/A",
    "short_ratio": 6.93,
    "two_hundred_day_moving_average": 53.18,
    "volume": 204605.0,
    "market_cap": 1820000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.86,
    "roa_ttm": -0.2696,
    "roe_ttm": -0.5134000000000001,
    "shares_outstanding": 25120000.0,
    "pcnt_held_by_insiders": 0.1741,
    "pcnt_held_by_institutions": 0.10300000000000001,
    "pcnt_short_of_float": 0.2137,
    "operating_cash_flow_ttm": -72280000.0,
    "levered_cash_flow_ttm": -41550000.0,
    "book_value_per_share_mrq": 9.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "ZS Pharma, Inc."
  },
  "ZYNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.36,
    "ebitda": -7030000.0,
    "eps_estimate_current_year": -1.66,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 18.62,
    "fifty_two_week_low": 17.7,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.29,
    "two_hundred_day_moving_average": 0.0,
    "volume": 36651.0,
    "market_cap": 162280000.0,
    "price_to_sales_ttm": 249.44,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 8730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.010700000000000001,
    "operating_cash_flow_ttm": -6380000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -5.5,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Zynerba Pharmaceuticals, Inc."
  }
}